## Introduction to Proteomics

Sudhir Awasthi

<!-- image -->

## Introduction to Proteomics

## INTRODUCTION TO PROTEOMICS

Sudhir Awasthi

<!-- image -->

## Introduction to Proteomics

Sudhir Awasthi

## Arcler Press

224 Shoreacres Road

Burlington, ON L7L 2H2

Canada

www.arclerpress.com

Email: orders@arclereducation.com

e-book Edition 2023

ISBN: 978-1-77469-624-8 (e-book)

This  book  contains  information  obtained  from  highly  regarded  resources.  Reprinted  material sources are indicated and copyright remains with the original owners. Copyright for images and other graphics remains with the original owners as indicated. A Wide variety of references are listed. Reasonable efforts have been made to publish reliable data. Authors or Editors or Publishers are not responsible for the accuracy of the information in the published chapters or consequences of their use. The publisher assumes no responsibility for any damage or grievance to the persons or property arising out of the use of any materials, instructions, methods or thoughts in the book. The authors or editors and the publisher have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission has not been obtained. If any copyright holder has not been acknowledged, please write to us so we may rectify.

Notice : Registered trademark of products or corporate names are used only for explanation and identification without intent of infringement.

## Â© 2023 Arcler Press

ISBN: 978-1-77469-509-8 (Hardcover)

Arcler  Press  publishes  wide  variety  of  books  and  eBooks.  For  more  information  about Arcler Press and its products, visit our website at www.arclerpress.com

## ABOUT THE AUTHOR

<!-- image -->

Prof. Sudhir K. Awasthi did his M.Sc in Life Sciences securing first position in CSJM University,  Kanpur.  Thereafter  he  completed  his  PhD  in  the  same  discipline  from CSJM University, Kanpur and joined the faculty of Life Sciences as Asstt. Professor in 1991. He became Professor in 2008 &amp; presently working as Pro- Vice Chancellor &amp; Dean , Faculty Life Sciences in this university . He is also holding the post of Director ,  Deendayal  Shodh  Kendra  of  the  University  campus  from  past  one  year  he  is  also occupying the post of Co-ordinator, Recruitment &amp; Assessment Cell (RAC) responsible for  the  recruitment  &amp;  assessment  of  university  faculty  members.  Prof. Awasthi  has more than 30 years of teaching &amp; research experience. His area of research has been Immuno-toxicology &amp; Environmental Biochemistry. He has been widely recognized as one of those few researchers who did excellent work in the field of Mycobacterial Dormancy &amp; the role of Heat Shock Proteins / Chaperons in its granuloma state. He has published more than 40 research papers &amp; completed two research projects funded by DST &amp; UPCST respectively. He is Principle Investigator of Centre of Excellence Project for Department of Life Sciences funded by UP Council of Higher Education. He is reckoned as prolific orator &amp; popular article writer in different domains of knowledge related to higher education. He has been successful in advocating the importance of traditional Indian Knowledge System which is being re- explored in present context. He has participated in several conferences as Lead Speaker &amp; Chaired the session in numerous seminars &amp; symposia.

TABLE OF CONTENTS

| List of Tables ........................................................................................................xv   | List of Figures  ........................................................................................................xi                                          |
|-----------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                             | Preface........................................................................ .................................. ....xvii                                          |
|                                                                                                                             | 1.1 Introduction  ......................................................................................... 2                                                        |
|                                                                                                                             | 1.2 Proteins that Perform Particular Functions ............................................ 7                                                                        |
|                                                                                                                             | 1.3 Pregenomic Proteomics ....................................................................... 8                                                                  |
|                                                                                                                             | 1.4 Genetics of Proteins  ........................................................................... 10                                                             |
|                                                                                                                             | 1.5 One Gene-Many Protein: Challenge to Proteomics  ............................ 17                                                                                  |
|                                                                                                                             | 1.6 RNA Silencing and Proteomics .......................................................... 23                                                                       |
|                                                                                                                             | 1.7 Molecular Biology of Genes and Proteins .......................................... 25                                                                            |
|                                                                                                                             | 1.8 Protein Chemistry Before Proteomics  ................................................. 30                                                                        |
|                                                                                                                             | 1.9 Unstructured Protein  .......................................................................... 42                                                              |
|                                                                                                                             | 1.10 Protein Misfolding and Human Disease  ........................................... 44                                                                            |
|                                                                                                                             | References  ............................................................................................... 47                                                       |
| Chapter 2                                                                                                                   | Proteomics-Relation to Genomics  ......................................................... 59                                                                        |
| Chapter 2                                                                                                                   | 2.1 Introduction  ....................................................................................... 60                                                         |
| Chapter 2                                                                                                                   | 2.2 Genomics .......................................................................................... 60                                                           |
| Chapter 2                                                                                                                   | References  ............................................................................................... 80                                                       |
| Chapter 3                                                                                                                   | Methodology for Separation and Identification of Proteins   and Their Interactions  ............................................................................. 87 |
| Chapter 3                                                                                                                   | 3.1 Introduction  ....................................................................................... 88                                                         |
| Chapter 3                                                                                                                   | 3.2 Separation of Protein Via the Multidimensional Approach  .................. 88                                                                                   |
| Chapter 3                                                                                                                   | 3.3 Determination of the Primary Structure of Proteins ............................ 94                                                                               |
| Chapter 3                                                                                                                   | 3.4 Determination of the 3D Structure of a Protein ................................ 103                                                                              |
| Chapter 3                                                                                                                   | 3.5 Determination of the Number of Proteins ........................................ 108                                                                             |

|           | 3.6 Structural and Functional Proteomics  ............................................... 113                                                    |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------|
|           | References  ............................................................................................. 119                                    |
| Chapter 4 | Principles of Liquid Chromatography In Proteomics ............................. 129                                                              |
|           | 4.1 Introduction  ..................................................................................... 130                                      |
|           | 4.2 General Chromatographic Principles for Peptide   and Protein Segregation ............................................................... 130 |
|           | 4.3 Affinity Chromatography  .................................................................. 133                                              |
|           | 4.4 Ion Exchange Chromatography ........................................................ 134                                                     |
|           | 4.5 Reversed-Phase Chromatography  ..................................................... 135                                                     |
|           | 4.6 Size Exclusion Chromatography  ....................................................... 138                                                   |
|           | 4.7 Multidimensional Liquid Chromatography  ....................................... 139                                                          |
|           | References  ............................................................................................. 143                                    |
| Chapter 5 | Proteomics of Protein Modifications ..................................................... 147                                                    |
|           | 5.1 Introduction  ..................................................................................... 148                                      |
|           | 5.2 Phosphorylation and Phosphoproteomics ........................................ 149                                                           |
|           | 5.3 Glycosylation and Glycosylation ..................................................... 153                                                    |
|           | 5.4 Ubiquitination and Ubiquitinomics ................................................. 158                                                      |
|           | 5.5 Miscellaneous Modifications of Proteins  .......................................... 161                                                      |
|           | References  ............................................................................................. 164                                    |
| Chapter 6 | Proteomics of Protein-Protein Interactomes ......................................... 169                                                         |
|           | 6.1 Introduction  ..................................................................................... 170                                      |
|           | 6.2 Protein-Protein Interactions  In Vivo ................................................. 171                                                  |
|           | 6.3 Analysis of Protein Interaction  In Vitro ............................................ 175                                                   |
|           | 6.4 Analysis of Protein Interactions In Silico  ........................................... 180                                                  |
|           | 6.5 Interactomes  .................................................................................... 182                                       |
|           | 6.6 Evolution and Conservation of Interactions ...................................... 190                                                        |
|           | 6.7 Interaction of Proteins with Small Molecules ................................... 191                                                         |
|           | References  ............................................................................................. 192                                    |
| Chapter 7 | Applications of Proteomics ................................................................... 199                                               |
|           | 7.1 Introduction  ..................................................................................... 200                                      |
|           | 7.2 Diseasome  ....................................................................................... 201                                       |
|           | 7.3 Medical Proteomics  ......................................................................... 202                                            |
|           | 7.4 Clinical Proteomics  .......................................................................... 207                                          |

|           | 7.5 Metaproteomics and Human Health ................................................ 211 References  ............................................................................................. 214   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Chapter 8 | Developments in Proteomics  ................................................................. 219                                                                                                        |
|           | 8.1 Introduction  ..................................................................................... 220                                                                                              |
|           | 8.2 Technical Scope of Proteomics  ......................................................... 220                                                                                                         |
|           | 8.3 Scientific Scope of Proteomics  ......................................................... 222                                                                                                        |
|           | 8.4 Medical Scope of Proteomics  ........................................................... 224                                                                                                         |
|           | 8.5 Proteomics, Energy Production, and Bioremediation  ........................ 230                                                                                                                      |
|           | 8.6 Proteomics and Biodefense  .............................................................. 230                                                                                                        |
|           | References  ............................................................................................. 232                                                                                            |
|           | Index  ..................................................................................................... 237                                                                                         |

## LIST OF FIGURES

- Figure 1.1. Fundamental Proteomics Workflow
- Figure 1.2 . Proteomics kinds and its biological applications
- Figure 1.3. Phosphorylation may make a protein inactive or active.
- Figure 1.4. Metabolomics Schema
- Figure 1.5. The Process of Protein Synthesis.

Figure 1.6. The N-terminal amino acid pattern of the beta chain of sickle and normal cell hemoglobin was compared.

Figure 1.7. Outcomes of a phenylalanine-tyrosine metabolic bottleneck in phenylketonuric newborns, a faulty phenylalanine hydroxylase may cause a buildup of phenylalanine, that may damage brain cells and cause mental disabilities. Alkaptonuria is caused by a metabolic obstruction induced by a faulty enzyme.

Figure 1.8. Colinearity of Gene and Protein

Figure 1.9. Sequence similarity between protein and DNA. The X indicates the mutation location in the gene or DNA as determined by recombinational analysis. The O indicates the location of changed amino acids within the gene-encoded protein. Vertical lines link the locations of mutations in the protein and gene to illustrate their exact relationship.

Figure 1.10. Protein structure with various degrees of order. Darryl Leza of NIHGR/ NIH granted permission for this reproduction.

Figure 1.11. A diagram depicting the RNA splicing procedure.

- Figure 1.12. Intron deletion from a transcript.
- Figure 1.13. RNA editing is depicted graphically.
- Figure 1.14. RNA Silencing is depicted graphically.

Figure 1.15. DNA commands are converted into messenger RNA. Ribosomes can read the genetic data encoding a strand of mRNA and utilize it to link amino acids together to produce a protein.

Figure 1.16. Various sorts of transcript splicing.

Figure 1.17 Protein separation represented graphically

Figure 1.18. Chemical Synthesis of Proteins

Figure 1.19. Protein Engineering Cycle

Figure 1.20. The active site's function in the lock-and-key fit of a substrate (the key) to an enzyme (the lock)

| Figure 1.21.  Protein targeting                                                                                                                                                                                                                   |                                                                                  |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------|
| Figure 1.22.  A summary of Intein                                                                                                                                                                                                                 |                                                                                  |
| Figure 1.23.  Induced folding of intrinsically disordered proteins                                                                                                                                                                                |                                                                                  |
| Figure 1.24.  Protein Misfolding                                                                                                                                                                                                                  |                                                                                  |
| Figure 2.1.  The caterpillar and butterfly exemplify the differences in proteomics at two  different stages in the life cycle of an insect.                                                                                                       |                                                                                  |
| Figure 2.2.  Graphical representation of genomics and its applications                                                                                                                                                                            |                                                                                  |
| Figure  2.3.   This  illustration  depicts  the  shotgun  reading  technique,  which  involves                                                                                                                                                    |                                                                                  |
| copying, breaking, scanning, and computer analysis of DNA to determine the initial  genetic sequence.                                                                                                                                             |                                                                                  |
| Figure 2.4.  Clone and sequencing cover ranges.                                                                                                                                                                                                   |                                                                                  |
| Figure 2.5.  A general method for the cloning of a gene.                                                                                                                                                                                          |                                                                                  |
| Figure  2.7. Functional,  structural,  and  comparative  genomics  techniques  are  all  interconnected                                                                                                                                           |                                                                                  |
| Figure  2.8. Comparative  genomics  may  aid  in  the  prediction  of  unidentified  physiological and metabolic genes' activity-here shown for venomics.                                                                                         |                                                                                  |
| Figure 2.9.  Functional Genome Illustration                                                                                                                                                                                                       |                                                                                  |
| Figure 3.1.  Basic Electrophoresis Principle                                                                                                                                                                                                      |                                                                                  |
| Figure 3.2.  depicts the stages of Edman's degradation. Without hydrolyzing the rest of  the peptide, the tagged aminoterminal residue (PTH - alanine in round one) is liberated.  Repeating the cycle reveals the entire pattern of the peptide. |                                                                                  |
| Figure 3.3.  Typical route stream in liquid chromatography                                                                                                                                                                                        |                                                                                  |
| Figure 3.4.  Gel filtering is used to separate molecules of various sizes.                                                                                                                                                                        |                                                                                  |
| Figure 3.5.  Ion-exchange chromatography diagrammatic representation                                                                                                                                                                              |                                                                                  |
| Figure 3.6.  Edman degradation, invented by Pehr Edman, may be used to determine the  order of amino acids in the protein or peptide.                                                                                                             |                                                                                  |
| Figure 3.7.  Protocol for mass spectrometry                                                                                                                                                                                                       |                                                                                  |
| Figure 3.8.  Mass Spectrometry Theory                                                                                                                                                                                                             |                                                                                  |
| Figure 3.9.  Different processes in top-down and bottom-up proteomics are shown.                                                                                                                                                                  | Figure 3.9.  Different processes in top-down and bottom-up proteomics are shown. |
| Figure 3.10.   demonstrates  that  protein  structure,  amino  acid  makeup,  and  sequence  influence proteome susceptibility to oxidation-induced degradation.                                                                                  |                                                                                  |
| . X-ray crystallography process for molecular structural characterization.                                                                                                                                                                        |                                                                                  |
| Figure 3.11                                                                                                                                                                                                                                       |                                                                                  |
| Figure 3.12.  Graphic depiction of the dispersion of neutrons as they strike an object.                                                                                                                                                           |                                                                                  |
| Figure 3.13 . Nuclear Magnetic Resonance (NMR) Spectroscopy Theory                                                                                                                                                                                |                                                                                  |
| Figure 3.14.  General-workflow-for-quantitative-mass-spectrometry-based-                                                                                                                                                                          |                                                                                  |

translational-neuroproteomics

Figure 3.15. Protein-microarrays-a-Functional-protein-microarrays-for-studyingproteins

Figure 4.1. A summary of gel-free and gel-based proteomics experimental processes.

Figure 4.2. Enzymatic digestion is used in both gel-free and gel-based experimental setups.

Figure 4.3. Protein separation and specimen preparation are detailed in this LC-based proteomics method.

Figure 4.4 . Chromatograms displaying the outcomes of protein mixture separations via ion-exchange chromatography

Figure 4.5. On reversed-phase resins, certain frequently utilized n-alkyl hydrocarbon ligands

Figure  4.6. Schematic  of  hydrophobic  interaction  chromatography  that  responds  to temperature

- Figure 4.7. Peptide separation using discontinuous multidimensional chromatography
- Figure 5.1. Strategies for Post-Translational Modifications (PTMs)
- Figure 5.2. Protein Phosphorylation as well as Phosphoproteome
- Figure 5.3. Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers

Figure 5.4. The two primary kinds of protein glycosylation are shown in Figure 5.4. Attaching  sugar  moieties  to  protein  is  a  post-translational  alteration  that  gives  the proteins more proteome variety.

Figure  5.5. Glycans  are  ubiquitous.  High-throughput  glycoproteomics  techniques provide information

- Figure 5.6. Brief-Introduction-to-Ubiquitin-and-Protein-Ubiquitination
- Figure 5.7 . Modification sites on ubiquitin
- Figure 5.8. Proteolysis is the breakdown of proteins into smaller polypeptides or amino acids
- Figure 6.1. Functional test of the two gal4p domains separately.
- Figure 6.2. The yeast two-hybrid system involves two Yep plasmids
- Figure 6.3 Graphical illustration of the yeast two-hybrid system.
- Figure 6.4. Visualization of Phage Display
- Figure 6.5. Protein-Protein Interactions

Figure 6.6. Protein-microarrays-a-Functional-protein-microarrays-for-studyingproteins

Figure 6.7. Ability To visualize of Protein-Protein Interactions

Figure 6.8. 3-D illustration of the Interactome

- Figure 6.9. Cytoscape depiction of yeast protein-protein contact networks
- Figure 7.1. Applications of Proteomics
- Figure 7.2 Proteomics' Part in the Growth of Personalized Cancer Medicine.
- Figure 7.3. Fluids in the Body
- Figure 7.4. Hepatocytes' secretory protein processing
- Figure 7.5. Human Brain Structure
- Figure 7.6. Proteomics of the Human Heart
- Figure 7.7. The PEA-NGS method's principle and cohort descriptions
- Figure 7.8. Human gut metaproteomic and its applications
- Figure 8.1. Types-of-proteomics-and-their-applications-to-biology
- Figure 8.2. Genes, proteins, and molecular machinery
- Figure 8.3. An overview of how proteomics methods are used in One Health.
- Figure 8.4. Schematic displaying the prevalent NCDs in the body.
- Figure 8.5. Drug Discovery Steps
- Figure 8.6. Integrated-proteomic-and-metabolomic-analysis 4-h and 24-h post-IRI-A Metabolites.

## LIST OF TABLES

- Table 1.1. The function of different proteins.
- Table 2.1. Genomes of different organisms
- Table 3.1. Molecular weights of amino acids in peptides.
- Table 4.1. Functional groups utilized on ion exchangers

## PREFACE

With  the  previous  decade,  a  technological  revolution  culminated  in  the  sequencing of the human genome and the beginning of the postgenomic era. In the early 1990s, Marc  Williams  and  his  colleagues  created  the  phrases  proteomics  and  proteome, which have subsequently been used by the research community at large. The proteome is  the  collection  of  all  proteins  encoded  by  the  genome.  Historically,  biochemical investigations  of  protein  function  have  concentrated  on  analyzing  single  molecular species.  The  fast  identification  of  novel  gene  products  through  large-scale  genomic and proteomic programs has forced the development of alternate methods for assessing protein activity. In recent years, the goal has been to create high-throughput methods to permit systematic protein analysis in biological samples, to map functional connections between proteins on a global scale, and to position them in a biological context.

This book introduces the emerging topic of proteomics. It aims to describe how proteins and proteomes may be researched and assessed. In spite of the increased interest in proteomics, the scientific community as a whole is only slowly gaining knowledge of proteomics methods and technology. This book tackles the need to introduce biologists to new tools and methods and is intended for both biology students and experienced biologists in practice. This book should provide anyone who has attended a graduatelevel biochemistry course with a reasonable knowledge of what proteomics is and how it  is  conducted.  Much  of  this  should  be  recognizable  to  the  seasoned  biologist,  but refocused to assist proteome research.

Long-sought  benchmarks  in  genome  sequencing,  analytical  apparatus,  computing power, and user-friendly software tools have fundamentally altered the profession of biology. After years of researching the separate components of biological systems, it is now possible to examine the systems as a whole in molecular detail. We must thus efficiently deploy new technology, cope with mounds of data, and, most importantly, adapt  our  thinking  to  comprehend  complex  systems  as  opposed  to  their  component parts.

The book is divided into eight chapters. The first chapter introduces the readers to the fundamentals of Proteomics. Chapter 2 deals with the discussion of proteomics with respect to genome and genomics. Chapter 3 thoroughly discusses the methodology for the separation and identification of proteins and their interactions.

Chapter 4 introduces the readers to information on chromatography and its application in protein studies. Chapter 5 focuses on proteomics of protein modifications. Chapter 6  illustrates  the  phenomena  of  proteomics  in  protein-protein  interactions.  Chapter  7 describes the modern applications of proteomics in various fields. Finally, chapter 8 focuses on the recent developments in the field of proteomics and protein studies.

The book provides an excellent overview of the many facets of the proteome. The text succeeds in presenting the information in a manner that familiarizes the inexperienced reader with the important concepts and tools of proteomic. Introduction to Proteomics is equally beneficial for students of physics and other multidisciplinary fields.

-Author

<!-- image -->

## FUNDAMENTALS OF PROTEOMICS

## CONTENTS

| 1.1 Introduction  ......................................................................................... 2   |
|-----------------------------------------------------------------------------------------------------------------|
| 1.2 Proteins that Perform Particular Functions ............................................ 7                   |
| 1.3 Pregenomic Proteomics ....................................................................... 8             |
| 1.4 Genetics of Proteins  ........................................................................... 10        |
| 1.5 One Gene-Many Protein: Challenge to Proteomics  ............................ 17                             |
| 1.6 RNA Silencing and Proteomics .......................................................... 23                  |
| 1.7 Molecular Biology of Genes and Proteins .......................................... 25                       |
| 1.8 Protein Chemistry Before Proteomics  ................................................. 30                   |
| 1.9 Unstructured Protein  .......................................................................... 42         |
| 1.10 Protein Misfolding and Human Disease  ........................................... 44                       |
| References  ............................................................................................... 47  |

## 1.1 INTRODUCTION

The  word  'proteome'  is  derived  from  the  terms  genome  and  protein.  It reflects the whole assortment of proteins encoded by an organism's DNA. Thus, proteomics is expressed as the total protein composition of an organism or a cell.  Proteomics is the study of the function, structure, and relationships of  an  organism's  complete  protein  composition.  Proteins  regulate  the phenotypic  of  a  cell  by  defining  its  structure  and,  more  importantly,  by performing all cellular activities. Diseases are mostly caused by defective proteins, which serve as important markers for the identification of a specific disease. Proteins are the basic targets of the majority of pharmaceuticals and serve as the basic foundation for the creation of novel medications. Thus, the research of proteomics is essential to comprehend their involvement in the etiology and management of illnesses, and also in the growth of children and other species (Alsagaby, 2019).

Although RNA is used by some viruses, DNA has served as the medium for  the  transmission of proteins in the vast majority of organisms. DNA, apart from RNA viruses, has been transcribed into RNA, which has been then  always  translated  into  a  protein.  RNA  viruses  are  an  exception  to this rule (Arruda et al., 2011; Xia, 2018). When it comes to RNA viruses, RNA undergoes direct translation into proteins. At one point in time, it was thought that a single gene would generate a single enzyme, which would then regulate a phenotypic trait. The discovery that eukaryotic genes are split into two parts, which results in RNA splicing, the possibility of RNA editing, and the phenomenon of RNA silencing, has caused substantial alterations in this perspective over the last few decades. The fragmented nature of genes, RNA splicing, RNA silencing, and RNA editing are all topics that are going to be discussed later on in this section (Bousquet et al., 2011).

In eukaryotes, noncoding regions of nucleotides known as introns disrupt the coding patterns of a gene known as exons (Zhang et al.,2008). Upon elimination of introns, exons have been spliced either consistently (known as  cis  splicing)  or  intermittently  (known  as  alternative  splicing)  inside  a gene, or between exons of other genes (trans-splicing). Protein abundance in eukaryotic organisms is a result of the many types of exon splicing and post-translational modifications of proteins. There have been around 23,000 genes and over 500,000 proteins in humans (Barlow et al., 2008; Bonetta&amp; Valentino, 2020).

Figure 1.1. Fundamental Proteomics Workflow.

<!-- image -->

Source: https://health.usf.edu/medicine/corefacilities/proteomics/introduction

The finding  that  each  gene  encodes  for  a  single  enzyme  may  appear to  conflict  with  recent  findings  on  the  existence  of  suppressor  genes  and the  division  of  genes.  It  was  not  until  the  establishment  of  fundamental dogma in biology (Crick, 1958, 1970, Watson 1965, Mattick 2003, Lewin 2004) and the deciphering of the genetic code (Leder and Nirenberg 1964, Khorana  1968)  that  it  became  apparent  how  suppressor  genes  carry  out their functions. Therefore, the method of action of suppressor genes does not  in  any  way  contradict  the  essential  assumptions  suggested  in  Beadle and Tatum's one-gene-one-enzyme model.   It is understandable, given the fundamental dogma, that certain genes or parts of DNA can code for a variety of  proteins,  or  that  the  coding  region  of  the  protein  in  DNA  is  scattered throughout a large area of DNA and is broken up by noncoding sequences.  It is already common knowledge that the concept of 'one-gene-one-enzyme' relates exclusively to genes that code for a single polypeptide and does not apply to genes that have a split nature and are capable of producing several proteins.  Therefore,  the  assumption  that  one  gene  encodes  for  only  one enzyme is restricted to the nature of genes, just as the Mendelian principles of inheritance only apply to genes that are placed in the nucleus of the cell and do not apply to genes that are located in any other portion of the cell (Watson et al., 2005; Huberts&amp; van der Klei, 2010). Therefore, Mendelian inheritance relates to the arrangement of the genes, whereas the assumption that 'one-gene-one-enzyme' is limited to the type of gene.

What Tatum and Beadle proposed is a rule, not an axiom, and certain circumstances  are  just  exceptions  to  their  deep  rule.  Nature,  it  appears, follows the British dictum that 'exceptions establish the rule.' Exceptions

abound in the history  of  science. The  basic  dogma  in  molecular  biology stated  by  Francis  Crick,  the  co-discoverer  of  the  DNA  structure,  is  the most obvious case of such an exception. Crick (1958, 1970) hypothesized that sequential data in DNA is transmitted to RNA, which is subsequently transferred to protein , and that the direction of this data transmission is fixed. Moreover, it was later discovered that RNA is reverse transcribed into DNA and that messenger RNA (mRNA) is sometimes edited before translation into protein by adding or removing cytidine or uridine, implying that data in a DNA fragment has not been translated directly into protein as implied by central dogma. This theory proposes that DNA produces RNA, which then produces protein. The Nobel Prize was awarded to Howard Temin and David Baltimore in  1975  for  proving  the  reverse  transfer  of  information from RNA to DNA. The enzymes are another obvious instance of such an exception. The discovery that enzymes are proteins was made by Cornell University's James Sumner. Soon after, Sydney Altman of Yale University and Thomas Cech of the University of Colorado separately demonstrated that  some  enzymes  are  comprised  of  RNA  rather  than  proteins.  Sumner received  the  Nobel  Prize  in  1946,  while Altman  and  Cech  received  it  in 1989 for their work in chemistry. As a result, it appears that biology, like any other discipline of study, is full of exceptions to the laws (Nabieva et al., 2005; Lee et al., 2007).

Berzelius (1838)1, a Swedish chemist, classified several naturally present polymers proteins. Sumner stated the fact that enzymes are proteins (1946). Proteins  are  formed  up  of  patterns  of  amino  acids,  according  to  Sanger (1958). Linus Pauling showed in the 1940s that a substrate and an enzyme (or an antibody and an antigen) must have a perfect complementary fit in their structures to interact with each other, similar to a hand in a glove. Aside from Sumner (1946), both Sanger (1958) and Pauling (1954) were awarded Nobel Prizes for their works in chemistry. Although most proteins serve as enzymes, some, like fibronectin and actin, serve as structural elements of cells. Muscle, bones, and cartilage are all made up of proteins. Proteins are also essential for muscle cell motility. Proteins can act in a variety of ways, such  as  receptors  for  other  molecules,  as  immunoglobulins  or  antigens, as  allergens,  or  as  components  in  the  transport  of  other  substances,  such as oxygen or sex hormones. All of these roles can be played by proteins. Several  proteins  are  hormones  that  control  critical  metabolic  functions in  humans  and  other  creatures,  like  insulin  and  human  growth  hormone (HGH). Proteins' 3-dimensional structure and chemical changes are critical

to understanding their functioning in many capacities (Thomas et al., 2003; Jiang et al., 2007).

Figure 1.2. Proteomics kinds and its biological applications.

<!-- image -->

Source: https://pharmaceuticalintelligence.com/2014/11/07/introduction-toproteomics/

Gorrod  (1909)  was  the  first  to  identify  various  human  problems  as inborn metabolic defects, implying a genetic foundation for such illnesses. However, it was the brilliance of  Tatum and Beadle (1941) that resulted in the discovery that a gene encodes a protein. They demonstrated that a mutant's synthesis of a component in a metabolic pathway was hampered by working with Neurospora. They demonstrated that when a gene directing an enzyme that catalyzes a biochemical step in a metabolic pathway was disabled, the mutant  acquired  dietary  needs  for  such  substance.  These  mutants  might not  grow  on  a  minimum  media,  but  only  when  a  specific  chemical  was introduced to the minimal medium did they grow. A mutant having impaired arginine  production,  for  instance,  might  not  grow  on  a  minimal  medium and might only grow when arginine was given to the minimal medium. The biochemical pathways were also mapped using this method (Schlessinger et al., 2007; Hinman&amp; Lou, 2008).

Tatum and Beadle (1941) referred to this theory as the 'one gene-one enzyme hypothesis.' This concept has been reworked in several different ways. Nevertheless, the one-gene-one-enzyme concept has maintained the cornerstone of the biological discipline despite several notable outliers. This strategy was essential in bringing chemistry and genetics closer together,

which  was  a  prerequisite  for  the  development  of  molecular  biology. Producing a mutant and demonstrating which protein lacks a function or which function is hindered in a specific protein is the standard method for assigning a function to a protein. Because of this theory, it was feasible to do study and analysis on the genetics of viruses, plants, microbes, and animals. The development of knockout mutations and mutagenesis in vitro have both been  built  on  top  of  this  basis.  This  theory  has  shown  to  be  a  vital  tool for studying any fundamental genetic mechanism, such as recombination, repairing, and replication of DNA, as well as for determining the role that a protein plays in any metabolic pathway. In the end, Beadle and Tatum's concept was responsible for breakthroughs made in the fields of agriculture , medicine, and pharmaceutical sciences. The one-gene-one-enzyme hypothesis is significant in the research and treatment of human diseases, as well as the development of gene therapy. This theory also served as the basis for the theory (Alberts et al., 2002; Ajit Tamadaddi &amp;Sahi, 2016).

According  to  the  one-gene-one-enzyme  concept,  a  mutation  should have changed the protein. Due to a lack of available technology at the time, Tatum and Beadle were unable to illustrate the faulty character of the mutant protein. Yanofsky(1952, 2005a,b) and Lein and Mitchell (1948, Mitchell, et  al.  1948)  first  proved  this  at  the  biochemical  level  using  mutants  of Neurospora lacking the enzyme essential for tryptophan production. This hypothesis was demonstrated previously at the molecular level by Ingram (1957) in the example of sickle cell anemia patients' hemoglobin. Ingram demonstrated that the 6th amino acid 'glutamic acid,' which is present in the hemoglobin molecule of a healthy individual, is replaced by valine in a patient's hemoglobin molecule. This single shift from glutamic acid to valine is the cause of sickle cell blood diseases. Subsequently, it was discovered that other additional mutants lacked proteins entirely or possessed proteins with changed amino acid sequences.

There is a correlation between the ordered location of nucleotides in a gene and the organized position of amino acids in the protein that is made by that gene, which is another thing that is represented by the one-geneone-enzyme theory. Both Yanofsky et al. (1964) and Sarabhai et al. (1964) independently demonstrated that there is a colinear relationship between the structure of a gene and that of a protein. This colinearity will be explored in further detail in the following sections (Lill, 2009).

## 1.2 PROTEINS THAT PERFORM PARTICULAR FUNCTIONS

The  proteome  is  the  total  number  of  proteins  encoded  by  an  organism's DNA. Proteomics is  the  study  of  characterizing  an  organism's  proteome classification and characteristics.

Marc Wilkins coined the phrase 'proteome' in 1994. (Wilkins 1996). O'Farrell  (1975)  and  Klose  (1976)  both  attempted  to  characterize  the total  proteins  of  an  organism  (1975).  By  performing  gel  electrophoresis of proteins in 2 planes at right angles to one another, they invented twodimensional gel electrophoresis (O'Farrell 1975, Klose 1975). On the gel, our approach sorted a complicated mixture of greater than 1100 Escherichia coli proteins into discrete bands of individual elements. Subsequently, the application  of  mass  spectrometry  in  combination  with  genomics  for  the large-scale identification and isolation of proteins transformed the field of proteomics.

Figure 1.3. Phosphorylation may make a protein inactive or active.

<!-- image -->

Source: Seok S-H. Structural Insights into Protein Regulation by Phosphorylation and Substrate Recognition of Protein Kinases/Phosphatases. Life. 2021; 11(9):957. https://doi.org/10.3390/life11090957

An organism's genome is stable in the sense that it is identical in all types of cells at all times. The proteome of an organism, on either hand, is dynamic since it varies from one type of cell to the next and changes even within the identical type of cell at various times of development or activity. A change in the proteome reflects differences in gene activity that are reliant on the type of cell to produce the protein required for a certain function. Blood cells, for instance, mostly exhibit the hemoglobin gene, which creates the  hemoglobin  protein  essential  for  oxygen  transport,  while  pancreatic

cells primarily exhibit the insulin gene, which generates the insulin peptide needed for glucose entry into cells (Neuwald et al., 1999; Song &amp; Singh, 2009).

Since  every  protein  controls  a  particular function, variable gene expression is necessary for the creation of diverse proteins. Table 1.1 lists the  functions  of  numerous  proteins.  Furthermore,  a  cell 's  protein  profile might alter based on the numerous types of protein modifications, which may include phosphorylation, acetylation, glycosylation, or interaction with lipid or carbohydrate molecules. Protein enhancements happen as a result of  post-translational  processes  and  change  protein  function.  The  mitosis activator protein (MAP) kinase protein, for instance, controls mitosis and is phosphorylated to produce  MAP Kinase Kinase (MAPKK), MAP Kinase (MAPK),  and  MAP  Kinase  Kinasekinase  (MAPKKK).  The  significance of protein enhancement in cellular activity regulation has been examined (Pellegrini, 2003; Marschalek, 2011).

## 1.3 PREGENOMIC PROTEOMICS

Protein  functioning  as  enzymes  in  regulating  cellular  activity  was  well understood even before their structure had been discovered. The enunciation of  the  one-gene  enzyme  notion  provided  the  conceptual  insight  into interpreting the structure of a protein as a linear arrangement of amino acids. Several technological advancements enabled this conceptual breakthrough (Axe, 2004; Rittmann et al., 2008).

Figure 1.4. Metabolomics Schema.

<!-- image -->

Source: https://en.wikipedia.org/wiki/File:Metabolomics\_schema.png

The  technological  advancements  included  the  creation  of  equipment for  analyzing  the  amino  acid  content  and  determining  the  amino  acid sequence of a protein. Using such machines, the structure of proteins was determined by protein for many years. Subsequently, the development of the two-dimensional gel technique and mass spectrometry made it possible to simultaneously resolve the structures of many proteins (Shishkin et al., 2004; Paape &amp;Aebischer, 2011).

Table 1.1. The function of different proteins

| Protein                                                                                          | Function                     |
|--------------------------------------------------------------------------------------------------|------------------------------|
| Enzymes (greater than ninety percent of  proteins) Catalyze biochemical reactions in the  cell . | Catalyst                     |
| Hemoglobin (carrier of oxygen) Albumin (car- rier of hormones)                                   | Transport                    |
| Cartilage/bone proteins                                                                          | Structure                    |
| Actin, fibrinoactin                                                                              | Cellular skeleton            |
| Insulin, a growth hormone                                                                        | Hormone                      |
| Immunoglobulins                                                                                  | Antibody                     |
| Bacterial and viral proteins                                                                     | Antigens and allergens       |
| Myosin                                                                                           | Mobility/muscle movement     |
| Receptor for cholesterol                                                                         | Receptors                    |
| Transduction proteins, junction proteins                                                         | Cell communication/signaling |

With  the  advent  of  bioinformatics  and  genomics,  it  became  possible to understand the shape of multiple proteins at the same time using mass spectrometry. The nucleotide pattern of DNA/genes in the chromosomes of many creatures was decoded using genomics approaches. Bioinformatics approaches  entailed  studying  the  majority  of  an  organism's  nucleotide sequence using computers and a variety of software tools. Bioinformatics is also utilized to deduce a protein's amino acid sequence from the nucleotide sequence of a DNA molecule (D'Hooghe et al., 2004; Chen et al., 2016).

## 1.4 GENETICS OF PROTEINS

The  one-gene-one-enzyme  concept  necessitated  a  genetic  model  for understanding the function and structure  of  proteins.  This  notion  indicated  that the function and structure of proteins might be comprehended by comparing proteins derived from wild-type animals and mutant species. Understanding the  involvement  of  a  protein  in  either  metabolic  or  developmental  path is  now  standard  practice.  Following  this  rule,  the  hemoglobin  molecules of  healthy  persons  and  sickle  cell  sufferers  had  been  compared.  The  6th amino acid in normal persons' hemoglobin is distinct from that of sickle cell sufferers. Normal persons have glutamic acid at this location, while the sickle  cell  sufferer  have  valine  (Ingram  1956,  1957).  Therefore,  a  single amino acid substitution entirely transformed the function and structure of hemoglobin (Vandahl et al., 2004; Jurkiewicz et al., 2009).

Figure 1.5. The Process of Protein Synthesis.

<!-- image -->

Source:  By  Kep17  -  Own  work,  CC  BY-SA  4.0,  https://commons.wikimedia. org/w/index.php?curid=89042835 One-Gene-One-Enzyme Theory

According to the idea that was presented by Tatum and Beadle (1941), the structure of an enzyme or protein is thought to be controlled by a single gene. This idea is based on the fact that a single gene will only ever encode for a single protein. This concept proved to be useful for understanding the biology of any metabolic pathway as well as the function of proteins that were responsible for triggering the biochemical reaction at each stage of that process.

11

Figure  1.6. The  N-terminal  amino  acid  pattern  of  the  beta  chain  of  sickle and normal cell hemoglobin was compared.

<!-- image -->

Source: https://commons.wikimedia.org/wiki/File:Hbs.svg

In  the  beginning,  it  was  discovered  that  if  an  organism  is  unable  to develop  without  the  assistance  of  a  supplement,  such  as  a  nucleotide,  a specific amino acid, or a vitamin, then that organism is lacking in the protein that catalyzes the biochemical reaction that is responsible for the synthesis of that substance, which is now a nutritional necessity for its growth (Chemale et al., 2006; Li et al., 2016).

This resulted in the development of a technique for identifying mutants with a particular dietary demand and the sequence of biological processes in a metabolic path. This investigation of nutritional mutants indicated the existence of a distinct category of mutants. It had been discovered that a subset of mutants needs the amino acids ornithine, arginine, or citrulline for development. The 3rd set of mutants might only develop in the existence of arginine,  but  a  second  group  needed  either  arginine  or  citrulline  for development (Colozza et al., 2007). The nutritional needs of this last group of  mutants  were  not  addressed  by  adding  citrulline  or  ornithine  to  the development media, either alone or in combination. The dietary needs of such 3 mutant groups revealed a metabolic route for the organism's manufacture of arginine. This metabolic route consisted of biochemical processes including the sequential production of ornithine from a precursor molecule, citrulline

from ornithine,  and  arginine  from  citrulline.  Consequently,  the  following metabolic passageway was founded:

Precursor âOrnithineâCitrullineâArginine.

It  is  clear,  based  on  the  order  of  the  biochemical  activities  that  take place in this route, that the first set of mutants has a problem with the step that involves the transformation of the precursor into ornithine. As a result, this population of mutants is capable of obtaining the nutrients necessary for  development  from  either  citrulline,  ornithine,    or  arginine.  The  2nd set of mutants is deficient in the process that involves the transformation of ornithine into citrulline. As a consequence of this, the requirement for development in  this  group  of  mutants  can  potentially  be  satisfied  by  the introduction of citrulline or arginine, but not ornithine. The third group of mutants has a problem in the very last phase of the biochemical process, which is the moment in which citrulline is converted into arginine. As a consequence of this, the only way for an organism to mature is if arginine is  supplied  in  the  form  of  a  supplement.  As  a  consequence  of  this,  the idea  of  'one  gene-one  enzyme'  eventually  developed  into  a  useful  tool for  determining  the  sequential  order  of  biological  events  that  take  place along  a  certain  passageway. This  theory  also  claimed  that  if  the  enzyme that catalyzes the transition of substance A into substance B is incorrect for whatever reason, then the molecules of substance A would gather within the organism. A potential threat to the health of mutants can emerge if an excessive amount of this substance is allowed to build up in their bodies.

The buildup of phenylalanine in phenyl-ketoneurics and the buildup of homogentisic acid in newborns with alcaptonuria demonstrate this. These metabolic bottlenecks arise in the phenylalanine-tyrosine metabolic route as  a  consequence  of  certain  enzyme  abnormalities.  Gorrod  referred  to these genetic flaws as 'inherited metabolic disorders' (1909). An excess of phenylalanine can harm the brain's growth in the initial phases of growth, perhaps leading to mental impairment. In the US and other industrialized nations,  now  it  is  essential  to  test  newborns  after  delivery  for  phenylketoneuria by looking for an elevated level of phenylalanine in the blood. To control phenylalanine levels, phenyl-ketoneuric newborns are put on a particular protein -deficient diet. Such children are reintroduced to a regular diet  after  their  brain  growth  is  completed.  Therefore,  a  phenylketoneuric woman should limit her phenylalanine consumption during pregnancy for the baby's brain to develop properly (Choi et al., 1999; Hu, 2000).

By  comparing  the  biophysical  characteristics  of  the  wild-type  and mutant enzymes participating in a certain metabolic passageway, this idea was later utilized to demonstrate the identification of a specific protein and its participation in a biochemical step.

Figure 1.7. Outcomes of a phenylalanine-tyrosine metabolic bottleneck in phenylketonuric newborns, a faulty phenylalanine hydroxylase may cause a buildup of phenylalanine, that may damage brain cells and cause mental disabilities. Alkaptonuria is caused by a metabolic obstruction induced by a faulty enzyme.

<!-- image -->

Source: By Bradford Morris - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=78901270

It  was  immediately  determined  that  a  mutant  either  did  not  produce a  particular protein, produced only a portion of that protein, or produced an imperfect protein that included a particular amino acid in a particular location. The  presence  of  distinct  subtypes  of  mutant  proteins  is  directly proportional to the nature of the transformations that take place as a result of  alterations  to  the  genetic  code.  Examples  of  these  alterations  include changing  the  position  of  one  nucleotide  in  the  genetic  code  relative  to another, as well as removing or adding a nucleotide in the order of the gene's DNA. A single nucleotide can be changed within the genetic code, which can then lead to a mutation in the protein that is either missense, nonsense, or silent. In the process of converting an existing amino acid codon into a stop codon, a nonsense mutation can take place. If there is a nonsense mutation at the beginning of a gene that codes for the protein, the resulting protein

will either be a short peptide or nothing at all. Any mutation in the gene that is considered to be nonsense would produce truncated proteins of varying lengths. A protein's biochemical properties can be altered through a mutation known as missense, which involves the replacement of single amino acid with another. This can result in the protein being active or partially active. In  addition,  because  of  degeneracy  in  the  genetic  code  or  the  fact  that  a replacement amino acid cannot affect the overall function and structure of the protein, the replacement of a single nucleotide in the genetic code with another nucleotide cannot produce any change in the protein that is produced. These mutations are referred to be silent or neutral mutations. A shift in the reading of the triplet genetic code occurs when a nucleotide is deleted or inserted in the genetic code. From the point of addition or removal of the nucleotide, a frameshift mutation causes changes like all amino acids. If it happens at the start or in the center of the gene, then it causes alterations in a high number of the amino acids that are produced, which renders the protein entirely inactive. If it happens at the end of the gene, then it has no effect. Conversely, if the addition or removal of a nucleotide arises toward the end of the gene, it is feasible that the resultant amino acid changes will still leave the function of the protein unaffected. This is because the end of the gene has fewer nucleotides than the beginning. It has been discovered that all such different sorts of mutations can happen in the genome of an organism (Lee et al., 1995; Colozza et al., 2007).

According to the one-gene-one-enzyme approach, a mutant will either be deficient in a certain protein or lack that protein entirely. This had been demonstrated initially with a mutant of Neurospora that had been dependent on  tryptophan,  and  afterwards  with  analogous  mutants  of E.  coli .  At  the moment, dozens of mutants are investigated, which demonstrates the one-toone existence of a relationship between genes and proteins. Mutants usually have either no protein or a faulty protein that is devoid of enzymatic activity. Therefore,  the  one-gene-one-enzyme  theory  offers  not  only  an  important role in the understanding of the gene in the procedure of encoding a protein, but it also supplied a tool for dissecting the biochemistry of every simple to complicated procedures in the living system. This was accomplished by generating mutants and afterwards comparing the biochemical changes that have taken place in the mutant. There is not a single system that is not within the scope of this potent instrument (Kniemeyer, 2011; Muthuirulan, 2016).

## 1.4.1 Colinearity of Gene and Protein

The  one-gene-one-enzyme  idea  of  Tatum  and  Beadle  (1941)  laid  the groundwork  for  colinearity  in  the  protein  structures  and  DNA/gene  by proposing that the gene reflects a nucleotide pattern and the protein reflects the  amino  acids  sequence.  By  transfecting  bacteria  and  bacterial  viruses, Avery et al. (1944) and Hershey and Chase (1952) demonstrated that genes are composed of DNA molecules. The correspondence between the genetic maps of particular mutants and nucleotide blocks demonstrated that the gene is a pattern of nucleotides. The investigation of missense mutants of E. coli (Yanofsky et al., 1964) or nonsense mutants of a bacterial virus revealed this  colinearity  between  the  amino  acid  pattern  of  proteins  and  the  DNA sequence of genes (Sarabhai et al. 1964).

## Colinearity of Gene and Protein

Figure 1.8. Colinearity of Gene and Protein.

<!-- image -->

Source: https://slideplayer.com/slide/10600038/

The  site  of  the  modification  in  the  genetic  code  coincided  with  the position of the amino acid modification in the protein in both situations. A mutation in the initial nucleotide order of a bacterial gene for protein was discovered by Yan of Sky et al. A mutation in the gene's middle correlated to a mutation in the protein's middle amino acid position. A modification in the terminus of a gene correlated to a mutation in the location of the protein toward  the  end.  An  enzyme  that  synthesizes  tryptophan.  Sarabhai  et  al. (1964) demonstrated that a virus produces shortened viral proteins; the size of the peptides is related to the length of the gene, and sense modification ensued (Florens et al., 2002; Sun et al., 2017).

## 1.4.2 Protein as a Sequence of Amino Acids

By  deciphering  the  structure  of  insulin  polypeptide  as  a  linear  series  of various  amino  acids,  Sanger  showed  beyond  a  reasonable  doubt  that  a protein is in reality an order of amino acids (1958). As a result, insulin had been the 1st polypeptide or tiny protein to be sequenced, and Sanger did it using his method (1958). Stein and Moore (1972) were the first people to sequence a full-size protein when they did so with ribonuclease A, which was an enzyme (Biron et al., 2007; Yao et al., 2018).

sequence

<!-- image -->

Figure 1.9. Sequence similarity between protein and DNA. The X indicates the mutation location in the gene or DNA as determined by recombinational analysis. The O indicates the location of changed amino acids within the geneencoded protein. Vertical lines link the locations of mutations in the protein and gene to illustrate their exact relationship.

Source: https://www.nature.com/scitable/topicpage/what-is-a-gene-colinearity-and-transcription-430/

When  the  technology  for  cloning  a  gene  as  well  as  its  sequence analysis became accessible, although, the direct evidence that a gene is an order of nucleotides had been achieved. Before a 3-dimensional structure is established, proteins typically have four types of structure. Such distinct structures  are  referred  to  as  primary,  secondary,  tertiary,  and  quaternary structures. The main structure of proteins is the linear order of amino acids. The tertiary and secondary structures occur from the interaction between the side groups connected to the amino acids and the folding of polypeptide upon itself. Two or more completely folded polypeptides link with one another to form the quaternary structure of the proteins (Sunagar et al., 2016; Taha et al., 2020).

The one-gene-one-enzyme concept implied that the basic structure of the peptide defines the quaternary, tertiary, and secondary structure, and this had been formed by Anfinsen (1973) through a study of mutant ribonuclease and chemical change, and the renaturation and denaturation kinetics of such an enzyme (Anfinsen1973).

## 1.5 ONE GENE-MANY PROTEIN: CHALLENGE TO PROTEOMICS

The basic dogma of biology implies that genetic data flows from DNA to RNA to protein in the order of DNA-RNA Protein.

The  Tatum  and  Beadle  one-gene-one-enzyme  theory  is  expressed  as follows in this system: One DNA (Transcript or mRNA) a single protein So the protein-encoding data in bacterial genes is continuous and the transcript is immediately translatable and comparable to mRNA, this technique works well  for  them.  Furthermore,  it  had  been  quickly  discovered  that  several genes  in  eukaryotes  had  a  split  gene  structure,  with  noncoding  regions (intron) interrupting the protein-encoding sequences (exon). Because several eukaryotic genes are divided, the transcript should be processed to remove noncoding intervening  regions  (introns)  and  make  all  coding  portions  or exons continuous to produce mRNA that can be translated. Exon splicing may occur in a variety of ways, resulting in distinct types of mRNA from the same transcript (Loscalzo, 2011; Bludau&amp;Aebersold, 2020).

As  a  result  of  the  split  structure  of  eukaryotic  genes,  the  Tatum and Beadle idea of the gene-enzyme relationship must be amended, as one gene may produce several proteins, and might be described in core dogma language as

One DNAâone transcriptâseveral mRNAsâseveral proteins

It's worth noting that when it had been discovered that RNA might be reverse transcribed into DNA, the core dogma shifted. The central dogma has been renamed.

DNAâRNAâProtein, instead of DNAâRNAâProtein

between

Figure 1.10. Protein structure with various degrees of order. Darryl Leza of NIHGR/NIH granted permission for this reproduction.

<!-- image -->

Source: https://www.quora.com/What-is-the-difference-between-the-disordered-structure-of-a-protein-and-loop-structure

As a result, the core dogma is no longer an axiom, which also applies to Tatum and Beadle's one-gene-one-enzyme idea. They do embody several important  biological  principles.  Therefore,  when  new  facts  about  the nature of genes emerge, such rules must be updated to accommodate them (Chaijaroenkul et al., 2014; Makjaroen et al., 2018).

The novel concept that a single gene may encode several proteins has aided in comprehending how a human with just 23,000 genes can encode over 90,000 proteins. Humans were estimated to contain 100,000 or more genes in the pre-genomic era. The human genome project, on the other hand, revealed the existence of approximately 23,000 genes that encode proteins. This apparent contradiction is resolved by the principle that although each gene only produces a single transcript,  each  transcript  can  give  rise  to  a large number of mRNAs. These mRNAs are then translated into a variety of proteins. As a consequence of this, the 23,000 human genes may encode all

of the body's 90,000 proteins. In higher eukaryotic organisms like primates (including humans) and rodents, more than 50% of the genes encode several proteins (Lander et al. 2001). It has been hypothesized that the Drosophila DSCAM gene is responsible for the encoding of more than 38,000 different proteins.  It  is  estimated  that  there  are  approximately  500,000  different proteins present in different human cells at different stages. This increase in the number of proteins found in human cells is caused by post-translational modifications of the 90,000 proteins that are encoded by the 23,000 human genes. Furthermore, it's worth noting that nearly every gene in prokaryotes encodes only one protein (Kuhn &amp; Goebel, 2006; Matheson et al., 2015).

Over  ninety  percent  of  genes  in  lower  eukaryotic  organisms,  like filamentous or yeast fungus, encode for just one protein each. This image is completely different in higher creatures, such as humans, in which more than fifty percent of genes only encode one protein per gene while other genes encode many proteins per gene. It would appear that one gene may code for more than 3 distinct proteins in higher eukaryotic organisms on average (Neidhardt et al., 1984; Shewry et al., 2003).

## 1.5.1 RNA Splicing

A gene must first undergo transcription into a transcript or pre-mRNA before it can be used by higher organisms. To create mRNA that can be translated the latter goes through a series of further alterations known as 'processing.' There has been a minimum of three phases involved in the procedure. In the 1st phase, a cap or a new guanosine nucleotide is added at the 5'end. In the 2nd phase, a tail or poly-A nucleotides is added at the 3'end. Both of these phases are optional. The 3rd phase in the process involves removing from the transcript any intervening noncoding sequences that are known as introns. The process of RNA splicing includes the elimination of introns and the merging of exons to ensure that the various coding sequences included within  a  transcript  are  continuous  in  the  mRNA  that  has  been  produced. A combination of proteins and RNAs that is structured into an organelle known as splicosomes are responsible for carrying out the process of RNA splicing. A splicosome is comparable in size to a ribosome and serves as a  platform  for  the  joining  of  exons  and  the  elimination  of  introns.  This process  takes  place  on  the  surface  of  the  splicosome.  Several  consensus sequences, like GA at the 5'end and GU at the 3'end of the intron, are used to identify the two ends of an intron. An intron is a segment of DNA that is  located  between  2  exons.  Throughout  the  procedure  of  RNA  splicing, an  intron  will  loop  out  and  then  be  eliminated  as  a  lariat  structure.  This

structure will have a guanine nucleotide serving as the tail, which will link the adjacent exons together. Certain introns can eliminate themselves by a process known as self-splicing, which does not require a splicosome. Only in eukaryotic organisms can the pre-mRNA transcript undergo the process of RNA splicing. Furthermore, several transfer RNAs (tRNAs) can undergo splicing in both eukaryotes and prokaryotes. The splicing of these tRNAs is performed by specific enzymes and does not require splicosomes in any way (Payne et al., 1984; Garattini et al., 2003).

Figure 1.11. A diagram depicting the RNA splicing procedure.

<!-- image -->

Source: https://www.yourgenome.org/facts/what-is-rna-splicing

Pre-mRNA  in  eukaryotes  can  be  processed  in  a  range  of  methods. The multiple exons of a pre-mRNA are 1st brought together consistently by  removing  introns,  resulting  in  one  translatable  mRNA. A  pre-mRNA with 3 exons and 2 introns, for instance, would create an mRNA with all 3 exons together when the introns are removed; this mRNA would translate into a lengthy protein. Secondly, the many exons of this or comparable premRNAs can go through alternative splicing, resulting in multiple translatable mRNAs. For instance, a pre-mRNA containing 3 exons and 2 introns can perform alternative splicing, resulting in 2 distinct messages: one mRNA having one and two exons combined, as well as the other mRNA having one

and three exons together. As a result, during translation, these 2 mRNAs would  create  separate  proteins.  Exons  from  2  distinct  pre-mRNAs  can sometimes be spliced together to produce distinct mRNAs. Trans splicing is a type of splicing which includes the exons of separate pre-mRNAs (Payne, 1987; Floros&amp; Hoover, 1998).

Alternate splicing is the primary reason for the creation of several proteins from a single gene. Trans-splicing results in the production of single or more proteins from two genes. These two situations are a significant deviation from Tatum and Beadle's original one-gene-one-enzyme idea (1941). Although, it  appears  reasonable  at  the  molecular  level  as  proteins  and  enzymes  are formed up of modules transcribed by exons. Nature has created methods to bring such modules together, like alternative trans-splicing and splicing, to generate a functional protein or enzyme (Maestri et al., 2002; Emilsson et al., 2018).

Figure 1.12. Intron deletion from a transcript.

<!-- image -->

Source: ZalabÃ¡k D, Ikeda Y. First Come, First Served: Sui Generis Features of the First Intron. Plants. 2020; 9(7):911. https://doi.org/10.3390/plants9070911

## 1.5.2 RNA Editing

The  editing  of  RNA,  in  addition  to  the  splicing  of  RNA,  seems  to  be another factor, which alters the nature of proteins. By the editing of RNA, a single gene can create several functional proteins. As a result, the editing of  RNA  may  have  an  impact  on  an  organism's  proteome.  The  deletion or insertion of a cytidine or uridine nucleotide from the mRNA produces a change in the character of the codon in the mRNA before it is translated, which is known as RNA editing. The deletion or addition of a nucleotide while RNA editing is aided by an RNA termed as guide RNA (gRNA). Organellar mRNA is frequently edited. RNA can be modified in various ways besides deletion or insertion editing, like the transformation of cytidine to uridine or  the  transformation  of  adenosine  to  inosine  by  particular  deaminases. Conversion  editing  is  the  term  for  such  procedures.  When  adenosine  is transformed into inosine, it is interpreted as guanosine by the ribosome. As a result, a CAG codon for glutamine becomes CGG after inosine conversion, and it encodes for arginine rather than glutamine. Apart from tRNA, mRNA, micro RNA (miRNA), and ribosomal (rRNA) can all be edited. The editing of tRNA usually results in the reading of a stop codon into leucine (Chiti et al., 2002; Rasheed et al., 2014).

Figure 1.13. RNA editing is depicted graphically.

<!-- image -->

Source: https://www.sciencedirect.com/topics/neuroscience/rna-editing

Not only does the procedure of the editing of RNA alter the protein's nature, but it also provides a counterexample to something called the central

dogma. This is because it shows that data may be transferred directly from DNA to RNA into proteins.

RNA editing demonstrates that proteins are produced from information not  found  in  the  DNA  sequence  in  some  cases.  Lou  Gehrig  and  Human cancer  disease,  also  known  as  amyotrophic  lateral  sclerosis  (ALS),  have been linked to poor RNA editing (Begun et al., 2000).

## 1.6 RNA SILENCING AND PROTEOMICS

In  animals,  fungi,  and  plants,  a  whole  new  method  for  gene  regulation  has  been discovered in current years. This method involves triggering the breakdown of mRNA to silence a particular gene-specific signal. The expression of the resident  gene(s),    viral-induced  gene(s),  transgene(s),  and  transposons  is controlled by RNA silencing (Bishop et al., 2000). Whenever a gene for anthocyanin had been inserted to elaborate the pigment or color development in the petunia flower, this had been discovered initially. In these tests both the resident and foreign transgenes for the synthesis of color were inhibited, and the plant rather generated white flowers. Post-transcriptional gene silencing (PTGS)  had  been  coined  to  describe  this  phenomenon.  Gene  repression was later discovered in the fungus Neurospora. The insertion of an orange color gene into Neurospora led to albino or white transformants, according to the findings. Quelling is the process of silencing a gene, like a pigment synthesis gene in Neurospora. The white or albino Neurospora transformants didn't create mRNA particular for the color gene, according to the findings. The quelling of the resident gene had also been revealed to be limited to a portion of the transgenic having up to 130 nucleotides in length and not the complete color gene. Whenever a heterokaryon had been created between the transgenic and wild-type strains of Neurospora, the transgene had been observed to quell or inhibit the expression of resident genes while in another nucleus.  Subsequently,  quelling-deficient  Neurospora  mutant  strains  had been discovered; such mutants had been dubbed 'quelling deficient' (qde). In Neurospora, there have been 3 classes of these mutations. RNA-dependent RNA polymerase (RdRP) is important for the formation of double-stranded RNA dsRNA like siRNA or miRNA throughout the silencing of the gene in Neurospora.

The Sting or Piwi class of proteins, which are linked to the translational factor  eIF2C,  are  encoded  by  the  qde-2  gene.  The  Neurospora  qde3  gene  codes  for  a  WRN  (Warner's  syndrome)  protein  having  DNA or  RNase helicase functions that are comparable to RecQ DNA helicase.

Various organisms, like fission yeast, worms ( Caenorhabditis elegans ),  and Arabidopsis,  have  been  shown  to  have  counterparts  of  Neurospora  qde3, qde-2, and qde-1, genes. RdRP family proteins are identified in a variety of  plants,  such  as  wheat,  tomato,  fission  yeast,  petunia,  and C elegans . . This  protein  is  capable  of  synthesizing  a  complimentary  copy  of  geneparticular mRNA. That copy of RNA becomes a two-stranded RNA when it combines with mRNA. An enzyme known as Dicer, which is related to RNase III ribonuclease, degrades the latter into smaller RNA pieces. The RNA segments attach to an RNA-induced silencing complex (RISC) and break the mRNA specific to a gene, resulting in gene silence or suppression (Aschaffenburg, 1968; Setlow, 1988).

Figure 1.14. RNA Silencing is depicted graphically.

<!-- image -->

Source: https://viralzone.expasy.org/891?outline=all\_by\_species

Experiments  using  Drosophila  or  worms  revealed  the  importance  of dsRNA in silencing, and it has been now detected in cells of Mammalia too. The introduction of little fragments of dsRNA unique to a gene has been proven to cause the disintegration of its mRNA, resulting in the reduction of that gene's expression. As a result, RNA silencing may be utilized to modify gene expression in organisms, and it has the potential to be a powerful tool in the treatment of a variety of human disorders, such as cancer. In 2006, Mello and Fire were awarded the Nobel Prize for discovering the process of RNA interference (Fire et al. 1998). Several infectious organisms, such as trypanosomes, intestinal parasites, and viruses are called to cause havoc in  humans due to their  antigenic  differences.  Moreover,  it  has  been  now recognized  that  some  human  intestinal  parasites,  like Giardia lamblia , utilize RNA interference to sustain antigenic diversity (Prucca et al. 2008). Knowing  this  mechanism  could  lead  to  better  control  of  various  human viral diseases (Snipes &amp; Suter, 1995; Ecker et al., 2008).

## 1.7 MOLECULAR BIOLOGY OF GENES AND PROTEINS

A gene is a stretch of nucleotide order or a DNA segment that, via translation or  transcription,  encodes  a  protein.  Certain  genes,  although,  produce  RNA  that is not translated into proteins. Throughout transcription, such genes produce tRNA or rRNA, that aid in the interpretation  of  transcripts  from  protein-coding genes. The coding section of DNA in bacterial genes is uninterrupted, and their transcripts have been translated straight into protein without alteration. Therefore,  mRNA and transcript are synonymous in prokaryotes (such as RNA, which transmits the instructions for building a protein through the ribosome translation procedure). Astrachan and  Volkin (1957) confirmed the presence of mRNA in the cells of bacteria, and Brenner et al. proposed that mRNAs convey data from DNA to ribosomes for interpretation into proteins (1961).  H.  G.  Khorana  and      Marshall  Nirenberg  discovered  the  genetic information as well as the process of data transfer and storage predicted by the Watson-Crick structure of DNA at the same time. The Nobel Prize was awarded to Nirenberg and Khorana in 1968 for its accomplishments. In the early  1960s, the variable size of eukaryotic transcripts had been recognized. The eukaryotic transcripts are known as pre-messenger RNA (premRNA) or heterogeneous nuclear RNA (hnRNA). Consequently, the finding of the separate nature of eukaryotic genes demolished the notion of the diverse nature  of  eukaryotic  transcripts.  Midway  through  the  1970s,  it  became

evident that certain genes in eukaryotes contain separate structures wherein the coding DNA compartment termed exons are separated by the noncoding DNA compartment termed introns. This finding had been derived from the findings  of  heteroduplex  mapping,  which  involved  the  hybridization  of a  gene's  DNA  using  mRNA and the electron microscope imaging of the heteroduplex structure. Whenever the DNA of a gene had been hybridized with the mRNA in these kinds of tests, specific DNA sequences displayed as loops (Sharp, 2005). The existence of such loops suggested the existence of introns,  which  had  been  lacking  from  the  mRNA.  Based  on  the  outcomes of such hybridization experiments, it had been determined that a transcript experiences splicing processes that result in the removal of introns. Therefore, the exons have been rendered continuous, and the message is only then capable of being translated. In eukaryotes, such findings showed a contrast between the  structure  of  a  transcript  and  its  mRNA.  Subsequently,  the  existence  of introns and exons in a gene had been established by comparing the chicken ovalbumin gene's DNA order and its mRNA. Upon completion of the genome projects of numerous animals, the existence of introns and exons in a gene may be readily determined by locating conserved nucleotides at the exonintron junctions (Payne et al., 1982; FerrÃ© et al., 1995).

Figure 1.15. DNA commands are converted into messenger RNA. Ribosomes can read the genetic data encoding a strand of mRNA and utilize it to link amino acids together to produce a protein.

<!-- image -->

Source: By Dhorspool at en.wikipedia, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=15183788

At  first,  it  was  believed  that  introns  are  effectively  removed  from  a transcript  through  the  process  of  splicing,  which  then  causes  the  exons to form a continuous sequence in the mRNA. Later on, it was discovered that  a  single  transcript  might  result  in  the  production  of  a  wide  variety of  mRNAs.  This  was  made  possible  by  two  distinct  processes  known respectively  as  alternative  and  trans-splicing.  During  the  process  known as alternative splicing, the exons are pieced back together in a variety of various configurations. For instance, if a gene has three exons, one mRNA could comprise exon 1 and exon 2, while another messenger RNA from a similar gene could possess exon 1 and exon 3. This would cause the two messenger  RNAs  to  generate  completely  distinct  proteins  having  unique amino acid sequences at the C-terminal ends of the proteins. The functions controlled  by  such  two  proteins  in  an  organism's  physiology  will  be completely distinct from one another and involve the regulation of various biochemical reactions. Therefore, based on the total number of exons in a gene, this form of alternative splicing has the potential to generate a wide variety of messenger RNA for unique proteins (Akam et al., 1978; Andersen et al., 2021).

The  DSCAM  gene  in  Drosophila  is  thought  to  create  over  38,000 messenger  RNAs  encoding  various  proteins.  Because  of  a  variety  of factors,  such  as  the  existence  of  an  initial  stop  codon,  not  all  messenger RNAs are translatable. Alternate splicing may be tissue-specific, resulting in proteins having specialized functions. The Bcl-x gene produces a protein that regulates apoptosis, or programmed cell death. Furthermore, this gene uses a distinct splicing method to produce two separate mRNAs. A mini version of messenger RNA generates the protein Bcl-x(s), which regulates cancer and enhances apoptosis, while a bigger version of messenger RNA generates a large protein that increases cancer growth and reduces apoptosis.

Intron retention or exon skipping may occur during alternative splicing. Exon  skipping  occurs  often  in  higher  eukaryotes.  While  exon  skipping, a  certain  exon  is  omitted  from  the  splicing  process.  There  have  been multiple instances of exon skipping, that are utilized to generate variants of tropomyosin that have been unique to smooth muscle, skeletal muscle, and the cells of the brain. Drosophila utilizes exon skipping to regulate sexual maturation. Drosophila possesses a sex lethal gene known as sxl; if exon 2 is bypassed while splicing, a female-specific sxl protein is  created, that connects with all succeeding transcripts of the similar gene, which induces excision of exon 2 from all mRNAs, and results in the generation of female

flies. If the male-specific exon 2 is kept during the 1st round of splicing, the male-specific sxl protein is produced, and male flies hatch. The retention of  introns  leads  to  the  synthesis  of  messenger  RNAs  and  their  encoding proteins of various lengths. The retention of introns is a typical occurrence in plants and lower multicellular animals (Virgin et al., 1991; Caestecker&amp; Meyrick, 2001).

One transcript has always been involved in the alternate splicing method. Trans splicing, in contrast to alternative splicing, comprises the splicing of exons from 2 transcripts generated by similar or different genes. In worms like C elegans . , trans-splicing is very common. Trans splicing can happen in human brain cells, according to certain evidence.

A  typical  human  gene  that  codes  for  a  protein  are  around  28,000 nucleotides  long,  has  approximately  eight  exons  that  are  at  least  120 nucleotides  long  and  has  approximately  seven  introns  that  range  in  size between 100 and 100,000 nucleotides. Introns typically have a length that is  many times greater than that of exons. Alternate splicing results in the production of an average of three different mRNAs from each human gene (Baker et al., 1966; Nasrallah et al., 1970 ).

Splicosomes  which  are  composed  of  greater  than  100  proteins  and 5  short  nuclear  (sn)  RNAs  (snRNAs)  are  responsible  for  facilitating  the splicing  process.  Splicing  regulator  proteins,  also  known  as  SR  proteins, are  regulatory  proteins  that  engage  splicosomes  by  binding  to  a  specific nucleotide  order  in  an  exon  known  as  an  exon  splicing  enhancer  (ESE). The exon may have an order known as an exon splicing suppressor (ESS), that stops the splicosome from doing its job (Swanson &amp; Bradfield, 1993; Barisoni et al., 2009).

The humans might get sick from improper splicing. Defective splicing is the outcome of more than fifteen percent of the mutations that are responsible for illnesses in humans. Splicing errors can lead to mutations that modify the splice site, the elements of splicesosomes, or the factors that drive splicing. Mutations can also alter the factors that influence splicing.

## Cis-splicing

Figure 1.16. Various sorts of transcript splicing.

<!-- image -->

Source: Blumenthal T. Trans-splicing and operons in C. elegans. In: WormBook: The Online Review of C. elegans Biology [Internet]. Pasadena (CA): WormBook; 2005-2018. Figure 1, Comparison of cis- and trans-splicing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK19704/figure/transsplicin -goperons\_figure1/

Mutations that trigger faulty splicing have been linked to a variety of human  illnesses,  such  as  cancer  (Faustino  and  Cooper  2003).  BRCA1; HGH,  BRCA2,  spinal  muscular  atrophy  (SMA),  cystic  fibrosis,  Wilms tumor suppressor, myotonic dystrophy (MD) linked with Frasier syndrome (WT1), as well as several other genes have been linked to faulty splicing and human disorders (Frith et al., 2006; Rossin et al., 2011).

In higher species, alternative splicing is the primary origin of protein abundance.  By  inserting  and  removing  codons  in  the  resultant  mRNA, alternative  splicing  not  only  enhances  the  number  of  proteins  and  also changes the character of the protein. It can also alter the mRNA's reading frame.  By  inserting  a  termination  codon  into  the  mRNA,  it  might  force protein  production  to  stop.  Modifications  in  regulatory  components  that impact mRNA stabilization and the translation procedure may regulate gene expression via alternative splicing.

Understanding the genome orders of mice or humans has indicated that alternative splicing has a significant impact on speciation. Both have a similar set of genes, and most of them have similar introns or exons. Furthermore, it's  thought  that  about  a  quarter  of  the  exons  that  experience  alternative

splicing  are  unique  to  humans  and  not  seen  in  mice.  Similarly,  primates have alternately spliced exons which set the stage for primate evolution. The primate-specific exons appear to be derived from mobile genetic components with alu sequences. As a result, alu sequences are unique to primates.

## 1.8 PROTEIN CHEMISTRY BEFORE PROTEOMICS

Proteins  have  been  called  'natural  robots'  because  they  appear  to  know precisely what they need to do both inside and outside of cells (Tanford and Reynolds 2004). A protein's function, like that of several other substances, is  governed  by  its  structure.  Proteins  can  serve  a  variety  of  purposes,  as previously  stated  (shown  in  Table  1.1).  Before  proteomics  science,  most of the basic biology of proteins had been known (see Bell and Bell 1988 and  Stryer  1982).  This  had  been  made  feasible  by  the  development  of technologies  for  separating  and  purifying  proteins,  and  also  determining their particular action, the sequence and composition of amino acids, and three-dimensional  structure.  Methods  for  characterizing  various  physical and biological features, as well as their modulation and artificial production, had also been established (Subramanian &amp; Kumar, 2004).

## 1.8.1 Separation and Purification of Proteins

During  the  production  of  the  cellular  extract,  proteins  were  isolated from  one  another.  Proteins  can  be  extracted  from  tissue  or  cells  using  a variety of ways. Proteins have been segregated by precipitation in various concentrations  of  ammonium  salts,  which  is  usually  done  in  a  stepwise fashion. The molecular weights and charges of partly purified proteins have been utilized to segregate them. A tiny number of proteins is typically refined via ultracentrifugation inside a sucrose gradient depending upon differences in molecular weights. Gel filtration, which serves as a molecular sieve to segregate protein molecules dependent upon their sizes, is another form of separation. The molecular sieve sepharose (Sephadex; Sigma-Aldrich, St. Louis, MO) is routinely utilized to segregate protein molecules of various sizes. Ion-exchange chromatography can also segregate proteins depending upon their net +ve or -ve charges. In this type of ion-exchanger matrix, diethyl aminoethyl  (DEAE)  cellulose  and  carboxymethyl  (CM)  cellulose  have been employed. Other chromatographic technologies that segregate protein molecules via their sizes and also their charges are generated. Apart from chromatography on a solid matrix, like sepharose, liquid chromatography and high-performance liquid chromatography (HPLC) are also generated. A

wide range of proteins has been homogeneously purified. The 3D structures of some proteins are established after they are crystallized (Stoebel et al., 2008).

Figure 1.17 . Protein separation represented graphically.

<!-- image -->

Source: Echave J, Fraga-Corral M, Garcia-Perez P, PopoviÄ-DjordjeviÄ J, H. AvdoviÄ E, RaduloviÄ M, Xiao J, A. Prieto M, Simal-Gandara J. Seaweed Pro -tein Hydrolysates and Bioactive Peptides: Extraction, Purification, and Appli -cations. Marine Drugs. 2021; 19(9):500. https://doi.org/10.3390/md19090500

In addition to various chromatographic techniques, many electrophoresis techniques are developed to segregate protein molecules depending upon their mass or charges on a conventional gel or a capillary gel by applying an  electrical  field.  To  segregate  proteins  of  various  molecular  weights, sodium dodecyl sulfate (SDS) has been injected into the gel matrix. Because SDS is extremely -ve charged, all proteins in a mixture become similarly -ve charged when it is present. As a result, all proteins travel in an electrical field  throughout  electrophoresis  in  the  existence  of  SDS  depending  upon its  molecular sizes rather than their charges. During electrophoresis in an SDS-containing gel, smaller proteins move considerably quicker than larger proteins. Electrophoresis is a gel containing a combination of ampholine of various isoelectric points that may also be used to segregate a mixture of proteins depending upon net charges. These 2 electrophoresis procedures in SDS and ampholine gels are integrated whereas a protein combination is  separated  the  1st  one  in  SDS  gel  and  subsequently  in  ampholine  gel depending upon electrical charges and molecular sizes. When 2 planes at

right angles to one another are run in this approach, it segregates proteins depending upon charges or sizes. Proteins have been separated into distinct spots and colored with a dye throughout electrophoresis. More than 1100 E. coli proteins were separated sequentially on a two-dimensional gel for the 1st time. The capability of a two-dimensional gel to segregate an organism's whole protein  composition  and  offer  information  about  it  in  a  single  try ushered in a new era in the study of proteomics (Radford, 1991).

## 1.8.1.1 Specific Activity of Proteins

The preparation activity of a protein per milligram of that protein is known as its particular action. Enzymatic activity, capability to bind to a ligand, and  biological  activity  are  all  used  to  evaluate  a  proteinâºs  activity.  A proteinâºs particular activity rises as its purity level rises. There have been various ways to figure out how much protein is in a generation. The most straightforward method is to measure light absorption at 280 nm. There are also various colorimetric techniques available, the most popular of which are the Bradford and Lowry systems (see Bell and Bell, 1988).

## 1.8.1.2 Determination of Molecular Weight

The molecular  weight  of  a  protein  is  an  important  necessity.  It  provides detail  on  the  relative  sizes  of  protein  molecules.  Chromatography  with  a matrix-like  Sepharose  or  ultracentrifugation  or  the  mobility  of  protein molecules in SDS gels on electrophoresis utilizing known protein markers are all common methods for determining molecular weight.

## 1.8.1.3 Amino Acid Composition

Proteins are made up of twenty distinct amino acids. The wide availability of such constituent amino acids in a protein is crucial. Knowing the number of various amino acids has also been useful for calculating the amino acid sequence in a protein molecule.  A protein has been hydrolyzed in 6 M HCl for several hours to ascertain its amino acid content, and afterwards segregated via  chromatography  or  electrophoresis.  To  make  an  electrophoretogram easier  to  see,  the  specific  amino  acid  spots  are  colored  using  ninhydrin. Colorimetric analysis determines the number of amino acids within every location since the intensity of dye in every spot is proportional to the number

of  amino  acids.  Instead,  the  amino  acids  are  segregated  as  eluents  via chromatography being stained using a fluorescent dye, and the number of amino acids in each eluant is estimated spectroscopically, as the number of amino acids is dependent on the amount of dye taken by the amino acids. The entire procedure is mechanized, and an amino acid analyzer, a commercially available machine, can identify the amino acid makeup of a protein in a short time. Rockefeller University in New York City was the 1st to invent the amino acid analyzer (Harth et al., 1996).

## 1.8.1.4 Amino Acid Sequence

The N-terminus is used as a starting point for the sequential determination of the amino acid order in a protein. The Edman degradation reaction, which was initially invented at Rockefeller University and afterwards mechanized in Melbourne,  Australia by Edman and his coworkers, is utilized to determine which amino acid is at the N-terminus (1950, 1967).

To  classify  a  protein,  it  is  often  split  up  into  smaller  pieces  called peptides which each contain about 50 amino acids. This can be done either through  cyanogen  bromide  cleavage  or  through  tryptic  digestion.  Firstly, the individual peptides have been isolated from each other. The peptide has been then adsorbed upon a solid surface, including a glass fiber that has been  coated  with  the  cationic  polymer  polybrene.  PTH,  also  known  as phenylisothiocyanate, is an Edman reagent that is applied to an adsorbed peptide that is suspended in a trimethylamine-based basic buffer solution. PTH interacts with an amino group of the N-terminal amino acid in this solution,  and  then  that  amino  group  is  preferentially  removed  from  the peptide by the injection of anhydrous acid. Isomerization of the amino acid with modified N-terminal results in the formation of phenylthiohydantoin. This is  removed by washing, and subsequent chromatography allows for identification. After  this,  the  cycle  is  repeated  to  identify  the  subsequent N-terminal amino acid in the peptide which is still adsorbed upon the glass fiber that has been coated using polybrene. The Edman degradation approach is sophisticated, but it has several drawbacks that must be considered. If the N-terminal amino acid is inhibited or buried in the majority of the protein, the approach would not operate.

## 1.8.2 Chemical Synthesis of Protein

Protein synthesis via chemical means has a long history. Emil Fischer was the first to synthesize the dipeptide glycylglycine in 1901. Subsequently, he created an octadecapeptide have a distinct amino acid order that included 15  glycine  and  3  leucine  residues.  He  couldn't  regulate  the  amino  acid order  throughout  the  peptide  synthesis.  Zervas  and  Bergmann  (1932) in  Germany  made  a  significant  contribution  in  this  regard  by  providing ways for preserving the amino group. Zervas and Bergmann both attended Rockefeller University in 1935, where they trained several protein biochemists,  notably  Standford  Moore  and William  Stein,  who  had  been awarded the Nobel Prize in 1972. In 1954, du Vigneaud et al. used Zervas and Bergmann technique to manufacture the octapeptide hormone oxytocin. The creation of oxytocin earned Vincent du Vigneaud the Nobel Prize in Chemistry in 1955. Such approaches for chemical synthesis in the solution medium, on either hand, had been time-consuming. Merrifield achieved a key breakthrough in protein chemistry by creating solid-phase synthesis at Rockefeller University in 1963. An amino acid is connected to impermeable support by its carboxyl end and then treated by another amino acid have an activated carboxyl group while being shielded by an alpha-amino group in this process. The dipeptide's amino group is then deprotected by removing the protective group at the amino-terminal, and a 3rd amino acid is reacted with a protected amino group and an activated carboxyl group to produce the  tripeptide.  Such  a  cyclic  procedure  of  activation,  deprotection,  and protection is repeated until the whole protein or peptide has been synthesized. It is critical to preserve particular reactive amino acid side chains throughout the chemical synthesis. All protected groups have been deprotected at the end of the chemical production, and the peptide is subsequently split off the strong support. The biological and biochemical features of these proteins or peptides are next tested to confirm their identification with the naturally produced  protein.  This  approach  was  employed  by  Merrifield  to  create the 1st enzyme named ribonuclease A. (RNaseA). The chemical synthesis procedure has now been mechanized. A machine designed at Rockefeller University performs the full peptide synthesis.

Figure 1.18. Chemical Synthesis of Proteins.

<!-- image -->

Source:  Chandrudu  S,  Simerska  P,  Toth  I.  Chemical  Methods  for  Peptide and Protein Production. Molecules. 2013; 18(4):4373-4388. https://doi. org/10.3390/molecules18044373

It's  worth  noting  that  the  Merrifield  group's  chemical  synthesis  of RNaseA relied heavily upon their understanding of the amino acid order. In a cell, the process of protein biosynthesis often begins with the N-terminal amino  acid,  whereas  the  process  of  chemical  synthesis  typically  begins with the C-terminal amino acid, which has been attached to an insoluble solid support.  First, a succession of component peptides for a long-chain protein such as RNaseA is generated in vitro . These peptides are then ligated together  to  form  the  full-length  protein.  During  the  process  of  chemical synthesis,  it  is  common  practice  to  make  use  of  either  a  base-sensitive 9-fluorenylmethyloxycarbonyl  (Fmoc)  group  or  an  acid-sensitive  tertbutoxycarbonyl (Boc) group to successfully secure the alpha-amino group of the amino acid that will be added to the growing chain of peptides. There are  other  places  where  a  detailed  method  for  the  chemical  production  of proteins can be found (Nilsson et al. 2005).

## 1.8.3 Protein Engineering

Protein engineering technology arose from our capability to create proteins both in  vitro and  in  vivo.  Proteins  of  relevance  having  specific  desirable features can be manufactured in large quantities using this approach. Protein engineering  is  carried  out  using  2  strategies  that  aren't  even  necessarily contradictory. Many laboratories produce proteins using both approaches. The 1st approach is known as 'logical design.' This necessitates a thorough understanding of the protein structure, which had been challenging before the introduction of proteomics and is now easily accessible. This procedure is cost-effective and utilizes site-directed mutagenesis. 'Directed evolution' is  the  2nd  way.  Since  proteins  of  various  types  are  created  via  random mutagenesis and afterwards chosen for desirable properties, this technique closely resembles natural evolution. Splicing DNA encoding various proteins to create an end-product, which combines the desirable properties of various proteins is sometimes done. The fundamental disadvantages of this approach are  twofold:  first,  it  is  a  time-consuming  procedure  that  needs  multiple constructions, and second, it needs high productivity, which is not attainable for some proteins.

Figure 1.19. Protein Engineering Cycle.

<!-- image -->

Source: Gomes LC, Ferreira C, MergulhÃ£o FJ. Implementation of a Practical Teaching Course on Protein Engineering. Biology. 2022; 11(3):387. https://doi. org/10.3390/biology11030387

## 1.8.4 Crystal Structure

The examination of the structure of the protein crystal reveals the threedimensional structure of a protein in terms of the location of each atom in the amino acid chain of the protein one by one. The X-ray diffraction trend of the protein crystal typically presents the three-dimensional structure of the protein. Whenever an X-ray beam is shone on a protein crystal, the electrons in  the  atom  disperse  the  X-ray,  creating  an  X-ray  diffraction  pattern.  To construct the three-dimensional structure, the X-ray pattern is next exposed to  Fourier  transformation  evaluation.  In  the  Cavendish  laboratory  in  the 1940s, Max Perutz and John Kendrew investigated the three-dimensional protein.  It  required  nearly  twenty-two  years  for  them  to  figure  out  the three-dimensional structure of myoglobin (Kendrew 1961) and hemoglobin (Perutz et al. 1960), for which both Perutz and Kendrew were awarded the Nobel Prize in 1962. Protein three-dimensional structural analysis developed slowly despite their work. By 1990, the X-ray diffraction pattern of protein crystals had disclosed the structure of lower than one hundred proteins.

The development of a novel method known as mad, wherein an X-ray beam  had  been  directed  at  protein  crystals  using  a  synchrotron,  was responsible  for  the  overall  acceleration  of  the  procedure.  The  stage  of diffraction could be easily determined using this method, which gave the data quickly. Both data on the phase and amplitude are needed to generate the structure in three dimensions. The X-ray diffraction of protein crystals that included heavy metals at distinct places, which necessitated the analysis of certain X-ray diffraction patterns, was used to identify an earlier stage. The increase in processing power expedited not only the process of analyzing three-dimensional  structures  but  also  the  procedure  overall.  The  threedimensional structure of tiny proteins in solution can be determined using X-rays and nuclear magnetic resonance (NMR), among other techniques. NMR is useful for studying proteins that are unable to crystallize. In contrast to the three-dimensional structure of a protein crystal, the three-dimensional structure of a protein in its dynamic state can be determined using NMR. Protein molecules exist in the solution.

## 1.8.5 Regulation of Proteins and Active Site

Understanding the function of a protein is a crucial element of proteomics. This is especially important for knowing the function of protein in sickness and medication development. Proteins have numerous functions in a cell. Many proteins work by either catalyzing a biological reaction or binding

to specific molecules, such as other proteins. An active site is a portion of a protein's structure; with the advancement of proteomics, the active site of an enzyme may now be identified utilizing bioinformatics software. During an enzymatic reaction, the active site binds to a substrate and then catalyzes the  activity.  The  catalysis  and  binding  of  a  substrate  are  explained  using 2 models. The 1st is known as the 'lock and key' model, while the 2nd is known as the 'induced fit' model. The substrate and the active site have a lock and key link in the 1st model, which explains their uniqueness. The active site in the induced fit model isn't a hard structure, implying that the binding of a substrate causes some elasticity in the active site. Molecules that resemble the substrate's structure may bind to the active site and impede binding  to  the  substrate;  that's  the  foundation  for  inhibition  of  enzymes via medicines and enzyme modulation, as detailed below.

Figure 1.20. The active site's function in the lock-and-key fit of a substrate (the key) to an enzyme (the lock).

<!-- image -->

Source: https://cdn.britannica.com/13/6513-004-2CDF9DFD/role-site-fit-sub -strate-enzyme.jpg

In the case of non-enzyme proteins, these sites can attach to other proteins or specific compounds. Several medicines that are structurally identical to the substrate can bind to the active site of the protein and block its enzymatic activity by preventing it from interacting with the natural substrate. Since they  contend  with  the  substrate  for  the  active  site  of  the  protein,  these inhibitors are considered competitive inhibitors. Although chemicals attach

to a protein's active site, some other molecules attach to the protein at a place beside the substrate-binding site, causing the protein's structure to change and preventing it from binding to the substrate. Since they don't compete with the substrate for attaching to the active site, these inhibitors are classified as  noncompetitive  inhibitors  and  allosteric  inhibitors.  Michaelis-Menton kinetics discriminates between non-competitive and competitive inhibitors. This type of kinetic study is done via plotting 1/V versus 1/S, wherein S is the concentration of substrate and V is the biological reaction velocity (see Bell and Bell 1988), resulting in a straight line. Monod and Jacob (1964) in Paris discovered the allosteric control of proteins. Monod and Jacob defined the function  of  an  allosteric  protein  or  a  repressor  protein  implicated  in  the regulation of Lac operon transcription in this bacteria by creating suitable mutants. In 1965, both Monod and Jacob were awarded the Nobel Prize for such achievement.

## 1.8.6 Protein Targeting and Signal Sequence

After being synthesized on ribosomes, proteins travel throughout the cell to their final destinations, where they not only take up residence but also perform a variety of functions depending on the region of the cell in which they are found. In the 1970s, Gunter Blobel from Rockefeller University recognized  approximately  fifteen  amino  acid  long  patterns  in  various proteins.  Such  patterns  target  proteins  to  their  locations,  which  include the cell membrane, the cell wall, and various organelles such as the Golgi bodies,  peroxisomes,  nucleus,  chloroplasts,  and  mitochondria  as  well as the outer of the cell. Such Signal patterns function similarly to the zip codes that have been used to direct mail carriers to the correct addresses. The signal patterns are often found at the beginning of the protein, which is known as the N-terminus. After the proteins have been transported, the signal patterns are often broken by a protease. Proteins that are being sent to various locations typically carry signal patterns that comprise a distinct amino  acid  composition.  For  instance,  proteins  that  are  intended  for  the endoplasmic  reticulum  are  composed  of  signal  patterns  that  encompass five  to  ten  hydrophobic  amino  acids  at  the  N-terminus,  while  the  signal pattern  of  proteins  which  are  being  transported  to  the  nucleus  comprises +ve charged amino acids inside the peptide. The pattern of amino acids that make up the mitochondrial targeting signals alternates between hydrophobic and positively charged amino acids. Typically, a signal pattern consisting of 3 amino acids located on the C-terminus of a protein is required for it to be targeted to peroxisomes. Such proteins are often in their unfolded state

while being accompanied by a chaperon protein during their journey to their destination. Once the transport process is finished, the unfolded proteins are refolded with the assistance of a protein called a chaperon so that they can take their tertiary structures. Glycosylation, also known as the acquisition of the carbohydrate moiety, may oftentimes lead to the successful conclusion of the protein's journey.

Figure 1.21. Protein targeting.

<!-- image -->

Source: Kellogg MK, Miller SC, Tikhonova EB, Karamyshev AL. SRPassing Co-translational Targeting: The Role of the Signal Recognition Particle in Protein Targeting and mRNA Protection. International Journal of Molecular Sciences. 2021; 22(12):6284. https://doi.org/10.3390/ijms22126284

Several human disorders are caused by a genetic deficiency in protein transport. As a result, studying protein transport is critical in gaining a better understanding of various human disorders and can give clues for treatment. Blobel won the Nobel Prize for discovering the process of protein transport in cells in 1999.

Over time, opinions on the distribution of enzymes and proteins within the cell have shifted. Previously, it had been assumed that enzymes were randomly dispersed in the  cytosol  and  that  enzymatic  reactions  occurred as  a  result  of  a  chance  encounter  between  a  substrate  molecule  and  an enzyme.  In  contrast  to  popular  belief,  enzymes  from  identical  or  related metabolic pathways have been clustered together in the cytosol rather than being scattered randomly. They occur together close to one another due to structural similarities that aid in their recognition.

## 1.8.7 Intein

Inteins are fragments of a protein that self-expel, succeeded by the exteins, which  unite  the  existing  fragments.  The  C-terminal  and  the  N-terminal exteins  have  been  connected  by  a  peptide  link  as  fast  as  the  peptide  is produced from the messenger RNA after the intein is removed. Inteins in proteins are similar to introns in genes in that they should be eliminated to  create  a  functional  protein,  just  as  an  intron  in  a  transcript  should  be eliminated  to  create  an  interpretable  message.  Over  two  hundred  inteins are identified in various proteins, and a database of inteins is accessible. The average length of a protein is between one hundred and eight hundred amino acids. Certain inteins are made up of 2 genes; for instance, cyanobacteria's dnae DNA polymerase (dnaE) comprises 2 elements, an N-intein segment with 123 amino acids and a C-intein segment with thirty-six amino acids. The 2 fragments have been encoded by 2 distinct genes for the alpha subunit of DNA polymerase III, dnaE-c and dnaE-n. In the situation of genes, this would be comparable to trans-splicing. The endonuclease found in geneencoding inteins aids in the propagation of inteins. Inteins are discovered in  eukaryotes,  bacteria,  and  archaea  among  other  forms  of  life.  Protein engineering and  protein marking  for NMR  characterisation  are  two examples of how proteins are employed. Inteins could be a beneficial tool in  the  development of a medicine that prevents the loss of intein from a protein, rendering it nonfunctional and hence accountable for the sickness.

Figure 1.22. A summary of Intein.

<!-- image -->

Source:  Pavankumar  TL.  Inteins:  Localized  Distribution,  Gene  Regulation, and Protein Engineering for Biological Applications. Microorganisms. 2018; 6(1):19. https://doi.org/10.3390/microorganisms6010019

## 1.9 UNSTRUCTURED PROTEIN

It has been demonstrated that there have been 2 types of proteins found in biological systems: one type of protein has a structure that has been arranged, while the other type of protein is fundamentally disordered and unorganized (Dyson and Wright 2005).

Before the advent of proteomics, a good deal of research had been done to figure out the structure of the 1st set of proteins. It is well knowledge that proteins can take several different levels of the organization, including tertiary, secondary, and primary structures. The quaternary structure is an additional degree of protein organization that is present in several proteins. The fundamental structure of a protein is made up of the order in which its amino acids are arranged. Since the folding in the main structure is dependent upon the  interconnections  of  the  amino  acids,  especially  their  side-chain amongst themselves, the secondary structure shows the coiled structure of the protein. It's because the main structure folds into itself. A protein's threedimensional structure, known as its tertiary structure, is determined by the polypeptide chain's ability to completely fold back on itself. The function of the protein and its three-dimensional shape are both determined by its tertiary  structure.  After  taking  a  tertiary  structure,  several  proteins  bind with one another or with another protein to assume a quaternary structure. Proteins that have the same peptides serving as subunits in their quaternary structures  are  referred  to  as  homomers,  while  proteins  that  have  distinct peptides serving as subunits in their quaternary structures are referred to as heteromers.Hemoglobin is a great instance of a protein that has a quaternary structure since it consists of four different chains: 2 intermediate chains, 2 beta chains, and 2 alpha chains.   As long as the proteins have been created, there have been no proteins that reside in their main structure like a straight stretch of peptide because of the instant biochemical interactions that occur among the various amino acids that have been present in the stretch of the polypeptide.

Circular  dichroism  or  even  gel  filtration  may  be  used  to  assess  the secondary  structure;  however,  this  is  not  always  the  case.  There  are  a few various approaches that may be taken to uncover the various protein structures.  Not  every  protein  has  a  three-dimensional  structure.  Because they do not possess a tertiary structure, it is believed that more than thirtyfive percent of the proteins that may be identified in living systems do not have an inherent structure. These proteins have been given the name 'intrinsically unstructured proteins' (Dyson and Wright 2005). The fundamental structures of such proteins typically do not contain any of the bulky amino acids that are  hydrophobic.  Such  proteins  only  have  a  short  lifespan  and  exist  as chains of random coils. In most cases, they are responsible for carrying out regulatory duties, like directing the regulation of the cell cycle, controlling translation and transcription, and signaling passageways. Although research

into such proteins is just getting started, it is anticipated that it will provide a great deal of light on how the functions of proteins are controlled.

Figure 1.23. Induced folding of intrinsically disordered proteins.

<!-- image -->

Source:  Burger  VM,  Gurry  T,  Stultz  CM.  Intrinsically  Disordered  Proteins: Where  Computation  Meets  Experiment.  Polymers.  2014;  6(10):2684-2719. https://doi.org/10.3390/polym6102684

## 1.10 PROTEIN MISFOLDING AND HUMAN DISEASE

The random coil shape of the intrinsically unorganized proteins, such an indeterminate form can be assumed by other proteins as a result of mutation or other modifications in the proteins. The structure of proteins is changed in several  disorders,  including  neurodegenerative  disorders  and  other illnesses. They are devoid of the tertiary and secondary structures that are often found in proteins. In most cases, they are the consequence of proteins failing  to  fold  correctly.  Anfinsen  demonstrated  that  the  main  structure of  the  protein  is  responsible  for  controlling  the  tertiary  and  secondary structures  of  the  protein.  He  was  able  to  demonstrate  that  denaturing circumstances,  like  the  injection  of  urea  into  the  solution  that  contained the protein, caused the enzyme ribonuclease to undergo a process that led to its unfolding. Ribonuclease that hasn't folded properly is inactive as an enzyme. Furthermore, once urea is withdrawn from the protein solution via dialysis, ribonuclease begins to fold and eventually acquires a fully folded

form with a tertiary and secondary structure as well as the full recovery of its enzymatic activity. Because of this achievement, Anfinsen was awarded the Nobel Prize in 1972. Moreover, because they have been manufactured within the cell, several proteins are unable to fold because they remain unfolded. The presence of proteins that have not folded correctly can lead to several illnesses  in  human  beings.  The  misfolding  of  proteins  is  the  root  cause of  several  neurodegenerative  disorders,  like  Creutzfeldt-Jakob  disease, Alzheimer's disease, Kuru, and mad cow disease.

Certain  proteins  which  induce  mad  cow  disease  had  been  identified as infectious protein complexes in the 1960s. Prions, which are similar to virions,  had  been  named as they only included proteins; the nucleic acid comprised  the  infectious  particles.  Prusiner  received  the  Nobel  Prize  in Physiology or Medicine in 1997 for its work defining prions as proteaseresistant  proteins  (PrPs).  After  a  mutation  in  the  gene  for  regular  PrP, prions are formed wherein the mutant PrP may not fold appropriately. Such misfolded PrPs had been later discovered to be infectious protein molecules that spread by triggering the misfolding of proteins that may have exited as fully functional, perfectly folded proteins. Misfolding of a protein known as the cystic fibrosis transmembrane conductance regulator (CFTR) causes various disorders, including cystic fibrosis. The biological activity essential for the transportation of chloride ions has been lost when misfolded proteins stay  in  the  random  coil  state.  Consequently,  with  Alzheimer's  disease, they become persistent and form the distinctive beta-sheet plaques in the sufferers' brains.

Figure 1.24. Protein Misfolding.

<!-- image -->

Source: Folger A, Wang Y. The Cytotoxicity and Clearance of Mutant Huntingtin  and  Other  Misfolded  Proteins.  Cells.  2021;  10(11):2835.  https://doi. org/10.3390/cells10112835

A protein molecule is normally destroyed when it becomes misfolded for  any  cause.  Furthermore,  it  can  sometimes  survive  disintegration  and subsequently  function  as  a  chaperon,  causing  other  protein  molecules  to misfold.  The  so-called  infectivity  of  prions,  which  induces  CreutzfeldtJakob disease and mad cow disease, is based on this. When a healthy cow is administered unfolded protein or prions, it induces other proteins in the brain cells to misfold, resulting in illness.

When prions had been originally found, they had been believed to be infected  protein  particles,  and  it  had  been  believed  for  a  time  that  they worked as a proteinaceous infectious agent in the same way that infective viral DNAs/RNAs did. This viewpoint contradicted the long-held belief that only nucleic acids function as genetic information. The idea of a protein as genetic information is resolved due to the discovery that the production of  novel  prion  particles  is  caused  by  the  misfolding  of  existing  naturally present proteins. Because prions are unable to replicate, they don't code for daughter prions. Rather than, these prions may cause misfolding of newly synthesized proteins encoded by the host genome, which attracts more prion particles. In cystic fibrosis, for instance, a misfolded CFTR protein causes additional CFTR proteins to misfold, and the cell loses its normal function. It  has  been  discovered  that  normal  PrP  regulates  long-term  memory  in mammals. Prions, or prion-like particles, are discovered in yeast and fungus, such  as  Podospora,  wherein  they  influence  various  phenotypes  in  the organisms that contain them. Therefore, understanding appropriate protein folding is critical to understanding the causes of various disorders and how to cure them. The yeast heat shock protein Hsp40/YdjI has been recognized as a protein that prevents misfolded proteins from aggregating and aids in their  refolding.  It  appears  to  detect  specific  repeat  patterns  as  a  protein's consensus motif. DnaJ, an E. coli protein, is similar to yeast protein. This protein could help researchers better understand human disorders involving protein misfolding.

## REFERENCES

- 1. AjitTamadaddi, C., &amp;Sahi, C. (2016). J domain independent functions of J proteins. Cell Stress and Chaperones , 21 (4), 563-570.
- 2. Akam, M. E., Roberts, D. B., Richards, G. P., &amp;Ashburner, M. (1978). Drosophila: the genetics of two major larval proteins. Cell , 13 (2), 215225.
- 3. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., &amp; Walter, P. (2002). The shape and structure of proteins. In Molecular Biology of the Cell. 4th edition . Garland Science.
- 4. Alsagaby, S. A. (2019). Understanding the fundamentals of proteomics. Curr. Top. Pept. Protein Res , 20 (3), 25.
- 5. Andersen, S. E., Bulman, L. M., Steiert, B., Faris, R., &amp; Weber, M. M. (2021). Got mutants? How advances in chlamydial genetics have furthered the study of effector proteins. Pathogens and disease , 79 (2), ftaa078.
- 6. Anfinsen  C.  B.  1973  Principles  that  govern  the  folding  of  protein chains. Science 181, 223.
- 7. Arruda, S. C. C., de Sousa Barbosa, H., Azevedo, R. A., &amp;Arruda, M. A. Z. (2011). Two-dimensional difference gel electrophoresis applied for analytical proteomics: fundamentals and applications to the study of plant proteomics. Analyst , 136 (20), 4119-4126.
- 8. Aschaffenburg, R. (1968). Section G. Genetics. Genetic variants of milk proteins:  their  breed  distribution. Journal of  Dairy  Research , 35 (3), 447-460.
- 9. Avery,  O. T.,  C.  M.  MacLeod,  and  M.  McCarthy.  1944.  Studies  on the  chemical  nature  of  the  substance  inducing  transformation  of pneumococcal  types  I  induction  of  transformation  by  DNA  from Pneumococcus type III. J. Exp. Med. 79, 137
- 10. Axe,  D.  D.  (2004).  Estimating  the  prevalence  of  protein  sequences adopting functional enzyme folds. Journal of molecular biology 341 , (5), 1295-1315.
- 11. Ayala, F. J. and J. A. Kiger. 1984. Modern Genetics, Second Edition. Menlo Park, CA: Benjamin Cummings.
- 12. Baker,  C. A.,  Manwell,  C.,  Labisky,  R.  F.,  &amp;  Harper,  J. A.  (1966). Molecular genetics of avian proteins-V. Egg, blood and tissue proteins of  the  ring-necked  pheasant, Phasianus  colchicus L. Comparative Biochemistry and Physiology , 17 (2), 467-499.

- 13. Barisoni, L., Schnaper, H. W., &amp; Kopp, J. B. (2009). Advances in the biology and genetics of the podocytopathies: implications for diagnosis and  therapy. Archives  of  pathology  &amp;  laboratory  medicine , 133 (2), 201-216.
- 14. Barlow, C. K., &amp; O'Hair, R.  A.  (2008).  Gas phase  peptide  fragmentation: -how  understanding  the  fundamentals  provides  a  springboard  to developing new chemistry and novel proteomic tools. Journal of mass spectrometry , 43 (10), 1301-1319.
- 15. Beadle, G. W. and E. L. Tatum. 1941. Genetic Control of Biochemical Reactions in Neurospora. Proc. Nat. Acad. Sci. U. S. A. 27 (11), 499506.
- 16. Begun, D. J., Whitley, P., Todd, B. L., Waldrip-Dail, H. M., &amp; Clark, A. G. (2000). Molecular population genetics of male accessory gland proteins in Drosophila. Genetics , 156 (4), 1879-1888.
- 17. Bell,  J.  E.  and  E.  T.  Bell.  1988.  Proteins  and  Enzymes.  Englewood Cliffs, NJ: Prentice Hall.
- 18. Bergmann, M. and Zervas L. 1932. UbereinallgemeinesVerfahren der Peptid-  Synthese. Berichte  der  DeutschenChemischenGesellschaft 65(7), 1192-1201.
- 19. Berzelius, J. J. 1838. The word 'protein' was coined from Greek word proteios meaning the first by JonsJakob Berzelius in 1838 in a letter to his friend.
- 20. Biron,  D.  G.,  Hughes, A.  L.,  Loxdale,  H.  D.,  &amp;Moura,  H.  (2007). The  need  for  megatechnologies:  massive  sequencing,  proteomics and  bioinformatics. Encyclopedia  of  Infectious  Diseases:  Modern Technologies , 357-377.
- 21. Bishop,  A.,  Buzko,  O.,  Heyeck-Dumas,  S.,  Jung,  I.,  Kraybill,  B., Liu, Y., ... &amp;Shokat, K. M. (2000). Unnatural ligands for engineered proteins: new tools for chemical genetics. Annual review of biophysics and biomolecular structure , 29 (1), 577-606.
- 22. Bludau, I., &amp;Aebersold, R. (2020). Proteomic and interactomic insights into the molecular basis of cell functional diversity. Nature Reviews Molecular Cell Biology , 21 (6), 327-340.
- 23. Bonetta,  R.,  &amp;  Valentino,  G.  (2020).  Machine  learning  techniques for  protein  function  prediction. Proteins:  Structure,  Function,  and Bioinformatics , 88 (3), 397-413.

- 24. Bousquet-Dubouch, M. P., Fabre, B., Monsarrat, B., &amp;BurletSchiltz, O. (2011). Proteomics to study the diversity and dynamics of proteasome complexes: from fundamentals to the clinic. Expert review of proteomics , 8 (4), 459-481.
- 25. Brenner, S., F. Jacob, and M. Meselson. 1961. An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature 190, 576-581.
- 26. Caestecker,  M.  D.,  &amp;  Meyrick,  B.  (2001).  Bone  morphogenetic proteins,  genetics  and  the  pathophysiology  of  primary  pulmonary hypertension. Respiratory research , 2 (4), 1-5.
- 27. Chaijaroenkul,  W.,  Thiengsusuk,  A.,  Rungsihirunrat,  K.,  Ward,  S. A., &amp; Na-Bangchang, K. (2014). Proteomics analysis of antimalarial targets of Garcinia mangostana Linn. Asian Pacific Journal of Tropical Biomedicine , 4 (7), 515-519.
- 28. Chemale, G., Morphew, R., Moxon, J. V., Morassuti, A. L., LaCourse, E.  J.,  Barrett,  J.,  ...  &amp;Brophy,  P.  M.  (2006).  Proteomic  analysis of  glutathione  transferases  from  the  liver  fluke  parasite, Fasciola hepatica . Proteomics , 6 (23), 6263-6273.
- 29. Chen, F., Cseke, L. J., Lin, H., Kirakosyan, A., Yuan, J. S., &amp; Kaufman, P.  B.  (2016).  The  study  of  plant  natural  product  biosynthesis  in  the pregenomics and genomics eras. Natural Products From Plants. Taylor &amp; Francis , 203-220.
- 30. Chiti, F., Calamai, M., Taddei, N., Stefani, M., Ramponi, G., &amp; Dobson, C. M. (2002). Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proceedings of the National Academy of Sciences , 99 (suppl 4), 16419-16426.
- 31. Choi, B. H., Park, G. T., &amp; Rho, H. M. (1999). Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein Î± synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. Journal of Biological Chemistry , 274 (5), 2858-2865.
- 32. Colozza, M., de Azambuja, E., Cardoso, F., Bernard, C., &amp;Piccart, M. J. (2006). Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era. The Oncologist , 11 (2), 111-125.
- 33. Colozza, M., De Azambuja, E., Personeni, N., Lebrun, F., Piccart, M. J.,  &amp;  Cardoso, F. (2007). Achievements in systemic therapies in the pregenomic era in metastatic breast cancer. The oncologist , 12 (3), 253270.

- 34. Crick, F. H. 1970. Central dogma of molecular biology. Nature 227, 561-563.
- 35. Crick,  F.  H.  C.  1958.  Biosynthesis  of  macromolecules.  Symp.  Soc. Exp. Biol. XII, 138-163.
- 36. Darwin, C. 1859. On the Origin of Species, 1st ed. London, UK: John Murray.
- 37. D'HOOGHE, T. M., Kyama, C., Debrock, S., Meuleman, C., &amp;Mwenda, J. M. (2004). Future directions in endometriosis research. Annals of the New York Academy of Sciences , 1034 (1), 316-325.
- 38. du Vigneaud, V.,  C.  Ressler,  J.  M.  Swan,  C.  W.  Roberts,  and  P.  G. Katsoyannis. 1954. Oxytocin: synthesis. J. Am. Chem. Soc . 76; 31153118.
- 39. Dyson, H. J. and P. E. Wright. 2005. Elucidation of the protein folding landscape by NMR. Methods Enzymol. 394, 299-321.
- 40. Ecker, A., Bushell, E. S., Tewari, R., &amp;Sinden, R. E. (2008). Reverse genetics screen  identifies  six  proteins  important  for  malaria  development in the mosquito. Molecular microbiology , 70 (1), 209-220.
- 41. Edman, P. 1950. Method for determination of the amino acid sequence in peptides. ActaChemica Scandinavia. 4, 283-284.
- 42. Edman, P. and G. Begg. 1967. A protein Sequenator Eur. J. Biochem. 1, 80-91.
- 43. Emilsson, V., Ilkov, M., Lamb, J. R., Finkel, N., Gudmundsson, E. F., Pitts, R., ... &amp;Gudnason, V. (2018). Co-regulatory networks of human serum proteins link genetics to disease. Science , 361 (6404), 769-773.
- 44. Faustino, N. A. and T. A. Cooper. 2003. Pre-mRNA splicing and human disease. Genes Dev 17, 419-437.
- 45. FerrÃ©,  J.,  Escriche,  B.,  Bel, Y .,  &amp;  Van  Rie,  J.  (1995).  Biochemistry and genetics of insect resistance to Bacillus thuringiensis insecticidal crystal proteins. FEMS Microbiology Letters , 132 (1-2), 1-7.
- 46. Fire, S. Q., M. K. Xu, S. A. Montgomery, S. E. Kostas, and C. C. Driver. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans . Nature. 391, 806-811
- 47. Fischer, E. 1902. Nobel Lectures, Chemistry 1901-1921 , Amsterdam, The Netherlands: Elsevier 1966
- 48. Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M., Grainger, M., Haynes, J. D., ... &amp;Carucci, D. J. (2002). A proteomic view of the

Plasmodium falciparum life cycle. Nature , 419 (6906), 520-526.

- 49. Floros,  J.,  &amp;  Hoover,  R.  R.  (1998).  Genetics  of  the  hydrophilic surfactant  proteins  A  and  D. Biochimica  et  BiophysicaActa  (BBA)Molecular Basis of Disease , 1408 (2-3), 312-322.
- 50. Frith, M. C., Forrest,  A. R., Nourbakhsh, E., Pang, K. C., Kai, C., Kawai, J., ... &amp;PLoS Genetics EIC Wayne Frankel. (2006). The abundance of short proteins in the mammalian proteome. PLoS genetics , 2 (4), e52.
- 51. Garattini, E., Mendel,  R., RomÃ£o,  M.  J.,  Wright, R., &amp;Terao, M. (2003). Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochemical Journal , 372 (1), 15-32.
- 52. Gorrod, A. E. 1909. Inborn Errors of Metabolism. Oxford, UK: Oxford University Press.
- 53. Harth,  G.,  Lee,  B.  Y .,  Wang,  J.,  Clemens,  D.  L.,  &amp;Horwitz,  M. A. (1996). Novel  insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infection and immunity , 64 (8), 30383047.
- 54. Hershey, A. D. and M. Chase. 1952. Independent functions of viral protein and nucleic acids in growth of bacteriophage. J. Gen. Physiol. 36, 39-56
- 55. Hinman, M. N., &amp; Lou, H. (2008). Diverse molecular functions of Hu proteins. Cellular and molecular life sciences , 65 (20), 3168-3181.
- 56. Hu,  J.  C.  (2000). A  guided  tour  in  protein  interaction  space:  coiled coils from the yeast proteome. Proceedings of the National Academy of Sciences , 97 (24), 12935-12936.
- 57. Huberts, D. H., &amp; van der Klei, I. J. (2010). Moonlighting proteins: an intriguing mode of multitasking. Biochimica et BiophysicaActa (BBA)Molecular Cell Research , 1803 (4), 520-525.
- 58. Ingram, V. M. 1956. A specific chemical difference between globins of normal and sickle-cell an'umiahemoglobins. Nature 178, 792-794.
- 59. Ingram,  V.  M.  1957.  Gene  mutations  in  human  hemoglobin:  the chemical difference between normal and sickle h'umoglobin. Nature 180, 326-328.
- 60. Jacob, F., and J. Monod. 1964. Biochemical and genetic mechanisms of regulation in the bacterial cell. Bull. Soc. Chim. Biol. 46, 1499-1532.

- 61. Jiang,  Y.,  Oron,  T.  R.,  Clark,  W.  T.,  Bankapur,  A.  R.,  D'Andrea, D.,  Lepore,  R.,  ...  &amp;Radivojac,  P.  (2016).  An  expanded  evaluation of  protein  function  prediction  methods  shows  an  improvement  in accuracy. Genome biology , 17 (1), 1-19.
- 62. Jurkiewicz, A., Caricati-Neto, A., &amp;Jurkiewicz, N. H. (2009). Functionomics:  the  analysis  of  a  postgenomic  concept  on  the  basis of  pregenomic pharmacological studies in smooth muscle. Anais da Academia Brasileira de CiÃªncias , 81 (3), 605-613.
- 63. Kendrew,  J.  1961.  The  three-dimensional  structure  of  a  protein molecule. Sci. Am. 205, 96-110.
- 64. Khorana, H. G. 1968 Nucleic acid synthesis in the study of Genetic code. Nobel Lecture 341-366.
- 65. Klose,  J.  1975.  Protein  mapping  by  combined  isoelectric  focusing and electrophoresis in mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26: 231-243.
- 66. Kniemeyer,  O.  (2011).  Proteomics  of  eukaryotic  microorganisms: The medically and biotechnologically important fungal genus Aspergillus. Proteomics , 11 (15), 3232-3243.
- 67. Kuhn, M., &amp; Goebel, W. (2006). Genomics of Listeria monocytogenes. Pathogenomics:  Genome  Analysis  of  Pathogenic Microbes , 339-366.
- 68. Lander,  E.  et  al.  2001.  International  Human  Genome  Sequencing Consortium:  Initial  sequencing  and  analysis  of  the  human  genome. Nature 409, 860-921.
- 69. Leder, P., and M. W. Nirenberg. 1964. RNA codewords and protein synthesis3.On the nucleotide sequence of a cysteine and leucine RNA code words. Proc. Na. Acad. Sci. U.S.A. 52, 1521-1529.
- 70. Lee, D., Redfern, O., &amp;Orengo,  C.  (2007). Predicting protein function from sequence and structure. Nature reviews molecular cell biology , 8 (12), 995-1005.
- 71. Lee, H., Lee, Y. H., Huh, Y. S., Moon, H., &amp; Yun, Y. (1995). X-gene Product Antagonizes the p53-mediated Inhibition of Hepatitis B Virus Replication  through  Regulation  of  the  Pregenomic/Core  Promoter ( â ). Journal of Biological Chemistry , 270 (52), 31405-31412.
- 72. Lewin, B. 2004. Gene VIII. Upper Saddle River, NJ: Prentice Hall.
- 73. Li, Y., Ito, M., Sun, S., Chida, T., Nakashima, K., &amp; Suzuki, T. (2016). LUC7L3/CROP inhibits replication of hepatitis B virus via suppressing

enhancer II/basal core promoter activity. Scientific reports , 6 (1), 1-11.

- 74. Lill, R. (2009). Function and biogenesis of iron-sulphur proteins. Nature , 460 (7257), 831-838.
- 75. Loscalzo,  J.  (2011).  Systems  biology  and  personalized  medicine:  a network  approach  to  human  disease. Proceedings  of  the  American Thoracic Society , 8 (2), 196-198.
- 76. Maestri,  E.,  Klueva,  N.,  Perrotta,  C.,  Gulli,  M.,  Nguyen,  H.  T., &amp;Marmiroli, N. (2002). Molecular genetics of heat tolerance and heat shock proteins in cereals. Plant molecular biology , 48 (5), 667-681.
- 77. Makjaroen, J., Somparn, P., Hodge, K., Poomipak, W., Hirankarn, N., &amp;Pisitkun, T. (2018). Comprehensive proteomics identification of IFNÎ»3-regulated antiviral proteins in HBV-transfected cells. Molecular &amp; Cellular Proteomics , 17 (11), 2197-2215.
- 78. Marschalek, R. (2011). Mechanisms of leukemogenesis by MLL fusion proteins. British journal of haematology , 152 (2), 141-154.
- 79. Matheson, N. J., Sumner, J., Wals, K., Rapiteanu, R., Weekes, M. P., Vigan, R., ... &amp;Lehner, P. J. (2015). Cell surface proteomic map of HIV infection reveals antagonism of amino acid metabolism by Vpu and Nef. Cell host &amp; microbe , 18 (4), 409-423.
- 80. Mattick, J. S. 2003. Challenging the dogma: the hidden layer of nonprotein-coding RNAs in complex organisms. BioEssays 25, 930-939.
- 81. Mendel, J. G. 1866. Versuche uberPlflanzenhybridenVerhandlungen des naturforschendenVereines in Brunn, Bd. IV fur das Jahr, 1865. Abhandlungen, 3-47. For the English translation, see: Druery, C. T. and W. Bateson. 1901. Experiments in plant hybridization. J. R. Horticul. Soc. 26, 1-32.
- 82. Merrifield, R. B. 1963. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J. Am. ChemSci J. 85(14), 2149-2154.
- 83. Mishra, N. C. 2002. Nucleases-Molecular Biology and Applications. New York: Wiley.
- 84. Mitchell, H. K. and J. Lein. 1948. A Neurospora mutant deficient in the enzymatic synthesis of tryptophan. J. Biol. Chem. 175, 481-482.
- 85. Mitchell, H. K., M. B. Houlahan, J. Lein. 1948. Some aspects of genetic control of tryptophan metabolism in Neurospora. Genetics 33, 620.
- 86. Moore, S. and W. Stein. 1972. The chemical synthesis of pancreatic ribonuclease and deoxyribonuclease. Nobel Lecture 80-93.

- 87. Muthuirulan, P. (2016). Insight into Phenotypic and Genotypic Discrimination  of  Bacterial  Pathogens:  From  Pre-Genomic  to  PostGenomic Era. BAOJ Med Nursing , 2 , 018.
- 88. Nabieva, E., Jim, K., Agarwal, A., Chazelle, B., &amp; Singh, M. (2005). Whole-proteome  prediction  of  protein  function  via  graph-theoretic analysis of interaction maps. Bioinformatics , 21 (suppl\_1), i302-i310.
- 89. Nasrallah,  M.  E.,  Barber,  J.  T.,  &amp;  Wallace,  D.  H.  (1970).  Selfincompatibility  proteins  in  plants:  detection,  genetics,  and  possible mode of action. Heredity , 25 (Pt. 1), 23-27.
- 90. Neidhardt, F. C., VanBogelen, R. A., &amp; Vaughn, V. (1984). The genetics and regulation of heat-shock proteins. Annual review of genetics , 18 (1), 295-329.
- 91. Neuwald, A. F., Aravind, L., Spouge, J. L., &amp;Koonin, E. V. (1999). AAA+:  A  class  of  chaperone-like  ATPases  associated  with  the assembly, operation, and disassembly of protein complexes. Genome research , 9 (1), 27-43
- 92. Nilsson,  B.  L.,  M.  B.  Soellner,  and  R.  T.  Raines.  2005.  Chemical synthesis of proteins. Annu. Rev. Biophys. Biomol. Struct. 34, 91-118.
- 93. O'Farrell, P. H. 1975. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021.
- 94. Paape, D., &amp;Aebischer, T. (2011). Contribution of proteomics of Leishmania spp.  to  the  understanding  of  differentiation,  drug resistance  mechanisms,  vaccine  and  drug  development. Journal  of proteomics , 74 (9), 1614-1624.
- 95. Pauling Linus 1954 in Nobel Lectures, Chemistry 1942-1962 , Elsevier Publishing Company, Amsterdam, 1964.
- 96. Payne, P. I. (1987). Genetics of wheat storage proteins and the effect of allelic variation on bread-making quality. Annual Review of Plant Physiology , 38 (1), 141-153.
- 97. Payne, P. I., Holt, L. M., Jackson, E. A., &amp; Law, C. N. (1984). Wheat storage  proteins:  their  genetics  and  their  potential  for  manipulation by plant breeding. Philosophical Transactions of the Royal Society of London. B, Biological Sciences , 304 (1120), 359-371.
- 98. Payne, P. I., Holt, L. M., Lawrence, G. J., &amp; Law, C. N. (1982). The genetics of gliadin and glutenin, the major storage proteins of the wheat endosperm. Plant Foods for Human Nutrition , 31 (3), 229-241.

- 99. Pellegrini,  A.  (2003).  Antimicrobial  peptides  from  food  proteins. Current pharmaceutical design , 9 (16), 1225-1238.
- 100. Perutz, M. F. Rossman, MG; Cullis, AF; Muirhead, H; Will, G; North, 1960. Structure of haemoglobin: a three-dimensional Fourier synthesis at 5.5A resolution, obtained by x-ray analysis. Nature 185, 416-422.
- 101. Prucca, C. G., I. Salvin, R. Quiroga, E. V . Elias, F. D. Rivero, A. Saura, P. G. Carranza, and H. D. Lujan. 2008 Antigenic variation in Giardia lamblia is regulated by RNA interference. Nature 456, 750-754.
- 102. Radford, A. (1991). Methods in yeast genetics-A laboratory course manual  by  M  Rose,  F  Winston  and  P  Hieter.  pp  198.  Cold  Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 1990. $34 ISBN 0 87969 354 1. ---
- 103. Rasheed, A.,  Xia,  X., Yan, Y., Appels,  R.,  Mahmood,  T.,  &amp;  He,  Z. (2014). Wheat seed storage proteins: Advances in molecular genetics, diversity and breeding applications. Journal of Cereal Science , 60 (1), 11-24.
- 104. Rittmann, B. E., Krajmalnik-Brown, R., &amp;Halden, R. U. (2008). Pregenomic, genomic and post-genomic study of microbial communities involved in bioenergy. Nature reviews microbiology , 6 (8), 604-612.
- 105. Rossin,  E.  J.,  Lage,  K.,  Raychaudhuri,  S.,  Xavier,  R.  J.,  Tatar,  D., Benita,  Y.,  ...  &amp;  Daly,  M.  J.  (2011).  Proteins  encoded  in  genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS genetics , 7 (1), e1001273.
- 106. Sanger,  F.  1952.  The  arrangement  of  amino  acids  in  proteins. Adv. Protein Chem. 7, 1-28
- 107. Sanger, F. 1958. The chemistry of insulin. Nobel Lecture 544-556.
- 108. Sarabhai, A.  S., A. W.  O.  Stretton,  S.  Brenner,  and A.  Bolle.  1964. Colinearity of the gene with the peptide chain. Nature 201, 13-17.
- 109. Schlessinger, A., Punta, M., &amp;Rost, B. (2007). Natively unstructured regions in proteins identified from contact predictions. Bioinformatics , 23 (18), 2376-2384.
- 110. Setlow, P. (1988). Small, acid-soluble spore proteins of Bacillus species: structure, synthesis, genetics, function, and  degradation. Annual Reviews in Microbiology , 42 (1), 319-338.
- 111.  Sharp,  P. A.  2005.  The  discovery  of  split  genes  and  RNA  splicing. Trends Biochem Sci. 30, 279-81.

- 112. Shewry,  P.  R.,  Halford,  N.  G.,  &amp;Lafiandra,  D.  (2003).  Genetics  of wheat gluten proteins. Advances in genetics , 49 , 111-184.
- 113. Shishkin, S. S., Kovalyov, L. I., &amp;Kovalyova, M. A. (2004). Proteomic studies of human and other vertebrate muscle proteins. Biochemistry (Moscow) , 69 (11), 1283-1298.
- 114. Snipes,  G.  J.,  &amp;  Suter,  U.  E.  L.  I.  (1995).  Molecular  anatomy  and genetics of myelin proteins in the peripheral nervous system. Journal of anatomy , 186 (Pt 3), 483.
- 115. Song,  J.,  &amp;  Singh,  M.  (2009).  How  and  when  should  interactomederived  clusters  be  used  to  predict  functional  modules  and  protein function?. Bioinformatics , 25 (23), 3143-3150.
- 116. Stoebel, D. M., Dean, A. M., &amp;Dykhuizen, D. E. (2008). The cost of expression of Escherichia coli lac operon proteins is in the process, not in the products. Genetics , 178 (3), 1653-1660.
- 117. Stryer, L. 1982. Biochemistry, 2nd edition. San Francisco, CA: W.H. Freeman Co.
- 118. Subramanian,  S.,  &amp;  Kumar,  S.  (2004).  Gene  expression  intensity shapes  evolutionary  rates  of  the  proteins  encoded  by  the  vertebrate genome. Genetics , 168 (1), 373-381.
- 119. Sumner, J. B. 1946. The chemical nature of enzyme. Nobel Lectures 114-121
- 120. Sun, S., Nakashima, K., Ito, M., Li, Y., Chida, T., Takahashi, H., ... &amp;  Suzuki,  T.  (2017).  Involvement  of  PUF60  in  transcriptional  and post-transcriptional regulation of hepatitis B virus pregenomic RNA expression. Scientific reports , 7 (1), 1-15.
- 121. Sunagar,  K.,  Morgenstern,  D.,  Reitzel, A.  M.,  &amp;  Moran, Y.  (2016). Ecological venomics: How genomics, transcriptomics and proteomics can shed new light on the ecology and evolution of venom. Journal of Proteomics , 135 , 62-72.
- 122. Swanson, H. I., &amp; Bradfield, C. A. (1993). The AH-receptor: genetics, structure and function. Pharmacogenetics , 3 (5), 213-230.
- 123. Taha, T. Y., Anirudhan, V., Limothai, U., Loeb, D. D., Petukhov, P. A., &amp; McLachlan, A. (2020). Modulation of hepatitis B virus pregenomic RNA stability  and  splicing  by  histone  deacetylase  5  enhances  viral biosynthesis. PLoS pathogens , 16 (8), e1008802.
- 124. Tanford,  C.  and  J.  Reynolds.  2004.  Nature's  Robot:  A  History  of Proteins. Oxford, UK: Oxford University Press.

- 125. Thomas,  P.  D.,  Campbell,  M.  J.,  Kejariwal, A.,  Mi,  H.,  Karlak,  B., Daverman,  R.,  ...  &amp;Narechania,  A.  (2003).  PANTHER:  a  library of  protein  families  and  subfamilies  indexed  by  function. Genome research , 13 (9), 2129-2141.
- 126. Vandahl, B. B., Birkelund, S., &amp; Christiansen, G. (2004). Genome and proteome analysis of Chlamydia. Proteomics , 4 (10), 2831-2842.
- 127. Virgin  4th,  H.  W.,  Mann,  M.  A.,  Fields,  B.  N.,  &amp;  Tyler,  K.  L. (1991).  Monoclonal  antibodies  to  reovirus  reveal  structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. Journal of virology , 65 (12), 6772-6781.
- 128. Volkin,  E.  and  L.  Astrachan.  1957.  Phosphorus  incorporation  in Escherichia coli ribo-nucleic acid after infection with bacteriophage T2. Virology 1956,149-161.
- 129. Watson, J. 1965. Molecular Biology of Gene. Melno Park, CA: W. A. Benjamin.
- 130. Watson, J. D. and F. H. C. Crick 1953a. Molecular structure of nucleic acids: A structure for desoxyribonucleic acids. Nature 171 731
- 131. Watson, J. D. and F. H. C. Crick 1953b. General implications of the structure of desoxyribonucleic acids. Nature 171. 964
- 132. Watson, J. D., Laskowski, R. A., &amp; Thornton, J. M. (2005). Predicting protein function from sequence and structural data. Current opinion in structural biology , 15 (3), 275-284.
- 133. Wilkins, M. 1996. 1997. Protein identification in the post-genome era: the rapid rise of proteomics. Q. Rev. Biophys. 30(4), 279-331.
- 134. Xia, X. (2018). Fundamentals of Proteomics. In Bioinformatics and the Cell (pp. 421-436). Springer, Cham.
- 135. Yanofsky, C. 1952. The effect of gene changes on tryptophan desmolase formation. Proc. Nal. Acad. Sci. U.S.A. 38, 215-226.
- 136. Yanofsky, C. 2005a. The favorable features of Tryptophan synthetase for  proving  Beadle  and  Tatum's  one  gene-one  enzyme  hypotheis. Genetics 169, 511-516.
- 137. Yanofsky,  C.  2005b.  Using  studies  on  Tryptophan  metabolism  to answer basic biological questions. J. Biol. Chem. 278, 19859-10878.
- 138. Yanofsky, C., B. C. Carlton, J. R. Guest, D. R. Helinski, and U. Henning. 1964. On the colinearity of gene structure and protein structure. Proc. Nat. Acad. Sci . U.S.A. 51, 266-27

- 139. Yao, Z., Jia, X., Megger, D. A., Chen, J., Liu, Y., Li, J., ... &amp; Yuan, Z. (2018). Label-free proteomic analysis of exosomes secreted from THP1-derived macrophages treated with IFN-Î± identifies antiviral proteins enriched in exosomes. Journal of proteome research , 18 (3), 855-864.
- 140. Zhang,  J.,  Keene,  C.  D.,  Pan,  C.,  Montine,  K.  S.,  &amp;Montine,  T.  J. (2008). Proteomics of human neurodegenerative diseases. Journal of Neuropathology &amp; Experimental Neurology , 67 (10), 923-932.

<!-- image -->

## PROTEOMICS-RELATION TO GENOMICS

| CONTENTS                                                                                                       |
|----------------------------------------------------------------------------------------------------------------|
| 2.1 Introduction  ....................................................................................... 60   |
| 2.2 Genomics .......................................................................................... 60     |
| References  ............................................................................................... 80 |

## 2.1 INTRODUCTION

Proteomics is the research among all proteins as well as their relationships in  a  cell  or  a  species;  as  a  result,  proteomics  is  inextricably  linked  to genomics, which is the study of all genetics in just about any species as well  as  how  genes  translate  for  proteins.  Bioinformatics,  also  known  as computational biology, aids in the interpretation as well as administration of all data produced during the investigation of an organism's genomes and proteome. Since the  origin  of  genes  or  the  DNA  pattern  stays  similar  in all  cells  in  the  human  body,  genomics  is  static.  Proteomics,  on  the  other hand, is dynamic because protein patterns vary from one kind of cell to the next or throughout developmental stages. The several phases of an insect's life  highlight  the  striking  difference  between  biology  and  genetics:  The caterpillar  and  the  butterfly,  for  instance,  have  the  same  DNA,  yet  their proteomes or protein profiles are separate, giving them opposite forms and content as if they were two separate species (Figure 2.1).

Roughly 30,000 genes in humans are essential for the manufacture of 4.5 million  proteins.  It  is  difficult  to  understand  how  a  tiny  set  of  genes  can  produce just too many proteins. Variant splicing of transcripts and posttranslational alteration  of  proteins  are  responsible  for  most  of  the  variation  in  protein composition (Zivy&amp; de Vienne, 2000; Martyniuk&amp;Denslow, 2009).

<!-- image -->

Figure 2.1. The caterpillar and butterfly exemplify the differences in proteomics at two different stages in the life cycle of an insect.

<!-- image -->

Source: https://www.charismaticplanet.com/life-cycle-butterfly/

## 2.2 GENOMICS

Genomics involves determining the whole pattern of DNA of an individual's chromosome(s) and comprehending the structure of these patterns. And over 500 creatures' whole DNA patterns have been discovered. It started with the sequencing of a bacterial virus 174 as well as advanced to the human genome (see Table 2.1: Genomes of various organisms).

Table 2.1. Genomes of different organism

|             |   2000 | 3000 Mb   | The first draft of human genome sequence announced.                    |
|-------------|--------|-----------|------------------------------------------------------------------------|
| Chimpanzee  |   2005 | 3000 Mb   | The closet relative of living                                          |
| Ncanderthal |   2006 | 3000 Mb   | The extinct cousin of human, more than a million basc sequenced. pairs |

A minimum of three types of DNA appear to occur in higher species. These DNA patterns are subsequently translated into proteins which regulate the  shape  and  groups  of  organisms.  The  second  category  contains  just translated DNAs; through the transmission of RNA (tRNA) and ribosomal RNA  (rRNA)  production,  these  RNAs  facilitate  the  synthesis  of  other regions  into  proteins.  The  third  type  of  DNA  pattern,  like  a  regulator, activator,  promoter,  and  silencer  sections,  regulates  the  transcription  of genes involved throughout transcription into tiny nuclear RNA (snRNA) as well as microRNA, or as whole DNA. Consequently, the third type of DNA pattern solely functions as a regulatory pattern to govern the transcription of other DNA patterns.

Moreover, certain DNA sequences may act as structural elements or other types of codes outside certain necessary for encoding proteins (Lan et al., 2003; Low et al., 2013). These DNA patterns are necessary for chromosomal stability and functioning. For instance, the nucleotide patterns in telomeres need not encode for any protein yet are necessary for the preservation of chromosomal  size  or  integrity  during  replication.  Similarly,  the  DNA sequences  that  make  up  the  centromeres  need  not  encode  any  proteins yet are necessary for the separation of daughter chromosomes at the time of  cell  division.  Without  correct  centromere  activity,  cell  division  would lead to uneven chromosomes' division to daughter cells, a condition known as aneuploidy. Aneuploidy in people is responsible for multiple disorders, like  Down  syndrome,  and  illnesses,  like  cancer.  Moreover,  certain  DNA sequences serve as regulatory areas or structural parts of the chromosome in undefined manners. The remaining 30-40% of DNA sequences are made

up of retroposons collected during the evolution of species, such as humans. Consequently, the origin of a substantial fraction of the nucleotide sequences in larger species remains unclear. These DNA sequences are referred to as 'junk DNA' since their purpose in the form and composition of the genome is unknown.

Figure 2.2. Graphical representation of genomics and its applications.

<!-- image -->

## Source:https://databricks.com/glossary/genomics

Supposedly, genomics began with Watson and Crick's 1953 discovery of the double-helix structure of DNA. This DNA framework involves the characteristics of the genetic data. The property is such that the DNA strand is equivalent to the other inside a DNA molecule. Utilizing one strand as a material for the formation of the strand inside the DNA, the double helix offers the method for the duplication of genetic data. It also facilitates the storage and processing of genetic data. The data is contained as triplets or codons,  which  are  composed  of  the  four  nucleotides  (adenine,  cytosine, guanine, and thymine) present in DNA. Data is relayed from DNA to RNA Molecule (mRNA) and ultimately to proteins by transcriptional regulation, respectively. Lastly, the DNA structure allows for mutagenesis or hereditary alteration in the genetic data in the event of a duplicating mistake that occurs in the duplication of the DNA molecule (Fabian et al., 2008; Oldham, 2009).

Till  the  identification  of  enzymes  like  DNA  polymerases,  constraint endonucleases, and ligases for the manufacture, cutting, and joining of DNA sections, genomics stayed a pipe dream.  The advent of tools like DNA cloning, Gene sequencing (Maxam and Gilbert 1977, Sanger Nicklen and Coulson 1977), and DNA replication hastened the march to genomics (Mullis and Faloona 1987). The mechanization of large-scale DNA designing (Smith et al., 1985) enabled the sequencing of over one million nucleotides per day. The introduction of technology and accompanying software made it feasible to  automate  DNA  sequencing.  Computers  also  created  an  opportunity  to organize and evaluate Genomic DNA data, paving the way for the initiation of genome projects (Collins and Galas 1993).

## 2.2.1 Human Genome Project and Other Genome Projects

After the technology for assembling DNA fragments had become accessible, it formed critical to producing projects to understand the DNA sequence of people and other species to better grasp how DNA needs to carry data for the design of living species into the adult stage, including a fertilized egg cell and their interrelatedness. To accomplish this, efforts were undertaken to create and enhance DNA sequencing techniques based on throughput and efficiency, as well as to undertake genome projects. All components of DNA sequencing  were  carried  out  concurrently.  The  Human  Genome  Project was developed in 1990 by the US Department of Energy and the National Institutes of Health to discover the whole Sequence of DNA of people in terms of understanding its function in human development and health. Many genetic  creaturesâº  genome  studies  were  also  conducted  as  experimental models for studying the significance of genes that can not be investigated in humans due to technological and ethical constraints. The noted the following of the human DNA sequence was disclosed and released in June 2000, and it was christened the language of God in which our destiny is written by W. Clin- ton, then-President of the United States. Whenever the human genome project was completed, the whole genomes of various model species were determined. Hemophilus, yeast, fruit fliesor Drosophila melanogaster , the roundworm Caenorhabditis  elegans ,  and Arabidopsis  thaliana ,  a  model plant were among them (Mustafa, 2005; Gstaiger &amp;Aebersold, 2009).

Figure 2.3. This illustration depicts the shotgun reading technique, which involves copying, breaking, scanning, and computer analysis of DNA to determine the initial genetic sequence.

<!-- image -->

Source: https://commons.wikimedia.org/wiki/File:Whole\_genome\_shotgun\_se-quencing\_versus\_Hierarchical\_shotgun\_sequencing.png

The  DNA  sequence  of  Hemophilus  revealed  that  a  single  organism may survive with as few as 460 protein-coding genes. The DNA sequence of yeast revealed that a eukaryotic cell requires roughly 6000 genes. The number  of  genes  necessary  for  distinct  cellular  metabolic  processes  was also found by analyzing the yeast genome. The fruit fly's DNA sequence

revealed  the  existence  of  around  13,000  genes  essential  for  the  ongoing production of a multicellular creature (Kenyon et al., 2002; Gupta et al., 2016). Around 19,000 genes were discovered in the roundworm's genome investigation. This research also revealed the importance of programmed cell death in the worm's growth. The human genome investigation revealed the astonishing finding that just roughly 23,000 genes are necessary for the ongoing production of a complex creature from one fertilized cell to an adult comprising 1013 cells with over 700 cell types grouped into distinct tissues and organs. Originally, it was believed that humans had up to 100,000 genes. This figure was predicated on the presumption that each protein had one gene, however, it comes out that the human genome has less than 23,000 genes  but  also  more  than  100,000  proteins,  which  are  made  possible  by alternative splicing of transcripts from a limited number of genes. The human genome project not just identified the whole patterns of around 3 billion nucleotides spread over 24 chromosomes, comprising 22 autosomes and X and Y chromosomes, but also released the technologies used throughout such procedure public. For the first time, our effort attempted to comprehend the ethical, legal, and social implications (ELSI) of the results. This endeavor was a significant divergence from previous scientific endeavors. The care with which ethical concerns were developed was unlike anything else before attempted. For instance, whenever the Manhattan Project was launched to produce  a  nuclear  weapon,  ethical  issues  were  completely  disregarded, which atomic physicists subsequently condemned (Yates, 2000; Wright et al., 2010).

## 2.2.2 Methods to Study the Genome Project

The  invention  and  production  of  vectors,  as  well  as  the  creation  of recombinant  DNA  technology,  were  crucial  in  molecular  cloning.  By treating  with  restriction  enzymes,  human  DNA  and  perhaps  other  DNA might be easily produced as required length pieces. These pieces might then be put into round vector DNA, like plasmid DNA, using ligases after being linearized by restriction endonucleases cut at a specific spot (Skylas et al., 2005; Ãzdemir et al., 2017).

Figure 2.4. Clone and sequencing cover ranges.

<!-- image -->

Source: https://commons.wikimedia.org/wiki/File:DNA\_Sequencing\_gDNA\_li-braries.jpg

Transfection might be used to deliver recombinant vector DNA carrying mammalian or foreign DNA sequences as inserted into bacteria organisms like Escherichia coli (see  Figure  2.2).  Because  recombinant  vectors  may self-replicate in bacterial host cells, they are promoted in those cells. Several approaches  exist  for  dramatically  increasing  the  number  of  chimerical vectors in the host cells.

Figure 2.5. A general method for the cloning of a gene.

<!-- image -->

Source: By Kelvinsong - Own work, CC BY-SA 3.0, https://commons.wikimedia. org/w/index.php?curid=23730988

Many more types of vectors are now accessible in addition to plasmid DNA (Sali et al., 2003; McLean,  2013). Cosmid, phage DNA, and YAC (yeast artificial chromosome) ), BAC (bacterial artificial chromosome), and PAC (bacterial  artificial  chromosome)  (phage  artificial  chromosome)  are examples of  these. These  vectors  are  excellent  for  cloning  huge  Genetic material and, as a result, are important in genome sequencing. Much genetic information of importance, like the one that causes human disorders, was cloned to use the recently invented DNA cloning technology detailed here before the commencement of genome sequencing. Random  DNA sections first were cloned and afterward, bacterial cells with the cloned specific genes of relevance were chosen in this strategy to clone human genes or genes of relevance from many other resources. The shotgun technique of cloning was named after it (Pardanani et al., 2002; Baak et al., 2003). A group of bacterial  colonies  comprising  an  organism's  whole  genome  is  typically formed. The genomic library is a kind of gathering like this. Other types of DNA libraries exist in extra to the genomic collection created by the shotgun technique. After then, the cloned DNA sections from all these collections are utilized for analysis. Such DNA sections are sometimes expanded in vitro using the polymerase chain reaction (PCR) technology, which was invented by Mullis in 1985. (see Mullis &amp;Faloona 1987). Mullis received the Nobel Prize for inventing the PCR technique. The computers finally organize the DNA sequences  into  the  nucleotide  sequence  of  a  chromosome  (Cox  &amp; Mann, 2007; Li et al ., 2014).

Following  the  establishment  of  a  genomic  library,  more  specialized techniques  for  cloning  DNA  from  a  particular  chromosome  or  a  specific tissue  containing  a  specific  gene  were  created.  As  a  result,  many  DNA libraries were accessible. The genomic library, chromosomal collection, and expression collection are the three. A genomic library consists of bacterial cells that contain a whole genetic code achieved by the shotgun technique of cloning. A chromosome library consists of DNA sections from a specific chromosome contained in bacterial cells. The expression catalog, on the other hand, includes a total of demonstrated genes/DNA sections from a specific tissue, like blood cells, brain cells, or liver cells. The expression collection is made up of mRNA from a specific cell type. The mRNAs are extracted from a specific tissue as well as backward translated into complementary DNA (cDNA) using reverse transcription enzymes. Throughout the production of the expression collection, the single-stranded cDNA is made double using DNA polymerase and afterward put into vector DNA for proliferation in bacterial host cells (Kovac et al., 2013; Song &amp; Lin, 2017).

Clones of either the protein-encoding or protein-noncoding portions of DNA from a species are found in the genomic and chromosomal libraries. Nevertheless, inserting them into chromosomes for the aim of tracing and synthesizing the whole Sequence of DNA  chromosomes takes a lot of time and  work.  The  tracing  is  a  little  simpler  using  the  chromosome-specific library. It gives you the sequence of DNA of a chromosome from one side to another. For important information related, overlapping DNA fragments from a chromosome are beneficial. It is feasible to traverse from one side of the chromosome to another using overlapping areas (Bendixen, 2005; Rao &amp;Swamy, 2008).

To build a chromosomal library, an individual's chromosomes should be isolated from one another and acquired in their original state. Varied species have various numbers and sizes of chromosomes. Lower eukaryotes, like yeasts,  have  significantly  smaller  chromosomes,  containing  only  around 15  million  strands  or  fewer.  Pulsed-field  gel  electrophoresis  is  used  to isolate  them.  Humans  or  other  higher-order  creatures  have  substantially bigger  chromosomes.  In  general,  human  chromosomes  are  150  million nucleotide bases long. The individual chromosome 1 has around 260 million base pairs, whereas the Y chromosome only has roughly 60 million. They couldn't be isolated till the cell sorter was invented in the late 1980s at the Los Alamos National Laboratory.

## 2.2.3 The Outcome of the Study of the Human Genome

There are few human genes, and gene identification is difficult. The small estimate of protein-encoding genes was among the major discoveries of the human genome. Originally, it was considered that humans could have up to 100,000 genomes since they could have up to 100,000 activities, most of which are regulated through one enzyme. This viewpoint was congruent with Beadle and Tatum's (1941) one-gene-one-enzyme approach, and it remained until  the  mRNA sequence for mRNA research got accessible. An mRNA array study revealed the existence of around 100,000 mRNAs. Nevertheless, as the human genome project was completed and the nucleotide sequences for people were accessible, it had become clear that only roughly 23,000 gene encoding elements were present in people (Cahill et al., 2001; GÃ¼nther et al., 2014).

Figure 2.6. Overview of genome.

<!-- image -->

Source: Gim J-A. A Genomic Information Management System for Maintaining Healthy Genomic States and Application of Genomic Big Data in Clinical Research. International Journal of Molecular Sciences. 2022; 23(11):5963. https://doi.org/10.3390/ijms23115963

By gene splicing, a huge amount of mRNAs and proteins were produced in humans from a limited set of genes. It is presently believed that far more than  half  of  the  genetic  mutations  experience  alternative  splicing,  results as  in  the  estimation  of  three  proteins  per  gene.  On  the  appearance,  it  is incredible that humans (23,000 genes) have just a several thousand extra genes  than  a  fruit  fly  (13,000  genes)  or  a  roundworm  (19,000  genes). However, several thousand genes might create a big impact and contribute to the emergence of a sophisticated creature like a human. This viewpoint becomes more understandable whenever it is realized as humans and chimps vary by several hundred genes, with fewer than ten genes accounting for morphological  characteristics  and  a  max  of  forty  genes  accounting  for variations  in  intellectual  growth  (Fermin  et  al.,  2006;  Asgari  &amp;Mofrad, 2015).

The human genome research discovered the design of DNA that does not correspond to every protein. These non-protein-coding patterns account for about 95% of all human nucleotide patterns. These DNA sequences are not normal genes. They are referred to as junk DNA since they do not impact

human features. Nevertheless, as such junk DNA is not rubbish since it has been preserved throughout the evolutionary course of human history as well as  a  change  in  it  may  halt  human  growth  (Pognan,  2004;  Latonen  et  al., 2018).

These strands are waste DNA similarly to that we collect rubbish in our basement in the hope that we could use it eventually. They are not junked DNA; if that was the case, this DNA would have been removed throughout the evolution change in the identical manner that we dispose of our rubbish. DNA hybridization tests by Britten and Kohne provided strong evidence for the occurrence of repeat sequences in higher creatures, like humans (1968).

The  human  genome  project  revealed  the  presence  and  placement  of these repetitive or junk DNA sections on the chromosomes. And over half of these repetitive sequences include recurrent nucleotides like GCGCGC. These have been copied numerous times and scattered haphazardly across the  genome  between  those  protein-coding  regions.  Such  segments  with many duplicates emerge as a fast renaturing segment of the genome in DNA hybridization tests. Protein coding patterns, on the other hand, seem as a progressively renaturing segment of the genome since they are retained as a small chunk of the DNA pattern in the genome. Several such sequences provide light on our evolutionary history. A small region of roughly 300 base pairs known as an Alu sequence is found amongst the junk DNA. Alu sequences account for approximately 7% of the genetic code (i.e., much more than protein-coding patterns, which show only 5 percent of the genome). So the junk DNA, which contains Alu sequences, has been dubbed 'selfish DNA.' They are self-centered in the idea that their only goal is to survive as a component of the genome. Through the evolution change, these patterns can not be deleted. The Alu patterns are exclusive to primates (Benesch et al., 2007; Carpi et al., 2010).

Understanding their function in humans as well as other higher species is a huge problem. Many junk DNAs are thought to be RNA transcribing sequences that play functions in the procedure of translation or the regulation of  gene  activity  or  gene  suppression. Additional  junk  DNAs  may have a range  of  structural  functions  in  linking  genes,  defining  gene  spacing,  or managing chromosomal supercoiling as well as total chromosome integrity (SolÃ©, &amp; Pastor-Satorras, 2002).

Before genome sequencing, it was considered that all rational human beings had the same nucleotide patterns in their chromosomes. It was also thought that people who were affected by an illness varied solely in the DNA

pattern of the gene(s) associated with producing the sickness. Nevertheless, after the full genome sequences of numerous normal people were decoded, it had become clear that their nucleotide sequences diverged in one or more locations.  This  variation  in  nucleotide  sequences  across  normal  people was referred to as an SNP. As a result, one person may have a sequence of AAGCCTA in a certain gene, but another person might also have AAGCTTA in a similar sequence in that gene, indicating an SNP. As a result, these two people show two distinct alleles of such a gene (i.e., the C allele and the T allele). SNPs are often found in populations where 1% or more of the people vary in their DNA sequence (Zivanovic et al., 2009). It is vital to note that SNPs are specific to a majority's ethnicity or geographic area. SNPs might arise in a gene's coding or non-coding sequences, as well as in intergenic areas between genes. Because of genetic code degeneracy, SNPs in a gene's coding sequence might nonetheless code for the similar amino acid in the protein. SNPs that result in the creation of similar proteins are referred to as alike, while SNPs that result in the creation of distinct proteins are referred to as nonsynonymous. SNPs in noncoding or intergenic areas may induce splicing or transcription factor binding errors, or they might modify the type of non-coding or roles In the regulation (Ju et al., 2010).

SNPs may be found all across the genetic code. They occur once per 300 nucleotide lengths of DNA. The human genome has around 10 million SNPs  and  3  billion  nucleotides.  Cytosine  is  substituted  by  thymine  in 2/3rd of all SNPs. Due to variations in the nucleotide sequence recognized by  a  restriction  enzyme,  SNPs  are  frequently  discovered  by  their  RFLP. Microarray examination or DNA sequencing is more effective in detecting SNPs.  SNPs  are  important  in  the  development  of  customized  medicine as  they  determine  an  individual's  reaction  to  a  medication,  chemical,  or infection.

Each chromosome has an identical number of genes or DNA sequences. Deletion  is  the  removal  of  a  chromosomal  section,  while  duplication  is the increase in the amount of a certain section; both are the fundamental reasons  for  various  human  disorders  or  syndromes.  The  findings  of  the human genome, on the other hand, have shown the existence of a varied proportion  of  similar  DNA  segments,  either  with  or  in  the  absence of  adverse  consequences  for  the  person. The  other  noteworthy  discovery from the human genome project is a difference in the genome size of the length of DNA in the different chromosomes. It has been discovered that a length of DNA may occur in several copies on the sister chromatids of a similar person or in dissimilar people, with or without creating health issues.

This is referred to as CNV. The variance generated by differing DNA section sequence similarity considerably outnumbers the latter referred to by SNPs.

CNV has been demonstrated to alter gene transcription as well as HIV and malaria resistance. CNV has been linked to immunological problems and neoplasia, as well as complex illnesses including diabetes and heart disease. CNV may  also  influence  an  individual's  capacity  to  adapt  to  a  specific environment. And  over  1400  CNVs  have  been  discovered  in  the  human genome. CNVs are found at several places on human as well as Chimpanzee chromosomes. Some hotspots are shared by both species, indicating that they have historical relevance. Surprisingly, CNVs for specific DNA sequences have been discovered in 80 percent of twin pairs. CNVs like this might be the cause of phenotypic variances between conjoined twins. CNV has been discovered in the DNA of people suffering from neuroblastoma, autism, and Alzheimer's disease.

Around 38 thousand human  transcribed components have been discovered during the latest study of human cDNA as well as transcribed sequence tags. These human transcriptional units were compared to those discovered in other primates plus non-primate sequences, and 131 primatespecific transcriptional units were discovered. Approximately half of such transcriptional  units  conserved  by  primates  include  protein-coding  sequences. These were likewise discovered to be devoid of introns, suggesting that they came from transposons. According to the expression profile of such primatespecific  genes,  they  are  solely  expressed  in  the  brain  and  reproductive systems. Around 21 of these primate-specific genes have been discovered to be included in the formation of human sperm, with several of them causing sterility in humans, such as teratozoospermia. The conclusion is that these primate-specific  genes  affected  primate  evolution.  In  several  respects, humans are distinct from other animals and primates, notably monkeys, our nearest surviving family. This contains our capability to walk upright and bipedally,  as  well  as  our  capability  to  speak,  language  development,  and several other sophisticated characteristics that form the foundation of our civilization and culture, such as agriculture, architecture, gourmet preparing food, songs, watercolor, advanced weaponry systems, the goal is to find and create  things,  and  a  desire  to  understand  the  fundamentals  of  nature.  So, what distinguishes us as human beings? This is an age-old conundrum. New findings in molecular biology and genomics, such as genome comparisons between humans and chimpanzees, appear to give a little insight into this subject.

Rapid alterations in primate genes are thought to be implicated in critical networks affecting sound perception, nerve signal propagation, cellular ions transport, and sperm generation, according to genomic research. Primates are distinguished from mammals and other species by the fast alterations in these gene groupings. The genetic basis for bipedal movement, a bigger brain, speech, and advanced language abilities are among the fundamental differences that separate humans from chimpanzees. Excluding the development  of  the  capacity  to  speak,  the  genetic  basis  for  such  a  task has as yet to be identified at the molecular level. It appears that a gene on chromosome  7  encoding  a  transcription  factor  protein  called  FOXP2  is essential for speech and communication in people. Svante Paabo and his team  at  the  Max  Planck  Institute  in  Leipzig,  Germany,  discovered  this by analyzing the amino acid pattern of Human FOXP2 with that of other creatures  (Enard  et  al.  2002).  The  discovery  that  a  British  family  with  a severe hereditary speech impediment had an adapted version of the FOXP2 gene supports this hypothesis (Lai et al. 2001, 2003). The human FOXP2 gene differs from those found in chimps and other monkeys (Enard et al. 2002).  The  mutant  human  FOXP2  gene,  like  the  chimp's  FOXP2,  was discovered in a British family with speech problems.

The  examination  of  the  Neanderthal  genome  sequencing  revealed  a significant fact: they have a similar nucleotide sequence in the FOXP2 gene as  people.  This  discovery  implies  that  Neanderthals  could  communicate. The  FOXP2  gene,  which  is  prevalent  in  humans  and  Neanderthals,  is thought to have evolved 400,000 years ago in a shared ancestor. Current studies demonstrate that transgenic mice with even a personal version of the FOXP2 gene communicate differently, indicating that the FOXP2 gene is involved in speech regulation. Studies on such transgenic mice also point to the significance of additional genes in human voice regulation in addition to the FOXP2 gene.

The  absence  of  a  hereditary  kind  of  standup  walking  potential  has been discovered in  a Turkish  community.  Nevertheless,  researchers  have discovered  an  uncommon  gene  mutation  that  causes  individuals  to  lose their right to move straight. This gene regulates a protein involved in the formation of the cerebellum in the mind. This gene mutation might decrease speech and mental skills in addition to monitoring vertical gait. Other genes may be involved in influencing the capacity to walk bipedally upright in humans, according to a study of identical individuals in Iraq and Brazil.

Humans also have significantly bigger brains. The ASPM gene, which influences human brain size, has been identified. Moreover, the genes HAR1 and  HAR2,  which  are  crucial  in  deciding  human  distinctiveness,  have recently been identified. These genes are known as HAR (human accelerated region) since they are situated in an area with significant mutation activity; for instance, the HAR-1 DNA sequence exhibits just one mutation variation in chimps and mice, but 32 mutations in humans and chimps for the same length of DNA. At minimum two of these genes, HAR-1 and HAR-2, have been identified in humans. The transcription factor HAR-1 is essential for the onset of the human cortex's six-layer organization. In humans, HAR-2 is involved in the regulation of the hands. Aside from such variations, humans are the only species to have various variants of the amylase gene, as well as a type of the lactose gene which permits an adult person to digest lactose, or 'milk sugar.' These genes provide people with nutritional benefits. Human and chimp genomes have 3 billion base units in common and are 99 percent similar. There is a 1.23 percent discrepancy, which equals 35 million DNA base pairs.  Moreover,  the  human  genome has around 5 million losses as well as penetrations of DNA sequences. As a result, the genomes of humans and chimps vary by around 4%. Approximately 580 genes out of the 25,000 have experienced quick and positive changes as the FOXP2 gene has. HARs are also among such genes. All of such genes are found in DNA sequences that serve no use. In addition, the chimp genome lacks several such genes. Three  essential  genes  that  govern  inflammation,  for  instance,  are  absent from the chimp genome, explaining why humans and chimps have different immunological and inflammatory responses. Similarly, the human genome is  lacking  numerous  genes.  This  contains  the  caspase-12  gene,  which protects chimps from Alzheimer's disease yet induces Alzheimer's disease in humans when it is absent. Another significant finding of the compared research of human and chimpanzee genomes is that evolving an organism does not need a large number of genomic alterations; rather, a small number of mutations may create a new creature (Pollard 2009).

## 2.2.4 Structural Genomics, Functional Genomics, and Comparative Genomics

Genome studies have many purposes. These tasks involve identifying their nucleotide  sequences,  defining  their  functionality,  and  comparing  them to  determine  their  evolutionary  pattern.  Structure  genomics,  functional genomics,  and  comparative  genomics  are  the  three  fields  of  genomics. As a result, structural genomics entails determining an organism's whole

nucleotide sequence.  Additional than 500 species' whole nucleotide sequences have been obtained, and roughly 3000 more organisms' sequences are being studied.

Figure 2.7. Functional, structural, and comparative genomics techniques are all interconnected.

<!-- image -->

Source: Akpinar, Ani &amp; Lucas, Stuart &amp; Budak, Hikmet. (2013). Genomics Approaches  for  Crop  Improvement  against  Abiotic  Stress.  TheScientificWorld -Journal. 2013. 361921. 10.1155/2013/361921

The  study  of  the  result  of  various  DNA  sequences  in  any  species  is known as functional genomics. It tries to analyze the function of around 25,000 genes in humans, as well as noncoding and repetitive sequences. It also tries to figure out what function SNPs play in the genome by studying the differences in the reaction of various copies of the similar DNA sequences or  genes  to  diverse  pharmacological,  chemical,  or  disease  sensitivities. Pharmacogenomics is the study of how drugs react differently in different people.

The study of genomes from various species is known as comparative genomics. Typically, the sequence homology of their genomes is calculated. This involves comparing a gene's introns and exons, the genome's internal transcribed noncoding regions, and gene placement on the chromosomal of the animals being studied. Its major goal is to figure out how various creatures are  related  evolutionarily. A  software  tool  named  Basic  Local Alignment Search Tool  determines  the  sequence  similarity  (BLAST).  This  software tool compares nucleotide or protein patterns to a data set and calculates the statistical validity of similarities to discover the areas of local homology. By finding both operational and historical links across sequences, BLAST may

also be utilized to allocate a specific sequence to a family of genes.

Figure 2.8. Comparative genomics may aid in the prediction of unidentified physiological and metabolic genes' activity-here shown for venomics.

<!-- image -->

Source: Drukewitz SH and von Reumont BM (2019) The Significance of Com -parative Genomics in Modern Evolutionary Venomics. Front. Ecol. Evol. 7:163. doi: 10.3389/fevo.2019.00163

## 2.2.5 Technical Advantages of Genomics

The  growth  of  advanced  methods  enabled  the  satisfactory  conclusion  of genome  sequencing  and  numerous  other  genome-related  studies.  Such techniques  comprise  mass  spectrometry,  DNA/RNA  microarrays,  protein chips, and mass sampling. Typically, such technologies create an enormous volume of data in a brief quantity of time. Many robotics- and computerbased high-throughput technologies have assisted the analysis of DNA at a  massive  scale.  454  Life  Sciences  created  this  one  approach  (Branford, CT). This technology utilizes picolitre reactors equipped with robotic fluidic as well as optical devices for combining sequenced reagents and detecting the result of the sequencing process (Margulies et al. 2005). This method analyzes around 20 million bases in nearly 4 hours. This approach produces a unique collection of DNA fragments from the complete genome, separates

single-stranded  DNA  molecules  on  a  bead,  multiplies  and  identifies them  using  PCR,  and  then  analyzes  the  DNA  fragments.  This  approach does  not  need  subcloning  of  DNA  fragments  in  bacteria  or  single  clone manipulation.  This  approach  employs  picoliter-volume  pyrosequencing on a solid substrate. Pyrosequencing involves synthesis-based analyzes. In this  technique,  a  template  DNA segment is replicated, and each period a nucleotide is introduced to the side chain, a group of enzymatic reactions provokes chemoluminescence or a light massage that is seized by a chargecoupled  device  (CCD)  camera  and  evaluated  by  a  computer  algorithm to  create  the  nucleotide  sequence.  This  technique  provides  a  significant improvement  over  all  techniques  that  use  Sanger's  approach  (Sanger  et al. 1977). VisiGen Biotechnologies, Inc. (Houston, TX) is creating a DNA sequencing device capable of analyzing 1 million characters per second. By 2010, this equipment will be accessible. This device, like some of the other throughput technologies, is premised on the idea of sorting by synthesized. This will analyze a 3.3 billion-base genetic code in one hour. This tool will be very beneficial for clinical applications and customized treatment.

Figure 2.9. Functional Genome Illustration.

<!-- image -->

Source: https://www.mdpi.com/2073-4360/13/7/1026

DNA microarray is the other high-throughput technique for determining the transcription of a group of genes in diverse circumstances in a single experiment. In this procedure, DNA sequences covering all or the majority of an individual's genetics are first positioned at a specified location on a glass chip, which is then hybridized with cDNA or mRNA from a cell. By attaching to two separate fluorophores, like rhodamine (red) and fluorescein (green), the cDNA derived from mRNA from two distinct cell lines or even a cell line cultured over two distinct growth circumstances is color-tagged (green). The combination of colored cDNA with Target DNA on a glass chip

allows for the processing of various hues. cDNA from mRNA generated from yeast maintained in anaerobic and aerobic circumstances, for instance, will only display a red color for gene products under oxygenated settings but would display a green color for genes shown under anaerobic environments. The genes produced in either aerobic or anaerobic situations will appear in yellow. Similarly, a normal cell might create red colors, as well as a cancerous cell, as well as a cancerous cell, might generate green colors for the genetics solely produced by such two cell lines. Nevertheless, the genes produced by the cell lines will appear in yellow. This technique was created by Schena and colleagues at Stanford University in 1995 (Schena et al., 1995), and it has undergone significant development since then. Southern hybridization relies  on  DNA-DNA  hybridization  to  create  a  DNA  array  for  analyzing gene expression (Southern 1975). Using the existing known methods, a chip holding the whole genome of an organism, such as 6000 yeast genes, may be manufactured with relative ease. In this kind of DNA matrix study, the color intensity may be utilized to assess the gene expression.

A  protein  matrix  has  been  designed  to  determine  a  cell's  protein expression  patterns.  Based  on  protein-protein  interactions,  like  antigen/ antibody  connections  employed  in  Western  hybridization.  A  significant quantity of antibodies or other ligands are placed on particular spots on a glass chip, and their association with rhodamine- or fluorescently protein lysates  representing  cell  lines  or  just  a  cell  line  cultured  in  two  distinct circumstances  is  then  evaluated.  The  outcomes  are  represented  by  red, green, and yellow dots. Likewise, the brightness of color may be utilized to denote the protein levels of expression. Protein chips are very useful in proteomics for analyzing protein-protein relationships, protein changes, and even identifying enzyme substrates. For several of these investigations, the protein chip is generated by fusing ORF transcripts of a cell with glutathione. This approach is very useful for drug development and the identification of proteins associated with disease management.

Mass  spectrometry  is  the  final  in  a  succession  of  high-throughput techniques  that  have  accelerated  the  detection  of  proteins  by  identifying the structure of peptides and matching them to the proteins expressed by the  target  DNA  in  the  genome  central  database.  The  whole  procedure  is completed  in  a  matter  of  minutes  utilizing  nanoscale  protein  quantity. A particular protein molecule or the entire set of proteins out of a cell is absorbed enzymatically, and afterward the volume of the arising peptide is ascertained by mass proportion in a mass spectrometer and paired with the protein pattern in a protein database to confirm the origin of the protein.

## REFERENCES

- 1. Asgari, E., &amp;Mofrad, M. R. (2015). Continuous distributed representation of biological sequences  for  deep  proteomics  and genomics. PloS one , 10 (11), e0141287.
- 2. Baak,  J.  P.  A.,  Path,  F.  R.  C.,  Hermsen,  M.  A.  J.  A.,  Meijer,  G., Schmidt, J., &amp; Janssen, E. A. M. (2003). Genomics and proteomics in cancer. European journal of cancer , 39 (9), 1199-1215.
- 3. Beadle, G. W. and E. L. Tatum, 1941. Genetic control of biochemical reactions in Neurospora. Proc. Natl. Acad. Sci. U.S.A. 27, 499-506.
- 4. Bendixen,  E.  (2005).  The  use  of  proteomics  in  meat  science. Meat science , 71 (1), 138-149.
- 5. Benesch, J. L., Ruotolo, B. T., Simmons, D. A., &amp; Robinson, C. V. (2007). Protein complexes in the gas phase: technology for structural genomics and proteomics. Chemical reviews , 107 (8), 3544-3567.
- 6. Botstein,  D.,  R.  L.  White,  M.  Skolnick,  and  R.  W.  Davis.  1980. Construction  of  genetic  linkage  in  man  using  restriction  fragment length polymorphism. Am. J. Hum. Genet. 32, 314.
- 7. Britten, R. J., and D. E. Kohne. 1968. Repeated sequences in DNA. Hundreds  of  thousands  of  copies  of  DNA  sequences  have  been incorporated into the genomes of higher organisms. Science 161, 529540.
- 8. Cahill,  D.  J.,  Nordhoff,  E.,  O'Brien,  J.,  Klose,  J.,  Eickhoff,  H., &amp;Lehrach, H. (2001). Bridging genomics and proteomics. Proteomics: from protein sequence to function. BIOS Scientific Publishers, Oxford , 1-22.
- 9. Carpi, A., Mechanick, J. I., Saussez, S., &amp;Nicolini, A. (2010). Thyroid tumor  marker  genomics  and  proteomics:  diagnostic  and  clinical implications. Journal of cellular physiology , 224 (3), 612-619.
- 10. Collins,  F.,  and  D.  Galas.  1993. A  new  five-year  plan  for  the  U.S. human genome project. Science 262, 43-46.
- 11. Cox, J., &amp; Mann, M. (2007). Is proteomics the new genomics?. Cell , 130 (3), 395-398.
- 12. de Groot,  A.,  Dulermo,  R.,  Ortet,  P .,  Blanchard,  L.,  GuÃ©rin,  P .,  Fernandez, B., ... &amp;Armengaud, J. (2009). Alliance of proteomics and genomics to unravel the specificities of Sahara bacterium Deinococcusdeserti. PLoS genetics , 5 (3), e1000434.

- 13. Di  Michele,  M.,  Thys,  C.,  Waelkens,  E.,  Overbergh,  L.,  D'Hertog, W.,  Mathieu,  C.,  ...  &amp;Freson,  K.  (2011).  An  integrated  proteomics and genomics analysis to unravel a heterogeneous platelet secretion defect. Journal of proteomics , 74 (6), 902-913.
- 14. Elango, N., B. G. Hunt, M. A. D. Goodisman, and S. V. Yip. 2009. DNA methylation is widespread and associated with differential gene expression in castes of the honeybee, Apis mellifera . Proc. Natl. Acad. Sci. U.S.A. (in press).
- 15. Enard, W., M. Przeworski, S. E. Fisher, C. S. L. Lai, V . Wiebe, T. Kitano, A. P. Monaco, and S. Paabo. 2002. Molecular evolution of FOXP2, a gene involved in speech and language. Nature 418, 869-872.
- 16. Fabian, T. K., Fejerdy, P., &amp;Csermely, P. (2008). Salivary genomics, transcriptomics  and  proteomics:  the  emerging  concept  of  the  oral ecosystem  and  their  use  in  the  early  diagnosis  of  cancer  and  other diseases. Current genomics , 9 (1), 11-21.
- 17. Fermin,  D.,  Allen,  B.  B.,  Blackwell,  T.  W.,  Menon,  R.,  Adamski, M., Xu, Y., ...  &amp;Omenn, G. S. (2006). Novel gene and gene model detection  using  a  whole  genome  open  reading  frame  analysis  in proteomics. Genome biology , 7 (4), 1-13.
- 18. Fry, B. G. (2005). From genome to 'venome': molecular origin and evolution  of  the  snake  venom  proteome  inferred  from  phylogenetic analysis  of  toxin  sequences  and  related  body  proteins. Genome Research , 15 (3), 403-420.
- 19. Gstaiger,  M.,  &amp;Aebersold,  R.  (2009). Applying  mass  spectrometrybased proteomics to genetics, genomics and network biology. Nature Reviews Genetics , 10 (9), 617-627.
- 20. GÃ¼nther,  O.  P.,  Shin,  H.,  Ng,  R.  T.,  McMaster,  W.  R.,  McManus, B. M., Keown, P. A., ... &amp;LÃª Cao, K. A. (2014). Novel multivariate methods for integration of genomics and proteomics data: applications in a kidney transplant rejection study. Omics: a journal of integrative biology , 18 (11), 682-695.
- 21. Gupta, A. K., Kaur, K., Rajput,  A., Dhanda, S. K., Sehgal, M., Khan, M., ... &amp; Kumar, M. (2016). ZikaVR: an integrated Zika virus resource for genomics, proteomics, phylogenetic and therapeutic analysis. Scientific reports , 6 (1), 1-16.
- 22. Hall,  N.,  Karras,  M.,  Raine,  J.  D.,  Carlton,  J.  M.,  Kooij,  T.  W., Berriman, M., ... &amp;Sinden, R. E. (2005). A comprehensive survey of

- the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science , 307 (5706), 82-86.
- 23. Hanash, S. M. (2001). Global profiling of gene expression in cancer using genomics  and  proteomics. Current  Opinion  in  Molecular Therapeutics , 3 (6), 538-545.
- 24. Hogeweg, P. 1978. Simulating the growth of cellular forms. Simulation 31, 90-96.
- 25. Hogeweg, P. and B. Hesper. 1978. Interactive instruction on population interactions. ComputBiol Med 8, 319-327.
- 26. Ibrahim, S. M., &amp; Gold, R. (2005). Genomics, proteomics, metabolomics:  what  is  in  a  word  for  multiple  sclerosis? Current opinion in neurology , 18 (3), 231-235.
- 27. inhibitors. Proc. Nat. Acad. Sci. U.S.A. 74, 5463-5467.
- 28. Ju,  C.,  Feng,  Z.,  Brindley,  P.  J.,  McManus,  D.  P.,  Han,  Z.,  Peng,  J. X.,  &amp;  Hu,  W.  (2010).  Our  wormy  world:  genomics,  proteomics and transcriptomics in East and Southeast Asia. Advances in parasitology , 73 , 327-371.
- 29. Kan, Y. W. and A. M. Dozy. 1978. Polymorphism of DNA sequence adjacent to human beta-globin gene: Relationship to sickle mutation. Proc. Natl. Acad. Sci. U.S.A. 75, 5637.
- 30. Kenyon, G. L., DeMarini, D. M., Fuchs, E., Galas, D. J., Kirsch, J. F., Leyh, T. S., ... &amp;Sheahan, L. C. (2002). Defining the mandate of proteomics in the post-genomics era: workshop report. Molecular &amp; Cellular Proteomics , 1 (10), 763-780.
- 31. Kovac,  J.  R.,  Pastuszak, A.  W.,  &amp;  Lamb,  D.  J.  (2013).  The  use  of genomics, proteomics, and metabolomics in identifying biomarkers of male infertility. Fertility and sterility , 99 (4), 998-1007.
- 32. Lai C. S., D. Gerrelli, A. P. Monaco, S. E. Fisher, A. J. Copp. 2003. FOXP2  expression  during  brain  development  coincides  with  adult sites of pathology in a severe speech and language disorder. Brain 126, 2455-2462.
- 33. Lai, C. S., S. E. Fisher, J. A. Hurst, F. Vargha-Khadem, A. P. Monaco. 2001.  A  forkhead-domain  gene  is  mutated  in  a  severe  speech  and language disorder. Nature 413, 519-523.
- 34. Lan,  N.,  Montelione,  G.  T.,  &amp;  Gerstein,  M.  (2003).  Ontologies for  proteomics:  towards  a  systematic  definition  of  structure  and

function that scales to the genome level. Current opinion in chemical biology , 7 (1), 44-54.

- 35. Latonen, L., Afyounian, E., JylhÃ¤, A., NÃ¤ttinen, J., Aapola, U., Annala, M., ... &amp;Visakorpi, T. (2018). Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression. Nature communications , 9 (1), 1-13.
- 36. Li, H. D., Menon, R., Omenn, G. S., &amp; Guan, Y. (2014). Revisiting the identification of canonical splice isoforms through integration of functional genomics and proteomics evidence. Proteomics , 14 (23-24), 2709-2718.
- 37. Low, T. Y., van Heesch, S., van den Toorn, H., Giansanti, P., Cristobal, A., Toonen, P., ... &amp; Guryev, V. (2013). Quantitative and qualitative proteome characteristics extracted from in-depth integrated genomics and proteomics analysis. Cell reports , 5 (5), 1469-1478.
- 38. Margulies, M., M. Egholm, W. E. Altman, S. Attiya, J. S. Bader, L. A. Bemben, J. Berka, M. S. Braverman, Y. J. Chen, Z. Chen et al.. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376-380.
- 39. Martyniuk, C. J., &amp;Denslow, N. D. (2009).  Towards functional genomics in fish using  quantitative proteomics. General  and  comparative endocrinology , 164 (2-3), 135-141.
- 40. Maxam, A. M. and W. Gilbert. 1977. A new method for sequencing DNA. Proc. Natl. Acad. Sci. U.S.A. 74, 560.
- 41. McLean,  T.  I.  (2013).  'Eco-omics':  a  review  of  the  application  of genomics, transcriptomics, and proteomics for the study of the ecology of harmful algae. Microbial ecology , 65 (4), 901-915.
- 42. Miller, I., Rogel-Gaillard, C., Spina, D., Fontanesi, L., &amp; M de  Almeida, A. (2014). The rabbit as an experimental and production animal: from genomics to proteomics. Current Protein and Peptide Science , 15 (2), 134-145.
- 43. Mullis, K. B. and F. A. Faloona. 1987. Specific synthesis of DNA in vitro via  a  polymerase  catalyzed  chain  reaction.  Methods  Enzymol. 155, 335.
- 44. Mustafa, A.  S.  (2005).  Mycobacterial  gene  cloning  and  expression, comparative genomics, bioinformatics and proteomics in relation to the  development  of  new  vaccines  and  diagnostic  reagents. Medical Principles and Practice , 14 (Suppl. 1), 27-34.

- 45. Oldham, P. D. (2009). Global status and trends in intellectual property claims:  genomics,  proteomics  and  biotechnology. Proteomics  and Biotechnology (January, 22 2009) .
- 46. Ãzdemir,  V.,  Dove,  E.  S.,  GÃ¼rsoy,  U.  K., ÅardaÅ,  S.,  YÄ±ldÄ±rÄ±m,  A., YÄ±lmaz, Å. G., ... &amp; Srivastava, S. (2017). Personalized medicine beyond genomics:  alternative  futures  in  big  data-proteomics,  environtome and the social proteome. Journal of neural transmission , 124 (1), 2532.
- 47. Pardanani, A., Wieben,  E.  D.,  Spelsberg, T.  C.,  &amp;Tefferi, A.  (2002, November). Primer on medical genomics part IV: expression proteomics. In Mayo Clinic Proceedings (V ol.  77, No. 11, pp. 11851196). Elsevier.
- 48. Pognan,  F.  (2004).  Genomics,  proteomics  and  metabonomics  in toxicology: Hopefully not 'fashionomics'. Pharmacogenomics , 5 (7), 879-893.
- 49. Pollard, K. S. 2009. What makes us human? Sci. Am. 300, 44-49.
- 50. Rao,  K.  D.,  &amp;Swamy,  M.  N.  S.  (2008). Analysis  of  genomics  and proteomics using DSP techniques. IEEE Transactions on Circuits and Systems I: Regular Papers , 55 (1), 370-378.
- 51. Rodrigues, P. M., Silva, T. S., Dias, J., &amp;Jessen, F. (2012). Proteomics in aquaculture: applications and trends. Journal of proteomics , 75 (14), 4325-4345.
- 52. Sali, A., Glaeser, R., Earnest, T., &amp;Baumeister, W. (2003). From words to literature in structural proteomics. Nature , 422 (6928), 216-225.
- 53. Sanger. F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain terminating
- 54. Schena, M., D. Shalon, R. W. Davis, and P. O. Brown. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 567-570.
- 55. Skylas, D. J., Van Dyk, D., &amp; Wrigley, C. W. (2005). Proteomics of wheat grain. Journal of cereal science , 41 (2), 165-179.
- 56. Smith,  L.  M.,  Fung,  S.,  Hunkapiller,  M.  W.,  Hunkapiller, T.  J.,  and Hood,  L.  E.  1985.  The  synthesis  of  oligonucleotides  containing  an aliphatic  amino  group  at  the  5\_  terminus:  Synthesis  of  fluorescent DNA primers for use in DNA sequence analysis. Nucleic Acids Res . 13, 2399-2412.

- 57. SolÃ©,  R.  V.,  &amp;  Pastor-Satorras,  R.  (2002).  Complex  networks  in genomics and proteomics. Handbook of Graphs and Networks ,  145167.
- 58. Song, X., &amp; Lin, Q. (2017). Genomics, transcriptomics and proteomics to  elucidate  the  pathogenesis  of  rheumatoid  arthritis. Rheumatology international , 37 (8), 1257-1265.
- 59. Southern,  E.  M.  1975.  Detection  of  specific  sequences  of  DNA fragments separated by gel electrophoresis. J Mol. Biol. 98, 503.
- 60. Sullivan,  M.  B.,  Krastins,  B.,  Hughes,  J.  L.,  Kelly,  L.,  Chase,  M., Sarracino, D., &amp; Chisholm, S. W. (2009). The genome and structural proteome of an ocean siphovirus: a new window into the cyanobacterial 'mobilome'. Environmental Microbiology , 11 (11), 2935-2951.
- 61. Vaidyanathan, P. P., &amp; Yoon, B. J. (2004). The role of signal-processing concepts  in genomics  and  proteomics. Journal  of the Franklin Institute , 341 (1-2), 111-135.
- 62. Wright, J. C., Beynon, R. J., &amp; Hubbard, S. J. (2010). Cross species proteomics. In Proteome Bioinformatics (pp. 123-135). Humana Press.
- 63. Yates III, J. R. (2000). Mass  spectrometry:  from  genomics  to proteomics. Trends in genetics , 16 (1), 5-8.
- 64. Zivanovic,  Y.,  Armengaud,  J.,  Lagorce,  A.,  Leplat,  C.,  GuÃ©rin,  P., Dutertre,  M.,  ...  &amp;Confalonieri,  F.  (2009).  Genome  analysis  and genome-wide proteomics of Thermococcusgammatolerans, the most  radioresistant  organism  known  amongst  the Archaea. Genome biology , 10 (6), 1-23.
- 65. Zivy, M., &amp; de Vienne, D. (2000). Proteomics: a link between genomics, genetics and physiology. Plant Molecular Biology , 44 (5), 575-580.

<!-- image -->

## METHODOLOGY FOR SEPARATION AND IDENTIFICATION OF PROTEINS AND THEIR INTERACTIONS

## CONTENTS

| 3.1 Introduction  ....................................................................................... 88   |
|----------------------------------------------------------------------------------------------------------------|
| 3.2 Separation of Protein Via the Multidimensional Approach  .................. 88                             |
| 3.3 Determination of the Primary Structure of Proteins ............................ 94                         |
| 3.4 Determination of the 3D Structure of a Protein ................................ 103                        |
| 3.5 Determination of the Number of Proteins ........................................ 108                       |
| 3.6 Structural and Functional Proteomics  ............................................... 113                  |
| References  ............................................................................................. 119  |

## 3.1 INTRODUCTION

In this lesson, we will cover techniques for (a) the separation of proteins, (b)  the  discovery  of  the  basic  protein  molecule  by  identification  of  their amino acid patterns, (c) the 3D structure, of proteins, and (d) the number of proteins at the proteome scale.

A cell has a multitude of proteins. The constituent proteins are isolated and  characterized  to  know  the  function  of  distinct  proteins  plus  their functional  and  structural  interactions.  Proteins  are  extracted  by  some techniques as they have a wide range of characteristics (Abdelhamid &amp; Wu, 2015; Field et al., 2020).

## 3.2 SEPARATION OF PROTEIN VIA THE MULTIDIMENSIONAL APPROACH

As discussed in Chapter 1, a multidimensional strategy is better for separating them as compared to the single one. A multifaceted method like this must handle issues like resolution, throughput, automation, and adaptation to mass spectrometry  analysis.  Electrophoresis,  which  includes  two-dimensional (2D) gel electrophoresis plus capillary electrophoresis, is among the most essential  methods  for  separating  them.  After  these  technologies  have separated them, mass spectrometry is used to identify them. This section elaborates  on  such  techniques  (Salzer  et  al.,  2008;  BÃ¼yÃ¼kkÃ¶roÄlu  et  al., 2018).

## 3.1.1 Electrophoresis

Molecules may be sorted depending on their electrostatic forces in an electric field. This technique is known as electrophoresis, and it was discovered by Swedish scientist Arne Teselius, who was given the 1948 Nobel Prize for this achievement. A solid substrate, like paper or gel, is coated with molecules, which are subsequently exposed to an electrical field. The motion of the molecules  in  an  electric  field  is  determined  by  their  electrical  charges. Typically, this separates proteins using a gel matrix, as shown below.

Figure 3.1. Basic Electrophoresis Principle.

<!-- image -->

Source:  By  Apblum  -  http://en.wikipedia.org/wiki/Capillary\_electrophoresis, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=35013009

2D Gel Electrophoresis is a technology invented separately by O'Farrell (1975) and Klose (1975) for separating proteins (Figure 3.1). Proteins in the Escherichia coli cell isolate were isolated by gel electrophoresis conducted on two surfaces that were perpendicular to one another. Initially, the proteins were extracted according to their charges, then they were sorted according to their molecular weights in a vertical plane to the first layer. Following two electrophoretic cycles, the solution was mixed to see the protein bands. Thus, over 1100 protein bands were recovered from the whole-cell extract of E. coli . The 2D gel technique has also been referred to as the Iso-Dalt method, since it separates proteins depending on their differences in electrical charge and mass, as indicated by isoelectrofocusing (IEF) [isoelectric point (pI)] and Dalton, the unit of mass (Arima &amp; Iwata, 2007; Jorrin-Novo, 2014).

Electrophoresis is a typical technique for isolating molecules, particularly proteins, according to their charge-to-mass ratio (e/m) and the intensity of the electric field . When a protein composition is exposed to an electric field, the protein molecules migrate into distinct zones depending on their carrier concentration, which is defined by the charge to mass (e/m) proportion of protein complexes (Kay et al., 2000; Turriziani et al., 2016). Typically, it separates proteins on a solid substrate, like polyacrylamide gel. On a solid matrix,  isolated  protein  molecules  are  kept  to  their  corresponding  zones with little diffusion and heat production.

Figure 3.2. Depicts the stages of Edman's degradation. Without hydrolyzing the rest of the peptide, the tagged aminoterminal residue (PTH - alanine in round one) is liberated. Repeating the cycle reveals the entire pattern of the peptide.

<!-- image -->

Source: https://chem.libretexts.org/Courses/University\_of\_Arkansas\_Lit-tle\_Rock/CHEM\_4320\_5320%3A\_Biochemistry\_1/02%3A\_\_Protein\_ Structure/2.2%3A\_Protein\_Sequencing

Heat production presents substantial complications in separating proteins in a liquid matrix. Under particular circumstances employing a small tube containing a combination of proteins in liquid, as in capillary electrophoresis, such challenges of separating proteins are significantly reduced. Polyacrylamide gel electrophoresis (PAGE) is often used to separate proteins since polyacrylamide gel produces a sieving impact throughout separating proteins due to the pore diameter of the gel. In addition, the diameter of the holes may be altered by adjusting the concentration of monomers in the gel, like acrylamide, the gelling agent, and bisacrylamide, the crosslinking agent in  the  gel. With  a  higher  quantity  of  acylamide, the hole diameter of the gel decreases. PAGE gels comprising 15  percent acrylamide and 5 percent bisacrylamide are often used to separate proteins. Based on the scale of the proteins, gels having 3 to 30 percent polyacrylamide may be used for protein extraction. For separating proteins with a molecular weight larger than 1 million Daltons, a 3 percent gel is utilized. For the separating proteins with a molecular mass of just under 1000 Daltons, a 30 percent gel is utilized. A 3 percent polyacrylamide gel is fragile and complicated to manipulate; these issues  are  typically  eliminated  by  the  addition  of  agarose  all  through  gel

formation. Agarose stabilizes the gel with not impairing the movement of the gel's proteins (Meyer &amp; Peters, 2003; Mahmoudi et al., 2011).

The 2D gel or Iso-Dalt is the most popular mechanism in proteomics due to its relative ease of using it, robotization, good reproducibility, resolving power  of  proteins,  and  mass  spectrometry  validity.  In  addition,  protein bands separated by Iso-Dalt are amenable to Edman degradation and amino acid structure assessment (Chouchani et al., 2011). As previously stated, the 2D gel technique separates proteins by resolution depending on the mass and  charge  of  the  proteins  in  two  distinct  aspects.  Separation  depending on this double property of proteins offers superior resolution by ignoring the existence of multiple proteins per band and/or cross-contamination of a protein band through other protein parts and by allowing the visualization of proteins that are present in minute quantities in the cell or body fluid. To obtain a high resolving power of newly synthesized proteins in proteomics, it  is  necessary,  to  begin  with,  a  test  tube  containing  all  of  the  proteins introduced  in  a  cell  or  body  fluid.  Care  must  be  taken  to  involve  every protein membrane that exists in the cell or body fluid or other hydrophobic proteins,  rare  protein  parts,  and  proteins  with  large  differences  in  charge material, like those, for example with a pH below 3 or over 10 (Brohee&amp; Van Helden, 2006; Cedervall et al., 2007).

The  2D  gel  technique  for  separating  proteins  has  been  discussed  in detail  by  Gorg  and  others  (1988),  and  Gorg  himself  is  credited  with  its development  (2000).  The  following  phases  include  the  most  essential features of this technique:

- Â· Preparing  the specimen, solubility, and applying to the gel
- Â· Protein segregation on an implanted pH gradient (IPG) gel strip using IEF
- Â· On a sodium dodecyl sulfate (SDS)-PAGE, the proteins in the IPG strip were separated.
- Â· After  SDS-PAGE,  observation  of  divided  protein  bands  and assessment of the structure of the divided proteins on the gel

## 3.1.2 Liquid Chromatography

Chromatography is the isolation of proteins or peptides by putting a mixture of  proteins  or  peptides  in  a  suitable  solvent  more  than  a  solid  matrix. Several types of chromatography exist dependent on the type of the matrix, including  liquid  or  column  chromatography,  paper  chromatography,  thin

gel chromatography, and gas chromatography. The type of chromatography most  applicable  to  proteome  analysis  as  well  as  appropriate  for  mass spectrometric analysis is liquid chromatography, also recognized as column chromatography since the matrix comprised of beads packed as a column in a glass tube whereby the protein or peptide solution is passed, resolved depending on their  size,  charge,  or  affinity  to  a  ligand,  and  segments  of divided proteins or peptides are gathered (Haque, 1998; Haque, 1998).

Figure 3.3. Typical route stream in liquid chromatography.

<!-- image -->

Source: By  This W3C-unspecified  vector  image  was  created  with  Ink -scape.  -  Own  work,  CC  BY  3.0,  https://commons.wikimedia.org/w/index. php?curid=10988849

## 3.1.2.1 Gel Filtration

Size-exclusion chromatography, often known as gel filtration, is a kind of liquid chromatography that separates proteins based on their size. Proteins are isolated using this approach depending on their molecular size. A protein solution is handed down a column of neutral materials having a set pore size, like agarose or Sephadex, and afterward eluted with a buffer. Oversized proteins that are unable to penetrate the hole of the beads snake thru the gap across beads and are ejected from the column throughout the elution phase. As a result,  bigger  proteins  emerge  first,  well  ahead  of  smaller  proteins. Smaller  proteins,  on  the  other  hand,  penetrate  the  bead  hole  and  require significantly longer to exit the holes upon elution, therefore they are eluted considerably  later  than  bigger  proteins.  Following  elution,  the  distinct

proteins are isolated and gathered as separate fractions (ZÃ¶lls et al., 2012; Sorci et al., 2013).

Figure 3.4. Gel filtering is used to separate molecules of various sizes.

<!-- image -->

Source; https://commons.wikimedia.org/wiki/File:SizeExChrom.png

## 3.1.2.2 Affinity Chromatography .

Affinity  chromatography  is  liquid  chromatography  that  isolates  proteins depending on their affinity for a ligand linked to the matrix. In this procedure, proteins without affinity for the matrix-bound ligand stay unattached and are easily eluted from the column. In comparison, a specific protein in the combination may attach to a ligand, delaying its clearance from the column; this protein gets deleted from the column later due to a variation in elution circumstances. This chromatographic technique is utilized for the separation of proteins that stay bound to the ligand connected to the column from the majority of a protein. Some proteins including histidine oligopeptides that are eliminated on a nickel column serve as an excellent illustration of protein purification via affinity chromatography (Reinders et al., 2006; Urey et al., 2016). Additionally,  glutathione-S-transferase-containing proteins  may be kept  and  isolated  specifically  from  a  column  having  glutathione-coated beads. An affinity tag may be developed specifically to separate or clear a certain protein. For instance, proteins required for DNA interactions, like Replication  of  DNA,  maintenance,  and  crossover,  may  be  isolated  using a matrix containing DNA as an affinity tag. Alternately, a protein may be purified by passing it across a matrix having an antibody with an affinity tag linked to it.

## 3.1.2.3 Ion Exchange Chromatography

Ion  exchange  chromatography  is  a  kind  of  liquid  chromatography  that differentiates proteins depending on electrical charges. Proteins are adsorbed onto a charged pair linked to the cellulose substrate in this procedure. Organic molecules which are anionic or cationic make up the charged pairs. The most popular cation and anion exchangers utilized as a matrix throughout ionexchange chromatography are carboxymethyls (CM) cellulose and diethyl aminoethyl (DEAE) cellulose (Issaq et al., 2002; Washburn, 2004).

Figure 3.5. Ion-exchange chromatography diagrammatic representation.

<!-- image -->

Source: WoÅowicz A, Wawrzkiewicz M. Screening of Ion Exchange Resins for Hazardous Ni(II) Removal from Aqueous Solutions: Kinetic and Equilibrium Batch Adsorption Method. Processes. 2021; 9(2):285. https://doi.org/10.3390/ pr9020285

Along with a variation in the concentration of ions or pH of the elution buffer, the unattached proteins are eliminated first, followed by the bound proteins.

## 3.3 DETERMINATION OF THE PRIMARY STRUCTURE OF PROTEINS

The main frame of a protein is constituted by the chain of amino acids. This governs how a protein folds and acquires the three-dimensional (3D) shape

which regulates a protein's function. Many additional conclusions might be drawn from the amino acid pattern of a protein; for instance, the protein's (pI) might be derived from its amino acid pattern. In addition, the existence of numerous hydrophobic amino acids in the sequencing suggests as it is either a membrane protein or a receptor protein (Link, 2002; BergstrÃ¶m et al., 2006). Additionally, the existence of particular amino acids may signal that protein will develop a beta-sheet structure. Thus, a protein's amino acid pattern and fundamental structure are essential. There are three approaches to identifying a protein's amino acid sequence. Deciphering the nucleotide pattern of a DNA molecule, Edman degradation, and mass spectrometry are examples of such techniques (Issaq et al., 2005; Capriotti et al., 2011).

## 3.3.1 Proteomics without Spectrometry

## 3.3.1.1 Determination of Amino acid Sequence from DNA sequence

The amino acid structure of a protein expressed by a gene might be deciphered thanks  to  our  knowledge  of  gene  sequences  and  our  capacity  to  pattern nucleotides in a DNA part. As long as DNA pattern data was accessible in the GenBank database, it formed common practice to infer the amino acid patterns of various proteins. A considerable percentage of proteins in the protein data bank (PDB) have their main structure determined directly from DNA sequencing (Peng et al., 2008; Acquah et al., 2019).

But  it  is  simple  to  deduce  a  protein's  amino  acid  composition  from its target DNA, the opposite is not accurate (i.e. decadence of the genetic sequence makes it difficult to deduce the sequence of nucleotides of a gene from  the  amino  acid  structure  of  the  protein.).  To  deduce  the  pattern  of DNA of a gene from the amino acid pattern of a protein, one must depend on  the  individual's  shared  use  of  genetic  coding.  In  molecular  biology investigations, it is usual to generate a gene for cloning. In this way, the first insulin gene was created using the amino acid pattern of insulin protein. The polypeptide chain might be deduced directly from the nucleotide sequence in  prokaryotes  and  lesser  eukaryotes,  like  yeast  and  several  filamentous fungi.  Due  to  the  huge  existence  of  intron  patterns  in  higher  eukaryotes, like  mammals,  there  is  no  consistent  link  between  nucleotide  sequence and amino acid sequencing. To interpret the amino acid composition of a protein as determined by a gene for higher animals, the intron patterns must be disregarded. Moreover, depending on how exons are spliced in higher

organisms, multiple proteins may possibly be created. In nature, an organism may not have all of these potentially potential proteins (Wolters et al., 2001; Dixon et al., 2006).

The accessibility of the target DNA of the gene that encodes a protein is sometimes critical in determining the amino acid sequence; for instance, in mass spectrometric analysis, two neighboring glycine residues, including one with a molecular mass of 57 daltons, could show up as asparagines with a molecular mass of 114 daltons. Studying the nucleotide sequence, which shows separate genetic codes for glycine and asparagine, may quickly clarify this dilemma. This kind of nucleotide sequence analysis can determine if a  protein's  amino  acid  sequence  has  two  contiguous  glycine  residues  or merely one asparagine residue.

## 3.3.1.2 Edman Degradation-N-Terminal Amino Acid Sequence Analysis.

The pattern of amino acids was established via Edman degradation until mass  spectrometry  formed  accessible.  The  process  included  identifying one amino acid at a period first from the peptide's N-terminus. The initial N-terminal amino acid is treated with phenyl-iso-thiocyanate, and it will be split away by moderate hydrolysis as phenyl hydration, a cyclic compound of the N-terminal amino acid. The truncated peptide is preserved throughout this  procedure.  The  chromatographic  profile  of  the  degraded  amino  acid is  used  to  identify  it.  The  second  N-terminal  amino  acid  then  is  broken, leaving at least one peptide intact but truncated by two amino acids. The chromatographic profile of the degraded amino acid is used to identify it. After each round, the procedure is continued until all of the amino acids have been recognized. This procedure is entirely automated. Nevertheless, it  is  time  taking  and  tedious.  Notwithstanding  such  inherent  challenges, this process, known as Edman degradation and invented by Pehr Edman, was the sole way to identify the amino acid pattern of a protein until mass spectrometry. Here are the stages in the Edman degrading process (Gordon et al., 2013; Cassidy et al., 2021).

## EDMAN DEGRADATION

Figure 3.6. Edman degradation, invented by Pehr Edman, may be used to determine the order of amino acids in the protein or peptide.

<!-- image -->

Source: https://en.wikibooks.org/wiki/Structural\_Biochemistry/Proteins/Pro-tein\_sequence\_determination\_techniques

Whenever the 2D gel approach for separating proteins was accessible in the mid-1970s, proteins isolated by 2D gel were frequently put to Edman degradation to identify the amino acid order, since this was the only means to do so at the moment. Nevertheless, there are two issues with this proteomics approach: For starters, several proteins have blocked N-terminal proteins that  can't  combine  with  the  phenyl  isothiocyanate  needed  for  Edman breakdown. Secondly, Edman degradation can only identify the amino acid composition of one protein at a moment, which is in contrast to the goals of proteomics, which are to get data on multiple proteins at once.

## 3.3.2 Proteomics Based on Mass Spectrometry- Identification of Proteins Based on Their Amino Acid Sequence

After extraction by different techniques, like electrophoresis and/or liquid chromatography, peptides or proteins are recognized by identifying their  amino  acid  pattern.  This  was  formerly  accomplished  using  Edman

degradation, which identified one amino acid at a period from the N-terminus of  proteins  or  peptides.  Nevertheless,  the  identification  of  proteins  was transformed  by  the  discovery  and  deployment  of  the  mass  spectrometer, together with breakthroughs in genomics and bioinformatics, who enabled gene  and  protein  data  accessible  for  the  attribution  of  a  specific  peptide pattern to a protein and its encoding gene.

Figure 3.7. Protocol for mass spectrometry.

<!-- image -->

Source;https://upload.wikimedia.org/wikipedia/commons/thumb/1/1f/Mass\_ spectrometry\_protocol.png/440px-Mass\_spectrometry\_protocol.png

## 3.3.2.1 Mass Spectrometry

A mass spectrometer is a useful tool that precisely analyzes the molecular weight of a sample and assists in determining its chemical makeup. That device  splits  molecules  of  a  sample  based  on  their  mass/charge  (m/z) relation,  providing  data  on  every  ion's  molecular  mass. Their  position  is formed using this data. Every amino acid has its molecular weight, which provides every peptide its unique molecular weight. The pattern of amino

acids in a peptide or protein is deciphered using the molecular mass of the peptide.

Figure 3.8. Mass Spectrometry Theory.

<!-- image -->

Source; Chen C, Hou J, Tanner JJ, Cheng J. Bioinformatics Methods for Mass Spectrometry-Based Proteomics Data Analysis. International Journal of Molecular Sciences. 2020; 21(8):2873. https://doi.org/10.3390/ijms21082873

Just a little variation in molecular weight may indicate the substitution of one amino acid for something else or a posttranslational alteration such as phosphorylation, acetylation, or even other structural alteration in a peptide. Table 3.1 shows the molecular mass of various amino acids.

It's worth noting that the molecular mass of amino acids in peptides is lower than those of free amino acids. Since a molecule of water is eliminated throughout most of the peptide synthesis, it is reduced by 18 daltons, which is the molecular weight of water. Proteomics makes extensive utilization of mass spectrometry . This device is being used to define the type of a protein, namely its amino acid pattern and protein-ligand complex creation during physiological  settings,  such  as  post-transcriptional  alterations,  enzymesubstrate bindings, and antigen-antibody or orphan receptors relationships. By measuring the hydrogen/deuterium exchange, this device is also utilized to improve the understanding of protein function.

## 3.3.2.2 Components of the Instrument.

A spectrometer comprises the following main parts: a connector or gadget for  the  insertion  of  a  specimen  into  the  device,  an  ionization  gadget,  for the  splitting  of  ionized  molecules  based  on  their  mass  to  charge  (m/z) proportion, a sensor that supervises the split ions and registers them, and a vacuum environment system to enable the free transport of ions inside the spectrometer and analysis software.

Table 3.1. Molecular weights of amino acids in peptides

| Amino acids     | Symbols-3letter/1letter       Molecular weight   | Symbols-3letter/1letter       Molecular weight   |
|-----------------|--------------------------------------------------|--------------------------------------------------|
| Alanine         | ala/A                                            | 71                                               |
| Asparagine      | asn/N                                            | 114                                              |
| Aspartate       | asp/D                                            | 115                                              |
| Arginine  arg/R | 156                                              |                                                  |
| Cysteine  cys/C | 103                                              |                                                  |
| Glutamine       | gin/Q                                            | 128                                              |
| Glutamate       | glu/E                                            | 129                                              |
| Glycine  gly/G  | 57                                               |                                                  |
| Histidine       | his/H                                            | 137                                              |
| Isoleucine      | ile/I                                            | 113                                              |
| Leucine leu/L   | 113                                              |                                                  |
| Lysine  lys/K   | 128                                              |                                                  |
| Methionine      | met/M                                            | 131                                              |
| Phenylalanine   | phe/F                                            | 147                                              |
| Proline  pro/P  | 97                                               |                                                  |
| Serine  ser/S   | 87                                               |                                                  |
| Threonine       | thr/T                                            | 101                                              |
| Tryptophan      | trp/W                                            | 186                                              |
| Tyrosine tyr/Y  | 163                                              |                                                  |
| Valine  val/V   | 99                                               |                                                  |

The instrument for introducing samples into the system. Based on the sample's composition and technique of ionization, a specimen might well be injected into the spectrometer. A specimen is injected into the spectrometer's ionization resource. Typically, it is injected on a probe, platform, or capillary tube immediately following the HPLC or capillary electrophoresis of peptides and proteins. A specimen has always been entered via a lock mechanism to sustain the machine's high vacuum with no disturbance.

Ionization device . Molecules are polarized in a spectrophotometer since it  is  simpler  to  regulate  and  command the motion of ionized, electrically charged ones than neutral molecules. Typically, ionization is accomplished by protonation (the addition of an H ion) or deprotonation (removal of an H ion). Such two techniques are known as positively and negatively ionization, respectively. Since this NH2 band in protein rapidly takes an H ion, small proteins  are  often  sensitive  to  positively  ionization.  Multiple  techniques of  molecular  ionization  are  put  into  the  device  for  evaluation.  However, two basic types of ionization machines are utilized in proteomics. Among them are the electrospray ionization (ESI) and matrix-aided laser desorption ionization (MALDI) devices. These gadgets are discussed in the sections that follow.

## 3.3.3 Bottom-Up andTop-Down Mass Spectrometry

'Bottom-up' or peptide-level spectroscopy determines the molecular mass of the peptides formed following proteolysis. Highest or whole protein-level spectrometry, on the other hand, is used to detect intact proteins. Such two approaches are not necessarily incompatible; rather, they are complementary and necessary for obtaining a complete picture of a protein's amino acid composition and various posttranslational modifications. Such two concepts, 'bottom-up' and 'top-down,' are derived from genomics and are similar to those utilized in genetic sequencing for DNA sequencing.

Figure  3.9. Different  processes  in  top-down  and  bottom-up  proteomics  are shown.

<!-- image -->

Source: Gracia KC, Husi H. Computational Approaches in Proteomics. In: Husi H, editor. Computational Biology [Internet]. Brisbane (AU): Codon Publications; 2019 Nov 21. Figure 2, [Bottom-up, middle-down and top-down proteomic...].  Available  from:  https://www.ncbi.nlm.nih.gov/books/NBK550333/ figure/Ch8-f0002/ doi: 10.15586/computationalbiology.2019.ch8

The typical  technique  for  peptide  identification  is  bottom-up  spectrometry. The proteins are were broken by bacteria into tiny parts containing 5- 20 amino acids,  but  then  their  weight  is  measured  using  a  spectrometer.  To determine the protein, these data are compared to the weights of peptides of a recognized amino acid pattern stored in a database. Nevertheless, this method relies on partial data to present a fuller view of a protein and ensure its  recognition.  Furthermore,  the  bottom-up  technique  is  unable  to  give details  on  a  protein's  posttranslational  modifications,  which  is  necessary to  fully  understand  its  activity,  especially  its  enzymatic  involvement  in  a metabolic  circuit.  The  top-down  approach  to  protein  study  starts  with  a whole protein. This protein is broken in a high-energy system with warm air in a spectrometer, and the molecular mass data of the intact protein that avoided fragmentation, as well as the molecular weight data of the various pieces, is obtained. The information collected is then compared to existing protein  sequences and fragments in a database to get the protein's entire amino acid pattern. An examination like that might reveal a disparity in the

molecular mass of a particular fragment, which generally signals a protein change. It can determine which amino acid has been modified. (Han et al. 2006).

## 3.4 DETERMINATION OF THE 3D S TRUCTURE OF A PROTEIN

The amino acid pattern and three-dimensional shape of a protein may be determined by techniques apart from the mass spectrometric examination. Before spectroscopic protein analysis, the amino acid pattern is established using  Edman  degradation.  Mass  spectrometry  has  superseded  the  laborintensive and time-consuming Edman degradation technique. Mass spectrometric  analysis  cannot  be  used  to  identify  the  three-dimensional structure of a protein. Nevertheless, the mass spectrometry-obtained amino acid sequence data may be utilized in conjunction with a protein dataset to predict or build the three-dimensional structure of certain proteins. X-ray crystallography (XRC), X-ray diffraction, and nuclear magnetic resonance (NMR) are the only direct methods for establishing the 3D shape of the protein. However, XRC and NMR each have their benefits and disadvantages, which will be explored in the following part.

Figure 3.10. demonstrates that protein structure, amino acid makeup, and sequence influence proteome susceptibility to oxidation-induced degradation.

<!-- image -->

Source: Pakhrin SC, Shrestha B, Adhikari B, KC DB. Deep Learning-Based Advances in Protein Structure Prediction. International Journal of Molecular Sciences. 2021; 22(11):5553. https://doi.org/10.3390/ijms22115553

## 3.4.1 X-Ray Crystallography/X-Ray Diffraction

The crystals of a pure protein are subjected to an X-ray laser in just this procedure. The arrangement of atoms contained in a protein crystal diffracts the  X-ray.  The  number  of  electrons  in  the  particles  and  the  structure  of particles in a protein molecule determine the X-ray diffraction sequence. An electron network is designed by diffraction pattern X-rays that are received as a reflection on a sensor. That map is used to build a depiction of the atoms in  a  protein  complex  to  show  the  protein's  three-dimensional  structure. X-ray  crystallography  has  brought  a  new  age  in  biology  by  elucidating the  3d  image  of  various  biomolecules  and  nucleotides.  J.  D.  Bernal  of Cambridge University discovered X-ray crystallography about 70 years ago when he produced the first 3D structure of a tiny protein called pepsin. In 1958, Max Perutz, a colleague of Bernal and Sir John Kendrew, established the three-dimensional structure of the very first major proteins (hemoglobin and  myoglobin)  using  X-ray  crystallography,  about  which  they  received the  Nobel Prize in Chemistry. X-ray diffraction was also used to resolve the shape of the DNA duplex, which would have been done by Rosalind Franklin,  a  Bernal  student  working  in  Maurice  Wilkins'  group.  Their findings of the double-helical shape of the DNA molecule were predicated on Rosalind Franklin's X-ray diffraction peak. In 1962, Maurice Wilkins, James Watson, and Francis Crick received the Nobel Prize in Medicine for elucidating the double-helical DNA structure.

X-ray crystallography is a time-consuming technique for determining a protein's 3D structure. Among the most challenging aspects of this process is obtaining pure protein and afterward creating crystals of protein complexes. Crystallized  proteins  are  hard  to  come  by.  The  production  of  protein crystals seems more like artwork as compared to science. It's challenging to  crystalline  low-abundance  proteins,  especially  hydrophobic  proteins or  proteins  having  hydrophobic  regions,  like  protein  molecules.  X-ray crystallography  cannot  be  used  to  study  such  proteins.  Nonetheless,  the latest innovations have solved certain challenges with protein crystallization, such as the introduction of robots or crystal workstations that employ many factors concurrently to create optimal protein crystallization.

Figure 3.11. X-ray crystallography process for molecular structural characterization.

<!-- image -->

Source: https://commons.wikimedia.org/wiki/File:X\_ray\_diffraction.png

Aside  from  the  difficulties  of  crystallization,  X-ray  crystallography creates  a  massive  volume  of  data  that  should  be  evaluated  to  obtain  a 3D image of the protein molecule. X-ray study of the crystalline protein molecule or nucleic acids wouldn't be conceivable with no utilization of computers and bioinformatics.

## 3.4.2 Neutron Scattering

Neutron diffraction also reveals the three-dimensional shape of the protein. A protein crystal is subjected to the neutron ray, and the dispersed neutron determines the location of molecules inside the protein. In contrast to X-ray diffraction,  the  neutron  is  dispersed  by  the  nuclei  of  atoms  and  not  by electrons; hence, this technique produces a unique type of actual nuclear image than X-ray crystallography. By nuclear reactions, a limited set of genes

have been examined. There are just a few neutron bouncing instruments around the globe, which is a significant drawback of this technique. Using this technology, less than a few proteins have indeed been examined at the atomic scale.

Figure 3.12. Graphic depiction of the dispersion of neutrons as they strike an object.

<!-- image -->

Source:https://chem.libretexts.org/Bookshelves/Analytical\_Chemistry/Physi-cal\_Methods\_in\_Chemistry\_and\_Nano\_Science\_(Barron)/07%3A\_Molecu-lar\_and\_Solid\_State\_Structure/7.05%3A\_Neutron\_Diffraction

## 3.4.3 Nuclear Magnetic Resonance Spectroscopy

The magnetic characteristics of the nucleus of specific atoms provide the basis for NMR spectroscopy. Atoms with unusual protons in the nucleus or neutrons have spinning and act like magnets. As a result, hydrogens (H1) or some steady isotopes with just unusual protons in the nucleus or neutrons, like H2, C13, N15, P31, and F19, act like magnets. Such particles collect radio signals of the same rate as their rotation whenever subjected to radio signals of specific frequencies in an externally applied magnetic field; this technique  is  termed  'resonance.'  This  change  in  the  atom's  condition  is known as 'chemical shift,' which is used to identify the atom's chemical characteristics.  Following  the  reception  of  radio  signals,  the  atoms  get energized,  but  subsequently,  produce  radiation  equivalent  to  the  quantity received. The quantity of radiation released as well as the time required to

release it may both be monitored and utilized to learn about the structure of the atom (SpÃ¡Äil et al., 2008).

NMR was invented separately by Felix Bloch at Stanford University and Edward Purcell at MIT, who both received the Nobel Prize in Physics in 1952. Whilst the NMR signal supplied certain data around an atom's nucleus, it had a limited resolution and a limited signal-to-noise (S/N) ratio. Robert Ernst used Discrete Fourier transform to solve this issue of NMR, and 2D and multidimensional NMR were soon accessible; for such achievements, Robert Ernst earned the Nobel Prize in Chemistry in 1991. Kurt Wuthrich later  invented  NMR  technology  that  could  be  used  to  analyze  the  threedimensional shape of a protein complex, by which he won a Nobel Prize in Chemistry in 2002. (Wuthrich 2002).

Figure 3.13. Nuclear Magnetic Resonance (NMR) Spectroscopy Theory.

<!-- image -->

Source; Pourmodheji H, Ghafar-Zadeh E, Magierowski S. A Multidisciplinary Approach  to  High  Throughput  Nuclear  Magnetic  Resonance  Spectroscopy. Sensors. 2016; 16(6):850. https://doi.org/10.3390/s16060850

The  most  prevalent  component  in  a  protein  is  hydrogen  (H1).  The 3D sequence of a protein is deciphered using NMR evidence for H1. The NMR values  for  H1  vary  depending  on  their  location;  for  instance,  the NMR signal for H in CH3 differs from CH or OH. H connected to C also has  a  distinct  NMR  signal  than  H  linked  to  N.  Furthermore,  whenever two  neighboring  H  atoms  bonded  by  bonds  are  formed  escape  as  non  covalently linked or as individual H atoms occurring separately or far from

each other, they produce distinct NMR signals. Since multifunctional NMR spectroscopy is now available, now it is possible to identify the many types of NMR signals for H1. In essence, three distinct types of NMR signals are produced.  Nuclear  Overhauser  effect  spectroscopy  (NOESY),  correlation spectroscopy  (COSY),  and  total  correlation  spectroscopy  (TOCSY)  are examples of these techniques. The Nuclear Overhauser effect refers to NMR results from atoms that are near in dimension but not connected by covalent connections.  This  approach  is  effective  for  determining  the  locations  of atoms in a protein structure when numerous faraway elements are pulled with  each  other  in  space  due  to  polypeptide  section  bending,  presuming the protein's secondary structure. COSY is a method for determining the locations of atoms connected by chemical reactions. TOCSY is a method of identifying atoms that really are sections of a network but are not linked by chemical bonds. All of these data are utilized to determine the ranges between individual atoms and to decode the protein's 3D structure. In terms of getting data on the positions of hydrogen atoms, additional data about carbon and nitrogen atoms is required. To do so, proteins are tagged with C13 and/or N15 and then expressed in bacteria utilizing the cloned gene. NMR is used to study the labeled proteins and determine where the C and N atoms are located in the protein (Horvath et al., 1976).

## 3.5 DETERMINATION OF THE NUMBER OF PROTEINS

Various approaches for identifying proteins and determining their primary, secondary, and three-dimensional structures to comprehend their involvement  in  proteomics  have  been  described.  In  proteomics,  though, it  is  crucial  to  learn  the  number  of  distinct  proteins  with  their  structural characteristics. There are several methods for determining the number of proteins in a specimen. The majority of such procedures are colorimetric, like the Lowry or Bradford's tests, and the spectrophotometric technique, which  calculates  the  protein  concentration  dependent  on  the  ultraviolet light  at  280  nm.  Such  techniques  compute  the  overall  protein  content  of a specimen. Such techniques are incapable of determining the proportions of e various proteins in a given sample. Consequently, such approaches do not apply to the high-throughput analysis necessary in proteomics. Since this  proteome  fluctuates  with  its  processes  of  the  cell  and  in  reaction  to

environmental events, it is essential to understand the abundances of various proteins  in  proteomics.  In  multicellular  animals,  the  protein  composition of each cell type varies, as do the growth requirements of a specific cell type. Furthermore, human cells and diseased cells may vary in their protein composition. Secondly, techniques for quantifying the various proteins in a specimen are explored. Procedures rely on antigen-antibody associations, like  radioimmunoassay  (RIA)  in  a  solution  or  Western  analyses,  that analyzes the antigen-antibody association on a gel, may be used to assess the relative abundance of specific proteins. The radioimmunoassay was created by Rosalyn Yalow, who'd been awarded the Nobel Prize in Medicine and Physiology  in  1977  for  her  contribution  to  the  identification  of  insulin in human blood. She has been the second lady to win the Nobel Prize in Medicine and Physiology in mankind. Her RIA work cleared the path for the measurement of minute levels of proteins and hormones in the human body. Proteomics necessitates the determination of the high abundance of a huge range of proteins in representative groups, which is not possible with current techniques. Contrary to the goals of proteomics, RIA and Western testing may offer insight into the relative quantity of a single protein at a moment (MESBAH et al., 1989).

## 3.5.1 Quantitation of Proteins After Separation on a 2D Gel

A range of methodologies may be used to determine the number of proteins that occur in a huge number band segregated on a 2D gel, as well as their abundances.  The  strength  of  protein  bands  is  assessed  by  the  brightness of dyes employed to see the bands after the various protein specimens are resolved on a 2D gel. A densitometric scan may be used to determine the magnitude of protein bands. Silver staining is a sensitive process. Staining with a fluorescent dye is also effective. Developing cells in the existence of radiological amino acids, like methionine carrying S35 sulfur, labels proteins in two kinds of cells. A 2D gel is used to isolate the protein specimen from the two kinds of cells. The protein bands are visible on the gel as dots on an X-ray picture. Densitometry determines the strength of every point on the image.

## 3.5.2 Differential Gel Analysis

Therefore in the procedure, protein molecules from two distinct cell kinds are  acquired,  with  one  specimen stained with Cy3 flour (providing a red color) and the second specimen stained with Cy5 flour (producing a green

color) (releasing green color). The specimens are combined and then run together  on  a  2D  gel.  Visualization  of  protein  bands  upon  separation. A specific band having an equal quantity of proteins with Cy3 and Cy5 flours appears as a yellow point. Nevertheless, if there is a significant change in protein concentration within a band, these proteins will show as a green or red spot. A sample with an abundance of Cy3 flour seems red, while those with an abundance of Cy5 flour look green. Therefore, the variously colored bands indicated the proportional presence of various proteins (Å estÃ¡k, et al., 2015).

## 3.5.3 Quantitative Spectrometry of Proteins

In  a  proteome  study,  spectrometry  has  been  utilized  to  analyze  the  high protein content of specimens to estimate the frequency of numerous proteins at a similar time. The relative quantity of proteins in two specimens derived from two distinct kinds of cells may be measured in at minimum two methods. The first cell type is produced in ordinary water having hydrogen, while the second cell type is grown in water that contains deuterium. Proteins from either kind of cell are isolated individually, then combined, and evaluated in a spectrometer. Every protein shows as a doublet on the spectrometric graph in an assessment: Since their m/z ratios vary, one indicates the protein has hydrogen and the other indicates the protein has deuterium. The proportion of such graph heights will be used to determine their abundances (Horvath &amp; Melander, 1977).

The second principle,  like  the  first,  is  dependent  on  tagging  proteins differently with hydrogen and deuterium. Every protein sample, though, is given isotope-coded affinity tags (ICATs). This method includes processing protein specimens with iodoacetamide biotin derivatives, which bind with cysteine  residues  in  proteins.  Such  proteins  are  subsequently  isolated using affinity chromatography on a column that contains streptavidin and binds  biotin  specifically.  Such  proteins  are  then  isolated,  combined,  and spectrometer-analyzed.  The  spectrometer  produces  a  doublet  of  proteins having hydrogen and deuterium once again. Their abundance is determined by measuring their elevation in a doublet (Ishii et al., 1977).

Figure 3.14. General-workflow-for-quantitative-mass-spectrometry-basedtranslational-neuroproteomics.

<!-- image -->

Source: Wilson RS, Rauniyar N, Sakaue F, Lam TT, Williams KR, Nairn AC. Development of Targeted Mass Spectrometry-Based Approaches for Quantitation of Proteins Enriched in the Postsynaptic Density (PSD). Proteomes. 2019; 7(2):12. https://doi.org/10.3390/proteomes7020012

## 3.5.4 Protein Microarray

Protein microarrays have helped evaluate the frequency of a large number of proteins across two cell types produced beneath two different environments. This method is ideal for proteome research because it allows researchers to track changes in a large number of proteins throughout two kinds of cells at the same time (Xiao &amp;Oefner, 2001).

A microarray is a protein sample in which several antibodies are placed in specific locations on a microscope glass plate. The slide is then submerged in a solution that contains. The dots representing protein-protein interactions are detected and used to detect a wide range of proteins and their amounts on a specified scale. By comparing the brightness of markings on several slides subjected to protein soluble from several types of cells or by a type of cell

cultivated in different conditions, the relative amount of individual proteins may be calculated. It might indicate an increase in a protein's activity in a variety of cells. In comparison to a similar microarray sheet of a cell line solution, the protein solution from malignant cells may exhibit a decline or spike in as many as several proteins. A protein solubility microarray from a kind of cell kept in a minimal or enriched medium will show changes in a variety of proteins, as well as the presence or absence of particular proteins. Microarrays are being used to identify not just the abundances of certain proteins, but also a variety of other associations, such as enzyme-substrate interactions and the discovery of a variety of other chemical compounds that interact with protein molecules or enzymes. A number of these microarray components will be discussed in the following chapters.

Figure 3.15. Protein-microarrays-a-Functional-protein-microarrays-for-studying-proteins.

<!-- image -->

Source: Brezina S, Soldo R, Kreuzhuber R, Hofer P, Gsur A, Weinhaeusel A. Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies. Microarrays. 2015; 4(2):162-187. https:// doi.org/10.3390/microarrays4020162

## 3.6 STRUCTURAL AND FUNCTIONAL PROTEOMICS

The basic structure is a protein's arrangement of amino acids, that defines its tertiary and secondary structures. Moreover, it gives the protein various elements and characteristics. The mass of the molecule, its pI, and its threedimensional  structure  may  be  simply  determined  by  the  chain  of  amino acids. It is also possible to determine the activity of a protein based on its shape, for instance, if it operates like an enzyme or a sensor protein, as a hormonal or antibody, or as a protein known. It may also determine if it dwells in distinct sites inside a cell, is a component of the wall, or is released from the cell. The three-dimensional structure of a protein is dictated by how its amino acid chain folds around itself, putting essential amino acids into proximity. That folding structure identifies the enzymatic activity for binding or locations that interact with drugs, ligands, and inhibitors. Moreover, this could identify additional control areas of an enzyme protein on its interface or in the crevices of its three-dimensional structure. The correct packing of amino acids affects the total surface charge of a protein, resulting in a stable crystalline structure. The findings of an in vitro investigation involving the denaturation  and  re-denaturation  of  proteins  support  the  notion  that  the amino acid pattern or the fundamental structure of a protein contains all the data necessary to determine its form and composition. Understanding the principles that regulate the folding of a protein into its natural 3D structure is crucial (Martin &amp;Guiochon, 2005).

Even as an amino acid structure of a protein is stored in the nucleotide gene  sequence,  it  is  now  feasible  to  identify  the  amino  acid  residues  or basic shapes of a huge range of proteins by decoding the genomic regions of  an  organism  that  have  been  placed  in  the  gene  dataset.  This  has  led to  increased  levels  of  the  amino  acid  composition  of  a  huge  array  of  an organism's proteins. This is known as the PDB. The yeast PDB contains data  on  all  6000  proteins  produced  by  the  yeast  genomes.  The  PDB  of higher species is far from complete; the classification of extensive stretches of nucleotide sequences in people and other higher creatures into proteins with known features has to be decoded. Conventionally, the activity of a protein  is  defined  by  its  biochemical  analysis,  often  by  its  capacity  to activate  a  biochemical  process.  This  laborious  task  involves  purifying  a protein  and  then  identifying  the  biological  process  that  it  catalyzes. This cannot be done on a huge scale. Consequently, going to follow a throughput strategy in proteomics, the feature of a protein is calculated by evaluating the basic structure and/or the three-dimensional framework of the protein in inquiry with the main sequence and/or the three-dimensional framework of

a huge range of proteins obtainable in the PDB. Following is a discussion of the numerous facets of the link connecting protein structure and function (Guillarme et al., 2010).

## 3.6.1 Moonlighting by Protein

So we can go into detail about the link between a protein's function and structure, it's important to note that most proteins have just one function. This viewpoint is based on Beadle and Tatum's previous idea of the onegene-one-enzyme hypothesis (1941). According to this view, each protein has  just  one  activity,  or  one  gene-one  enzyme-one  function.  In  larger organisms,  we  have  previously  shown  that  the  one  gene-one  enzymatic model is invalid. And over one gene changes the development of nearly half of all proteins in humans. Similarly, it is now known that a protein might influence  many  functions  (Yarnell,  2003). A  vast  number  of  proteins  are now recognized to be versatile. Proteins such as the tumor suppressor P53 and the Warner syndrome protein WRN, which has multiple helicases and nuclease activities, are instances of multifunctional proteins. Distinct patterns or regions are found in all multipurpose proteins, every directing diverse functions. As a result, it promotes the notion of exon reshuffling for gene formation, which will be described later. Different variables can influence the  diverse  activities  of  a  similar  protein.  Phosphoglucoisomerase  (PGI), for  instance,  stimulates  a  metabolic  step  in  the  cell's  internal  glycolysis. Whenever released to the exterior of the cell, the same enzyme functions as cytokine neuroleukin, which helps B cells mature into antibiotic cells. That protein also has a neural growth parameter function. Whenever coupled to a specific receptor, the blood-clotting molecule thrombin acts as a cytokine. A protein's function can also change depending on where it is found in the cell. Whenever the bacterial protein Put A is linked with the cell surface, it  operates  as  an  enzymatic  dehydrogenase,  so  when  it's  loose  inside  the cell, it acts as a transcriptional activation that wraps to DNA and regulates transcription.  A  protein's  activity  may  vary  across  cells.  Neuropilin,  for instance, affects the formation of new blood cells in endothelial cells but not the orientation of brain development in an axion. Also, a protein's role could vary based on if it occurs as a monomer or a multimer inside a cell; for instance, the similar protein operations as glyceraldehyde-3-phosphate dehydrogenase in the glycolysis when found in a tetrameric type, but then as uracil-DNA glucosylase in the DNA repair path when found in a monomeric form. Moonlighting refers to a protein's ability to perform many functions. (Yarnell, 2003).

## 3.6.2 Determining the Primary Structure of Proteins by Different Methods

As discussed above, there are three ways for showing the order of amino acids in a protein to identify its main structure. (a) decoding the amino acid composition  from  the  nucleotide  pattern  of  DNA  or  cDNA;  (b)  Edman degradation; and (c) mass spectrometry. The amino acid pattern of a protein is  easily  extracted  from  its  corresponding  DNA  sequence.  Nevertheless, in  larger  species  using  splicing  processes  to  produce  messenger  RNA (mRNA)  for  protein  synthesis,  it  is  important  to  detect  the  nucleotides at  the  intersection  of  exon  and  intron.  Under  the  existence  of  conserved nucleotides,  exon-intron  junctions  may  be  easily  detected.  Consequently, the DNA coding sequence is determined by recognizing and disregarding the intervening noncoding intron regions. Typically, the constantly coding DNA sequence of a gene is derived from the target DNA of complementary DNA (cDNA), which is produced by replicating the mRNA for a certain protein. The data sets from the sample of DNA of a species and the cDNA library of tissues of a species are thus valuable for interpreting the amino acid sequences of various proteins. Such information is now freely accessible in the gene and protein databases (Linden et al., 1975; Blakley&amp; Vestal, 1983).

## 3.6.2.1 Determination of Amino Acid Sequence by Edman Degradation

This approach may be used to figure out the pattern of amino acids of a polypeptide with up to 50 amino acids. Typically, fragmentation of a larger peptide  exposed  to  moderate  hydrolysis  or  breakage  by  endopeptidases produces  numerous  tinier  overlapping  peptides.  Such  finer  particles  are analyzed,  and  the  ordering  of  amino  acids  is  determined  by  looking  for matching amino acids in the pattern of a smaller peptide fragmented from a bigger peptide.

Before performing an amino acid analysis, it is essential to identify the overall amino acid composition of a peptide. This aids in determining the peptide's ultimate amino acid sequence. Knowing composition also aids in determining if the peptide has two contiguous glycine residues (mol wt 57 daltons) residues or only one asparagine residue (mol wt 114 daltons). This conundrum is founded only on molecular weight data.

Thorough hydrolysis of the peptide with 6 M HCl at a high temperature determines  the  entire  amino  acid  makeup.  To  extract  the  amino  acids, the  hydrolysate  is  passed  through  paper  electrophoresis.  A  dye  named

dinitrophenol is used to identify the various amino acids. Except for proline, which looks blue, all amino acids create yellow dots. The quantity of every amino  acid  in  a  given  location  is  determined  by  the  color  intensity.  In electrophoresis, the individual amino acid spots are recognized by matching their motility to recognized amino acids for use as standards (Sawardeker et al., 1965; Dugo et al., 2008).

Edman degradation determines the sequence of amino acids in a peptide. As previously stated, a larger peptide is broken into smaller peptides with overlaps. The sequence of amino acids in the peptide is determined by the overlapped  amino  acid(s). A  peptide  of  three  alanine,  one  arginine,  two glutamic  acids,  two  lysines,  one  phenylalanine,  and  one  threonine,  for instance,  maybe split  into  smaller  fragments. These  have  been  proven  to get the corresponding patterns using the technique of Edman degradation organized in an overlapping manner:

lysgluthrala

alaalaalalysthralaala

alalysphenglu

phengluarg

The structure of such 10 amino acids in the peptide may thus be derived as follows:lysgluthralaalaalalysphengluarg.

Chemical  cleavage  using  cyanogen  bromide  or  enzymatic  breakage using endopeptidases like trypsin or chymotrypsin are used to break bigger peptides (Lindsey et al., 2006; Song et al., 2010).

Just before doing Edman degradation sequencing, it is usually beneficial to know  the  N-terminal  amino  acid  in  the  peptide.  The  N-terminal amino acid  is  detected  by  combining  the  peptide  using  Sanger's  reagent fluorodinitrobenzene (FDNB), separating the amino acids on electrophoresis, and  identifying  the  N-terminal  amino  acid  by  the  color  produced  by Sanger's reagent reactions. The color of FDBN is yellow. Dansyl chloride, other than FDBN, could be used to tag the N-terminal amino acid. Like this in an examination, the existence of more than one N-terminal amino acid indicates  the  existence  of  much  more  than  one  peptide  in  the  protein,  as was discovered in the case of insulin. The amino acid pattern of the bigger component may sometimes be determined by examining the sequence of segments created by two separate enzymes. For instance, Edman degradation revealed that tryptic digestion of a peptide produces two short breaks with the following amino acid composition:

## Ala-alatrpglylys;thrasnvallys

Nevertheless, the identical peptide is digested by a shorter peptide with the pattern shown below:

## vallysalaalatrp.

A study of such three patterns reveals that the bigger peptide's amino acid pattern must be thrasnvallys ala alatrpglylys, as shown by Stryer(1982).

## 3.6.2.2 Determination of AminoAcid Sequence by Mass Spectrometry

Typically,  the  amino  acid  structure  of  a  protein  is  established  by  mass spectrometric analyses of the peptides and their components. The rapidity and  scope  of  spectrometric  analysis  are  compatible  with  the  goals  of proteome  investigations. A  2D  gel-separated  protein  is  typically  injected into a mass spectrometer with two quadrupole analyzers and a TOF analyzer. The broken ionized particles approach the very first quadrupole analyzer. A specific peptide segment is preferentially permitted to approach the second quadrupole detector, in which it is combined with neutral gases like nitrogen as well as argon. The gases aid in separating the peptide fragment's peptide bonds. To create tiny parts with lesser amino acids per fragmentation, care is designed to fail the protein complex even once in every fraction, although at many sites, to minimize the number of amino acids per segment. Alternately, it  is  feasible  to  delete  one  amino  acid  at  a  moment  from  the  C-terminus ending to form an arrangement of peptides that seems to be one amino acid smaller than the subsequent larger chain in the sequence. Every time this fragmentation  happens,  a  charged  fragment  with  an  N-terminal  end  and an uncharged fragment with such a C-terminus are produced. The charged particles  pass  via  the  TOF  detector  en  route  to  the  sensor.  Their  flight duration is proportional to their mass; tiny particles pass quicker than bigger ones. Thus, the time required to reach the sensor is precisely proportional to the molecule's mass. On the lateral x-x axis of a chart, the flight duration is noted; the height on the y-y axis shows the concentration or quantity of each fragment. A typical finding relates the weight of the various segments of an 8-amino acid chain peptide (Wagner et al., 2003; Grinias et al., 2016).

## 3.6.2.3 Determining the Secondary Structure of Protein

The fundamental basis of a peptide, or its amino acid sequence, determines its  secondary  and  tertiary  structure.  Depending  upon  the  denaturation  or unraveling of an enzyme ribonuclease in the presence of urea and the folded

form  of  the  similar  enzyme  with  complete  elimination  of  the  denaturing agent,  urea,  Christian  Anfinsen  discovered  this  finding.  Knowing  the secondary structure  of  the  protein  is  necessary  before  learning  about  the tertiary expression of proteins. Since of their significance in cell processes and modification in biotechnology and medication synthesis, it's critical to understand the principles which proteins take to adopt a 3D shape (Dunham et al., 2011).

Since contact between the main chain of neighboring amino acids, the linear peptide begins to fold upon itself its original shape. This results in the  creation  of  various  configurations,  including  (a)  an  alpha  helix,  (b) stranded folds known as beta sheets or beta strands, and (c) random coils. Some parameters may now be utilized to anticipate the presence of such components in the protein's secondary structure. Chow and Fasman (1978) were the first to discover this, depending on the affinity of particular amino acids to connect with such structures, namely the helix and beta-sheet. The amino acids Glu, met, ala, and lys, for example, are mostly related to the helix structure, while val, ile, and tyr are mostly connected with the betasheet structure. Either helix or the beta-sheet are connected with the amino acid leucine. The amino acids glycine and proline act as helix breakers, with proline being the first residue in the helix. At the N-terminus, asp and glu are found, while arg and lys are found at the C-terminus. These are some generalizations based on Chou and Fasman's statistical study (also see Chou and Kai, 2004).

The  presence  of  hydrophobic  amino  acids  grouped  on  the  top  of globular proteins seems to be another feature of protein secondary structure. Hydrophobic  amino  acids  appear  to  be  the  twentieth  amino  acid  in  the peptide's  main  building  regularly.  Such  amino  acids  are  twisted  on  the axes of the protein by 100 degrees, resulting in globular proteins with all hydrophobic amino acids grouped on one end on the helical protein surface and polar amino acids at another end. As a result, a wheel of amino acids may be generated in a protein, with hydrophobic amino acids grouped with one face of the helix and polar amino acids on another.

The structure of proteins in the proteins dataset may now be examined using a variety of software packages. Furthermore, computer simulations are  being  created  to  see  the  secondary  and  tertiary  structure  of  proteins, that  occurs  within  microseconds  after  the  main  structure's  development. Such computer simulations are likely to provide researchers with a better understanding of protein structure, as well as the principles for secondary and tertiary structure synthesis (Stobaugh et al., 2013; Unger et al., 2000).

## REFERENCES

- 1. Abdelhamid, H. N., &amp; Wu, H. F. (2015). Proteomics analysis of the mode  of  antibacterial  action  of  nanoparticles  and  their  interactions with proteins. TrAC Trends in Analytical Chemistry , 65 , 30-46.
- 2. Acquah, C., Chan, Y. W., Pan, S., Agyei, D., &amp;Udenigwe, C. C. (2019). Structure informed separation of bioactive peptides. -Journal of Food Biochemistry , 43 (1), e12765.
- 3. Alharbi, R.  A. (2020). Proteomics  approach  and  techniques  in identification  of  reliable  biomarkers  for  diseases. Saudi  journal  of biological sciences , 27 (3), 968-974.
- 4. Arima,  Y.,  &amp;  Iwata,  H.  (2007).  Effect  of  wettability  and  surface functional groups on protein adsorption and cell adhesion using welldefined mixed  self-assembled monolayers. Biomaterials , 28 (20), 3074-3082.
- 5. Baker, D. and A., Sali. 2001. Protein structure prediction and structural genomics. Science 294, 93-96.
- 6. Beadle, G. W. and Tatum, E. L. 1941. Genetic control of biochemical reactions in Neurospora. Proc. Natl. Acad. Sci. U.S.A. 27, 499-506.
- 7. Bellot, J. C., &amp;Condoret, J. S. (1993). Modelling of liquid chromatography equilibria. Process Biochemistry , 28 (6), 365-376.
- 8. BergstrÃ¶m,  S.  K.,  Dahlin,  A.  P.,  RamstrÃ¶m,  M.,  Andersson,  M., Markides, K. E., &amp;Bergquist, J. (2006). A simplified multidimensional approach for analysis of complex biological samples: on-line LC-CEMS. Analyst , 131 (7), 791-798.
- 9. Blakley, C. R., &amp; Vestal, M. L. (1983). Thermospray interface for liquid chromatography/mass spectrometry. Analytical Chemistry , 55 (4), 750754.
- 10. Bowie, J. U., R. Luthy, and D. Eisenberg. 1991. A method to identify protein sequences that fold into a known three-dimensional structure. Science 253, 164-170.
- 11. Brohee, S., &amp; Van Helden, J. (2006). Evaluation of clustering algorithms for  protein-protein  interaction  networks. BMC Bioinformatics , 7 (1), 1-19.
- 12. BÃ¼yÃ¼kkÃ¶roÄlu,  G.,  Dora,  D.  D., Ãzdemir , F.,  &amp;HÄ±zel,  C.  (2018). Techniques  for  protein  analysis.  In Omics  technologies  and  bioengineering (pp. 317-351). Academic Press.

- 13. Capriotti,  A.  L.,  Cavaliere,  C.,  Foglia,  P.,  Samperi,  R.,  &amp;LaganÃ , A. (2011). Intact protein separation by chromatographic  and/or electrophoretic techniques for top-down proteomics. Journal of Chromatography A , 1218 (49), 8760-8776.
- 14. Cassidy, L., Helbig, A. O., Kaulich, P. T., Weidenbach, K., Schmitz, R. A., &amp;Tholey, A. (2021). Multidimensional separation schemes enhance the  identification  and  molecular  characterization  of  low  molecular weight proteomes and short open reading frame-encoded peptides in top-down proteomics. Journal of Proteomics , 230 , 103988.
- 15. Cedervall, T., Lynch, I., Lindman, S., BerggÃ¥rd, T., Thulin, E., Nilsson, H.,  ...  &amp;Linse,  S.  (2007).  Understanding  the  nanoparticle-protein corona  using  methods  to  quantify  exchange  rates  and  affinities  of proteins  for  nanoparticles. Proceedings  of  the  National  Academy  of Sciences , 104 (7), 2050-2055.
- 16. Chou, K. C. and Y. D. Kai. 2004. A novel approach to predict active sites of enzyme molecules. Proteins 55, 77-82.
- 17. Chou, P. Y. and C. D. Fasman. 1978. Empirical prediction of protein conformation. Ann. Rev. Biochem . 47, 251-278.
- 18. Chouchani,  E.  T.,  James,  A.  M.,  Fearnley,  I.  M.,  Lilley,  K.  S.,  &amp; Murphy, M. P. (2011). Proteomic approaches to the characterization of protein thiol modification. Current opinion in chemical biology , 15 (1), 120-128.
- 19. Comisarow,  M.  B.  and A.  G.  Marshall.  1974.  Fourier  transformion cyclotron resonance spectroscopy. Chem. Phys. Lett. 25, 282-283.
- 20. Covey, T. R., Lee, E. D., Bruins, A. P., &amp;Henion, J. D. (1986). Liquid chromatography/mass  spectrometry. Analytical chemistry , 58 (14), 1451A-1461A.
- 21. Di Palma, S., Hennrich, M. L., Heck, A. J., &amp; Mohammed, S. (2012). Recent  advances  in  peptide  separation  by  multidimensional  liquid chromatography for proteome analysis. Journal of proteomics , 75 (13), 3791-3813.
- 22. Dixon,  S.  P.,  Pitfield,  I.  D.,  &amp;  Perrett,  D.  (2006).  Comprehensive multi dimensional  liquid  chromatographic  separation  in  biomedical -and pharmaceutical analysis: a review. Biomedical Chromatography , 20 (6 7), 508-529. -

- 23. Dugo, P., Cacciola, F., Kumm, T., Dugo, G., &amp;Mondello, L. (2008). Comprehensive multidimensional liquid chromatography: theory and applications. Journal of Chromatography A , 1184 (1-2), 353-368.
- 24. Dunham,  W.  H.,  Larsen,  B.,  Tate,  S.,  Badillo,  B.  G.,  Goudreault, M.,  Tehami, Y.,  ...  &amp;Gingras, A.  C.  (2011). A  cost-benefit  analysis of multidimensional fractionation of affinity purification -mass spectrometry samples. Proteomics , 11 (13), 2603-2612.
- 25. Fenn, J. B. M. Mann, G. K. Meng, S. F. Wong, and C. M. Whitehouse. 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science 246, 64.
- 26. Fenn, John. B. 2002. Electrospray wings for molecular elephants. Les Prix Nobel. The Nobel Prizes 2002 , Editor Tore Frangsmyr, [Nobel Foundation], Stockholm,2003.
- 27. Field,  J.  K.,  Euerby,  M.  R.,  &amp;Petersson,  P.  (2020).  Investigation into reversed phase chromatography  peptide  separation systems part III:  Establishing a column characterisation database. Journal of Chromatography A , 1622 , 461093.
- 28. Fournier, M. L., Gilmore, J. M., Martin-Brown, S. A., &amp; Washburn, M. P. (2007). Multidimensional separations-based shotgun proteomics. Chemical reviews , 107 (8), 3654-3686.
- 29. FranÃ§ois, I., Sandra, K., &amp; Sandra, P. (2009). Comprehensive liquid chromatography: fundamental aspects and practical considerations-a review. Analytica Chimica Acta , 641 (1-2), 14-31.
- 30. Gordon,  S.  M.,  Deng,  J.,  Tomann, A.  B.,  Shah, A.  S.,  Lu,  L.  J.,  &amp; Davidson,  W.  S.  (2013).  Multi-dimensional  co-separation  analysis reveals protein-protein interactions defining plasma lipoprotein subspecies. Molecular &amp; Cellular Proteomics , 12 (11), 3123-3134.
- 31. Gorg, A. 2000. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21, 1037-1053.
- 32. Gorg,  A.  et  al.  1988.  The  current  state  of  two-dimensional  electrophoresis with immobilized pH gradients. Electrophoresis 9: 531-546.
- 33. Greibrokk,  T., &amp;  Andersen,  T. (2003). High-temperature  liquid chromatography. Journal of Chromatography A , 1000 (1-2), 743-755.
- 34. Grinias,  K.  M.,  Godinho,  J.  M.,  Franklin,  E.  G.,  Stobaugh,  J. T.,  &amp; Jorgenson, J. W. (2016). Development of a 45 kpsi ultrahigh pressure liquid chromatography instrument for gradient separations of peptides

using long microcapillary columns and sub-2 Î¼m particles. Journal of Chromatography A , 1469 , 60-67.

- 35. Guillarme, D., Ruta, J., Rudaz, S., &amp;Veuthey, J. L. (2010). New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches. Analytical and bioanalytical chemistry , 397 (3), 1069-1082.
- 36. Hamilton, R. J., &amp; Sewell, P.  A.  (1982).  Introduction  to  high  performance liquid  chromatography.  In Introduction  to  high  performance  liquid chromatography (pp. 1-12). Springer, Dordrecht.
- 37. Han, X., M. Jin, K. Breuker, and F. W. McLafferty. 2006. Extending topdown mass spectrometry to proteins with masses &gt; 200 kDa. Science 314, 109-112.
- 38. Haque,  A.  (1998). Part  I.  Direct  injection  of  selected  medications in  serum  using  restricted  access  media  columns.  Part  II.  Capillary electrophoretic  measurements  of  selected  drugs  in  pharmaceutical dosage forms. Part III. Enantiomeric separations of medicinals using a protein-bonded chiral stationary phase . University of Georgia.
- 39. Horvath,  C.,  &amp;Melander,  W.  (1977).  Liquid  chromatography  with hydrocarbonaceous  bonded  phases;  theory  and  practice  of  reversed phase chromatography. Journal of  Chromatographic Science , 15 (9), 393-404.
- 40. Horvath, C., Melander,  W., &amp;  Molnar,  I. (1976). Solvophobic interactions in liquid chromatography with nonpolar stationary phases. Journal of Chromatography A , 125 (1), 129-156.
- 41. Ishii,  D.,  Asai,  K.,  Hibi,  K.,  Jonokuchi,  T.,  &amp;  Nagaya,  M.  (1977). A study of micro-high-performance liquid chromatography: I. Development  of  technique  for  miniaturization  of  high-performance liquid  chromatography. Journal of Chromatography A , 144 (2),  157168.
- 42. Issaq, H. J. (2003).  Application of separation technologies to proteomics research. Advances in protein chemistry , 65 , 249-269.
- 43. Issaq,  H.  J.,  Chan,  K.  C.,  Blonder,  J.,  Ye,  X.,  &amp;Veenstra,  T.  D. (2009).  Separation,  detection  and  quantitation  of  peptides  by  liquid chromatography  and  capillary  electrochromatography. Journal  of Chromatography A , 1216 (10), 1825-1837.

- 44. Issaq,  H.  J.,  Chan,  K.  C.,  Janini,  G.  M.,  Conrads,  T.  P.,  &amp;Veenstra, T.  D.  (2005).  Multidimensional  separation  of  peptides  for  effective proteomic analysis. Journal of Chromatography B , 817 (1), 35-47.
- 45. Issaq,  H.  J.,  Conrads, T.  P.,  Janini,  G.  M.,  &amp;Veenstra, T.  D.  (2002). Methods  for  fractionation,  separation  and  profiling  of  proteins  and peptides. Electrophoresis , 23 (17), 3048-3061.
- 46. Jacobs, J. M., Mottaz, H. M., Yu, L. R., Anderson, D. J., Moore, R. J., Chen, W. N. U., ... &amp; Smith, R. D. (2004). Multidimensional proteome analysis  of  human  mammary  epithelial  cells. Journal  of  proteome research , 3 (1), 68-75.
- 47. Jones,  D.  T.,  and  C.  Hadley.  2000.  Threading  methods  for  protein structure prediction. In D. Higgins, and W. R. Taylor (eds.) Bioinformatics: Sequence, Structure and Databanks. Heidelberg, Germany Springer-Verlag.
- 48. Jones, D. T., W. R. Taylor, and J. M. Thornton. 1992. A new approach to protein fold recognition. Nature 358, 86-89.
- 49. Jorrin-Novo, J. V. (2014). Plant proteomics methods and protocols. In Plant proteomics (pp. 3-13). Humana Press, Totowa, NJ.
- 50. Karas,  M.  and  F.  Hillenkamp.  1988.  Laser  desorption  ionization  of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem . 60, 2299-2301.
- 51. Kay, B. K., Williamson, M. P., &amp;Sudol, M. (2000). The importance of  being  proline:  the  interaction  of  proline rich  motifs  in  signaling -proteins with their cognate domains. The FASEB journal , 14 (2), 231241.
- 52. Klose,  J.  1975.  Protein  mapping  by  combined  isoelectric  focusing and electrophoresis in mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26, 231-243.
- 53. Knox, J. H.,  &amp;  Grant,  I.  H.  (1987).  Miniaturisation  in  pressure  and electroendosmotically driven liquid chromatography: Some theoretical considerations. Chromatographia , 24 (1), 135-143.
- 54. Kollman, P., I. et al.. 2000. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res . 33, 889-897.
- 55. Linden,  J.  C.,  &amp;Lawhead,  C.  L.  (1975).  Liquid  chromatography  of saccharides. Journal of chromatography A , 105 (1), 125-133.

- 56. Lindsey,  M.  L.,  Goshorn,  D.  K.,  Comte Walters,  S.,  Hendrick,  J. -W., Hapke, E., Zile, M. R., &amp;Schey, K. (2006). A multidimensional proteomic approach to identify hypertrophy associated -proteins. Proteomics , 6 (7), 2225-2235.
- 57. Link, A. J. (2002). Multidimensional peptide separations in proteomics. Trends in Biotechnology , 20 (12), s8-s13.
- 58. Mahmoudi, M., Lynch, I., Ejtehadi, M. R., Monopoli, M. P., Bombelli, F. B., &amp;  Laurent,  S.  (2011).  Protein-  nanoparticle  interactions: opportunities and challenges. Chemical reviews , 111 (9), 5610-5637.
- 59. Martin, M., &amp;Guiochon, G. (2005). Effects of high pressure in liquid chromatography. Journal of Chromatography A , 1090 (1-2), 16-38.
- 60. McCall,  J.  M.  (1975).  Liquid-liquid  partition  coefficients  by  highpressure  liquid  chromatography. Journal  of  medicinal  chemistry , 18 (6), 549-552.
- 61. McNeff, C. V., Yan, B., Stoll, D. R., &amp; Henry, R. A. (2007). Practice and  theory  of  high  temperature  liquid  chromatography. Journal  of separation science , 30 (11), 1672-1685.
- 62. MESBAH,  M.,  PREMACHANDRAN,  U.,  &amp;  WHITMAN,  W.  B. (1989). Precise measurement of the G+ C content of deoxyribonucleic acid by high-performance liquid chromatography. International Journal of Systematic and Evolutionary Microbiology , 39 (2), 159-167.
- 63. Meyer,  B.,  &amp;  Peters,  T. (2003). NMR  spectroscopy  techniques for  screening  and  identifying  ligand  binding  to  protein  receptors. AngewandteChemie International Edition , 42 (8), 864-890.
- 64. Nawrocki,  J. (1997). The  silanol group  and  its role in liquid chromatography. Journal of Chromatography A , 779 (1-2), 29-71.
- 65. Neverova,  I.,  &amp;  Van  Eyk,  J.  E.  (2005).  Role  of  chromatographic techniques  in  proteomic  analysis. Journal  of  Chromatography  B , 815 (1-2), 51-63.
- 66. Nguen, H. D. and K. Carol, Hall. 2004. Molecular dynamics simulation of spontaneous formation by random-coil peptides. Proc. Natl. Acad. Sci. U.S.A. 101, 16180-85.
- 67. Niessen, W. M. A. (1999). State-of-the-art in liquid chromatographymass spectrometry. Journal of Chromatography A , 856 (1-2), 179-197.
- 68. Nikolin, B., ImamoviÄ, B., MedanhodÅ¾iÄ-Vuk, S., &amp; Sober, M. (2004). High perfomance liquid chromatography in pharmaceutical analyses. Bosnian journal of basic medical sciences , 4 (2), 5.

- 69. Novotny, M. (1981). Microcolumns in liquid chromatography. Analytical chemistry , 53 (12), 1294A-1308A.
- 70. O'Farrell, P. H. 1975. High resolution two dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021.
- 71. Oppenheimer, J. A. 1986. 1945 First nuclear blast. In R. Rhodes, (ed.) The Making of the Atomic Bomb. New York: Simon &amp; Schuster.
- 72. Peng,  J.,  Elias,  J.  E.,  Thoreen,  C.  C.,  Licklider,  L.  J.,  &amp;Gygi,  S.  P. (2003). Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC- MS/MS) for large-scale protein analysis: the yeast proteome. Journal of proteome research , 2 (1), 4350.
- 73. Peng,  Y.,  Pallandre,  A.,  Tran,  N.  T.,  &amp;Taverna,  M.  (2008).  Recent innovations  in  protein  separation  on  microchips  by  electrophoretic methods. Electrophoresis , 29 (1), 157-178.
- 74. Pitt, J. J. (2009). Principles and applications of liquid chromatographymass spectrometry in clinical biochemistry. The Clinical Biochemist Reviews , 30 (1), 19.
- 75. Reinders,  J.,  Zahedi,  R.  P.,  Pfanner,  N.,  Meisinger,  C.,  &amp;Sickmann, A.  (2006).  Toward  the  complete  yeast  mitochondrial  proteome: multidimensional separation techniques for mitochondrial proteomics. Journal of proteome research , 5 (7), 1543-1554.
- 76. Salzer, U., Hunger, U., &amp;Prohaska, R. (2008). Chapter Three Insights in the Organization and Dynamics of Erythrocyte Lipid Rafts. Advances in Planar Lipid Bilayers and Liposomes , 6 , 49-259.
- 77. Sawardeker, J. S., Sloneker, J. H., &amp; Jeanes, A. (1965). Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography. Analytical Chemistry , 37 (12), 1602-1604.
- 78. Å estÃ¡k, J.,  MoravcovÃ¡, D., &amp;Kahle, V. (2015). Instrument platforms for nano liquid chromatography. Journal of Chromatography A , 1421 , 2-17.
- 79. Song,  C.,  Ye,  M.,  Han,  G.,  Jiang,  X.,  Wang,  F.,  Yu,  Z.,  ...  &amp;  Zou, H. (2010). Reversed-phase-reversed-phase  liquid  chromatography approach with high orthogonality for multidimensional separation of phosphopeptides. Analytical chemistry , 82 (1), 53-56.
- 80. Sorci, M., Gu, M., Heldt, C. L., Grafeld, E., &amp; Belfort, G. (2013). A multi dimensional approach for fractionating proteins using charged -membranes. Biotechnology and Bioengineering , 110 (6), 1704-1713.

- 81. SpÃ¡Äil,  Z.,  NovÃ¡kovÃ¡,  L.,  &amp;Solich,  P.  (2008). Analysis  of  phenolic compounds  by  high  performance  liquid  chromatography  and  ultra performance liquid chromatography. Talanta , 76 (1), 189-199.
- 82. Stobaugh, J. T., Fague, K. M., &amp; Jorgenson, J. W. (2013). Prefractionation  of  intact  proteins  by  reversed-phase  and  anionexchange  chromatography  for  the  differential  proteomic  analysis  of Saccharomyces cerevisiae. Journal of Proteome Research , 12 (2), 626636.
- 83. Stoffel, W., Chu, F., &amp; Ahrens, E. H. (1959). Analysis of long-chain fatty acids by gas-liquid chromatography. Analytical Chemistry , 31 (2), 307-308.
- 84. Stryer,  L.  1982.  Biochemistry  Second  Edition,  W.H.  Freeman  and Company, San Francisco, CA.
- 85. Tanaka,  K.  2002.  The  origin  of  macromolecule  ionization  by  laser irradiation. Nobel Lecture 197-217.
- 86. Tanaka, K., H. Waki, Y. Ido, S. Akita, Y . Yoshida, and T. Yoshida. 1988. Protein  and  polymer  analysis  uo  to  m/z100.000by  laser  ionization time-of-flight mass spectrometry . Rapid Commun. Mass. Spectrom . 2, 151-153.
- 87. Tapuhi,  Y.,  Schmidt,  D.  E.,  Lindner,  W.,  &amp;Karger,  B.  L.  (1981). Dansylation  of  amino  acids  for  high-performance  liquid  chromatography analysis. Analytical biochemistry , 115 (1), 123-129.
- 88. Trufelli, H., Palma, P., Famiglini, G., &amp;Cappiello,  A. (2011). An  overview  of matrix effects in liquid chromatography-mass spectrometry. Mass spectrometry reviews , 30 (3), 491-509.
- 89. Turriziani, B., Kriegsheim, A. V., &amp; Pennington, S. R. (2016). Proteinprotein interaction detection via mass spectrometry-based proteomics. Modern  Proteomics-Sample  Preparation,  Analysis  and  Practical Applications , 383-396.
- 90. Unger, K. K., Racaityte, K., Wagner, K., Miliotis, T., Edholm, L. E., Bischoff,  R.,  &amp;  Marko Varga,  G.  (2000).  Is  multidimensional  high -performance liquid chromatography (HPLC) an alternative in protein analysis  to  2D  gel  electrophoresis?. Journal  of  High  Resolution Chromatography , 23 (3), 259-265.
- 91. Urey, C., Weiss, V. U., Gondikas, A., von der Kammer, F., Hofmann, T., Marchetti-Deschmann, M., ... &amp;Andersson, R. (2016). Combining gasphase  electrophoretic  mobility  molecular  analysis  (GEMMA),  light

scattering, field flow fractionation and cryo electron microscopy in a multidimensional approach to characterize liposomal carrier vesicles. International journal of pharmaceutics , 513 (1-2), 309-318.

- 92. Vissers, J. P., Claessens, H. A., &amp;Cramers, C. A. (1997). Microcolumn liquid  chromatography:  instrumentation,  detection  and  applications. Journal of Chromatography A , 779 (1-2), 1-28.
- 93. Wagner,  Y., Sickmann,  A., Meyer,  H.  E., &amp;Daum,  G.  (2003). Multidimensional  nano-HPLC  for  analysis  of  protein  complexes. Journal of the American Society for Mass Spectrometry , 14 (9), 10031011.
- 94. Washburn, M. P. (2004). Utilisation of proteomics datasets generated via  multidimensional  protein  identification  technology  (MudPIT). Briefings in Functional Genomics , 3 (3), 280-286.
- 95. Wolters, D. A., Washburn, M. P., &amp; Yates, J. R. (2001). An automated multidimensional protein identification technology for shotgun proteomics. Analytical chemistry , 73 (23), 5683-5690.
- 96. Wren,  S.  A.,  &amp;Tchelitcheff,  P.  (2006).  Use  of  ultra-performance liquid  chromatography  in  pharmaceutical  development. Journal  of Chromatography A , 1119 (1-2), 140-146.
- 97. Wuthrich, K. 1986. NMR of Proteins and Nucleic Acids. New York: Wiley.
- 98. Wuthrich, K. 2002. NMR studies of structure and function of biological macromolecules. Nobel Lecture 235-267.
- 99. Xia, S., Tao, D., Yuan, H., Zhou, Y., Liang, Z., Zhang, L., &amp; Zhang, Y. (2012). Nano -flow multidimensional liquid chromatography platform integrated  with  combination  of  protein  and  peptide  separation  for proteome analysis. Journal of separation science , 35 (14), 1764-1770.
- 100. Xiao, W., &amp;Oefner, P. J. (2001). Denaturing high performance liquid -chromatography: A review. Human mutation , 17 (6), 439-474.
- 101. Yarnell, A. 2003. The double lives of enzymes. C&amp;EN 81, 35-36.
- 102. ZÃ¶lls,  S.,  Tantipolphan,  R.,  Wiggenhorn,  M.,  Winter,  G.,  Jiskoot, W.,  Friess,  W.,  &amp;Hawe,  A.  (2012).  Particles  in  therapeutic  protein formulations,  Part  1:  overview  of  analytical  methods. Journal  of pharmaceutical sciences , 101 (3), 914-935.

<!-- image -->

4

## PRINCIPLES OF LIQUID CHROMATOGRAPHY IN PROTEOMICS

## CONTENTS

| 4.1 Introduction  ..................................................................................... 130                                      |
|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.2 General Chromatographic Principles for Peptide   and Protein Segregation ............................................................... 130 |
| 4.3 Affinity Chromatography  .................................................................. 133                                              |
| 4.4 Ion Exchange Chromatography ........................................................ 134                                                     |
| 4.5 Reversed-Phase Chromatography  ..................................................... 135                                                     |
| 4.6 Size Exclusion Chromatography  ....................................................... 138                                                   |
| 4.7 Multidimensional Liquid Chromatography  ....................................... 139                                                          |
| References  ............................................................................................. 143                                    |

## 4.1 INTRODUCTION

Chromatography  is  a  separation  process  that  separates  the elements of  a  mixture  across  two  states;  a  free-moving  mobile  phase  and  a  stable stationary phase. Thin-layer chromatography, paper chromatography, gas  chromatography,  and  liquid  chromatography  are  various  types  of chromatography, yet they all work on a similar concept (Zhang et al., 2010). The chromatography procedure uses a mixture of molecules that have been dissolved  in  the  solvent.  The  elements  of  the  mixture  may  mix  with  the molecules of both the stationary matrix and solvent when the mobile phase passes over the stationary phase. Due to their varying affinities for every phase,  various  elements  in  the  mixture  flow  at  various  speeds  (Cutillas, 2005).

## 4.2 GENERAL CHROMATOGRAPHIC PRINCIPLES FOR PEPTIDE AND PROTEIN SEGREGATION

Molecules  having  the  minimum  affinity  for  the  stationary  phase  would travel  at  high  speed  due  to  their  tendency  to  retain  the  solvent,  whereas molecules having the maximum affinity would move at slow speed due to their  tendency  to  be  linked  with  the  stationary  phase  and  be  left  behind. This leads to the separation of the mixture into several fractions that may be drawn off and collected separately (Staes et al., 2008).

Due to its flexibility and comparability having mass spectrometry, liquid chromatography (LC) is employed more frequently in proteomics than other chromatography forms. Although gel electrophoresis, LC can separate both peptides and proteins, and may thus be used either before or after 2DGE to  pre-fractionate  the  specimen,  segregate  peptide  mixtures  from  solitary excised spots, or replace 2DGE as the primary protein segregation method (Van Damme et al., 2009). Various separation principles, including charge, size, hydrophobicity, and affinity for certain ligands, may be used in multiple liquid chromatography procedures. The highest-resolution separations have been  accomplished  when  two  or  more  segregation  principles  have  been applied one after another in orthogonal dimensions, and so is the case with electrophoresis (Lee W &amp; Lee K., 2004).

The  stationary  phase  in  proteomics  LC  techniques  is  a  permeable matrix, generally in the shape of packed beads supported on a certain type of column. The mobile phase which is a solvent having dissolved peptides or  proteins  travels  through  the  column  either  naturally  or  under  higher

pressure. The rate at which a peptide or protein flows down a column is determined by its affinity for the, and matrices having various physical and chemical characteristics may be utilized to segregate peptides and proteins using various selection principles. The next sections go through these ideas and how they have been used (Staes et al., 2011).

Figure 4.1. A summary of gel-free and gel-based proteomics experimental processes.

<!-- image -->

Source: Smolikova, Galina &amp; Gorbach, Daria &amp; Lukasheva, Elena &amp; Mavropolo-Stolyarenko, Gregory &amp; Bilova, Tatiana &amp; Soboleva, Alena &amp; Tsarev, Alexander &amp; Romanovskaya, Ekaterina &amp; Podolskaya, Ekaterina &amp; Zhukov, V. &amp; Tikhonovich, Igor &amp; Medvedev, Sergei &amp; Hoehenwarter, Wolfgang &amp; Frolov, Andrej. (2020). Bringing New Methods to the Seed Proteomics Platform: Challenges and Perspectives. International Journal of Molecular Sciences. 21. 9162. 10.3390/ijms21239162.

For  peptide  and  protein  separation,  multidimensional  LC  may  be employed  rather  than  2DGE.  (b)  Without  or  with  a  preceding  affinity depletion or enhancement step, chromatography processes having alternative separative principles can be utilized as a straight replacement for 2DGE for protein segregation (Gevaert et al., 2006). The second cycle of RP-HPLC is  used to feed specific peptide fractions into the mass spectrometer after

on-column  digestion  with  trypsin.  (c)  Complex  peptide  mixtures  can  be separated using multidimensional liquid-phase segregation. Because of the complicated structure of the peptide mixture, this method usually invariably includes  an  affinity  enrichment  or  depletion  phase.  AC-RPHPLC-CEMS AC-SEC-RPHPLC-MS and AC-IEC-RPHPLC-MS are three popular methods. The picture depicts mass spectrometry analysis of peptides and proteins (Kaufmann, 1997).

Figure 4.2. Enzymatic digestion is used in both gel-free and gel-based experimental setups.

<!-- image -->

Source: Smolikova, Galina &amp; Gorbach, Daria &amp; Lukasheva, Elena &amp; Mavropolo-Stolyarenko, Gregory &amp; Bilova, Tatiana &amp; Soboleva, Alena &amp; Tsarev, Alexander &amp; Romanovskaya, Ekaterina &amp; Podolskaya, Ekaterina &amp; Zhukov, V. &amp; Tikhonovich, Igor &amp; Medvedev, Sergei &amp; Hoehenwarter, Wolfgang &amp; Frolov, Andrej. (2020). Bringing New Methods to the Seed Proteomics Platform: Challenges and Perspectives. International Journal of Molecular Sciences. 21. 9162. 10.3390/ijms21239162.

## 4.3 AFFINITY CHROMATOGRAPHY

Affinity chromatography divides peptides and proteins according to their ligand-binding  affinity.  An  affinity  column's  matrix  comprises  ligands that have been extremely selective for specific proteins or protein groups (Walters, 1985). Antibody-coated beads may be used to separate peptides or proteins from a complex mixture, whereas glutathione-coated beads can be used to retain fusion proteins with GST affinity tags. Another kind of affinity  chromatography  is  immobilized  metal  affinity  chromatography (IMAC), which uses positively charged metal ions such as Fe 3+ or Ga 3+ in the solid phase. Containing this method, phosphoproteins/peptides, proteins with  oligo-histidine  affinity  tags,  and  other  -ve  charged  proteins  may  be distinguished (Hage, 1999).

The first fraction that is typically extracted from the column contains all of the peptides or proteins that had been unable to engage with the affinity matrix. The 2nd fraction, on the other hand, contains all of the peptides or proteins that had been maintained on the column throughout the extraction process. This has been achieved by doing two washes on the affinity matrix. The first solution washed away any proteins that were not connected to the matrix, and the second solution caused any proteins that were attached to the matrix to detach themselves from the matrix (Urh et al., 2009). There are  situations  in  which  the  initial  fraction  is  necessary,  such  as  when eliminating an excessive amount of protein from a specimen to facilitate an  examination  of  the  proteins  that  are  still  there.  In  certain  cases,  the objective is to segregate the second fraction, which has the proteins which preferentially attach to the affinity matrix. The goal might be to segregate fusion proteins or single, unique proteins with a particular affinity tag. A functional  or  structural  class  of  proteins  (for  example,  proteins,  or  that interact with a certain drug or enzyme-substrate) might also be the target. The investigation of phosphor-proteins and other post-translational variations by using affinity chromatography .  The separation of proteins that combine to produce a compound is another important use of affinity chromatography (Cuatrecasas&amp; Anfinsen, 1971).

Figure 4.3. Protein separation and specimen preparation are detailed in this LCbased proteomics method.

<!-- image -->

Source: Smolikova, Galina &amp; Gorbach, Daria &amp; Lukasheva, Elena &amp; Mavropolo-Stolyarenko, Gregory &amp; Bilova, Tatiana &amp; Soboleva, Alena &amp; Tsarev, Alexander &amp; Romanovskaya, Ekaterina &amp; Podolskaya, Ekaterina &amp; Zhukov, V. &amp; Tikhonovich, Igor &amp; Medvedev, Sergei &amp; Hoehenwarter, Wolfgang &amp; Frolov, Andrej. (2020). Bringing New Methods to the Seed Proteomics Platform: Challenges and Perspectives. International Journal of Molecular Sciences. 21. 9162. 10.3390/ijms21239162.

## 4.4 ION EXCHANGE CHROMATOGRAPHY

Other  types  of  chromatography  employed  in  proteomics,  in  contrast  to affinity chromatography, are nonselective for specific protein classes, that is they have been utilized to profile a specimen instead of targeting individual elements.  Ion-exchange  chromatography  (IEX,  IEC)  is  a  technique  for

separating peptides and proteins based on their charge. It works by reversibly adsorbing solute molecules to a solid phase containing charged chemical groups. Anionic and cationic resins can be utilized to attract molecules in the solvent with opposing charges. Gradient elution is performed by washing the column having buffers of steadily increasing pH or ionic strength, rather than a two-step elution technique (Jungbauer&amp; Hahn, 2009).

Table 4.1. Functional groups utilized on ion exchangers

Anion exchangers

Functional group

Diethylaminoethyl (DEAE)

Quatemnary aminoethyl (QAE)

Quatemnary ammonium (Q)

Cation exchangers

Functional group

Carboxymethyl (CM)

~O-CH2-COO-

Sulfopropyl (SP)

Methylsulfonate (S)

~O-CH2-CHOH-CH2-O-CH2-CHOH-CH2SO;

A chromatogram is the result of this technique, with the x-axis displaying extraction  time  and  the  y-axis  displaying  absorption  maxima  that  relates to  different  elements  of  the  specimen.  This  value  is  used  to  define  the resolution of a chromatographic separation based on its number of peaks or the maximal capacity that can be discerned from the extraction spectrum's baseline.  Comparing peak areas might potentially offer quantitative data, whereas the number of peaks that appear on a chromatogram is reflective of the sample's level of complexity (Fekete et al., 2015).

Chromatofocusing,  often  known  as  CF,  is  a  technique  that  involves making use of an ion-exchange column that has been set to one pH and a  buffer  that  has  been  calibrated  to  another  pH.  The  result  of  this  is  the formation of a pH gradient through the column, which may be exploited for isoelectric  point-based  protein  extraction.  During  the  operation,  focusing effects generate strong peaks and aid in the concentration of distinct fractions (Harinarayan et al., 2006).

## 4.5 REVERSED-PHASE CHROMATOGRAPHY

Reversed-phase  (RP)  chromatography,  which  is  similar  to  ion-exchange chromatography, includes the reversible adsorption of peptides and proteins to the immoveable phase matrix, and RP chromatography produces various fractions through gradient elution. In this particular situation, although, the

peptides and proteins are divided as per the given peaks, which correlate to various proteins (A = ovalbumin, B = conalbumin, C = cytochrome c, and D = lysozyme) (Horvath &amp;Melander, 1977).

Figure 4.4. Chromatograms displaying the outcomes of protein mixture separations via ion-exchange chromatography.

<!-- image -->

Source: MatijaÅ¡iÄ BB, OberÄkal J, Mohar Lorbeg P, PaveljÅ¡ek D, Skale N, Ko -lenc B, Gruden Å , Poklar Ulrih N, Kete M, ZupanÄiÄ Justin M. Characterisation of Lactoferrin Isolated from Acid Whey Using Pilot-Scale Monolithic Ion-Exchange Chromatography. Processes. 2020; 8(7):804. https://doi.org/10.3390/ pr8070804

In  a  particular  research  article,  the  first  separation  (a)  had  been  done at  pH  5.85,  whereas  the  second  separation  (b)  had  been  done  at  pH  6.5. Operating variables like temperature and pH have a substantial impact on production. Julie Bordonaro and  Rebecca Carrier of Rensselaer Polytechnic Institute created the reversed-phase resin, which is made up of hydrophobic ligands  like  C4  to  C18  alkyl  groups.  The  higher  performance  liquid chromatography (RP-HPLC), wherein the mobile phase is driven through the column at higher pressure, is commonly used in proteomics for reversedphase separations (Vailaya&amp;HorvÃ¡th, 1998).

Figure 4.5. On reversed-phase resins, certain frequently utilized n-alkyl hydrocarbon ligands.

<!-- image -->

Source: Rusli H, Putri RM, Alni A. Recent Developments of Liquid Chromatography Stationary Phases for Compound Separation: From Proteins to Small Organic  Compounds.  Molecules.  2022;  27(3):907.  https://doi.org/10.3390/ molecules27030907

Examples include the octyl (C8) ligand, the 2-carbon capping group, and  the  octadecyl  (C18)  ligand.  RP-HPLC  creates  quasi-mass-dependent segregation since retention rises as molecular mass increases, but hydrophobicity is the separative principle. To accomplish gradient extraction, first, the weak hydrophobic interactions need to be disrupted, and then the quantity of an organic modifier used in the extraction solution needs to be gradually increased (Dill, 1987). The RP-HPLC chromatographic technique is the most powerful and has the best resolution of all the chromatographic methods  that  are  utilized  in  proteomics  (In  practice,  a  peak  capacity reaches up to one hundred components). To enable completely automated peptide segregation and analysis using LC-MS or LC-MS/MS, it is usual practice to connect HPLC columns directly to electrospray ionization mass spectrometers  (Dolan,  2002).  Proteins  are  separated  using  hydrophobic interaction  chromatography  based  on  their  hydrophobic  characteristics. Hydrophobic interaction chromatography, on the other hand, employs polar extraction buffers and a range of resin compositions (aryl ligands or C2C8 alkyl groups). On either hand, hydrophilic interaction chromatography separates proteins according to their hydrophilic characteristics by employing a polar solid phase in the separation process of protein (Fausnaugh et al., 1984).

## 4.6 SIZE EXCLUSION CHROMATOGRAPHY

Size exclusion chromatography (sometimes called gel filtration chromatography) has been a profiling method for separating proteins based on size. Inert beads composed of a permeable substance like agarose are put into the column. Smaller proteins may fit through the holes in the beads, therefore they need longer to move along the column than bigger proteins, which cannot fit through the perforations and must go via the spaces between the beads (Barth et al., 1994). The molecular exclusion principle separates the solutes from the stationary phase without requiring a chemical contact. Size exclusion chromatography beads, such as Sepharose, come in a variety of sizes to allow for the separation of peptide or protein mixtures over a wide variety of sizes. (Kostanski et al., 2004)

Figure  4.6. Schematic  of  hydrophobic  interaction  chromatography  that  responds to temperature.

<!-- image -->

Source: Matsuda Y, Leung M, Okuzumi T, Mendelsohn B. A Purification Strat -egy  Utilizing  Hydrophobic  Interaction  Chromatography  to  Obtain  Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJI -CAPâ¢ First Generation. Antibodies. 2020; 9(2):16. https://doi.org/10.3390/ antib9020016

## 4.7 MULTIDIMENSIONAL LIQUID CHROMATOGRAPHY

As previously mentioned, liquid chromatography is frequently employed to pre-fractionate materials to segregate tryptic peptides generated from single gel spots, either downstream or upstream of 2DGE (Dugo et al., 2008).

Multidimensional  chromatography,  on  either  hand,  is  an  appealing technique  to  replace  2DGE  entirely  due  to  the  versatility  of  Liquid chromatography techniques in terms of mixing multiple separative principles. Liquid chromatography methods get beyond several of the constraints of 2DGE. HPLC columns, for instance, permit high specimen quantities to be loaded and concentrated on the column, making low concentration proteins simpler to identify.  Many proteins that have been hard to segregate with 2DGE (for example membrane proteins, and extremely basic proteins) may be readily segregated by utilizing the right resins (Cacciola et al., 2017).

Proteins  separated  in  the  liquid  state  do  not  need  to  be  stained  to  be recognized. Because LC columns may be connected directly to the mass spectrometer  and  because  liquid  chromatography  methods  can  separate peptides  and  proteins,  the  entire  analytical  procedure,  from  specimen preparation  to  peptide  mass  profiling,  can  be  mechanized  (Fairchild  et al., 2009). The visual components of protein segregation via 2DGE, such as the pI and molecular mass information that may be obtained from the placements of spots on the gel, have been lost with Liquid chromatography techniques (such information may be utilized in database searches). Several gels  having  similar  specimens  may  be  performed  at  a  similar  time  with Liquid  chromatography,  making  it  a  sequential  analytic  approach.  Direct quantitative comparisons between specimens, on either hand, may be made by  marking  one  of  the  specimens  having  mass-coded  tags  that  may  be recognized in the mass spectrometer (Di Palma et al., 2012).

## 4.7.1 Multidimensional Liquid Chromatography Techniques in Proteomics

For the investigation of exceedingly complex peptide or protein mixtures, the successive use of multiple chromatographic  methods  employing distinct physical and chemical separative principles may offer an adequate resolution.  For  instance,  combining  ion-exchange  chromatography  (that segregates  proteins  based  on  charge)  with  RP-HPLC  (that  segregates proteins based on mass) may reach a similar resolution as 2DGE, with the added benefits of  automation,  greater  sensitivity,  and  a  good  example  of

membrane proteins (Zhang et al., 2010). Furthermore, the practical limits of  these  multidimensional  chromatography  methods  must  be  considered. The first thing that has to be looked at is whether or not the solvents and buffers that are utilized in the various stages of each method are appropriate for those stages. The extraction buffer for the 1st-dimension ion exchange step needs to be an appropriate RPHPLC solvent. On the other hand, the elution buffer for the 2nd-dimension RP-HPLC step needs to include the solvents that were employed in the mass spectrometry specimen preparation stage (Wu et al., 2012). A number of the benefits of automation, speed, and resolution will be lost if the fractions had been brought down for cleaning and preparation. However, the solvents and buffers indicated above are suitable, and various researchers have employed ion-exchange accompanied by RPHPLC-MS to examine the proteomes of species ranging from yeast to humans. HPLC has been almost routinely utilized as the ultimate segregation technique in multidimensional chromatography due to the suitability of RP-HPLC with the  solvents  utilized  in  MALDI-MS  and  ESI-MS  (Alternatively,  capillary electrophoresis  may  be  employed).  Many  of  the  other  profiling  techniques (ion-exchange chromatography, size exclusion chromatography, and chromatefocusing) are utilized as a first-dimension segregation technique in conjunction with HPLC, often with an affinity chromatography phase preceding it, resulting in a three-dimensional separation approach (Di Palma et al., 2012).

In the beginning, multidimensional chromatography was accomplished through a discontinuous procedure wherein  fractions had been first accumulated from the gel filtration or ion exchange column and thereafter manually infused into the HPLC column. This process had been repeated until the desired results had been obtained. The lack of a time limit is one of  the  benefits  of  using  a  discontinuous  multidimensional  system,  even though it requires a lot of manual effort (Okano et al., 2006). It is possible to keep the fractions that elute from the first column off-line constantly, and then feed them one at a time onto the HPLC column that is directly linked to the mass spectrometer. There is also the benefit of being able to apply high specimen volumes to the first column to collect adequate quantities of limited-abundance proteins for examination in the second dimension. This is an additional benefit of the method (Duong et al., 2020).

The first column may be equipped with an automated fraction collection system and a column-switching valve to do away with the requirement of injecting human specimens. After collecting fractions from the first column over  the  extraction  range,  the  switching  valve  can  bring  the  RP-HPLC column in line to progressively receive the fractions (Shi et al., 2004). This

occurs after the first column has finished eluting its contents. Instead, several researchers have constructed a piece of equipment that comprises a solitary ion exchange system that is connected to several HPLC columns in parallel through the utilization of the appropriate switching valves. Fractions from the ion exchange system have been routed progressively to numerous HPLC columns in this technique, and the cycle is repeated after the first column is regenerated (see Opiteket al.) (Wang &amp;Hanash, 2003).

The use of biphasic columns is the 3rd method for doing multidimensional chromatographic separations. In this method, the proximal section of the column  is  filled  with  reversed-phase  resin,  and  the  proximal  segment contains the ertainc kind of the matrix. This enables the stepwise extraction of fractions from the 1st resin and the gradient extraction of second dimension fractions from the other resin so long as the extraction solvents for the two different kinds of resin do not interact with one another.

Figure 4.7. Peptide separation using discontinuous multidimensional chromatography.

<!-- image -->

Source: Duong V-A, Park J-M, Lee H. Review of Three-Dimensional Liquid Chromatography Platforms for Bottom-Up Proteomics. International Journal of Molecular Sciences . 2020; 21(4):1524. https://doi.org/10.3390/ijms21041524

This  technology  was  initially  developed  as  direct  analysis  of  large protein complexes (DALPC) by colleagues and Link (see Related Reading), and it was later improved into a multidimensional chromatography system by colleagues and Yates (Brown et al., 2020). Proteins from two distinct yeast  specimens  had  been  tagged  with  mass-coded  biotin  affinity  tags which interacted exclusively with cysteine residues throughout this research (that labeling approach is not detailed; it is utilized for comparing protein quantification among specimens). Every protein sample had been digested using trypsin and combined to create a single peptide pool (Wolters et al., 2001).  The  affinity  tag  was  then  selected  using  affinity  chromatography , which reduced the complexity of the mixture by tenfold. Since almost all proteins include a minimum of one cysteine residue, the leftover peptide population  covered  almost  ninety  percent  of  the  yeast  proteome.  Ion exchange  chromatography  was  used  to  segregate  the  retrieved  peptides utilizing a strong cation exchange resin. Off-line collection of 30 separate specimens  resulted  in  the  application  of  RPHPLC  for  second-dimension separation on four of the samples (NÃ¤gele et al., 2003). Protein identification technology (MudPIT) was used.  Peptide mixtures were placed onto the ion exchange resin, and first-dimension fractions werereleased into the reversedphase  resin  utilizing  a  stepwise  salt  gradient.  A  gradient  of  acetonitrile was  used  to  extract  second-dimension  fractions  from  the  reversed-phase resin  into  the  mass  spectrometer  (BrandÃ£o  et  al.,  2019).  This  procedure, as  well  as  the  following  regeneration  stage,  doesn't  interact  with  the  ion exchange  chromatography  phase,  and  by  raising  the  salt  concentration upon regeneration, an additional fraction has been liberated from the ion exchange resin (Karpievitch et al., 2010). Whenever this approach had been implemented to the yeast proteome, it was possible to assign nearly 5000 peptides to 1484 yeast proteins, accounting for almost one-fourth of the yeast proteome. The  specimen  appeared  to  cover  all  protein  classes,  including those that are often neglected in 2DGE research (Slebos et al., 2008).

## REFERENCES

- 1. Barth,  H.  G.,  Jackson,  C.,  &amp;Boyes,  B.  E.  (1994).  Size  exclusion chromatography. Analytical Chemistry , 66(12), 595-620.
- 2. BrandÃ£o, P. F., Duarte, A. C., &amp; Duarte, R. M. (2019). Comprehensive multidimensional liquid chromatography for advancing environmental and natural products research. TrAC Trends in Analytical Chemistry , 116, 186-197.
- 3. Brown,  K.  A.,  Tucholski,  T.,  Alpert,  A.  J.,  Eken,  C.,  Wesemann, L.,  Kyrvasilis,  A.,  ...  &amp;  Ge,  Y .  (2020).  Top-Down  Proteomics  of Endogenous Membrane Proteins Enabled by Cloud Point Enrichment and  Multidimensional  Liquid  Chromatography-Mass  Spectrometry. Analytical Chemistry , 92(24), 15726-15735.
- 4. Cacciola, F., Dugo, P., &amp;Mondello, L. (2017). Multidimensional liquid chromatography in food analysis. TrAC Trends in Analytical Chemistry , 96(1), 116-123.
- 5. Cuatrecasas, P., &amp; Anfinsen, C. B. (1971).  Affinity chromatography. Methods in enzymology , 22(2), 345-378.
- 6. Cutillas, P. R. (2005). Principles of nanoflow liquid chromatography and applications to proteomics. Current Nanoscience , 1(1), 65-71.
- 7. Di Palma, S., Hennrich, M. L., Heck, A. J., &amp; Mohammed, S. (2012). Recent  advances  in  peptide  separation  by  multidimensional  liquid chromatography for proteome analysis. Journal of proteomics , 75(13), 3791-3813.
- 8. Dill,  K. A.  (1987).  The  mechanism  of  solute  retention  in  reversedphase  liquid  chromatography. Journal  of  physical  chemistry ,  91(7), 1980-1988.
- 9. Dolan, J. W. (2002). Temperature selectivity in reversed-phase high performance liquid  chromatography. Journal  of  Chromatography A , 965(1-2), 195-205.
- 10. Dugo, P., Cacciola, F., Kumm, T., Dugo, G., &amp;Mondello, L. (2008). Comprehensive multidimensional liquid chromatography: theory and applications. Journal of Chromatography A , 1184(1-2), 353-368.
- 11. Duong,  V.  A.,  Park,  J.  M.,  &amp;  Lee,  H.  (2020).  Review  of  threedimensional liquid chromatography platforms for bottom-up proteomics .  International  Journal  of  Molecular  Sciences ,  21(4),  pp. 1524.

- 12. Fairchild, J. N., HorvÃ¡th, K., &amp;Guiochon, G. (2009). Approaches to comprehensive  multidimensional  liquid chromatography  systems. Journal of Chromatography A , 1216(9), 1363-1371.
- 13. Fausnaugh, J. L., Kennedy, L. A., &amp;Regnier, F. E. (1984). Comparison of  hydrophobic-interaction  and  reversed-phase  chromatography  of proteins. Journal of Chromatography A , 317, 141-155.
- 14. Fekete,  S.,  Beck,  A.,  V euthey,  J.  L.,  &amp;Guillarme,  D.  (2015).  Ion-exchange chromatography for the characterization of biopharmaceuticals. Journal of pharmaceutical and biomedical analysis , 113(!), 43-55.
- 15. Gevaert,  K.,  Van  Damme,  P.,  GhesquiÃ¨re,  B.,  &amp;Vandekerckhove, J.  (2006).  Protein  processing  and  other  modifications  analyzed  by diagonal  peptide  chromatography. Biochimica  et  Biophysica  Acta (BBA)-Proteins and Proteomics , 1764(12), 1801-1810.
- 16. Hage,  D.  S.  (1999).  Affinity  chromatography:  a  review  of  clinical applications. Clinical chemistry , 45(5), 593-615.
- 17. Harinarayan, C., Mueller, J., LjunglÃ¶f, A., Fahrner, R., Van Alstine, J., &amp; Van Reis, R. (2006). An exclusion mechanism in ion exchange chromatography. Biotechnology and Bioengineering , 95(5), 775-787.
- 18. Horvath,  C.,  &amp;Melander,  W.  (1977).  Liquid  chromatography  with hydrocarbonaceous  bonded  phases;  theory  and  practice  of  reversed phase chromatography. Journal of  Chromatographic Science ,  15(9), 393-404.
- 19. Jungbauer,  A.,  &amp;  Hahn,  R.  (2009).  Ion-exchange  chromatography. Methods in enzymology , 463(!), 349-371.
- 20. Karpievitch, Y. V.,  Polpitiya, A.  D., Anderson,  G. A.,  Smith,  R.  D., &amp; Dabney, A. R. (2010). Liquid chromatography mass spectrometrybased proteomics: biological and technological aspects. The annals of applied statistics , 4(4), 1797.
- 21. Kaufmann,  M.  (1997).  Unstable  proteins:  how  to  subject  them  to chromatographic  separations  for  purification  procedures. Journal  of Chromatography B: Biomedical Sciences and Applications , 699(1-2), 347-369.
- 22. Kostanski,  L.  K.,  Keller,  D.  M.,  &amp;Hamielec,  A.  E.  (2004).  Sizeexclusion  chromatography-a  review  of  calibration  methodologies. Journal of biochemical and biophysical methods , 58(2), 159-186.
- 23. Lee,  W.  C.,  &amp;  Lee,  K.  H.  (2004).  Applications  of  affinity  chromatography in proteomics. Analytical biochemistry , 324(1), 1-10.

- 24. NÃ¤gele, E., Vollmer, M., &amp;HÃ¶rth, P. (2003). Two-dimensional nanoliquid chromatography-mass spectrometry system for applications in proteomics. Journal of Chromatography A , 1009(1-2), 197-205.
- 25. Okano, T., Kondo, T., Kakisaka, T., Fujii, K., Yamada, M., Kato, H., ... &amp;Hirohashi, S. (2006). Plasma proteomics of lung cancer by a linkage of  multi dimensional  liquid  chromatography  and  two dimensional --difference gel electrophoresis. Proteomics , 6(13), 3938-3948.
- 26. Shi, Y., Xiang, R., HorvÃ¡th, C., &amp; Wilkins, J. A. (2004). The role of liquid chromatography in proteomics. Journal of Chromatography A , 1053(1-2), 27-36.
- 27. Slebos, R. J., Brock, J. W., Winters, N. F., Stuart, S. R., Martinez, M. A., Li, M., ... &amp;Liebler, D. C. (2008). Evaluation of strong cation exchange versus  isoelectric  focusing  of  peptides  for  multidimensional  liquid chromatography-tandem  mass  spectrometry. Journal  of  proteome research , 7(12), 5286-5294.
- 28. Staes,  A., Impens, F., Van Damme, P., Ruttens, B., Goethals, M., Demol, H., ... &amp;Gevaert, K. (2011). Selecting protein N-terminal peptides by combined fractional diagonal chromatography. Nature protocols , 6(8), 1130-1141.
- 29. Staes, A., Van Damme, P., Helsens, K., Demol, H., Vandekerckhove, J., &amp;Gevaert, K. (2008). Improved recovery of proteome informative, -protein N terminal -peptides by combined fractional diagonal chromatography (COFRADIC). Proteomics , 8(7), 1362-1370.
- 30. Urh, M., Simpson, D., &amp; Zhao, K. (2009). Affinity chromatography: general methods. Methods in enzymology , 463(1), 417-438.
- 31. Vailaya, A., &amp;HorvÃ¡th,  C. (1998). Retention in reversed-phase chromatography: partition or adsorption? Journal of Chromatography A , 829(1-2), 1-27.
- 32. Van Damme, P., Van Damme, J., Demol, H., Staes, A., Vandekerckhove, J.,  &amp;Gevaert, K. (2009, December).  A review of COFRADIC techniques targeting protein N-terminal acetylation. In BMC proceedings (Vol. 3, No. 6, pp. 1-6). BioMed Central.
- 33. Walters, R. R. (1985). Affinity chromatography. Analytical chemistry , 57(11), 1099A-1114A.
- 34. Wang, H., &amp;Hanash, S. (2003). Multi-dimensional liquid phase based separations in proteomics. Journal of Chromatography B , 787(1), 1118.

- 35. Wolters, D. A., Washburn, M. P., &amp; Yates, J. R. (2001). An automated multidimensional protein identification technology for shotgun proteomics. Analytical chemistry , 73(23), 5683-5690.
- 36. Wu, Q., Yuan, H., Zhang, L., &amp; Zhang, Y. (2012). Recent advances on  multidimensional  liquid  chromatography-mass  spectrometry  for proteomics:  From  qualitative  to  quantitative  analysis-A  review. Analytica Chimica Acta , 731, 1-10.
- 37. Zhang, X., Fang, A., Riley, C. P., Wang, M., Regnier, F. E., &amp; Buck, C. (2010). Multi-dimensional liquid chromatography in proteomics-a review. Analytica Chimica Acta , 664(2), 101-113.

<!-- image -->

## PROTEOMICS OF PROTEIN MODIFICATIONS

## CONTENTS

| 5.1 Introduction  ..................................................................................... 148   |
|---------------------------------------------------------------------------------------------------------------|
| 5.2 Phosphorylation and Phosphoproteomics ........................................ 149                        |
| 5.3 Glycosylation and Glycosylation ..................................................... 153                 |
| 5.4 Ubiquitination and Ubiquitinomics ................................................. 158                   |
| 5.5 Miscellaneous Modifications of Proteins  .......................................... 161                   |
| References  ............................................................................................. 164 |

## 5.1 INTRODUCTION

In every organism, there are far more proteins as compared to the genes that code for them. A one-to-one relationship between the quantity of proteins and  genes  does  not  occur  in  higher  species;  for  instance,  people  have fewer than 25,000 genes however up to 500,000 proteins. The blending of transcripts typically creates numerous messenger RNAs (mRNA) per gene and at least one protein per gene helps in resolving a few of the imbalances in  the  number  of  proteins  and  genes.  Other  than  the  splicing  process, posttranslational  protein  alteration  is  the  other  primary  driver  of  protein excess in every species. This kind of posttranslational modification happens after or during ribosomes' translation of an mRNA into proteins (Butterfield &amp;Dalle Donne, 2014). -

Figure 5.1. Strategies for Post-Translational Modifications (PTMs).

<!-- image -->

Source:  Salas-Lloret  D,  GonzÃ¡lez-Prieto  R.  Insights  in  Post-Translational Modifications: Ubiquitin and SUMO. International Journal of Molecular Sci -ences. 2022; 23(6):3281. https://doi.org/10.3390/ijms23063281

Proteins need posttranslational change for their unique function and their storage, disintegration, and regulation of many biochemical functions. Some proteins, for instance, should be phosphorylated, which requires the addition of one or even more PO4 groups to the protein backbone (Arrell et al., 2001).

Proteins remain functional in the signaling pathways, division of the cell, as well as other processes in an entity once they have been phosphorylated. 1/3rd  of all proteins in eukaryotic organisms are phosphorylated (Repetto et al., 2003).

Similarly, glycosylation includes the insertion of carbohydrate monomers into 50% of all proteins in humans. Binding to fatty acids or lipids modifies some membrane proteins. The formation of disulfide connections between distinct  components  stabilizes  several  other  proteins,  such  as  insulin  and immunoglobulin (Soufi  ET  AL.,  2012).  Several  additional  proteins  are degraded  before  becoming  active;  for  instance,  insulin  is  translated  as  a preproinsulin  from  mRNA.  It  is  destroyed  by  removing  terminal  amino acids to create proinsulin, which is then further destroyed to produce insulin, which acts as a hormone to govern glucose absorption in mammalian cells. Furthermore, some proteins are ubiquitinated by the inclusion of a protein family known as ubiquitin, which marks these proteins for breakdown by the  protease  system  (Rudolf  et  al.,  2013).  Many  additional  proteins,  like arginine to citrulline, asparagine to aspartic acid, or glutamine to glutamic acid, may be modified by changing one amino acid to the other. Some proteins may  have  a  stretch  of  amino  acids  termed  'intein'  removed  from  their core at times. Intein elimination is aided by a protein splicing mechanism analogous to RNA splicing in the synthesis of transcribed. Phosphorylation, glycosylation,  and  ubiquitination  are  the  three  most  common  changes that  proteins  go  through.  These  alterations  were  previously  identified by  studying  one  protein  at  a  time,  and  now  that  proteomic  technologies employing mass spectrometry are available, these changes may be easily demonstrated in a huge range of proteins. This section covers this and many other posttranscriptional alterations that alter the pattern or composition of amino acids in proteins (Desiderio&amp;Nibbering, 2006).

## 5.2 PHOSPHORYLATION AND PHOSPHOPROTEOMICS

This  post-transcriptional  alteration  exists  in  above  30%  of  mammalian proteins. This entails adding one or maybe more PO4 molecules to certain amino acids in a protein. PO4 groups are attached to the protein amino acids threonine, serine, and tyrosine in human cells. In comparison, prokaryotes phosphorylate  amino  acids  like  aspartic,  glutamic,  and  histidine,  while eukaryotic phosphorylate tyrosine, serine, and threonine (Jers et al., 2008; Lemeer&amp; Heck, 2009). Sometimes, phosphorylation happens in arginine,

lysine, and cysteine residues of proteins in either prokaryotes or eukaryotes. In mammalian cells, the proportion of phosphorylation of the three amino acid  residues  is  1000:100:1  for  threonine,  serine,  as  well  as  tyrosine, respectively. Proteins are phosphorylated at several sites, and a cell typically contains  a  variety  of  phosphorylated  isomers  with  varying  amounts  of phosphorylation. The introduction  of  the  PO4  group  via  phosphorylation imparts a negative charge to the proteins (Ajadi et al., 2020).

Figure 5.2. Protein Phosphorylation as well as Phosphoproteome.

<!-- image -->

Source: Song J, Han D, Lee H, Kim DJ, Cho J-Y, Park J-H, Seok SH. A Comprehensive Proteomic and Phosphoproteomic Analysis of Retinal Pigment Epithelium Reveals Multiple Pathway Alterations in Response to the Inflamma -tory Stimuli. International Journal of Molecular Sciences. 2020; 21(9):3037. https://doi.org/10.3390/ijms21093037

Protein kinases are responsible for phosphorylation. Dephosphorylation is the process of removing the phosphate group from phosphorylated proteins (s). Protein phosphatase catalyzes the dephosphorylation process. About 2% of the human genome codes for protein kinases and protein phosphatases. In humans, about 500 protein kinases and over 100 protein phosphatases have been identified (Nakagami et al., 2010). There are roughly 120 kinase genes and 40 phosphatase genes in yeast. Typically, phosphorylation affects

the  activation  or  inactivation  of  a  protein  and  its  biological  or  metabolic function.  Following  dephosphorylation,  a  phosphorylated  protein  that  is functional might become inert. Similarly, a phosphorylated protein that is inert turns active following dephosphorylation. Proteins are phosphorylated to activate specific mechanisms, like signal transmission and cell division, and cancer-causing paths in mammalian cells (Engholm-Keller &amp; Larsen, 2013). The effective treatment of some types of human cancer with Gleevec (Novartis Pharmaceuticals Corp., East Hanover, NJ), a blocker of BCR-Abl protein kinase, demonstrates the importance of phosphorylation in cancer. Protein kinases are regarded as a good targeted therapy for cancer as well as  other  disorders  caused  by  signal  transduction  pathway  disruption.  A concerted attempt is required to discover blockers of various protein kinases to cure cancer and other disorders (NÃ¼hse et al., 2004).

Phosphoproteomics is the extensive investigation of genes associated with the phosphorylation process.  A huge number of enzymes and the various phosphorylation  sites  are  analyzed  in  a  single  effort.  In  comparison  to past  methods,  which  detailed  the  biochemistry  and  genetics  of  a  single protein at a period, this method describes the biochemistry and genetics of several  proteins  simultaneously  (Pinkse  et  al.,  2008).  Phosphoproteomics is  now  feasible  as  a  result  of  technological  advancements  such  as  mass spectrometry in the study of proteins as well as the existence of gene and protein  databanksPhosphoproteins  and  their  locations  of  phosphorylation are recognized by the rise in molecular mass of the peptides acquired after mass  spectrometric  comparative  method  of  their  amino  acid  or  inferred nucleotide pattern with the pattern data given in the protein as well as gene databanks (Umezawa et al., 2013).

Phosphoproteomics requires many processes, including the production of protein samples, their concentration, and tryptic digestion before mass spectrometric detection (Olsen et al., 2010).

Typically, the test proteins are produced using a variety of procedures. Between  these techniques, phosphoprotein isotope-coded affinity tag (PhIAT) , isotope-coded affinity tag (ICAT) , as well as carbon isotope tagging with  amino  acids  in  cell  culture  are  used  often  (SILAC).  PhIAT  directly inserts  isotopes  into  protein  phosphoserine  as  well  as  phosphothreonine residues (Hardman et al., 2019).

Besides phosphorylation sites, the various two techniques incorporate isotopes into the protein at other locations. In vitro proteins are labeled with PhIAT and ICAT, while in vivo proteins are labeled with SILAC. SILAC is

beneficial for in vivo tagging of proteins in cell cultures maintained under circumstances  that  may  affect  the  degree  of  phosphorylation.  In  Chapter 3, the ICAT and SILAC methodologies are explained (Van Bentem et al., 2006).

Figure 5.3. Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers.

<!-- image -->

Source: Schaab, C., Oppermann, F., Klammer, M. et al. Global phosphoproteome  analysis  of  human  bone  marrow  reveals  predictive  phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib. Leukemia 28, 716-719 (2014). https://doi.org/10.1038/leu.2013.347

On the affinities, column phosphoproteins are enhanced. SILAC is often used in tandem with immobilized metal affinity chromatography (IMAC). The  column  including  the  anti-phosphotyrosine  antibody  is  utilized  to concentrate phosphotyrosine-containing protein due to  their poor interaction with  phosphoproteins,  phosphoserine  and  phosphothreonine  antibodies could not be utilized to concentrate phosphoproteins on a column (Lin et

al.,  2009).  Nevertheless, they are employed to detect phosphoproteins on the gel. These antibodies are all widely accessible. As explained in Chapter 3, the optimized phosphoproteins are digested with trypsin; phosphorylated and unphosphorylated specimens are then combined and evaluated using a  mass  spectrometer.  Following  mass  spectrometry,  phosphoproteins  are distinguished by changes in molecular weights depending on the phosphate group connected to the amino acids of peptides. Proteins are confirmed by analyzing their amino acid patterns to those in the protein database (Schmidt et al., 2014).

Utilizing this approach for the investigation of phosphoproteins, a great number of novel phosphoproteins and phosphorylation locations in many paths have been found. Using mass spectrometry, the many elements of the signaling  pathways  and  other  control  mechanisms  have  been  discovered (Roux &amp;Thibault, 2013). For instance,  phosphoproteomics  has  improved our understanding of yeast mating pheromone-induced signaling cascades. And over 500 proteins and 729 phosphorylation sites in the yeast signal transduction pathway are receptive to the mating pheromone, and 139 of these phosphorylation sites were changed in response to the pheromone in yeast. In addition, this work sheds light on the function of phosphorylation in the RNA-processing and transport paths that regulate mRNA metabolism in  yeast  (Mithoe&amp;Menke,  2011).  The  phosphoproteomic  technique  has established the impact of phosphorylation on the subunits of the epidermal growth  factor  (EGF)  receptor  as  well  as  their  involvement  in  mRNA metabolism  in  mammals.  These  investigations  have  also  improved  our understanding of the signal transduction of extracellular regulated kinase (ERK)  protein  kinase.  Numerous  new  phosphorylation  sites  have  been found in tumor suppressor proteins (TSC1 and TSC2). By identifying the elements of such a system, phosphoproteomics has thrown considerable light on the function of phosphorylation in the signaling route. Phosphorylation research is very relevant since phosphorylation sites are consistent between organisms (Wong et al., 2019).

## 5.3 GLYCOSYLATION AND GLYCOSYLATION

## 5.3.1 Glycosylation

Protein glycosylation is a common posttranslational alteration. It includes integrating  a  glucose  moiety  into  proteins.  Glycoproteins  are  proteins that have been glycosylated. Glycoproteins make over half of all proteins

in mammalian  cells.  They  regulate  the  durability,  anchoring,  cell-tocell  connections,  antigenic  and  immunological  specialization,  secretion, reproduction, pathogenesis protection, and practically all other activities of proteins in the cell, as outlined in the following part (Hart, 1992).

Carbohydrates and proteins are the two primary elements of glycosylated proteins. The carbohydrate portion may range anywhere from 2% to 80% of the overall bulk. Proteoglycans are glycoproteins that have a large percentage of carbohydrates, as compared to glycoproteins that have a modest fraction of carbs. Glycoproteins, on the other hand, refer to all glycosylated proteins (Haltiwanger et al., 2004).

Figure 5.4 . The two primary kinds of protein glycosylation are shown in Figure 5.4. Attaching sugar moieties to protein is a post-translational alteration that gives the proteins more proteome variety.

<!-- image -->

Source: Nardy, Ana &amp; Freire de Lima, Leonardo &amp; Freire-de-Lima, Celio &amp; Morrot, Alexandre. (2016). The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression. Frontiers in Oncology. 6. 10.3389/ fonc.2016.00054.

Carbohydrate moieties are chemically attached to asparagine, serine, and threonine in glycoproteins. Carbohydrate connections may be divided into two types. Carbohydrates are connected to the aromatic ring of asparagines

for one type of protein known as 'N-linked glycoproteins.' Carbohydrates are  attached  to  the  OH  group  of  serine  or  threonine  in  the  next  type  of coupling, resulting in 'O-linked glycoproteins' (Rudd et al., 2001).

Acetylglucosamine is coupled to the N atom of the NH2 group in the asparagine  of  N-linked  glycoproteins.  Galactose  or  glucosyl-galactose  is bonded  to  the  O  atom  of  serine  or  threonine  in  O-linked  glycoproteins. Additional  sugar  molecules,  like  arabinose  or  mannose,  may  bind  to serine,  threonine,  or  proline  in  O-linked  glycoproteins  at  sometimes.  In O-linked  glycoproteins,  many  different  carbohydrates  may  be  connected to proteins (Lis &amp; Sharon, 1993). A glycoprotein may have just one kind of sugar molecule linkage or both O-linked and N-linked sugar molecules. Glycophorin, which has 15 O-linked sugar molecules but one N-linked sugar molecule,  is  an  instance  of  a  glycoprotein  with  both  links.  Glycophorin is  found in the erythrocyte cell membrane. The protein and carbohydrate constituents of glycoprotein dictate its characteristics.  The polymeric variants of the glycophorin gene, which codes for distinct amino acids at the 5 and 26 locations in the protein part of this glycoprotein, define the M, N, and MN blood types in people (Ohtsubo &amp;Marth, 2006). One of the immediate impacts  of  glycosylation  is  that  it  enhances  the  solubility  of  proteins  by making them more hydrophilic due to the existence of numerous OH groups on  the  carbohydrate  elements.  Glycoproteins  are  required  for  practically all cell processes. Glycoproteins have a variety of activities, including cell adhesion,  antigenic,  antibody,  enzymatic,  as  well  as  hormonal  functions; they also perform a part in fertility and cytoskeleton (Reily et al., 2019).

Glycoproteins help a cell adhere to some other cell and regulate cellto-cell contacts. N-CAM is a glycoprotein that lets nerve cells detect and attach. This glycoprotein also helps nerve cells and muscle cells connect at  the  neuromuscular  junction.  Fibroblasts  would  attach  to  every  ligand or  molecule  that  contains  fibronectin.  Antigens  and  antibodies  are  both glycoproteins.  The  existence  of  glycoprotein  in  the  cell  surface  of  the blood cell causes the antigenic feature of the human blood group (Kahne et  al.,  1989).  Antigen  A  is  found  in  blood  group  A,  antigen  B  is  found in  blood  group  B,  antigen  A  and  B  are  found  in  blood  group  AB,  and antigen A and B are not found in blood group O. N-acetyl galactosamine glycosylates  the  protein A  in  antigen.  Galactose  glycosylates  the  protein B in antigen. By eliminating their sugar moiety or substituting one sugar on the blood cell membrane with another, they might lose or modify their

antigenic properties (Pinho&amp; Reis, 2015). Antibody immunoglobulins are glycoproteins  that  lose  their  ability  to  act  as  antibodies  when  the  sugar component is removed. Glycoproteins are a kind of enzyme that includes oxidoreductases, hydrolases, and transferases; the latter can also act as a blocker of some enzymes. Glycoproteins include hormones such as human chorionic  gonadotropin  (hCG),  which  is  detected  in  human  female  urine throughout  pregnancy,  and  erythropoietin,  which  regulates  erythrocyte synthesis.  Glycoproteins  are  also  used  to  transport  hormones,  vitamins, and cations. Many glycoproteins are involved in the human reproductive process (Varki et al., 2009). Glycoproteins improve sperm attractiveness to the egg, enable sperm entry to the cervix, regulate sperm penetrance to the zona pellucida, and inhibit polyspermy, or egg fertilization by more than one sperm. Glycoproteins play an important role in cell structure. Glycoproteins are found in cartilage, synaptosomes, axons, and microsomes, among other places (Stowell et al., 2015). Blood clotting proteins including thrombin, prothrombin, and fibrinogen are also glycoproteins. The capsules present in S cell bacteria contain glycoproteins that coat the outside of the cell wall, giving the S cells a smooth look. Glycoproteins are also found in bacterial flagella,  which  govern  bacterial  motility.  Furthermore,  glycoproteins  like mucin play many additional roles, including cell protection, internal organ protection, and skin protection (Steen et al., 1998).

## 5.3.2 Glycoproteomics

Due to their  many  functions  in  the  construction  and  functioning  of  cells in  various  animals,  glycoproteins  are  very  important  for  human  health. Numerous  altered  glycoproteins  serve  as  disease  indicators  in  humans. Certain glycoproteins are modified in several malignancies. The prototypical case is prostate-specific antigen (PSA) (Wuhrer et al., 2007). Glycoproteins act as diagnostic markers for many different malignancies, such as breast cancer.  They  also  offer  a  foundation  for  the  immunotherapeutic  and pharmacological treatment of human disorders. Glycoproteins are excellent pharmacological and drug combination sites. Herceptin treatment is a great illustration of immunotherapy for specific tumors (Polasky et al., 2020).

Figure  5.5. Glycans  are  ubiquitous.  High-throughput  glycoproteomics  techniques provide information.

<!-- image -->

Source; Fang P, Ji Y, Oellerich T, Urlaub H, Pan K-T. Strategies for ProteomeWide  Quantification  of  Glycosylation  Macro-  and  Micro-Heterogeneity.  In -ternational  Journal  of  Molecular  Sciences.  2022;  23(3):1609.  https://doi. org/10.3390/ijms23031609

Consequently, knowing the nature of various glycoproteins has garnered considerable  attention.  Various  technologies  have  been  implemented  to examine their structure, such as the type of the proteins, their glycosylation, as well as the binding site of certain carbohydrate monomers or polymers (Tissot  et  al.,  2009).  These  approaches  use  affinity  chromatography  to enrich  glycoproteins  and  mass  spectrometry  to  determine  the  type  of proteins  and  conjugated  carbohydrates.  These  approaches  are  rapid  and high-throughput, and they offer data on a wide number of glycoproteins in a little amount of time. Some insoluble membrane glycoproteins are turned accessible  by  trypsin  hydrolysis,  and  the  resultant  soluble  glycopeptides are  concentrated  by  chromatographic  techniques  and  evaluated  by  mass spectrometry. The enriching of glycoproteins may be accomplished using two distinct but significant techniques. The first technique employs a family of plant proteins known as 'lectin.' Lectins link only to a certain class of glycoproteins (Tian &amp; Zhang, 2010). Consequently, glycoproteins may be readily isolated using affinity chromatography over a column that identifies a  specific  lectin.  Lectins  have  been  utilized  to  see  and  compare  different glycoproteins on microchips. Therefore, lectins cannot be used to affinitypurify all glycoproteins. Thus, different approaches for the enhancement of glycoproteins have been proposed. Just one of those techniques, which was

first established by Aebersold et al. (2003), is built on hydrazine chemistry. Initially, glycoproteins are degraded by contact with periodate, and they'll be attached to hydrazide resin in a column. The column is rinsed many times to remove unbound glycoproteins from the hydrazide column. Eventually, the attached glycoproteins are freed from the matrix by enzymatic hydrolysis that hydrolyzes the link for both the glycerol molecule of glycoproteins as well as the NH2 position of the hydrazide in the resin (Palaniappan&amp;Bertozzi, 2016).

## 5.4 UBIQUITINATION AND UBIQUITINOMICS

## 5.4.1 Ubiquitination or Ubiquitinylation

Ubiquitin is a tiny, evolutionarily conserved protein that is only present in eukaryotes. This protein's properties were determined in the 1980s. Aaron Ciechanover, Avram Hersko, and Irwin Rose received the Nobel Prize in Chemistry in 2004 for their great accomplishment (Welchman et al., 2005).

Ubiquitination is the method of assigning ubiquitin to a protein, marking it for  enzymatic  destruction  by  proteosomes.  Because  all  proteins  are destroyed at the time of destruction, ubiquitination is a nearly ubiquitous alteration of proteins. The half-life of proteins varies; most have a half-life of several seconds, while others contain a half-life of many weeks. The half-life of hemoglobin is nearly three weeks. It's still unclear what factors influence a protein's lifetime (Randles&amp; Walters, 2012). However it is not clear why the presence of a specific amino acid at the N-terminal would govern a protein's service life, the N-terminal rule predicts that proteins with aspartic acid at the N-terminal are relatively brief and proteins with serine at the N-terminal are  sustained  over  time.  The  ubiquitination  procedure  is  often  used  to assess a protein's longevity (Hicke et al., 2005). In addition to maintaining protein stability, ubiquitin also plays a role in the cell stage, DNA repair, and translation. Ubiquitin is a 76-amino-acid protein that is tiny yet is involved in gene regulation. Just three amino acid changes occur across the ubiquitin protein in yeast as well as in humans, indicating that it is conserved. The lysine residue of ubiquitin is bound to the glycine residue at the C-terminus of  a  protein,  which  would  be  subsequently  designated  for  destruction  by the proteasome (Abbas et al., 2008). Many additional ubiquitin molecules may be included in the ubiquitin molecule after it has been attached to the protein.  Monoubiquitination  occurs  when  only  one  ubiquitin  molecule  is connected to the protein of interest (Yao et al., 2011), polyubiquitination

occurs while a few ubiquitin molecules are attached in tandem to the first ubiquitin, and multiubiquitination occurs when multiple ubiquitin molecules are connected to the protein of interest at distinct lysine residues. Protein trafficking is aided by monoubiquitination, but protein breakdown is aided by polyubiquitination. Additional to protein stability, the diverse types of ubiquitinated molecules may affect other activities of the targeting proteins, although these functions remain unknown (Hoeller&amp;Dikic, 2009).

Figure 5.6 . Brief-Introduction-to-Ubiquitin-and-Protein-Ubiquitination.

<!-- image -->

Source;  LaPlante  G,  Zhang  W.  Targeting  the  Ubiquitin-Proteasome  System  for  Cancer  Therapeutics  by  Small-Molecule  Inhibitors.  Cancers.  2021; 13(12):3079. https://doi.org/10.3390/cancers13123079

The ubiquitination mechanism involves at least three different types of enzymes. The E1 activating enzyme, E2 conjugating enzyme, and E3 ligase are  among them. E1 activates ubiquitin in a resource way by converting adenosine  triphosphate  (ATP)  to  adenosine  diphosphate  (ADP).  E2  and E3 bind ubiquitin to the protein that  has  been  designated  for  destruction (Weissman et al., 2011). The ubiquitinated protein subsequently binds to the 26S proteasome through a collector or the 19S regulatory component of the proteasome straight. The proteosome's 20S catalytic component degrades the designated protein. Besides these types of enzymes, another group of enzymes is engaged in the elimination of ubiquitin from proteosomes. The deubiquitinating enzymes are a class of enzymes (DUB). There are 500600 ligases  and  roughly  70  DUB  enzymes  in  people. The  ubiquitination mechanism and the involvement of several enzymes inside this mechanism are thoroughly explained (Rolfe et al., 1995).

## 5.4.2 Proteomics of Ubiquitin Modifications

Ubiquitin changes proteins that are damaged, mistranslated, or biologically changed to have become dysfunctional; these proteins are then designated to  be  eliminated  by  proteasome  hydrolysis.  The  proteomics  of  ubiquitin alterations  was  initially  investigated  in  yeast  (Peng  et  al.,  2003).  These researchers replicated the ubiquitin gene &amp; inserted a 6x histidine tag just at the start of the gene. The cloned ubiquitin genes with histidine labels were transferred into yeast cells bearing a loss in the yeast chromosomes' native ubiquitin gene (Swatek&amp;Komander, 2016). These cells synthesized ubiquitin proteins using histidine hexamers. A nickel column was used to purify the ubiquitin  linked  with  conjugating  proteins  and  the  proteins  intended  for elimination. Mass spectrometry was used to evaluate the peptides generated following  tryptic  digestion  of  ubiquitin-attached  proteins,  and  they  were recognized  by  a  match  with  the  protein  pattern  in  the  protein  databank. Utilizing such an innovative technique, Peng et al. (2003) discovered over 1000 ubiquitination sites in 72 yeast ubiquitin-protein conjugates.

The  researchers  also  discovered  alterations  in  seven  ubiquitin  lysine residues  in  protein  conjugates,  suggesting  that  polyubiquitin  in  yeast  is diversifying in vivo. This strategy developed by Peng et al. (2003) serves as the foundation for the same method in other creatures, such as humans. Following  their  technique  of  cloned  ubiquitin  genes  with  histidine  tags were transfected into human hepatocytes, and several ubiquitin-associated proteins, including the conjugating and DUB enzymes, were identified in human cells. Furthermore, proteasome inhibitors were employed to extract

as well as to characterize ubiquitin-associated proteins in humans following mass spectrometry investigation (Kim et al., 2011). An examination of the ubiquitination  process  throughout  different  organisms,  such  as  humans, mice, worms, flies, and yeast, found that the proportion of E2, E3, and DUB enzymes is proportional to the complexity of an organism. In mice, many novel enzymes have been identified, including 4 E1, 13 E2, 97 E3, and 6 DUB. Errors in the ubiquitination mechanism have been linked to illnesses like Alzheimer's, Parkinson's, autoimmune, and cancer (Peng et al., 2003).

Figure 5.7. Modification sites on ubiquitin .

<!-- image -->

Source: Swatek, K., Komander, D. Ubiquitin modifications. Cell Res 26, 399422 (2016). https://doi.org/10.1038/cr.2016.39

## 5.5 MISCELLANEOUS MODIFICATIONS OF PROTEINS

Other than phosphorylation, glycosylation, and ubiquitination, proteins result in  a  variety  of  additional  changes.  Proteolysis,  acetylation,  methylation, sulfonation,  frensylation,  and  sumoylation  are  a  few  examples  (Barraud &amp;TisnÃ©, 2019).

## 5.5.1 Proteolysis

The extent of the chain of amino acids in proteins is reduced via proteolysis. The  N-terminal  amino  acid  methionine,  which  serves  as  the  starting amino acid in all proteins, is eliminated as quickly as and before creatine

supplementation is complete. Additionally, some proteins are first generated as a longer chain, which is then proteolytically cleaved to produce an even smaller  active  version  of  the  enzyme  and  protein.    Insulin  and  zymogen are common instances of this kind of protein. Such proteins are generated as pre-pro-proteins and afterward through proteolysis to give initially proproteins and subsequently proteins, that are their active component (King et al., 1996).

Figure 5.8. Proteolysis is the breakdown of proteins into smaller polypeptides or amino acids.

<!-- image -->

Source; Kurz A, Seifert J. Factors Influencing Proteolysis and Protein Utiliza -tion in the Intestine of Pigs: A Review. Animals. 2021; 11(12):3551. https://doi. org/10.3390/ani11123551

## 5.5.2 Methylation

The introduction of a methyl or CH  group to the lysine residue in many 3 proteins  causes  methylation.  Histone  methylation  is  essential  for  gene activity regulation (Costello &amp;Plass, 2001).

## 5.5.3 Sulfation

Certain proteins, such as gastrin, are sulfated by the attachment of a sulfate group  or  SO   to  a  tyrosine  receptor.  Sulfation  is  accomplished  by  two 4 enzymatic reactions  controlled  by  two  distinct  transferases  (Waqif  et  al., 1997).

## 5.5.4 Prenylation

Some proteins, like Ras and transducin, have isoprenoid groups linked to their cysteine residues. Farnesyl and geranyl are isoprenoids with 15 and 20 carbons, correspondingly (Zhang, &amp; Casey, 1996).

## 5.5.5 Hydroxylation and Carboxylation

The insertion  of  the  OH  group  to  proline  plus  lysine  sites  in  the  protein results in hydroxylation. Hydroxylation occurs in the synthesis of vitamin C, which acts as a complement for the corresponding hydroxylases. Some proteins  can  carboxylate  glutamine  residues.  Vitamin  K  is  required  as  a component in this mechanism (Chakraborty &amp; Coates, (2005).

## REFERENCES

- 1. Abbas, T., Sivaprasad, U., Terai, K., Amador, V., Pagano, M., &amp; Dutta, A.  (2008).  PCNA-dependent  regulation  of  p21  ubiquitylation  and degradation  via  the  CRL4Cdt2  ubiquitin  ligase  complex. Genes  &amp; development , 22(18), 2496-2506.
- 2. Ajadi,  A.  A.,  Cisse,  A.,  Ahmad,  S.,  Yifeng,  W.,  Yazhou,  S.  H.  U., Shufan,  L.  I.,  ...  &amp;  Jian,  Z.  (2020).  Protein  phosphorylation  and phosphoproteome: An overview of rice. Rice Science , 27(3), 184-200.
- 3. Arrell, D. K., Neverova, I., &amp; Van Eyk, J. E. (2001). Cardiovascular proteomics: evolution and potential. Circulation Research , 88(8), 763773.
- 4. Barraud,  P.,  &amp;TisnÃ©,  C.  (2019).  To  be  or  not  to  be  modified:  miscellaneous aspects influencing nucleotide modifications in tRNAs.  IUBMB life, 71(8), 1126-1140.
- 5. Butterfield, D.  A., &amp;Dalle -Donne,  I.  (2014).  Redox  proteomics: from protein modifications to cellular dysfunction and disease. Mass spectrometry reviews , 33(1), 1-6.
- 6. Chakraborty, R., &amp; Coates, J. D. (2005). Hydroxylation and carboxylation-two  crucial  steps  of  anaerobic  benzene  degradation by Dechloromonas strain RCB. Applied and Environmental Microbiology , 71(9), 5427-5432.
- 7. Costello,  J.  F.,  &amp;Plass,  C.  (2001).  Methylation  matters. Journal  of medical genetics , 38(5), 285-303.
- 8. Desiderio, D. M., &amp;Nibbering, N. M. (2006). Redox proteomics: from protein modifications to cellular dysfunction and diseases (Vol. 9, pp. 5). John Wiley &amp; Sons.
- 9. Engholm Keller,  K.,  &amp;  Larsen,  M.  R.  (2013).  Technologies  and -challenges in large scale phosphoproteomics. -Proteomics , 13(6), 910931.
- 10. Haltiwanger,  R.  S.,  &amp;  Lowe,  J.  B.  (2004).  Role  of  glycosylation  in development. Annual review of biochemistry , 73(1), 491-537.
- 11. Hardman, G., Perkins, S., Brownridge, P. J., Clarke, C. J., Byrne, D. P., Campbell, A. E., ... &amp;Eyers, C. E. (2019). Strong anion exchange -mediated phosphoproteomics reveals extensive human non canonical -phosphorylation. The EMBO journal , 38(21), e100847.
- 12. Hart, G. W. (1992). Glycosylation. Current opinion in cell biology ,  4(6), 1017-1023.

- 13. Hicke,  L.,  Schubert,  H.  L.,  &amp;  Hill,  C.  P.  (2005).  Ubiquitin-binding domains. Nature reviews Molecular cell biology , 6(8), 610-621.
- 14. Hoeller, D., &amp;Dikic, I. (2009). Targeting the ubiquitin system in cancer therapy. Nature , 458(7237), 438-444.
- 15. Jers, C., Soufi, B., Grangeasse, C., Deutscher, J., &amp;Mijakovic, I. (2008). Phosphoproteomics in bacteria: towards a systemic understanding of bacterial phosphorylation networks. Expert review of proteomics , 5(4), 619-627.
- 16. Kahne, D., Walker, S., Cheng,  Y., &amp;  Van  Engen,  D. (1989). Glycosylation  of  unreactive  substrates. Journal  of  the  American Chemical Society , 111(17), 6881-6882.
- 17. Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A., ... &amp;Gygi, S. P. (2011). Systematic and quantitative assessment of the ubiquitin -modified proteome. Molecular cell , 44(2), 325-340.
- 18. King, R. W., Deshaies, R. J., Peters, J. M., &amp;Kirschner, M. W. (1996). How proteolysis drives the cell cycle. Science , 274(5293), 1652-1659.
- 19. Lemeer,  S.,  &amp;  Heck,  A.  J.  (2009).  The  phosphoproteomics  data explosion. Current opinion in chemical biology , 13(4), 414-420.
- 20. Lin, M. H., Hsu, T. L., Lin, S. Y., Pan, Y. J., Jan, J. T., Wang, J. T., ... &amp; Wu, S. H. (2009). Phosphoproteomics of Klebsiella pneumoniae NTUH-K2044 reveals a tight link between tyrosine phosphorylation and virulence. Molecular &amp; Cellular Proteomics , 8(12), 2613-2623.
- 21. Lis,  H.,  &amp;  Sharon,  N.  (1993).  Protein  glycosylation:  structural  and functional aspects. European journal of biochemistry , 218(1), 1-27.
- 22. Mithoe, S. C., &amp;Menke, F. L. (2011). Phosphoproteomics perspective on plant signal transduction and tyrosine phosphorylation. Phytochemistry , 72(10), 997-1006.
- 23. Nakagami,  H.,  Sugiyama,  N.,  Mochida,  K.,  Daudi,  A.,  Yoshida, Y.,  Toyoda,  T.,  ...  &amp;Shirasu,  K.  (2010).  Large-scale  comparative phosphoproteomics  identifies conserved phosphorylation sites in plants. Plant Physiology , 153(3), 1161-1174.
- 24. NÃ¼hse,  T.  S.,  Stensballe,  A.,  Jensen,  O.  N.,  &amp;  Peck,  S.  C.  (2004). Phosphoproteomics of the Arabidopsis plasma membrane and a new phosphorylation site database. The Plant Cell , 16(9), 2394-2405.
- 25. Ohtsubo, K., &amp;Marth, J. D. (2006). Glycosylation in cellular mechanisms of health and disease. Cell , 126(5), 855-867.

- 26. Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., ... &amp; Mann, M. (2010). Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Science signaling , 3(104), ra3-ra3.
- 27. Palaniappan, K. K., &amp;Bertozzi, C. R. (2016). Chemical glycoproteomics. Chemical reviews , 116(23), 14277-14306.
- 28. Peng,  J.,  Schwartz,  D.,  Elias,  J.  E.,  Thoreen,  C.  C.,  Cheng,  D., Marsischky,  G.,  ...  &amp;Gygi,  S.  P.  (2003).  A  proteomics  approach  to understanding  protein  ubiquitination. Nature  Biotechnology , 21(8), 921-926.
- 29. Pinho, S. S., &amp; Reis, C.  A. (2015). Glycosylation in cancer: mechanisms and clinical implications. Nature Reviews Cancer , 15(9), 540-555.
- 30. Pinkse, M. W., Mohammed, S., Gouw, J. W., van Breukelen, B., Vos, H. R., &amp; Heck, A. J. (2008). Highly robust, automated, and sensitive online  TiO2-based  phosphoproteomics  applied  to  study  endogenous phosphorylation  in Drosophila  melanogaster . Journal  of  proteome research , 7(2), 687-697.
- 31. Polasky, D. A., Yu, F., Teo, G. C., &amp;Nesvizhskii, A. I. (2020). Fast and comprehensive N-and O-glycoproteomics analysis with MSFraggerGlyco. Nature methods , 17(11), 1125-1132.
- 32. Randles,  L.,  &amp;  Walters,  K.  J.  (2012).  Ubiquitin  and  its  binding domains. Frontiers in bioscience (Landmark edition), 17, 2140.
- 33. Reily,  C.,  Stewart,  T.  J.,  Renfrow,  M.  B.,  &amp;  Novak,  J.  (2019). Glycosylation in health and disease. Nature Reviews Nephrology ,  15(6), 346-366.
- 34. Repetto, O., Bestel Corre, G., Dumas Gaudot, E., Berta, G., Gianinazzi ---Pearson, V., &amp;Gianinazzi, S. (2003). Targeted proteomics to identify cadmium -induced protein modifications in Glomus mosseae -inoculated pea roots. New Phytologist , 157(3), 555-567.
- 35. Rolfe,  M.,  Beer-Romero,  P .,  Glass,  S.,  Eckstein,  J.,  Berdo,  I.,  Theodoras,  A., ... &amp;Draetta, G. (1995). Reconstitution of p53-ubiquitinylation reactions from  purified  components:  the  role  of  human  ubiquitin -conjugating enzyme UBC4 and E6-associated protein (E6AP). Proceedings of the National Academy of Sciences , 92(8), 3264-3268.
- 36. Roux, P. P., &amp;Thibault, P. (2013). The coming of age of phosphoproteomics-from  large  data  sets  to  inference  of  protein functions. Molecular &amp; Cellular Proteomics , 12(12), 3453-3464.

- 37. Rudd, P. M., Elliott, T.,  Cresswell,  P., Wilson,  I. A.,  &amp;Dwek,  R. A. (2001).  Glycosylation  and  the  immune  system. Science ,  291(5512), 2370-2376.
- 38. Rudolf,  G.  C.,  Heydenreuter,  W.,  &amp;Sieber,  S.  A.  (2013).  Chemical proteomics:  ligation  and  cleavage  of  protein  modifications. Current Opinion in Chemical Biology , 17(1), 110-117.
- 39. Schmidt, A., Trentini, D. B., Spiess, S., Fuhrmann, J., Ammerer, G., Mechtler, K., &amp; Clausen, T. (2014). Quantitative phosphoproteomics reveals  the  role  of  protein  arginine  phosphorylation  in  the  bacterial stress response. Molecular &amp; Cellular Proteomics , 13(2), 537-550.
- 40. Soufi, B., Soares, N. C., Ravikumar, V., &amp;Macek, B. (2012). Proteomics reveals evidence  of  cross-talk between  protein  modifications  in bacteria: focus on acetylation and phosphorylation. Current opinion in microbiology , 15(3), 357-363.
- 41. Steen, P. V. D., Rudd, P. M., Dwek, R. A., &amp;Opdenakker, G. (1998). Concepts and principles of O-linked glycosylation. Critical reviews in biochemistry and molecular biology , 33(3), 151-208.
- 42. Stowell, S. R., Ju, T., &amp; Cummings, R. D. (2015). Protein glycosylation in cancer. Annual Review of Pathology: Mechanisms of Disease , 10, 473-510.
- 43. Swatek, K. N., &amp;Komander, D. (2016). Ubiquitin modifications. Cell research , 26(4), 399-422.
- 44. Tian, Y., &amp; Zhang, H. (2010). Glycoproteomics and clinical applications. Proteomics-Clinical Applications , 4(2), 124-132.
- 45. Tissot,  B.,  North,  S.  J.,  Ceroni, A.,  Pang,  P.  C.,  Panico,  M.,  Rosati, F.,  ...  &amp;  Morris,  H.  R.  (2009).  Glycoproteomics:  past,  present  and future. FEBS letters , 583(11), 1728-1735.
- 46. Umezawa, T., Sugiyama, N.,  Takahashi, F.,  Anderson, J. C.,  Ishihama,  Y ., Peck, S. C., &amp; Shinozaki, K. (2013). Genetics and phosphoproteomics reveal a protein phosphorylation network in the abscisic acid signaling pathway in Arabidopsis thaliana . Science signaling , 6(270), rs8-rs8.
- 47. Van  Bentem,  S.  D.  L.  F.,  Anrather,  D.,  Roitinger,  E.,  Djamei,  A., Hufnagl, T., Barta, A., ... &amp;Hirt, H. (2006). Phosphoproteomics reveals extensive in vivo phosphorylation of Arabidopsis proteins involved in RNA metabolism. Nucleic acids research , 34(11), 3267-3278.
- 48. Varki, A., Kannagi, R., &amp; Toole, B. P. (2009). Glycosylation changes in cancer. Essentials of Glycobiology. 2nd edition, (pp. 1-5).

- 49. Waqif,  M.,  Bazin,  P.,  Saur,  O.,  Lavalley,  J.  C.,  Blanchard,  G., &amp;Touret,  O.  (1997).  Study  of  ceria  sulfation. Applied  Catalysis  B: Environmental , 11(2), 193-205.
- 50. Weissman, A. M., Shabek, N., &amp;Ciechanover, A. (2011). The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nature reviews Molecular cell biology ,  12(9), 605620.
- 51. Welchman, R. L., Gordon, C., &amp; Mayer, R. J. (2005). Ubiquitin and ubiquitin-like  proteins  as  multifunctional  signals. Nature  reviews Molecular cell biology , 6(8), 599-609.
- 52. Wong, M. M., Bhaskara, G. B., Wen, T. N., Lin, W. D., Nguyen, T. T.,  Chong,  G.  L.,  &amp;Verslues,  P.  E.  (2019).  Phosphoproteomics  of Arabidopsis Highly ABA-Induced1 identifies AT-Hook-Like10 phosphorylation required for stress growth regulation. Proceedings of the National Academy of Sciences, 116(6), 2354-2363.
- 53. Wuhrer,  M.,  Catalina, M.  I., Deelder,  A. M., &amp;Hokke,  C.  H. (2007).  Glycoproteomics  based  on  tandem  mass  spectrometry  of glycopeptides. Journal of Chromatography B , 849(1-2), 115-128.
- 54. Yao,  Q.,  Li,  H.,  Liu,  B.  Q.,  Huang,  X.  Y.,  &amp;Guo,  L.  (2011). SUMOylation-regulated protein phosphorylation, evidence from quantitative phosphoproteomics analyses. Journal of Biological Chemistry , 286(31), 27342-27349.
- 55. Zhang,  F.  L.,  &amp;  Casey,  P.  J.  (1996).  Protein  prenylation:  molecular mechanisms and functional consequences. Annual review of biochemistry , 65(1), 241-269.

<!-- image -->

6

## PROTEOMICS OF PROTEIN-PROTEIN INTERACTOMES

## CONTENTS

| 6.1 Introduction  ..................................................................................... 170   |
|---------------------------------------------------------------------------------------------------------------|
| 6.2 Protein-Protein Interactions  In Vivo ................................................. 171               |
| 6.3 Analysis of Protein Interaction  In Vitro ............................................ 175                |
| 6.4 Analysis of Protein Interactions In Silico  ........................................... 180               |
| 6.5 Interactomes  .................................................................................... 182    |
| 6.6 Evolution and Conservation of Interactions ...................................... 190                     |
| 6.7 Interaction of Proteins with Small Molecules ................................... 191                      |
| References  ............................................................................................. 192 |

## 6.1 INTRODUCTION

The  one-gene-one-enzyme  hypothesis  led  to  the  idea  that  biological processes are catalyzed individually by multiple enzymes in a biochemical way  after  the  other.  This  viewpoint  was  reinforced  by  the  advancement of molecular biology (Cafarelli et al., 2017). This concept of one enzyme performing  one  biochemical  process  in  separation  has  been  replaced  by modern knowledge that a type of protein connects in a metabolic path, thanks to the advent of systems biology. This new technique led to the discovery of  protein  connections  and  the  idea  of  interactomes.  Since  interactomes include several proteins involved in various metabolic processes, they are also known as complexosomes. Interactome analysis is becoming a critical element in improving protein complexes and activity (Chua &amp; Wong, 2008).

Figure 6.1. Functional test of the two gal4p domains separately.

<!-- image -->

Source: McLaughlin, W.A., Chen, K., Hou, T. et al. On the detection of functionally coherent groups of protein domains with an extension to protein annotation. BMC Bioinformatics 8, 390 (2007). https://doi.org/10.1186/1471-2105-8-390

For a comprehensive knowledge of all metabolic pathways, a thorough comprehension of interactomes is required. Furthermore, a better knowledge of interactomes is crucial to understanding illnesses and drug development, though either disease and drug discovery are linked to alterations in metabolic processes  regulated  by  multiple  proteins  cooperating  in  interactomes.  In yeast, almost full knowledge of interactomes has been achieved. Techniques for studying protein interactomes in vivo and in vitro have been created. This section presents a few of these ways (Rual et al., 2005).

## 6.2 PROTEIN-PROTEIN INTERACTIONS IN VIVO

## 6.2.1 Yeast Two-Hybrid Assay for Protein-Protein Interactions

The  majority  of  proteins  have  many  motifs  or  domains  with  specialized functions. Typically, a protein is known as a Transcription activator (TA) or transcription factor that facilitates DNA transcription (TF) (Causier&amp; Davies, 2002). At a minimum, two domains comprise the transcription factor: The one which connects with the DNA (to be transcribed) at a particular place, termed the DNA-binding domain (BD), and another that binds with RNA polymerase to activate transcription, termed the Activation Domain (AD). Those regions of the TA/TF protein must be encoded by a DNA portion. In terms of bringing those two domains together to allow the transcription of a gene, they have to be capable of binding whether on a similar DNA segment or distinct segments. Yeast GAL-4 is a transcription activator, and the yeast two-hybrid method makes it possible to indicate the existence of the BD and AD by activating a beta-galactosidase reporter gene. The transcription of the beta-galactosidase reporter gene in the yeast-two hybrid bacterium is deduced from its ability to produce blue yeast colonies in the addition of a chromogenic material in the growing medium (Walhout&amp; Vidal, 2001).

Figure 6.2. The yeast two-hybrid system involves two Yep plasmids.

<!-- image -->

Source: BrÃ¼ckner A, Polge C, Lentze N, Auerbach D, Schlattner U. Yeast TwoHybrid, a Powerful Tool for Systems Biology. International Journal of Molecular Sciences. 2009; 10(6):2763-2788. https://doi.org/10.3390/ijms10062763

Fields and Song conceptualized the yeast two-hybrid (Y2H) technology (1989).  By  expressing  a  reporter  gene,  the  association  of  many  proteins with a given protein is determined (Fields &amp; Song, 1989). This approach is predicated on the notion as well that the DNA binding domain (BD) and the activation domain (AD) are necessary for the transcription of a gene. This utilizes the yeast gal-4 gene system. The gal-4 gene makes a protein which is a lac gene transcription factor. The lac gene provides instructions for making the  beta-galactosidase  enzyme  in  the  existence  of  a  gal-4  gene  product containing a DNA BD and an AD. This enzyme catalyzes the transformation of a colorless chemical into a blue product that may be seen in developing yeast colonies on a plate (Luo et al., 1997). Therefore, the activation of the lac gene signals that the gal-4 gene is operating properly due to the contact between the two zones. If some of such domains are dysfunctional, the lac gene is not translated, and yeast colonies look translucent in the lack of beta-

galactosidase.  As soon as these two disciplines stay in close vicinity, although if  they  occur  on  two  distinct  peptides,  they  may  trigger  the  transcription of the beta-galactosidase gene in yeast, resulting in the blue coloration of yeast colonies. Therefore, this system offers a mechanism for determining the contact between different proteins comprising the gal-4 DNA binding domain  and  the  transcriptional  activation  domain.  If  such  two  proteins combine to put these two gal-4 regions into close contact, the yeast colonies look blue. If such proteins do not bind, then there is no translation of the galactosidase gene and the yeast colonies stay colorless (Sato et al., 1994). The gal-4 DNA segment encoding the BD is fused with the DNA segment encoding the protein involved in the protein-protein interaction. Similarly, the gal-4 AD DNA is fused with some other DNA fragment expressing the protein whose relationship with the protein expressed by the DNA fragment encoding the BD is being investigated. Such two chimeric gene complexes including the BD and AD are utilized to transplant yeast cells. If such two proteins combine to put the BD and AD into close contact, transfected yeast cells  will  form  blue  colonies.  In  the  addition  of  a  chromogenic  material, the network connections engage the lac gene and create beta-galactosidase, which alters the color of yeast colonies (Lentze&amp;Auerbach, 2008).

In their initial two-hybrid system, Fields and Song (1989) fused DNA expressing 2 main associating proteins (SNF1 and SNF4) to target DNA encoding gal-4 BD and gal-4 AD, correspondingly. The yeast cells were transfected  using  these  plasmid  variants.  The  interaction  between  the chimeric proteins created in the yeast cells brought along the BD with AD of the gal-4 transcription factor, resulting in the transcriptional activation of the beta-galactosidase gene as well as the formation of blue colonies in the  developing  yeast  cells.  The  construct  holding  BD  was  referred  to  as 'bait'  in  this  system,  whereas  the  construct  holding AD  was  referred  to as 'prey.' The chimeric protein having a peptide other than SNF4 or the other appropriate peptide users can interact with AD was not susceptible to bait having the SNF1 and BD sequences (Bartel et al., 1993). For their purpose of restoring the transcriptional activation of the beta-galactosidase gene and generating blue colonies in increasing yeast cells transfected with suitable structures in pairwise pairings, this system proved to be a valuable tool for identifying the conversing proteins with AD vs. a recognized bait comprising BD (Serebriiskii et al., 2000).

Figure 6.3 . Graphical illustration of the yeast two-hybrid system.

<!-- image -->

Source: By Anna - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/ index.php?curid=2890233

Because since conception, many improvements have been made to the yeast  two-hybrid  system,  including  the  utilization  of  a  reporting  scheme apart from galactosidase. Additionally, the yeast two-hybrid system may be made to function by fusing the alpha mating kind cell further with a different mating-type cell, i.e., a yeast cell independently transfected with Plasmid DNA having ORF for protein  complexes  including  BD  and AD  (Fields, 2005). The development of the yeast two-hybrid system by mating is seen as favorable since it provides for the posttranslational changes of the proteins necessary  for  their  associations.  Additionally,  it  has  been  conceivable to  develop  a  hybrid  system  to  investigate  protein  interactions  utilizing Escherichia coli or even mammalian cells as opposed to yeast cells. In yeast and other species, the yeast two-hybrid method has been crucial in building the web of protein complexes and interactomes. Figures above illustrate the

function of several yeast two-hybrid system components, including the BD and AD (James et al., 1996).

## 6.2.2 Phage Display

Since the associated protein is shown or generated on the exterior of the bacterial  virus,  this  process  is  termed  'phage  display.'  In  this  approach, the gene producing the desired protein is cloned alongside the target DNA producing the phage coat protein (Smith &amp;Petrenko, 1997). The bacteria then  are  infected  with  it.  Upon  infecting  bacteria  with  the  reconstructed phage genome, new disease particles are produced that produce the desired protein on the coat protein's exterior. These viral proteins are selected by engaging with an antibody vs. a protein on the well's membrane; the virus particles connect directly to the antibody-containing well while others are swept away. Such virus particles are utilized to attack a different microbial host to create only offspring virions with the protein of interest on the viral coat's surface. Isolated proteins out from coat protein are examined by mass spectrometry to determine which protein matches the sequence of amino acids in the protein database (Azzazy&amp; Highsmith, 2002).

Figure 6.4. Visualization of Phage Display.

<!-- image -->

Source:https://en.wikipedia.org/wiki/File:Phage\_display.png

## 6.3 ANALYSIS OF PROTEIN INTERACTION IN VITRO

In vitro , protein-protein contacts may be identified in a variety of methods. Coimmunoprecipitation,  protein  pulldown  assay,  chemical  crosslinking,

fluorescence resonance energy transfer (FRET), label transfer, and tandem affinity purification (TAP) are these methods. TAP is the first technique with high throughput (Piehler, 2005).

The conventional approach for demonstrating the existence of protein complexes is to coimmunoprecipitate proteins with an antibody. Whenever a  protein  is  caused  by  a  primary  antibody,  the  inter-acting  protein(s)  are also prompted together with the protein usually generated by the antigenantibody  contact;  upon  electrophoresis,  the  elements  of  the  associated proteins are viewed by Western analysis within the same band on the gel (Galarneau et al., 2002).

Protein pulldown is similar to coimmunoprecipitation, with the exception that rather than using an antibody, a ligand is used to identify interacting proteins on gel electrophoresis. The interacting proteins' combined movement on the gel seems to be much shorter as compared to the protein molecules in the interacting group. By transferring a radioactive tag from one protein to the other, a tag transmission can be utilized to find the sample with an insufficient or transient interplay (Doi et al., 2002).

TAP entails cleaning of associated proteins depending on their affinity for another molecule confined to a matrix, followed by mass spectrometric identifying associated proteins.  Although this is a high-throughput technique, it  is  unable to identify weak transitory interactionssince such proteins are isolated with the affinity purification (Kawahashi et al., 2003). In several organisms,  such  as  yeast ,  the  TAP  technique  has  been  utilized  to  define interactomes or protein systems. Following is a short explanation of this technique.

## 6.3.1 TAP and Mass Spectrometry

Proteins of interest are extracted using an epitope label in this approach. The epitope tags are short stretches of amino acids fused to the proteins of relevance. Purification of proteins with so epitopes is accomplished by column chromatography, which primarily involves a protein extract over a matrix containing a protein having an affinity for the epitope, like Sepharose beads (Sigma Aldrich Co., St. Louis, MO) (Montiel et al., 2018). The proteins are kept on the matrix surface and bind to the affinity protein-coupled to Sepharose  beads  throughout  this  kind  of  column  chromatography.  Two epitopes are likely connected to the protein sample. The TEV protease site

separates the immunoglobin G (IgG) binding domain (protein A) and the calmodulin-binding domain (CBD).

<!-- image -->

A  protein  mixture  is  initially  run  over  an  IgG-containing  Sepharose column  in  this  technique,  and  the  bound  proteins  are  then  extracted  by changing the ionic strength of the elution buffer. Following that, the proteins are digested using TEV proteases to eliminate the initial epitope with IgG high affinity. The protein mixture is then run through a second Sepharose column  containing  calmodulin  linked  to  the  beads.  The  CBD-containing proteins  are  kept  in  this  column  and  are  acquired  by  changing  the  ionic strength of the elution buffer (Goeury et al., 2019).

Mass spectrometry is then used to identify such the proteins of relevance and their interactions. Some proteins, particularly ones responsible for DNA reactions  (replication,  repair,  recombination,  and  transcription),  may  be isolated straight on a DNA Sepharose column with no need for epitope tags since they easily bind to the DNA connected to the Sepharose beads in the matrix. A variation in the elution buffer's ionic content removes the proteins attached to the matrix. Mass spectrometry is used to identify the proteins retrieved (Takaku et al., 1995).

## 6.3.2 Mass Spectrometric Identification of Interacting Proteins

The proteins  are  prepared  when TAP  is  put  into  a  spectrometer,  and  the various proteins are recognized. In such a study, stable isotopes are tagged on a specimen of protein affinity isolated to use the epitope tag and matched to  the  abundances  of  distinct  peaks  in  the  two  samples  to  discover  the associating  proteins  in  a  given  composition. As  a  result,  the  quantitative ICAT mass spectrometry presented in the chapter is substantially the same (Jauregui et al., 1997). The proteins are separated with no epitope tag on a  DNA column, they are compared to a specimen that could not bind to DNA in the matrix. Stable isotopes are used to identify the specimens. The quantity of the protein complexes is used to identify them (Rep et al., 2002).

Figure 6.5. Protein-Protein Interactions.

<!-- image -->

Source: By Philippe HupÃ© - Emmanuel Barillot, Laurence Calzone, Philippe HupÃ©,  Jean-Philippe  Vert,  Andrei  Zinovyev,  Computational  Systems  Biology of  Cancer  Chapman  &amp;amp;  Hall/CRC  Mathematical  &amp;amp;  Computational  Biology  ,  2012,  CC  BY-SA  3.0,  https://commons.wikimedia.org/w/index. php?curid=18532378

## 6.3.3 Functional Protein Microarray

As said before, a protein array comprises a glass slide about which specific antibodies  are  put  at  predetermined  places  before  being  subjected  to  a purified  protein.  The  proteins  in  the  material  respond  with  the  antibody at a defined place on the surface, and the antibody is then recognized by interacting with the antibody written in an array at point sets on the slide. Microarray is a technique for determining the relative assortment of various proteins in a type of cell produced under various growth circumstances, or in types of cells from both healthy and diseased people cultivated under the

same circumstances (MÃ¼ller et al., 2001). Protein arrays may also be utilized to look for connections amongst proteins either between enzymes and their substrates or inhibitors. Analytical microarrays, functional microarrays, and reverse-phase microarrays (RPAs) are the three types of protein microarrays now in use. Analytical microarrays are being used to assess the levels of translation  and  relative  abundance  of  various  proteins.  Protein  binding affinities are also determined using this approach. This is accomplished by exposing a glass slide with antibodies, aptamers, or affibodies printed in fixed places to light (Hu et al., 2011).

Figure  6.6. Protein-microarrays-a-Functional-protein-microarrays-for-studying-protein: (a) Capture arrays. (b) Cell-based protein microarrays. (c) Reverse phase arrays. (d) Cell-free nucleic acid programmable protein array.

<!-- image -->

Source: DÃ­ez P, Dasilva N, GonzÃ¡lez-GonzÃ¡lez M, Matarraz S, Casado-Vela J, Orfao A, Fuentes M. Data Analysis Strategies for Protein Microarrays. Microarrays. 2012; 1(2):64-83. https://doi.org/10.3390/microarrays1020064

A  functioning  microarray  is  a  group  of  fully  functioning  proteins  or protein  structures  produced  on  glass  slides  which  are  then  subjected  to protein preparations from a cell which reflects that cell's whole proteome (Bertone &amp; Snyder, 2005). Protein-protein interactions may be determined

using  this  approach.  This  approach  may  also  be  used  to  anticipate  how proteins  react  with  DNA,  RNA,  phospholipids,  and  tiny  molecules.  A cellular protein preparation is fixed on a microscope slide and subsequently probed  with  a  recognized  antibody  in  RPA  (Zhou  et  al.,  2012).  This approach  aids  in  finding  proteins  in  the  proteome  of  sick  cell  types  that have been changed and cannot bind to a recognized antibody. This approach also determines whether proteins are changed by phosphorylation or other posttranslational  alterations  in  healthy  and  pathologic  situations,  as  well as under growing conditions. The full yeast protein array, which contains roughly 5800 proteins, was cloned, overexpressed, and put on glass slides to use the functional protein analytical method. GST-His-tags were present on the proteins on the glass plate (Ramachandran et al., 2005). Such labels aided affinity filtration of such proteins on a nickel column before printing on glass slides. By scanning with luminous anti-GST antibody, those labels also  assisted  in  their  recognition.  In  yeast,  this  research  resulted  in  the discovery of completely undiscovered calmodulin and phospholipid-binding proteins. A similar investigation resulted in the discovery of numerous yeast transmembrane proteins (Ofran&amp;Rost, 2007).

## 6.4 ANALYSIS OF PROTEIN INTERACTIONS IN SILICO

This  method  entails  doing  computer  analysis  on  data  from  the  genome and protein databases. This method compares the relationship of specific nucleic acid sequences, transcribed proteins, or protein structures in various databanks. The  most  widely  used  approach  is  Rosetta  Stone,  which  was created by Marcotte and colleagues (1999). That method is based on the theory that particular network connections form the Rosetta stone protein. The proteins in the Rosetta Stone are found through studying the protein database which is used to build protein networks and interactomes (Marcotte et al., 1999).

Figure 6.7. Ability To visualize of Protein-Protein Interactions.

<!-- image -->

Source: Jiang, M., Niu, C., Cao, J. et al. In silico-prediction of protein-protein  interactions  network about MAPKs and PP2Cs reveals a novel docking site variants in Brachypodium distachyon. Sci Rep 8, 15083 (2018). https://doi. org/10.1038/s41598-018-33428-5

When  protein  A  and  protein  B  show  up  as  single-fused  proteins  in certain species after scanning the protein database, they might be termed associating proteins. The connecting proteins are shown in the figure below (Murakami et al., 2017).

Structure of Protein A

X-X-X-X-X-X-X-X-X

Structure of Protein B

0-0-0-0-0-0-0-0

Structure of Rosetta

X-X-X-X-X-X-X-X-X-0-0-0-0-0-0-0-0-0

Protein/Fused A-B Protein

The existence of the Rosetta protein in similar animals is searched for using a software program, and if discovered, the Rosetta protein is being used to show that such proteins indeed communicate. The Rosetta protein's results are being used to build the graph or interactome. The web of protein complexes  is  built  using  a  variety  of  various  computational  approaches (Shoemaker &amp;Panchenko, 2007). Among the most significant benefits of computational approaches is that they aid in reducing the high rate of false positives  in  data  generated  from  yeast  two-hybrid  investigations.  In  fact, as explained in detail in this chapter, computational approaches have been employed to analyze the interactomes of various species (Valente et al., 2013). The notion of sequence conservation of protein complexing or interactomes was born out of comparative interactomics. Thus, it has been demonstrated that  genes  and  proteins,  and  also  protein  complexes  or  interactomes  in nature, are maintained throughout evolution. Analyzing illnesses, examining the  interactomes  of  easy  model  organisms  like  yeast,  and  undertaking  a computer study all benefit from this idea of protein complexes' evolutionary conservation (Valencia &amp;Pazos, 2002). As a result, animal systems may be ignored,  and  pharmacological  adverse  effects  can  be  studied  in  a  virtual environment. Statistical approaches have served as the main aim of building PPI maps of various animals due to their speed and capacity to manage a great number of binding proteins at once. Several databanks holding PPI data for various organisms, such as humans, are currently accessible. Statistical approaches have become more popular owing to the accessibility of various protein databanks and software programs (Xing et al., 2016).

## 6.5 INTERACTOMES

Most proteins occur as complexes; several complexes together can carry out diverse cellular functions in an organism. These functions may involve different metabolic pathways, cell-to-cell communication including signaling,  several  DNA  reactions  such  as  DNA  replication,  transcription, repair  and  recombination,  cell  division  and  growth.  Such  a  complex  of proteins has been called an interactome (Shoemaker &amp;Panchenko, 2007).

Figure 6.8. 3-D illustration of the Interactome.

<!-- image -->

Source: Alanis-Lobato G (2015) Mining protein interactomes to improve their reliability  and  support  the  advancement  of  network  medicine.  Front.  Genet. 6:296. doi: 10.3389/fgene.2015.00296

Interactomes or PPI maps have been studied in numerous species, such as viruses, bacteria, and some eukaryotes, such as yeast , worms, flies, mice, humans, and such plants. The majority of such creatures are model organisms whose genetics, chemistry, and molecular genetics are very well (Lambert et al., 2013). The research of interactomes has contributed to the identification of genetic variants and their control. In particular, the analysis of PPI maps offers the foundation for comprehending the diversity of various species, which cannot be described by an easy change in the number of genes. It appears the number of PPIs determines the diversity of a creature. Complex organisms, such as humans, include a greater number of PPIs than yeast, flies, and worms. The research on interactomes has shown that throughout the development of life, not just gene products have been preserved, as well as the interactomes (Isabelle et al., 2010).

Various  techniques,  including  Y2H  studies,  TPA  accompanied  by spectrometry,  as  well  as  synthetic  genetic  analysis,  have  been  used  to reveal the nature of interactomes. Yeast seems to have around 6000 genes that produce 6000 proteins. Such proteins are temporarily or permanently structured into several interactomes that perform all cellular tasks throughout this organism (Cumberworth et al., 2013). The amount of interactomes varies based on the methodology being used to estimate them and the conclusions of other researchers employing a similar approach. The majority of variance in their quantities is due to false-positive interactions between proteins and the employment of multiple techniques to estimate certain properties. Y2H analysis,  for  instance,  evaluates  both  temporary  and  permanent  proteinprotein  interaction,  while  TAP  spectrometry  primarily  identifies  stable protein-protein  interaction  (VarnaitÄ  &amp;MacNeill,  2016).  Moreover,  the majority  of  connections  are  governed  by  proteins  produced  by  copying certain genes utilizing polymerase chain reaction (PCR) technology. PCR may produce a shift in the composition of proteins, which might also result in both false-positive and false-negative estimates of protein interactions. Consequently, PCR may result in a substantial difference in the number of interactomes (Das &amp; Yu, 2012).

## 6.5.1 Prokaryotic Interactomes

PPI maps of numerous bacteria, as well as some viruses, have now been studied in past years. The interactome of Escherichia coli is one of those partially understood. E. coli is the best-characterized prokaryotic organism in terms of biochemistry, genetics, and bacterial physiology. Starting with the finding of mating in E. coli ,  this  individual's early study transformed molecular  biology.  The  research  of  this  species  ultimately  resulted  in the development  of  molecular  cloning  techniques  using  recombinant technologies, ushering in the age of genomics (Bianco, 2021). To use the Y2H test, it has been determined that roughly 4000 prey proteins connect with  about  2700  bait  proteins  in E.  coli .  Seen  in  these  protein-protein interactions are many metabolic processes of the species. Treponema pallida , which produces the sexually transmitted illness syphilis in humans, has also been examined for such protein-protein connections. Treponema has one of  the  shortest  bacterial  genomes.  This  organism  cannot  be  cultivated in vitro and cannot be analyzed using genetic approaches; consequently, the investigation of protein interactions using the Y2H test has proved useful in comprehending it (Park et al., 2005).

By using Y2H assays, around 1000 proteins have been examined. In Y2H tests, over 700 of such proteins generated over 3600 connections. No syphilis-causing  contact  has  been  detected  in  this  research  (Klein  et  al., 2021). Multiple interactomes from different types of bacteria have also been examined. Helicobacter pylori is  a  bacteria that has been widely investigated. This  bacteria  is  present  in  around  fifty  percent  of  human  disorders  that invade the stomach lining and produce various diseases, including peptic ulcers  and  sometimes  even  cancer. Y2H  tests  have  examined  more  than 260 pylori proteins involved in more than 1200 PPIs. This accounts for 47 percent of its proteome. Nevertheless, a PPI databank is currently developed using statistical approaches (Horkawicz et al., 2014).

Figure 6.9. Cytoscape depiction of yeast protein-protein contact networks.

<!-- image -->

Source: Chen Y, Wang W, Liu J, Feng J and Gong X (2020) Protein Interface Complementarity and Gene Duplication Improve Link Prediction of Protein-Protein Interaction Network. Front. Genet. 11:291. doi: 10.3389/fgene.2020.00291

Utilizing Y2H tests, the protein-protein connections of the bacteriophage  have  been  extensively  explored  in  combination  with  the bacterial  interactomes. The majority of these proteins are engaged in the morphogenesis of the bacterium virus (Ding et al., 2020).

## 6.5.2 Eukaryotic Interactomes

The  PPI  maps  of  eukaryotes  have  been  explored.  The  interactomes  of many species,  namely  flies,  yeast,  flies,  worms,  and  humans,  have  been meticulously mapped. Several of those are detailed in the next section (Aw et al., 2016).

## 6.5.2.1 Yeast Interactome

Yeast is a prototypical easy eukaryote. It has created genetics, biochemistry, and  molecular  biology  departments.  It's  also  the  first  eukaryote  whose whole genomic DNA has been decoded and completely annotated. To gain better information on the system of biochemical processes that govern all cellular functions, such as the genesis, development, and shape of such a species as an instance of the basic eukaryote, the PPI map was tried inside this  species  (Yu  et  al.,  2008). Various  techniques have been employed to construct the web of binding proteins. Such techniques involve spectrometry, bioinformatics, genetic analysis, and Y2H tests. Nearly 40 million protein connections  are  expected  to  take  place  in  yeast  cells.  Only  a  portion  of such  connections  are  shown  by  some  of  these  methodologies  and  is  the primary reason for the lack of consistency between their results (Tarassov et al., 2008). Other issues plague the outcomes of these methods, including the identification of interactions that may not necessarily exist in the cell. Such data could include false negatives, indicating that the technology is incapable of revealing real cell connections. Statistical examination of the data may allow for the elimination of such.

The  PPI  map  reveals  the  physical  participation  of  proteins  in  binary interactions for both the bait protein and the prey protein, as shown by the Y2H test, or in regular connection including all proteins, as indicated by the TAP spectroscopy (Bertin et al., 2007). Two concepts, the spoke system, and the matrix framework are employed to represent the presence of binary and many connections, accordingly. It is claimed that there are three times more binary connections than interactive relationships. The PPI map illustrates that protein interactions take place in a hub or center where multiple proteins connect. Other protein connections link various reaction centers inside this core, suggesting the topology of the interacting proteins system within the cell (Figure 5.3). It has been discovered in several species, such as E. coli , yeast ,  flies,  and  worms,  that  proteins  with  sequence  homology  in  some regions link with one another more often than would be predicted by chance simply (Vo et al., 2016). Pfam group proteins link more often than would be

anticipated by chance. The classification of proteins is classified according to the type of regions.  A domain is the portion of a protein having a hydrophobic core that has been conserved throughout evolution. Families of proteins are generated depending on the nature of the domain they share; these families are cataloged in various databanks. Pfam is however one database of proteins with many homology domains in their sequence of amino acids. There are now more than 1815 families of Pfam proteins, which account for more than fifty percent of all proteins in eukaryotic organisms. Other groups of protein domains are ProCite, PRINT-S, SMART, and Prodom (Causier, 2004).

## 6.5.2.2 Fly Interactomes

Drosophila  melanogaster is  the  first  multicellular  creature  for  which  the whole genome sequence was made accessible. It was the first platform to comprehend multicellularity, tissue/organ formation, and differentiating at the genomic stages. This is an effective paradigm for comprehending human growth  and  disorders  at  the  most  fundamental  level  of  an  organization. Utilizing  the  Y2H  test,  protein-protein  interactions  in  Drosophila  were investigated. An initial map of over 4700 interactions involving over 4600 proteins has been produced. The Drosophila interactome map also reinforces the concept of a system of hub proteins and proteins that link such hubs. There are approximately 65,000 interactions in the Drosophila interactome (Gandhi et al., 2006).

## 6.5.2.3 Worm Interactome

Caenorhabditis elegans gives a good chance to comprehend the significance of  interactomes in determining multicellularity, cell fate, and cell growth throughout the lifetime of a common organism. Combining Y2H tests, TAP spectroscopy,  and  in  silico  analysis, C.  elegans protein  interactions  are determined using a variety of techniques. Over 3000 proteins directly or indirectly associated with multicellularity have been analyzed. More than 4000 interactions  involving  diverse  biological  processes  were  created  by these proteins. Such involves the mechanisms for vulval growth, formation of  the  germline,  pharyngeal  functioning,  protein  breakdown,  and  DNA repair. The Y2H assays discovered 2900 nodes linked by about 5500 corners within the complex formed (Gandhi et al., 2006). It was discovered that the nodes included ancient, multicellular, and worm-specific groups of proteins. Approximately 700 proteins from an old family were discovered to have yeast orthologs. Around 1100 multicellular proteins were also identified in

flies, Arabidopsis, and humans, but over 800 worm-specific proteins were identified (found exclusively in worms). Additionally, it is believed that the worm interactome might well have over 200,000 interactions (Polanska et al., 2009).

As stated before, a knowledge of the PPI map is crucial from several perspectives, including the annotation of gene activity and the involvement of genes and biochemical events in the metabolic regulation and supervision of species. Such an investigation is especially crucial for comprehending human growth and illness. So the protein connection web of model organisms like Escherichia, yeast , flies, and worms was accessible, and attempts were undertaken  to  create  the  human  PPI  map.  Several  groups'  early  findings (Seiler  &amp;  Raul,  2005,  Stelzl  et  al.,  2005)  showed  the  existence  of  a  web of protein interactions. And over 3100 new connections comprising 1705 proteins were found by Stelzl et al. These individuals conducted Y2H tests with 5632 preys and 4456 baits. Y2H tests revealed 2,800 interactions in a different Vidal group investigation (Seiler &amp; Raul, 2005). The findings of this investigation were 78 percent identical to those obtained using a different technique,  such  as  TAP  spectrometry.  Bioinformatic  methods  have  been used to attempt a large-scale determination of the PPI map (Chaurasia et al., 2009); these authors generated an interactive map based on the analysis of data obtained by Y2H assays and other methods, including a statistical approach by different researchers, and designated the network as the unified human  interactome  (UniH).  The  UniH  has  160,000  unique  interactions between 17,000 different human proteins. Currently, UniH is the network map closest to the estimate of 665,000 human interactions (Stumpf et al., 2008) including around 25,000 human genome-encoded proteins.

Plasmodium falciparum is responsible for up to 90 percent of malariarelated fatalities. A concentrated effort has been made to comprehend the genes and proteins of this parasite using genomic and proteomic techniques. Its whole genome has been sequenced, and several genes' roles have been annotated. A pentameric sequence has been found that modifies the parasite and host erythrocyte membrane, hence facilitating parasite entrance. The majority of plasmodium proteins lacked homology with eukaryotic proteins. About eight percent of the total number of genes in the plasmodium have been identified as erythrocyte-targeting proteins, totaling about 400 proteins. The most recent strategy for elucidating the function of different proteins involves the creation of a PPI map, with the expectation that a comprehension of the genes and proteins involved in the pathogenicity of the plasmodium will  provide  clues  and  information  for  the  development  of  antimalarial

drugs. Kelley and Idekar demonstrated in 2005 (Suthram et al. 2005 and Sharan  et  al.  2005)  that  PPI  maps  are  sufficiently  distinct  from  those  of other eukaryotes. Idekar and his team used Y2H tests to investigate over 1300 proteins involved in over 2800 interactions inside the plasmodium. They discovered that the plasmodium has no protein interaction complex with  higher  eukaryotes  such  as  flies,  worms,  and  humans.  However,  the plasmodium  was  shown  to  share  three  interaction  complexes  with  yeast (Simonis et al., 2009).

Numerous plant genomes have been completely sequenced, however, their  PPI  maps  are  not  yet  accessible. A  beginning  has  been  achieved  in the  model  plant Arabidopsis  thaliana ,  which  has  a  smaller  genome  than other plants such as maize and rice. It has been thoroughly researched to comprehend the molecular biology of plants, especially the genetic control of flowering, nutrient availability, and modification of plants. It is susceptible to manipulation by many genetics as well as molecular biology techniques. This  Y2H assays and protoplast two-hybrid system have been utilized to investigate  the  binary  interplay  between  many  proteins  in  this  organism. That  using  these  approaches,  plant  gene  encoding  has  been  thoroughly explored. Using statistical approaches, a dataset of the PPI in Arabidopsis has been produced (Mallam &amp;Marcotte, 2017).

## 6.5.2.4 Interactome During Human Development and Disease

Human evolution starts with the creation of an embryo, which would be the consequence of cell growth and division, resulting in the production of over 700 types of cells more than a billion cells as just an adult. Due to the obvious varied genetic expression that describes the function and structure of a given cell, every cell type has a diverse proteome; hence, a neuron cell is unique from a muscle cell. The neuronal cell and the muscle fiber have wholly distinct protein profiles which provide them their distinct structure and function. Several proteins distinguish these two cell types. Just several but distinct proteins are produced by a variety of cell types. The beta cells (pancreas), for instance, mostly produce insulin, while erythrocytes virtually solely produce hemoglobin. The biochemical/molecular foundation of human growth and function is being attempted to describe the links of distinct types of cells.  Although not much work has been done in that regard, examining the protein composition of human blastocytes at various phases of development provides a start. In the lab of Mandy Katz-Jaffe, blastocysts produced from discarded embryos received from an in vitro fertilization clinic in Colorado were evaluated for their protein profiles using gel electrophoresis (2006).

The  concentration  of  numerous  proteins  differs  in  early  and  advanced blastocysts,  according  to  this  study.  Early  embryogenesis  is  attributed  to several biomarkers, including parathyroid hormone-related peptide growth factor-like epidermal growth factor. Since of ethical issues and regulations, there are a limited number of human embryos available for research. Once it becomes feasible to examine stem cells, it is thought that certain progress may be achieved in this  area. As  a  result,  mapping  the  interactome  of  a growing  human  embryo  is  now  impossible.  However,  research  in  model animals like mice and pigs is thought to give PPI network information that is relevant to human evolution (Katz-Jaffe et al., 2007).

## 6.6 EVOLUTION AND CONSERVATION OF INTERACTIONS

All  in  our  cosmos  seems  to  have  evolved,  and  this  is  especially  true  of biological  systems.  It  seems  that  evolution  operates  by  adapting  current infrastructure to meet the demands of organisms in specific environments. This is true of the PPI map as well. The concept of interactome conservation is founded on the notion of interacting proteins coevolving. The interactomes have been preserved in living systems, according to Marc Vidal. Ideker, on the other hand, was the one who produced the proof. Idekar et al. (2001) studied protein interaction networks spanning 6000 proteins in yeast, flies, worms, and humans.

These  researchers  discovered  that  71  connections  were  maintained throughout 3 varieties: flies, worms, and humans. Their findings were based on the examination of many interactions between proteins with known and unknown activities. The attribution of function(s) to proteins that could not be anticipated only based on homology was a key discovery of their research. This  team  also  discovered  that  Plasmodium  falciparum  (the  parasite  that produces malaria in humans) has no interaction route in common with just about any higher eukaryote.

Geneticists have been confronted with a problem known as the 'C-value paradox' from the start of the chromosomal theory of inheritance. That is, the number of genes in an organism did not correspond with its complexity. Humans, for example, have roughly 24,000 genes, while worms have about 19,000 genes and fruit flies have 14,000 genes. Stumpf (2008) stated that the number of protein interactions dictates the complexity of an organism based on a recent investigation of the number of protein interactions in various animals. Humans, for example, have ten times as many protein interactions

as fruit flies and three times as many as worms. In their research, Stumpf et al. (2008) only looked at humans, fruit flies, and worms. When considering the  number of protein interactions in yeast and  fruit  flies,  it  appears  that neither the quantity as well as the kind of contacts must be addressed when understanding  an  organism's  diversity. The  research  of  plants  like  maize and rice may provide a lot of evidence for this theory about the relevance of the series of exchanges in understanding the complexity of organisms such as  humans.  Some  plants  have  genomes  that  are  bigger  than  humans'  yet significantly less complicated. As a result, the number of protein interactions in  maize and rice should be fewer than that expected for humans. These statistics are temporarily unavailable.

## 6.7 INTERACTION OF PROTEINS WITH SMALL MOLECULES

In each species, protein-protein interactions regulate cellular structure and function.  Molecules  often  connect  with  proteins  to  aid  their  functioning or, on rare occasions, to disturb these connections. Cofactors, coenzymes, inhibitors, stabilizers, and  allosteric effectors are the most  common chemicals  that  help  proteins  operate.  More  than  4000  tiny  compounds interact with more than 20,000 proteins, according to a study of the protein databank. Metal ions including magnesium, calcium, and zinc, as well as sugar molecules and nucleotides, make up the majority of these. In general, small compounds bind with a specific amino acid in a protein (Vidal et al., 2011).

## REFERENCES

- 1. Aw, J. G. A., Shen, Y., Wilm, A., Sun, M., Lim, X. N., Boon, K. L., ... &amp; Wan, Y. (2016). In vivo mapping of eukaryotic RNA interactomes reveals principles of higher-order organization and regulation. Molecular cell , 62 (4), 603-617.
- 2. Azzazy, H. M., &amp; Highsmith Jr, W. E. (2002). Phage display technology: clinical  applications  and  recent  innovations. Clinical  biochemistry , 35 (6), 425-445.
- 3. Bartel, P., Chien, C. T., Sternglanz, R., &amp;  Fields, S. (1993). Elimination of false positives that arise in using the two-hybrid system. Biotechniques , 14 (6), 920-924.
- 4. Bertin, N., Simonis, N., Dupuy, D., Cusick, M. E., Han, J. D. J., Fraser, H. B., ... &amp; Vidal, M. (2007). Confirmation of organized modularity in the yeast interactome. PLoS biology , 5 (6), 153.
- 5. Bertone,  P.,  &amp;  Snyder,  M.  (2005).  Advances  in  functional  protein microarray technology. The FEBS journal , 272 (21), 5400-5411.
- 6. Bianco, P. R. (2021). The mechanism of action of the SSB interactome reveals it is the first OB -fold family of genome guardians in prokaryotes. Protein Science , 30 (9), 1757-1775.
- 7. Boy Marcotte, E., Lagniel, G., Perrot, M., Bussereau, F., Boudsocq, -A., Jacquet, M., &amp;Labarre, J. (1999). The heat shock response in yeast: differential  regulations  and  contributions  of  the  Msn2p/Msn4p  and Hsf1p regulons. Molecular microbiology , 33 (2), 274-283.
- 8. Cafarelli,  T.  M.,  Desbuleux, A.,  Wang,  Y .,  Choi,  S.  G.,  De  Ridder, D., &amp; Vidal, M. (2017). Mapping, modeling, and characterization of protein-protein interactions on a proteomic scale. Current Opinion in Structural Biology , 44 , 201-210.
- 9. Causier, B. (2004). Studying the interactome with the yeast two hybrid -system and mass spectrometry. Mass spectrometry reviews , 23 (5), 350367.
- 10. Causier, B., &amp; Davies, B. (2002).  Analyzing protein-protein interactions with the yeast two-hybrid system. Plant molecular biology , 50 (6), 855870.
- 11. Chaurasia, S. S., Kaur, H., de Medeiros, F. W., Smith, S. D., &amp; Wilson, S.  E.  (2009).  Dynamics  of  the  expression  of  intermediate  filaments vimentin and desmin during myofibroblast differentiation after corneal injury. Experimental eye research , 89 (2), 133-139.

- 12. Chua, H. N., &amp; Wong, L. (2008). Increasing the reliability of protein interactomes. Drug discovery today , 13 (15-16), 652-658.
- 13. Cumberworth, A.,  Lamour,  G.,  Babu,  M.  M.,  &amp;Gsponer,  J.  (2013). Promiscuity  as  a  functional  trait:  intrinsically  disordered  regions  as central players of interactomes. Biochemical Journal , 454 (3), 361-369.
- 14. Das,  J.,  &amp;  Yu,  H.  (2012).  HINT:  High-quality  protein  interactomes and their applications in understanding human disease. BMC systems biology , 6 (1), 1-12.
- 15. Ding, W., Tan, H. Y., Zhang, J. X., Wilczek, L. A., Hsieh, K. R., Mulkin, J. A., &amp; Bianco, P. R. (2020). The mechanism of Single strand binding protein-RecG  binding:  Implications  for  SSB  interactome  function. Protein Science , 29 (5), 1211-1227.
- 16. Doi, N., Takashima, H., Kinjo, M., Sakata, K., Kawahashi, Y., Oishi, Y., ... &amp;Yanagawa,  H.  (2002).  Novel  fluorescence  labeling  and high-throughput  assay  technologies  for in  vitro analysis  of  protein interactions. Genome Research , 12 (3), 487-492.
- 17. Dunin-Horkawicz, S., Kopec, K. O., &amp;Lupas, A. N. (2014). Prokaryotic ancestry  of  eukaryotic  protein  networks  mediating  innate  immunity and apoptosis. Journal of molecular biology , 426 (7), 1568-1582.
- 18. Fields, S. (2005). High throughput two hybrid analysis: The promise --and the peril. The FEBS journal , 272 (21), 5391-5399.
- 19. Fields,  S.,  &amp;  Song,  O.  K.  (1989). A  novel  genetic  system  to  detect protein-protein interactions. Nature , 340 (6230), 245-246.
- 20. Galarneau, A., Primeau, M., Trudeau, L. E., &amp;Michnick, S. W. (2002). Î²-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein-protein interactions. Nature Biotechnology , 20 (6), 619-622.
- 21. Gandhi, T. K. B., Zhong, J., Mathivanan, S., Karthick, L., Chandrika, K. N., Mohan, S. S., ... &amp; Pandey, A. (2006). Analysis of the human protein interactome and comparison  with yeast , worm  and  fly interaction datasets. Nature genetics , 38 (3), 285-293.
- 22. Goeury, K., Duy, S. V., Munoz, G., PrÃ©vost, M., &amp; SauvÃ©, S. (2019). Analysis  of  Environmental  Protection  Agency  priority  endocrine disruptor  hormones  and  bisphenol A  in  tap,  surface  and  wastewater by online concentration liquid chromatography-tandem mass spectrometry. Journal of Chromatography A , 1591 , 87-98.

- 23. Hu, S., Xie, Z., Qian, J., Blackshaw, S., &amp; Zhu, H. (2011). Functional protein microarray technology. Wiley Interdisciplinary Reviews: Systems Biology and Medicine , 3 (3), 255-268.
- 24. Ideker, T., Galitski, T., &amp; Hood, L. (2001). A new approach to decoding life: systems biology. Annual review of genomics and human genetics , 2 (1), 343-372.
- 25. Isabelle, M., Moreel, X., GagnÃ©, J. P., Rouleau, M., Ethier, C., GagnÃ©, P.,  ...  &amp;  Poirier,  G.  G.  (2010).  Investigation  of  PARP-1,  PARP-2, and  PARG  interactomes  by  affinity-purification  mass  spectrometry. Proteome science , 8 (1), 1-11.
- 26. James, P., Halladay, J., &amp; Craig, E. A. (1996). Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast . Genetics , 144 (4), 1425-1436.
- 27. Jauregui, O., Moyano,  E., &amp;  Galceran, M.  T. (1997). Liquid chromatography-atmospheric  pressure  ionization  mass  spectrometry for  the  determination  of  chloro-and  nitrophenolic  compounds  in  tap water and sea water. Journal of Chromatography A , 787 (1-2), 79-89.
- 28. Katz-Jaffe,  M.  G.,  Schoolcraft,  W.  B.,  &amp;  Gardner,  D.  K.  (2006). Analysis  of  protein  expression  (secretome)  by  human  and  mouse preimplantation embryos. Fertility and sterility , 86 (3), 678-685.
- 29. Kawahashi, Y., Doi, N., Takashima, H., Tsuda, C., Oishi, Y., Oyama, R., ... &amp;Yanagawa,  H.  (2003). In vitro protein  microarrays  for detecting  protein protein  interactions: Application  of  a  new  method -for  fluorescence  labeling  of  proteins. PROTEOMICS:  International Edition , 3 (7), 1236-1243.
- 30. Kelley,  R.,  &amp;Ideker,  T.  (2005).  Systematic  interpretation  of  genetic interactions using protein networks. Nature Biotechnology , 23 (5), 561566.
- 31. Klein, B., Hoel, E., Swain, A., Griebenow, R., &amp; Levin, M. (2021). Evolution and emergence: higher order information structure in protein interactomes across the tree of life. Integrative Biology , 13 (12), 283294.
- 32. Lambert, J. P., Ivosev, G., Couzens, A. L., Larsen, B., Taipale, M., Lin, Z. Y., ... &amp;Gingras, A. C. (2013). Mapping differential interactomes by affinity purification coupled with data-independent mass spectrometry acquisition. Nature methods , 10 (12), 1239-1245.

- 33. Lentze, N., &amp;Auerbach, D. (2008). Membrane based yeast two hybrid --system  to  detect  protein  interactions. Current  Protocols  in  Protein Science , 52 (1), 19-17.
- 34. Luban, J., &amp; Goff, S. P. (1995).  The yeast two-hybrid system for studying protein-protein interactions. Current opinion in biotechnology , 6 (1), 59-64.
- 35. Luo, Y., Batalao, A., Zhou, H., &amp; Zhu, L. (1997). Mammalian twohybrid  system:  a  complementary  approach  to  the  yeast  two-hybrid system. Biotechniques , 22 (2), 350-352.
- 36. Mallam, A. L., &amp;Marcotte, E. M. (2017). Systems-wide studies uncover commander, a multiprotein complex essential to human development. Cell systems , 4 (5), 483-494.
- 37. Montiel-LeÃ³n, J.  M.,  Duy,  S. V.,  Munoz,  G., Amyot,  M.,  &amp;  SauvÃ©, S.  (2018).  Evaluation  of  on-line  concentration  coupled  to  liquid chromatography tandem mass spectrometry for the quantification of neonicotinoids and fipronil in surface water and tap water. Analytical and bioanalytical chemistry , 410 (11), 2765-2779.
- 38. MÃ¼ller, D. R., Schindler, P., Towbin, H., Wirth, U., V oshol, H., Hoving, S., &amp; Steinmetz, M. O. (2001). Isotope-tagged cross-linking reagents. A new tool in mass spectrometric protein interaction analysis. Analytical chemistry , 73 (9), 1927-1934.
- 39. Murakami, Y., Tripathi, L. P., Prathipati, P., &amp;Mizuguchi, K. (2017). Network analysis and in silico prediction of protein-protein interactions with  applications  in  drug  discovery. Current  opinion  in  structural biology , 44 , 134-142.
- 40. Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., &amp; Parker, M. W. (2014). Oncogenic protein interfaces: small molecules, big challenges. Nature Reviews Cancer , 14 (4), 248-262.
- 41. Ofran,  Y.,  &amp;Rost,  B.  (2007).  Protein-protein  interaction  hotspots carved into sequences. PLoS computational biology , 3 (7), 119.
- 42. Park, D., Lee, S., Bolser, D., Schroeder, M., Lappe, M., Oh, D., &amp;Bhak, J. (2005).  Comparative  interactomics  analysis  of  protein  family interaction  networks  using  PSIMAP  (protein  structural  interactome map). Bioinformatics , 21 (15), 3234-3240.
- 43. Piehler, J. (2005). New methodologies for measuring protein interactions in vivo and in vitro . Current opinion in structural biology , 15 (1), 4-14.

- 44. Polanska, U. M., Fernig, D. G., &amp;Kinnunen, T. (2009). Extracellular interactome of the FGF receptor-ligand system: Complexities and the relative  simplicity  of  the  worm. Developmental  Dynamics , 238 (2), 277-293.
- 45. Ramachandran,  N.,  Larson,  D.  N.,  Stark,  P.  R.,  Hainsworth,  E., &amp;LaBaer, J. (2005). Emerging tools for real time label free detection --of interactions on functional protein microarrays. The FEBS journal , 272 (21), 5412-5425.
- 46. Raman,  K.  (2010).  Construction  and  analysis  of  protein-protein interaction networks. Automated experimentation , 2 (1), 1-11.
- 47. Rep, M., Dekker, H. L., Vossen, J. H., de Boer, A. D., Houterman, P. M.,  Speijer,  D.,  ...  &amp;  Cornelissen,  B.  J.  (2002).  Mass  spectrometric identification  of  isoforms  of  PR  proteins  in  xylem  sap  of  fungusinfected tomato. Plant Physiology , 130 (2), 904-917.
- 48. Rual, J. F., Venkatesan, K., Hao, T., Hirozane-Kishikawa, T., Dricot, A., Li, N., ... &amp; Vidal, M. (2005). Towards a proteome-scale map of the human protein-protein interaction network. Nature , 437 (7062), 11731178.
- 49. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., ... &amp; Wang, H. G. (1994). Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proceedings of the National Academy of Sciences , 91 (20), 9238-9242.
- 50. Seiler,  N.,  &amp;  Raul,  F.  (2005).  Polyamines  and  apoptosis. Journal of cellular and molecular medicine , 9 (3), 623-642.
- 51. Serebriiskii,  I.,  Estojak,  J.,  Berman,  M.,  &amp;Golemis,  E.  A.  (2000). Approaches to detecting false positives in yeast two-hybrid systems. Biotechniques , 28 (2), 328-336.
- 52. Sharan, R., Ideker, T., Kelley, B., Shamir, R., &amp; Karp, R. M. (2005). Identification of protein complexes by comparative analysis of yeast and  bacterial protein interaction data. Journal  of  computational biology , 12 (6), 835-846.
- 53. Shoemaker, B. A., &amp;Panchenko, A. R. (2007). Deciphering proteinprotein interactions. Part II. Computational methods to predict protein and  domain  interaction  partners. PLoS computational biology , 3 (4), e43.
- 54. Simonis,  N.,  Rual,  J.  F.,  Carvunis,  A.  R.,  Tasan,  M.,  Lemmens,  I., Hirozane-Kishikawa, T., ... &amp; Vidal, M. (2009). Empirically controlled

mapping  of  the  Caenorhabditiselegans  protein-protein  interactome network. Nature methods , 6 (1), 47-54.

- 55. Smith,  G.  P.,  &amp;Petrenko,  V.  A.  (1997).  Phage  display. Chemical reviews , 97 (2), 391-410.
- 56. Stelzl,  U.,  Worm,  U.,  Lalowski,  M.,  Haenig,  C.,  Brembeck,  F.  H., Goehler,  H.,  ...  &amp;  Wanker,  E.  E.  (2005).  A  human  protein-protein interaction  network:  a  resource  for  annotating  the  proteome. Cell , 122 (6), 957-968.
- 57. Stumpf, M. P., Thorne, T., De Silva, E., Stewart, R., An, H. J., Lappe, M., &amp;Wiuf, C. (2008). Estimating the size of the human interactome. Proceedings of the National Academy of Sciences , 105 (19), 6959-6964.
- 58. Suthram, S., Sittler, T., &amp;Ideker, T. (2005). The Plasmodium protein network diverges from those of other eukaryotes. Nature , 438 (7064), 108-112.
- 59. Takaku, Y., Shimamura, T., Masuda, K., &amp; Igarashi, Y. (1995). Iodine determination  in  natural  and  tap  water  using  inductively  coupled plasma mass spectrometry. Analytical sciences , 11 (5), 823-827.
- 60. Tarassov, K., Messier, V., Landry, C. R., Radinovic, S., Molina, M. M. S., Shames, I., ... &amp;Michnick, S. W. (2008). An in vivo map of the yeast protein interactome. Science , 320 (5882), 1465-1470.
- 61. Valencia,  A.,  &amp;Pazos,  F.  (2002).  Computational  methods  for  the prediction of protein interactions. Current  opinion  in  structural biology , 12 (3), 368-373.
- 62. Valente,  G.  T.,  Acencio,  M.  L.,  Martins,  C.,  &amp;  Lemke,  N.  (2013). The development of a universal in silico predictor of protein-protein interactions. PloS one , 8 (5), 65587.
- 63. VarnaitÄ, R., &amp;MacNeill, S. A. (2016). Meet the neighbors: Mapping local protein  interactomes  by  proximity dependent  labeling  with -BioID. Proteomics , 16 (19), 2503-2518.
- 64. Vidal,  M.,  Cusick,  M.  E.,  &amp;BarabÃ¡si,  A.  L.  (2011).  Interactome networks and human disease. Cell , 144 (6), 986-998.
- 65. Vo, T. V., Das, J., Meyer, M. J., Cordero, N. A., Akturk, N., Wei, X., ... &amp; Yu, H. (2016). A proteome-wide fission yeast interactome reveals network  evolution  principles  from  yeasts  to  human. Cell , 164 (1-2), 310-323.

- 66. Walhout, A. J., &amp; Vidal, M. (2001). High-throughput yeast two-hybrid assays  for  large-scale  protein  interaction  mapping. Methods , 24 (3), 297-306.
- 67. Weinzierl, A.  O.,  Rudolf,  D.,  Hillen,  N.,  Tenzer,  S.,  van  Endert,  P., Schild, H., ... &amp;StevanoviÄ, S. (2008). Features of TAP -independent MHC  class  I  ligands  revealed  by  quantitative  mass  spectrometry. European journal of immunology , 38 (6), 1503-1510.
- 68. Xing,  S.,  Wallmeroth,  N.,  Berendzen,  K.  W.,  &amp;Grefen,  C.  (2016). Techniques  for  the  analysis  of  protein-protein  interactions  in  vivo. Plant physiology , 171 (2), 727-758.
- 69. Yu, H., Braun, P.,  YÄ±ldÄ±rÄ±m, M.  A., Lemmens, I., Venkatesan, K., Sahalie, J., ... &amp; Vidal, M. (2008). High-quality binary protein interaction map of the yeast interactome network. Science , 322 (5898), 104-110.
- 70. Zhou,  S.  M.,  Cheng,  L.,  Guo,  S.  J.,  Zhu,  H.,  &amp;  Tao,  S.  C.  (2012). Functional  protein  microarray:  an  ideal  platform  for  investigating protein binding property. Frontiers in biology , 7 (4), 336-349.

<!-- image -->

## CHAPTER 7

## APPLICATIONS OF PROTEOMICS

## CONTENTS

| 7.1 Introduction  ..................................................................................... 200   |
|---------------------------------------------------------------------------------------------------------------|
| 7.2 Diseasome  ....................................................................................... 201    |
| 7.3 Medical Proteomics  ......................................................................... 202         |
| 7.4 Clinical Proteomics  .......................................................................... 207       |
| 7.5 Metaproteomics and Human Health ................................................ 211                      |
| References  ............................................................................................. 214 |

## 7.1 INTRODUCTION

As mentioned throughout this chapter, proteomics technologies have been widely employed to comprehend human disorders and are the foundation of medicine in easing such diseases (Petricoin&amp;Liotta, 2003).

Gorrod (1909), in his classic 1903 paper on inborn defects of metabolism, was  the  first  to  claim  that  genes  govern  illnesses.  He  documented  the inheritance  of  alcaptonuria  and  numerous  other  human  disorders  in  this work. The one-gene-one-enzyme hypothesis proposed by Beadle and Tatum in 1941 postulated a relationship between genes, proteins, and illnesses, and also the possibility of medical assistance in disease. This idea proposed that in a person with a heritable condition, a specific protein governing cell shape or a chemical response is either absent or faulty (Mouradian, 2002).

Figure 7.1. Applications of Proteomics.

<!-- image -->

Source: Zsuga J, More CE, Erdei T, Papp C, Harsanyi S and Gesztelyi R (2018) Blind Spot for Sedentarism: Redefining the Diseasome of Physical Inactivity in View of Circadian System and the Irisin/BDNF Axis. Front. Neurol. 9:818. doi: 10.3389/fneur.2018.00818

The  finding  that  such  hemoglobin  protein is  changed  in  sickle  cell anemia patients provided the initial evidence for this viewpoint. Following that, numerous human disorders were discovered to have a faulty protein or to be lacking that protein entirely. As a result, the one-gene-one-enzyme paradigm formed the foundation of medical therapy by delivering insulin,

which is lacking in diabetes patients, or by providing the end product of a biochemical  process  that  is  not  being  created  by  the  deficient  enzymatic activity in an afflicted person (for instance, a thyroxin medicine was given to patients suffering from thyroid diseases) (Yokota, 2019).

## 7.2 DISEASOME

In  2007,  Marc  Vidal  and  his  team  at  Harvard  University  envisioned  the diseasome as a system of human disorders. It seeks to create a relationship between  gene  (disease  genome)  and  abnormality  (disease  phenome)  in people. Numerous human illnesses are monogenic, meaning that they are regulated by one gene. In certain cases, though, mutations at various places in a similar gene result in diseases with distinct symptoms (Goh &amp; Choi, 2012).  TP53 mutations, for instance, have been linked to 11 distinct cancer phenotypes.  Zellweger  syndrome,  on  the  other  hand,  may  be  caused  by mutations in any of eleven distinct genes. Vidal 2007 (see Goh et al. 2007) established the notion of diseasome in the shape of a gene-disease graph to  illustrate  all  of  these  instances  of  the  relationship  between  the  disease genome and illness phenome (Midic et al., 2009). In this figure, the onegene- the one-illness relationship was associated with a single line linking the gene to the disease, but the other gene-disease relationships were seen by separate linking a disease to many genes or, inversely, one gene to multiple diseases. That prototype of the diseasome is accompanied by a set of factors, such as  the  genetic  regulation  of  illness,  the  fundamental  protein-protein connections  outlined  in  an  earlier  chapter,  and  the  interconnected  nature of  cellular  metabolism.  Figure  6.1  depicts  the  structure  of  the  diseasome (Wysocki&amp; Ritter, 2011).

Vidal and many others have investigated 1284 gene-disease associations. In minimum 867 instances, they have demonstrated that one gene is associated with one illness. In 516 instances, though, an illness was regulated by much more than a gene, such that numerous diseases had a few  similar  components.  Goh  et  al.  (2007)  discovered  that  complicated illnesses, such as cancer, cardiovascular disease, and neurological disorders, were diverse, regulated by multiple genes, and linked to certain genes, while metabolic  disease is often ruled by a centralized gene (BarabÃ¡si, 2007).

## 7.3 MEDICAL PROTEOMICS

Medical  proteomics  tries  to  characterize  specific  proteins  since  proteins are useful in medicine as therapeutics or as targets for drug research, and the volume of the rings and rectangles on their edges is equivalent to the number of genes and diseases associated (Cash, 2000). Therefore, under the guidance and funding of HUPO, extensive efforts are underway to explain the  function  and  structure  of  proteins,  and  also  their  interconnections,  to assess  their  involvement  in  the  formation  of  novel  medications,  and  to comprehend and mitigate their harmful side effects. Proteomics of many human components is now being investigated. Under the funding of HUPO, the serum proteome is being explored in the United States, the liver proteome has been researched in China, and the brain proteome has been researched in Germany. Various labs are looking into various proteomes, such as the cancer proteome and the cardiovascular proteome (Cuervo et al., 2010).

Figure 7.2 . Proteomics' Part in the Growth of Personalized Cancer Medicine.

<!-- image -->

Source: Kwon YW, Jo H-S, Bae S, Seo Y, Song P, Song M and Yoon JH (2021) Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery. Front. Med. 8:747333. doi: 10.3389/fmed.2021.747333

## 7.3.1 Body Fluid Proteome

Proteomics of bodily fluids is significant since body fluids move thru the body and get into touch with multiple tissues of various organs; therefore, it is feasible to detect proteins that could serve as perfect biomarkers of illness

and give hints for drug discovery (Huang et al., 2021). Blood (including plasma and serum), urine, cerebrospinal fluid, amniotic fluid, salivary gland secretion,  nasal  secretion,  tears,  and  nasopharyngeal  aspirate  have  been investigated in depth. The significant differences in the quantity of a single protein between persons and between specimens obtained at various periods from a similar individual are the greatest technological barrier in the field of proteomics of bodily fluids. To define a baseline level for a given protein, it  is  necessary  to  examine  a  large  number  of  people  at  varied  periods  or settings (Hu et al., 2006).

Figure 7.3. Fluids in the Body.

<!-- image -->

Source: Ding, Z., Wang, N., Ji, N. et al. Proteomics technologies for cancer liquid biopsies. Mol Cancer 21, 53 (2022). https://doi.org/10.1186/s12943-02201526-8

## 7.3.2 Liver Proteome

From  a biological, physiological, pathological, and pharmacological standpoint, the liver is a vital organ. In regards to length and diversity, it is only next to the mind. It regulates the digestive process, embryonic red blood cell  production,  immunological  feature,  and  xenobiotic  detoxification  in the organism. Furthermore, it creates retinol. It contains additional proteins which attach to  medications  and  help  them  move  about  the  body,  which would be useful in pharmacological research (Shi et al., 2007). The liver's metabolic  activities  and  biliary  secretion  also  aid  in  drug  detoxification. From a medical standpoint, the liver is vulnerable to liver cancer, alcoholinduced  liver  cirrhosis,  and  viral  hepatitis,  which  particularly  affects globally.  The  liver  proteome  has  been  studied  in-depth  in  several  labs,

mostly in  China  under  the  support  of  HUPO,  due  to  its  essential  role  in biology, pathophysiology, and drug metabolism (Ding et al., 2016).

Figure 7.4. Hepatocytes' secretory protein processing.

<!-- image -->

Source: Serras AS, Rodrigues JS, Cipriano M, Rodrigues AV, Oliveira NG and Miranda JP (2021) A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies. Front. Cell Dev. Biol. 9:626805. doi: 10.3389/ fcell.2021.626805

This research looked at the proteomes of mature individuals, fetal, and diseased livers from a variety of individuals. Or more than 5000 distinct proteins  have  been  found  as  part  of  the  HUPO  liver  proteome  research. Several proteins are all being investigated as potential indicators of liver disease. A  thorough  examination  of  the  fetal  liver  revealed  2495  unique proteins (He, 2005). Proteomic studies of fetal, adult, and cancer liver cells were also performed. Proteins isolated from various liver cells produced in cultured cells were used in this research. Human fetal hepatocytes (HFH), human hepatocytes (HH4), and human liver cancer cells (Huh7) were among the cell lines used. A total of 2159 distinct proteins were discovered in such cells, with 496 of them being detected throughout all three cell lines. Yan et al. discovered features of diverse cell lines like Huh7, HFH, and HH4 cells between these 337, 364, and 414 proteins, respectively (2004). Furthermore, the mouse liver has been created as a model system for proteomic research. Several 3244 distinct proteins have been discovered in mouse liver, with 47  percent  being  membrane-bound  and  roughly  35  percent  containing transmembrane peptides (Kuscuoglu et al., 2018).

## 7.3.3 Brain Proteome

HUPO has allocated the Brain Proteome Project principally to Germany, but it is also being studied in labs in other nations. The primary goal of the brain proteome study was to understand all the proteins in the mind and to discover the proteins implicated in various neurodegenerative illnesses, like Alzheimer's  and  Parkinson's.  Nonetheless,  the  Human  Brain  Project  has achieved little development so far, except the normalization of many protein stages, which will assist detect the variations in protein levels across patients and create specific biomarkers for developing drugs and probable illness therapy (Klose et al., 2002).

Figure 7.5. Human Brain Structure.

<!-- image -->

Source: Georgiev DD, Georgieva I, Gong Z, Nanjappan V, Georgiev GV. Virtual Reality for Neurorehabilitation and Cognitive Enhancement. Brain Sciences. 2021; 11(2):221. https://doi.org/10.3390/brainsci11020221

Other than that of the Human Brain Project, the mouse brain proteome has been designated as a physical model. The mouse brain proteome has indeed been extensively described. There are at minimum 7792 proteins in the mouse proteome (Wang et al., 2007), and 1564 of them are recognized as  cysteinyl  peptides. Approximately  26%  of  proteins  were  identified  as membrane proteins having a role in transport and cell signaling. Over 1400 proteins were discovered to include transmembrane domains (Sharma et al., 2015).

## 7.3.4 Heart/Cardiovascular Proteome

Proteins  define  a  cell's function  and  structure,  and  consequently  an organism's.  Throughout  the  differentiating  and  developmental  stages  of an organ's existence, proteins are prone to alter based on cellular activity. Proteins may also alter under pathological situations, either as a source or as a result of the illness. Proteins may also vary in reaction to drugs and other regular  activities,  as  well  as  any  other  environmental  variables  including temperature,  nutrition,  and  allergies.  The  proteome  of  the  heart  and circulatory  system  has  therefore  been  studied  to  detect  heart  disease signs  and  develop  medications  to  cure  them  (HW  Dekkers  et  al.,  2010). A protein map of the human heart's left ventricle has been created using a 2D gel study of the cardiac proteome. The proteome of the left ventricle contains about 110 distinct proteins, according to this protein atlas. In rats, the influence of exercise on the cardiac proteome was studied (Sung et al., 2006). When compared to inactive rats, animals that undertook an exercise program revealed changes in 26 proteins.  Many  proteins  and  changes  in such proteins have been examined as results of the human heart and vascular network  using  spectrometric  analysis  following  2D  gel  or  other  protein isolation.  The  human  myocardium  has  been  shown  to  have  around  200 proteins. Proteins from the sarcoplasmic/endoplasmic reticulum have also been discovered (Channaveerappa et al., 2019). Heat shock proteins (Hsps) and mitochondrial proteins associated with energy generation were found to have lower amounts in heart disease patients (Arrell et al. 2008). Several proteins like crystalline, HSP27, and actin have their levels raised. Under illness circumstances, the heart demonstrated variations in the transcription of distinct isoforms of the enzyme/protein or posttranslational alteration of proteins, adding to variations in the size of particular proteins (Pedret et al., 2021).

Figure 7.6. Proteomics of the Human Heart.

<!-- image -->

Source: Tomin T, Schittmayer M, Sedej S, Bugger H, Gollmer J, Honeder S, Darnhofer  B,  Liesinger  L,  Zuckermann  A,  Rainer  PP,  Birner-Gruenberger R. Mass Spectrometry-Based Redox and Protein Profiling of Failing Human Hearts. International Journal of Molecular Sciences. 2021; 22(4):1787. https:// doi.org/10.3390/ijms22041787

## 7.4 CLINICAL PROTEOMICS

As mentioned below, proteomics will play a significant role in the prevention and therapy of human illnesses in the history of medicine (Liotta et al., 2003).

## 7.4.1 Genomics and Proteomics of Human Diseases

Genetics  and  genomics  have  aided  in  establishing  the  reality  of  human illnesses and their hereditary or nongenetic causes. To establish the genetic basis  of  an  illness,  traditional  genetics  and  epidemiology  or  population  genetic approaches have been applied. Disease-causing genes, their chromosomal placements,  and  DNA  pattern,  as  well  as  the  proteins  regulated  by  such genes, have been found utilizing genetics and genomics. The chromosomal position was determined utilizing somatic cell genetics, cytogenetics, and translocation roadmap (Macaulay et al., 2005).

Figure 7.7. The PEA-NGS method's principle and cohort descriptions.

<!-- image -->

Source: Zhong, W., Edfors, F., Gummesson, A. et al. Next generation plasma proteome profiling to monitor health and disease. Nat Commun 12, 2493 (2021). https://doi.org/10.1038/s41467-021-22767-z

Genomics  has  aided  in  deciphering  a  gene's  pattern  of  DNA  and discovering the protein that causes various human disorders. To assess if a disease is decided by a specific gene or numerous genes in the combination of genetic and environmental variables, both traditional genetics and genomics methodologies have been applied (Calvo &amp;Mootha, 2010). We now know why a faulty gene regulates a disease with various degrees of translation (i.e., the image-guided of a gene) or why a gene mutation is generated only in a small group of people (i.e., the expression involved in the gene) but not others thanks to genomics. This answer was developed by discovering the involvement of many other genes in the human genome which link with disease-causing  genes  to  modulate  their  expression.  Sickle  cell  anemia, Huntington's disease, and cystic fibrosis are all disorders produced by one mutated gene creating one malfunctioning protein (Chambers et al., 2000). Nevertheless, proteomics has revealed why a single gene mutation has many consequences  by  altering  the  interacting  proteins  route,  or  interactome, which  regulates  a  specific  metabolic  process.  A  modification  in  one metabolic route may potentially have many consequences on the operation of other metabolic processes. Many illnesses, including high blood pressure, diabetes,  obesity,  high  cholesterol,  and  a  variety  of  cardiovascular  and neurological problems, are influenced by a combination of environmental

and genetic variables (Bendixen et al., 2010). By defining the functions of diverse  proteins  and  their  connections  in  metabolic  processes,  the  study of  proteomics  is  exposing  the  involvement  of  numerous  gene  bases  in illnesses  and  the  impact  of  environmental  variables.  Proteomics  has  also been  effective  in  explaining  why  some  tumors  respond  to  specific  drugs while others do not. Proteomics has also helped us know the bad effects of a certain medicine. Proteomics is being utilized to discover specific proteins that  might  be  seen  as  disease  indicators  or  biomarkers.  Proteomics  helps determine the metabolic foundation of an illness, as well as diagnose and treat it (Jungblut et al., 1999).

## 7.4.2 Proteomics of Diagnostic Markers and Drug Development

Proteomics is essential for identifying the etiology and treatment of disease since proteins may serve as both biomarkers and medication targets. Henry Bence-Jones discovered a protein in 1847; this protein was subsequently dubbed  the  Bence-Jones  protein.  This  finding  sparked  the  concept  that proteins  may  be  utilized  as  biomarkers  for  human  illnesses  (He  &amp;  Chiu, 2003). Kyle found it in 1994 as a loose antibody light chain which is made in overabundance by cancers; due to its lower size, this protein may go past the kidney and is detected in the urine of myeloma patients. That protein was also detected in the serum of individuals with myeloma. As soon as possible,  an  immunodiagnostic  test  was  created  to  assess  this  protein's concentration in cancer patients (Lee et al., 2011). Calculating the volume of  Bence-Jones protein has been authorized by the Food and Medication Administration  (FDA)  and  is  frequently  used  to  identify  myeloma  or evaluate  the  effectiveness  of  drug  therapy  in  patients.  As  the  patient's situation is stable about a direct therapeutic therapy, this protein diminishes. Numerous proteins  have  been  discovered  as  potential  disease  indicators; nevertheless, the majority of those have no specificity and have little clinical utility in clinical practice. Few proteins have been authorized by the FDA as biomarkers for various human illnesses (Hanash, 2003).

The  loss  of  faith  in  utilizing  a  specific  protein  as  a  biomarker  for  a disease has resulted in the creation of an array of proteins as biomarkers for specific disorders, rather than a single protein. It has been demonstrated that an elevation of four protein levels, including leptin, prolactin, osteopontin, and insulin-like growth factor II, is a reliable indication of ovarian cancer. That neither of these proteins alone can act as a diagnostic biomarker for ovarian cancer. In combination with proteins, numerous hormones including

adrenocorticotropin  hormone  (ACTH),  human  chorionic  gonadotropin (hCG), and calcitonin are utilized as cancer biomarkers (Hu et al., 2016).

For a variety of disorders, proteins have been utilized as medications or have been the focus of several treatments. Insulin is the prototypical instance of  a  protein  consumed  as  a  medication  to  regulate  blood  sugar  levels  in diabetics.  Blood  clotting  components and immunoglobulins are instances of proteins used as pharmaceuticals. Medications that affect the amount of the protein leptin may be utilized to treat obesity. Some tumors have been successfully treated with Gleevec, a particular inhibitor of kinase implicated in the cell cycle. Similarly, Herceptin (Genentech Inc., South San Francisco, CA) has been used to treat people with cancer (Banks et al., 2000).

Drug  discovery  is a scientific discipline that employs  genomes, proteomics, metabolomics, bioinformatics, and structural chemistry including X-ray crystallography, synthetic chemistry, pharmacology, microbiology, biotechnology, and medical sciences. The first stage in the synthesis of medicine is to identify the source of an illness, which genomics, proteomics,  and  metabolomics  can  achieve  with  relative  simplicity.  By finding the faulty gene behind a specific illness, genomics may pinpoint the etiology of the sickness. Proteomics can identify the type of faulty protein. Metabolomics may shed light on the biochemical interaction between genes and reveal how the protein products of genes have been altered in a certain illness. Including species devoid of genetic influences, metabolomics may identify  the  disruption  of  metabolic  pathways  induced  by  environmental stimuli  (Jain,  2000).  Understanding  the  structure  of  proteins  and  their interactions is crucial for determining the origin of an illness and developing medicine for its treatment or amelioration. Proteins are the reason for an illness, the medications for the sickness, or the target of the pharmaceuticals used to cure the disease; proteomics is essential to comprehending a disease and its therapy (Martin 1999). Bioinformatics is utilized in the synthesis of medications and their ultimate choice as a candidate drug, that is subsequently subjected to biochemical and toxicological testing in model animal systems, followed by human testing, before FDA clearance. Due to the intricacy of

the problem and the various lines of approach comprising various scientific disciplines, medication development is a long, multimillion-dollar, multiyear procedure (Aslam et al., 2017).

## 7.5 METAPROTEOMICS AND HUMAN HEALTH

The DNA pattern of many microbes accessible as culturing in the lab is now available due to breakthroughs in genomics. In gene banks as well as protein databanks,  the  DNA  pattern  of  these  farmed  microbes  and  the  translated proteins are combined. Nevertheless, since most microbial organisms cannot be cultured, this figure means just around 1% of entire microbes. As a result, analyzing the mixture existing as a population in a specific habitat is the only approach to obtaining genomic and proteomic data on such bacteria (Mao &amp; Franke, 2015). Metagenomics and meta-proteomics are terms for genomic and  proteomic  investigations  of  a  population  of  microorganisms.  The earliest investigation of a community of microbes used 16SrRNA analysis, which was followed by DNA sequencing techniques after pyrosequencing technology  got  accessible.  Microorganism  metagenomics  is  progressed, and it  has  aided  in  the  classification  of  microbes  and  the  allocation  of  a protein  to  specific  microbes  as  quickly  as  it  is  detected  by  proteomics (Zhang et al.,  2017).  Nevertheless,  2D  gel  and  spectrometric  approaches are just now being used in microorganism metaproteomics. Metaproteomics research is more significant than metagenomics research. The research of metagenomics merely reveals the existence of a gene; however, the mere presence of a gene does not guarantee its activation, which determines how a phenotypic manifests. Proteomics, on the other hand, may offer a mapping of metabolic processes in species at a certain moment and in a particular setting.  Metaproteomics  research  is  therefore  critical  for  understanding phenotypic  manifestation.  Furthermore,  metaproteomics  is  critical  not just due to many bacterial groups cannot be produced as pure cultures, but because such various organisms collaborate to establish phenotypes. As a result, their gene expression should be investigated in tandem (Long et al., 2020).

Figure 7.8. Human gut metaproteomic and its applications.

<!-- image -->

Source:  Lee,  Pey  &amp;  Chin,  Siok-Fong  &amp;  Neoh,  Hui-min  &amp;  Jamal,  Rahman. (2017). Metaproteomic analysis of human gut microbiota: Where are we heading?. Journal of Biomedical Science. 24. 10.1186/s12929-017-0342-z.

Since  many  microbes  live  in  symbiotic  relationships  with  humans, metaproteomics research is crucial. Metaproteomics is now the sole approach to comprehending the many metabolic systems and their connections with one  another  and  also  with  the  host's  biochemistry,  which  includes  the identification of a specific phenotype (Petriz&amp; Franco, 2017). The human gut microbiome, oral flora, and the urine community of bacteria are instances of this. In humans, the relationship between the microbial community has been thoroughly  established.  The  proportion  of  distinct  microbiome  elements changes greatly between normal as well as obese people, indicating that the human gut flora differs greatly. The proportion of Bacteroides to firmicutes typically  changes  between  0.26  to  1.36;  obese  people  have  a  lower proportion of Bacteroides to firmicutes in their gut flora (Verberkmoes et al., 2009). Such proportion, though, maybe changed by fat people lowering their  calorie  consumption. The  gut  flora  also  affects  insulin  resistance  in humans, perhaps preventing the formation of type 2 diabetes. Variations in choline metabolism by microorganisms in the human gut appear to have an

impact on this. Furthermore, microflora secondary byproducts are beneficial in  2  directions:  they  provide  nutrition  to  the  host  and  they  influence  the usage of numerous medications and also their combinations with specific treatments (Zhang et al., 2018). As a result, microflora plays a crucial role in the synthesis of some medications. The elements of microflora vary amongst populations and ethnic communities, suggesting that the host genome has a  part  in  shaping  the  composition of the host microflora. Such variations in  microflora  composition  have  been  linked  to  the  results  of  a  proteome investigation of human intestinal flora employing a 2D gel and spectrometry (Zhang &amp;Figeys, 2019).

## REFERENCES

- 1. Aslam,  B.,  Basit,  M.,  Nisar,  M. A.,  Khurshid,  M.,  &amp;Rasool,  M.  H. (2017).  Proteomics:  technologies  and  their  applications. Journal  of chromatographic science , 55(2), 182-196.
- 2. Banks,  R.  E.,  Dunn,  M.  J.,  Hochstrasser,  D.  F.,  Sanchez,  J.  C., Blackstock, W., Pappin, D. J., &amp; Selby, P. J. (2000). Proteomics: new perspectives,  new  biomedical  opportunities. The Lancet ,  356(9243), 1749-1756.
- 3. BarabÃ¡si,  A.  L.  (2007).  Network  medicine-from  obesity  to  the 'diseasome'. New England Journal of Medicine , 357(4), 404-407.
- 4. Bendixen,  E.,  Danielsen,  M.,  Larsen,  K.,  &amp;Bendixen,  C.  (2010). Advances  in porcine genomics and proteomics-a  toolbox for developing  the  pig  as  a  model  organism  for  molecular  biomedical research. Briefings in functional genomics , 9(3), 208-219.
- 5. Calvo, S. E., &amp;Mootha, V. K. (2010). The mitochondrial proteome and human disease. Annual review of genomics and human genetics , 11(1), 25-44.
- 6. Cash, P. (2000). Proteomics in medical microbiology. Electrophoresis: An International Journal , 21(6), 1187-1201.
- 7. Chambers,  G.,  Lawrie,  L., Cash, P., &amp;  Murray,  G.  I. (2000). Proteomics: a new approach to the study of disease. The Journal of pathology , 192(3), 280-288.
- 8. Channaveerappa,  D.,  Panama,  B.  K.,  &amp;Darie,  C.  C.  (2019).  Mass Spectrometry Based Comparative Proteomics Using One Dimensional and Two Dimensional SDS-PAGE of Rat  Atria Induced with Obstructive Sleep Apnea. In Advancements of Mass Spectrometry in Biomedical Research (Vol. 1, pp. 541-561). Springer, Cham.
- 9. Cuervo,  P.,  Domont,  G.  B.,  &amp;  De  Jesus,  J.  B.  (2010).  Proteomics of trypanosomatids of human medical importance. Journal of Proteomics , 73(5), 845-867.
- 10. Ding,  C.,  Li,  Y .,  Guo,  F.,  Jiang,  Y .,  Ying,  W.,  Li,  D.,  ...  &amp;  He,  F. (2016).  A  cell-type-resolved  liver  proteome. Molecular  &amp;  Cellular Proteomics , 15(10), 3190-3202.
- 11. Goh, K. I., &amp; Choi, I. G. (2012). Exploring the human diseasome: the human disease network. Briefings in functional genomics , 11(6), 533542.

- 12. Hanash, S. (2003). Disease proteomics. Nature , 422(6928), 226-232.
- 13. He, F. (2005). Human liver proteome project. Molecular &amp; Cellular Proteomics , 4(12), 1841-1848.
- 14. He, Q. Y., &amp; Chiu, J. F. (2003). Proteomics in biomarker discovery and drug development. Journal of cellular biochemistry , 89(5), 868-886.
- 15. Hu, S., Loo, J. A., &amp; Wong, D. T. (2006). Human body fluid proteome analysis. Proteomics , 6(23), 6326-6353.
- 16. Hu, S., Yen, Y., Ann, D., &amp; Wong, D. T. (2007). Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery. Drug discovery today , 12(21-22), 911-916.
- 17. Huang, L., Shao, D., Wang, Y., Cui, X., Li, Y., Chen, Q., &amp; Cui, J. (2021). Human  body-fluid proteome: quantitative profiling and computational prediction. Briefings in bioinformatics , 22(1), 315-333.
- 18. HW  Dekkers,  D.,  Bezstarosti,  K.,  Kuster,  D.,  JM  Verhoeven,  A., &amp;  K  Das,  D.  (2010).  Application  of  proteomics  in  cardiovascular research. Current Proteomics , 7(2), 108-115.
- 19. Jain, K. K. (2000). Applications of proteomics in oncology. Pharmacogenomics , 1(4), 385-393.
- 20. Jungblut,  P.  R.,  Zimny Arndt,  U.,  Zeindl Eberhart,  E.,  Stulik,  J., --Koupilova, K., PleiÃner, K. P., ... &amp;StÃ¶ffler, G. (1999). Proteomics in human disease: cancer, heart and infectious diseases. Electrophoresis: An International Journal , 20(10), 2100-2110.
- 21. Klose, J., Nock, C., Herrmann, M., StÃ¼hler, K., Marcus, K., BlÃ¼ggel, M.,  ...  &amp;Lehrach,  H.  (2002).  Genetic  analysis  of  the  mouse  brain proteome. Nature genetics , 30(4), 385-393.
- 22. Kuscuoglu, D., Janciauskiene, S., Hamesch, K., Haybaeck, J., Trautwein, C., &amp;Strnad, P. (2018). Liver-master and servant of serum proteome. Journal of Hepatology , 69(2), 512-524.
- 23. Lee, J. M., Han, J. J., Altwerger, G., &amp; Kohn, E. C. (2011). Proteomics and  biomarkers  in  clinical  trials  for  drug  development. Journal  of proteomics , 74(12), 2632-2641.
- 24. Liotta, L. A., Ferrari, M., &amp;Petricoin, E. (2003). Clinical proteomics: written in blood. Nature , 425(6961), 905-905.
- 25. Long, S., Yang, Y., Shen, C., Wang, Y., Deng, A., Qin, Q., &amp;Qiao, L. (2020). Metaproteomics characterizes human gut microbiome function in colorectal cancer. NPJ biofilms and microbiomes, 6(1), 1-10.

- 26. Macaulay, I. C., Carr, P., Gusnanto,  A., Ouwehand, W. H., Fitzgerald, D., &amp; Watkins, N. A. (2005). Platelet genomics and proteomics in human health  and  disease. The  Journal  of  clinical  investigation ,  115(12), 3370-3377.
- 27. Mao, L., &amp; Franke, J. (2015). Symbiosis, dysbiosis, and rebiosis-The value of metaproteomics in human microbiome monitoring. Proteomics , 15(5-6), 1142-1151.
- 28. Midic, U., Oldfield, C. J., Dunker, A. K., Obradovic, Z., &amp;Uversky, V. N. (2009). Protein disorder in the human diseasome: unfoldomics of human genetic diseases. BMC genomics , 10(1), 1-24.
- 29. Mouradian, S. (2002). Lab-on-a-chip: applications in proteomics. Current opinion in chemical biology , 6(1), 51-56.
- 30. Pedret, A.,  CatalÃ¡n,  U.,  RubiÃ³,  L.,  Baiges,  I.,  Herrero,  P.,  PinÌol,  C., ... &amp; SolÃ , R. (2021). Phosphoproteomic Analysis and Protein-Protein Interaction of Rat Aorta GJA1 and Rat Heart FKBP1A after Secoiridoid Consumption from Virgin Olive Oil: A Functional Proteomic Approach. Journal of Agricultural and Food Chemistry , 69(5), 15361554.
- 31. Petricoin,  E.  F.,  &amp;Liotta,  L.  A.  (2003).  Clinical  applications  of proteomics. The Journal of nutrition , 133(7), 2476S-2484S.
- 32. Petriz,  B.  A.,  &amp;  Franco,  O.  L.  (2017).  Metaproteomics  as  a  complementary approach  to  gut  microbiota  in  health  and  disease. Frontiers  in chemistry , Vol. 5, pp. 1-4.
- 33. Sharma, K., Schmitt, S., Bergner, C. G., Tyanova, S., Kannaiyan, N., Manrique-Hoyos, N., ...  &amp;  Simons,  M.  (2015).  Cell  type-and  brain region-resolved mouse brain proteome. Nature neuroscience , 18(12), 1819-1831.
- 34. Shi, R., Kumar, C., Zougman, A., Zhang, Y., Podtelejnikov, A., Cox, J., ... &amp; Mann, M. (2007). Analysis of the mouse liver proteome using advanced  mass  spectrometry. Journal  of  proteome  research , 6(8), 2963-2972.
- 35. Sung, H. J., Ryang, Y. S., Jang, S. W., Lee, C. W., Han, K. H., &amp;Ko, J.  (2006).  Proteomic  analysis  of  differential  protein  expression  in atherosclerosis. Biomarkers , 11(3), 279-290.
- 36. Verberkmoes, N. C., Russell, A. L., Shah, M., Godzik, A., Rosenquist, M., Halfvarson, J., ... &amp;Jansson, J. K. (2009). Shotgun metaproteomics of the human distal gut microbiota. The ISME journal , 3(2), 179-189.

- 37. Wysocki, K., &amp; Ritter, L. (2011). Diseasome. Annual review of nursing research , 29(1), 55-72.
- 38. Yokota,  H.  (2019).  Applications  of  proteomics  in  pharmaceutical research  and  development. Biochimica  et  Biophysica  Acta  (BBA)Proteins and Proteomics , 1867(1), 17-21.
- 39. Zhang,  X.,  &amp;Figeys,  D.  (2019).  Perspective  and  guidelines  for metaproteomics in microbiome studies. Journal of proteome research , 18(6), 2370-2380.
- 40. Zhang, X., Chen, W., Ning, Z., Mayne, J., Mack, D., Stintzi, A., ... &amp;Figeys, D. (2017). Deep metaproteomics approach for the study of human microbiomes. Analytical chemistry , 89(17), 9407-9415.
- 41. Zhang, X., Li, L., Mayne, J., Ning, Z., Stintzi, A., &amp;Figeys, D. (2018). Assessing  the  impact  of  protein  extraction  methods  for  human  gut metaproteomics. Journal of proteomics , 180(1), 120-127.

<!-- image -->

## DEVELOPMENTS IN PROTEOMICS

## CONTENTS

| 8.1 Introduction  ..................................................................................... 220   |
|---------------------------------------------------------------------------------------------------------------|
| 8.2 Technical Scope of Proteomics  ......................................................... 220              |
| 8.3 Scientific Scope of Proteomics  ......................................................... 222             |
| 8.4 Medical Scope of Proteomics  ........................................................... 224              |
| 8.5 Proteomics, Energy Production, and Bioremediation  ........................ 230                           |
| 8.6 Proteomics and Biodefense  .............................................................. 230             |
| References  ............................................................................................. 232 |

## 8.1 INTRODUCTION

Proteomics began with the launch of protein cleaning processes. Originally, it consisted primarily of purifying a single protein at a moment by column chromatography. Electrofocusing of proteins was a significant advancement in protein purification that resulted in the creation of a two-dimensional (2D) gel. Numerous proteins were purified on a single two-dimensional gel for further characterization. The advent of mass spectrometry, genomics, and bioinformatics ushered in a new era of proteomics. Today, many proteins may be examined concurrently (Faber et al., 2006).

## 8.2 TECHNICAL SCOPE OF PROTEOMICS

Protein extraction by 2D gel and/or high-performance column chromatography (HPLC), and protein recognition by mass spectrometry (MS) in combination with  protein  data  banks  as  well  as  a  variety  of  software  applications,  are currently  adequate  proteomic  approaches.  To  be  more  effective,  these approaches must be enhanced in the near (Molloy et al., 2003).

Figure 8.1. Types-of-proteomics-and-their-applications-to-biology.

<!-- image -->

Source: Correa Rojo A, Heylen D, Aerts J, Thas O, Hooyberghs J, Ertaylan G and Valkenborg D (2021) Towards Building a Quantitative Proteomics Toolbox  in  Precision  Medicine:  A  Mini-Review.  Front.  Physiol.  12:723510.  doi: 10.3389/fphys.2021.723510

As noted by others, many predicted changes in the coming years must have the coming up strategies (Liska&amp; Shevchenko, 2003):

- Â· To enhance a low-abundance protein by preferentially removing high-abundance  proteins.  Today,  immunoprecipitation  is  used to concentrate low-abundance proteins due to the elimination of numerous high-abundance proteins. Several growth hormones and peptides, including cytokines, are also eliminated throughout this procedure due to the nonspecific attachment of such substances to abundant proteins. Low- and high-abundance proteins appear to occur with a 10-order magnitude difference. Modern protein extraction methods distinguish between high and low abundance proteins in the individual plasma proteome by three to four orders of magnitude. Numerous low-abundance molecules that are not yet found were amongst such strategies. This kind of signaling pathway and peptides could be prospective biomarkers; hence, ways  should  be  conducted  in  the  future  to  acquire  or  isolate them without removing them with the blood's abundant proteins (Cheung et al., 2021).
- Â· The lowering of the platform's size.

The small size of the platform is essential to start reducing the protein analysis procedure, which is extremely detailed with a much-limited sample volume. Eventually, it could be feasible to lower the sample group from a  nanoliter  to  a  picoliter,  hence  decreasing  the  quantity  of  protein  from females to automobiles. Miniaturization will need the use of microfluidics to manage minuscule samples with no absorption or evaporating waste. Thus, the protein specimen would be able to be analyzed on a protein chip (Dakna et al., 2009).

- Â· Automation.

Utilizing robots to perform programmed isoelectrofocusing (IEF) and 2D gel unit analysis as well as post-sample processing following the separating proteins, progress has been made to automate the protein analytical method. Automation will also include the removal of protein patches from the gel, their breakdown using trypsin, and the subsequent cleaning and placement of a limited sample on the MALDI-TOF-MS port (Figeys&amp; Pinto, 2001).

- Â· New software applications and quicker computers.

It  is  required  to  develop  new  software  and  faster  computers  to  allow more accurate detection, quantification, and identification of proteins in the gel spot.

Methods  will  be  developed  to  increase  the  sensitivity  of  current instruments to avoid false-positive or false-negative results among MS data. Currently,  up  to  20%  of  MS  data  included  such  false  positives/negatives (Phillips &amp;Bogyo, 2005).

- Â· Heightened sensibility.

As  discussed  in  Chapter  4,  new  software  is  needed  to  improve  the accuracy of separating proteins, measurement, and classification in gel spots (Procko, 2020).

- Â· Artificial intelligence (AI) .

It might be conceivable to create and use AI to discover and describe proteins. Recent advances in artificial intelligence have made it feasible to find several indicators for ovarian cancer (Demkow, 2010).

- Â· The evolution of in-situ mass spectrometry.

Techniques are now being developed to examine the proteins in tissue slices. To use this method, it is feasible to contrast the protein composition of a healthy cell to that of a cell from such a diseased individual. This one will  aid  in  identifying  the  disease's  protein  biomarker(s)  for  diagnostics, therapeutic  discovery ,  or  monitoring  the  efficacy  of  therapy  throughout treatment (Molloy &amp;Witzmann, 2002).

- Â· Analysis of biological pathways via computer.

Most illnesses include metabolic path connections. Novel computational systems will be able to discover the consequences of metabolic interactions, which will aid in the creation of diagnostic and therapeutic agents (Russell &amp; Lilley, 2012).

## 8.3 SCIENTIFIC SCOPE OF PROTEOMICS

Epigenomics encompasses both protein and small-molecule modifications to the genome. Knowing epigenomics is the best way to solve crucial biological problems. This is especially true in terms of diversity and growth. This could describe how the style and substance of countless cell types in multicellular organisms with a similar genome vary. Furthermore, cancer as well as other human illnesses, and aging, are caused by epigenetic alterations. Due to their significance in the nucleosomal arrangement of chromosomes, proteins play a unique role in addressing such concerns (Lindsey et al., 2015).

Figure 8.2. Genes, proteins, and molecular machinery.

<!-- image -->

Source: By ArneLH - Own work, CC BY-SA 3.0, https://commons.wikimedia. org/w/index.php?curid=5815139

Many  genes  are  transcribed whereas  others are masked  by  the nucleosomal arrangement of chromosomes, resulting in the diversification of types of cells and the formation of tissues. Moreover, transcriptionally proteins give an additional aspect to the differentiating of cell types. Shinya Yamanaka  and  his  Japanese  colleagues  (Takahashi  et  al.,  2007)  have transformed ordinary skin cells into pluripotent stem cells by introducing four genes for transcription factors. Shinya Yamanaka and his colleagues then  transformed  such  stem  cells  to  produce  an  assortment  of  tissues. These findings presented an option for acquiring human embryonic stem cells , that makes a significant contribution to the controversy involving the utilization of embryonic stem cells by some U.S. organizations. It is evident from  this  research  that  several  types  of  transcription  factors  occur.  Such a team of Japanese authors brought transcription parameters into skin cells that correspond to the category of master transcription parameters (Liska&amp; Shevchenko, 2003). This or other research demonstrates conclusively the relevance  of  proteomics  in  explaining  epigenesis.  Epigenesis  is  gaining importance from both a scientific and an applied standpoint: Based on a knowledge  of  the  epigenetic  modifications  of  genes,  several  diagnostics have been created. In the near, it is anticipated as proteomics may give hints for the diversification of cell types from stem cells and their usage in various forms of treatments for various human illnesses. Thus, it is anticipated that proteomics will soon give a comprehensive knowledge of the difficulties of diversification throughout human evolution, as well as its involvement in the generation and utilization of stem cells (Tsiamis et al., 2019).

## 8.4 MEDICAL SCOPE OF PROTEOMICS

The proteomic industry has brought researchers a better understanding of the  expression  of  proteins,  such  as  their  many  alterations,  connections, and  functions  in  metabolic  processes.  It  is  intended  to  give  light  on  the reasons for many illnesses, as well as how to diagnose, treat, and cure them. This chapter goes through some of these components (Xu et al., 2020).

Figure 8.3. An overview of how proteomics methods are used in One Health.

<!-- image -->

Source: Katsarou EI, Billinis C, Galamatis D, Fthenakis GC, Tsangaris GT, Katsafadou AI. Applied Proteomics in 'One Health'. Proteomes. 2021; 9(3):31. https://doi.org/10.3390/proteomes9030031

## 8.4.1 Human Diseases

Proteomics has significant potential for the prevention and therapy of cancer, cardiovascular,  neurodegenerative,  metabolic,  and  viral  illnesses,  among others. Proteomics has enabled the development of a panel of biomarkers for cancer diagnosis. The majority of such screens contain numerous proteins, often exceeding 25 proteins. In the years ahead, this might be feasible to select  fewer  proteins  as  important  biomarkers.  Utilizing  AI  technology and enhanced software tools, it would be feasible to identify the important indicators (Risch &amp;Merikangas, 1996). It'd be feasible to diagnose cancer at an earlier, benign phase, making therapy far more bearable. It might be conceivable  to  discover  biomarkers  that  differentiate  between  aggressive

and slowly developing cancer. Amongst some of the proteins for sending and receiving messages, protein complexes, regulators of metabolic paths, and switches, a few such indicators would've been discovered. Similarly, markers  for  the  early  identification  of  cardiovascular,  neurological,  and metabolic  illnesses  will  be  developed  and  utilized  to  diagnose  and  treat illness.  Proteomic  research  is  predicted  to  improve  the  early  diagnosis of  infectious  illnesses,  much  as  parasite  proteomics  is  improving  the identification of malaria (MatÃ©s et al., 1999).

Figure 8.4. Schematic displaying the prevalent NCDs in the body.

<!-- image -->

Source: Budreviciute A, Damiati S, Sabir DK, Onder K, Schuller-Goetzburg P, Plakys G, Katileviciute A, Khoja S and Kodzius R (2020) Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors. Front. Public Health 8:574111. doi: 10.3389/fpubh.2020.574111

Studying the proteome of the host following an assault by a bacteria should  offer  insight  into  the  treatment  of  antibiotic-resistant  bacteria (Malech &amp;Gallin, 1987). Knowing the genomes and proteomics of viruses might  give  insight  into  how  to  cure  or  avoid  viral  infections  like  severe acute respiratory syndrome (SARS) and the common cold. The genomes of over 97 cold viruses have enabled the identification of a common area in the whole of them, which would be attacked by a medicine in the near to give more effective treatment for the cold virus (Wilson et al., 2007).

## 8.4.2 Development of Drugs

The capacity to create better medications for various infections is the goal of proteomics. Proteomics is thought to be a safer test to treat, cure, and analyze the performance of pharmacological therapy. It is envisaged that biomarkers discovered via proteomic studies of healthy and sick individuals would be used to develop improved diagnoses and smarter medications in the area of proteomics. Smart medications will be developed by comparing the proteomes of healthy cells and cells from a sick individual and identifying protein biomarkers, their alteration, and changed metabolic pathways (Sena et al., 2007). A new drug is a costly endeavor. Proteomics is predicted to lower costs by expanding the range of protein targets employed in medication development. With the use of modern bioinformatics tools, understanding metabolic processes and protein connections would be exploited to aid in the cost-effective production of medications. The combination of potential compounds as medications with protein targets would be accessible quickly and cost-effectively in  the  future  using  high  throughput  screening  (HTS) technologies. The utilization of combinatorial chemistry and the chemical collection accessible on the web will help this method (Steverding, 2010).

Figure 8.5. Drug Discovery Steps.

<!-- image -->

Source: Hinkson IV, Madej B and Stahlberg EA (2020) Accelerating Therapeu -tics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery. Front. Pharmacol. 11:770. doi: 10.3389/fphar.2020.00770

Proteomics would also assist in the identification of novel proteins that can be used as pharmaceuticals. The research of Mark Tuszynski and his colleagues  at  the  University  of  California,  San  Diego,  suggests  this  idea (Winters &amp;Arria, 2011). The researchers discovered that injecting a brainderived neurotrophic factor (BDNF) into mice, rhesus monkeys, and other model animals may alleviate signs of Alzheimer's disease-like memory loss, brain  cell  degeneration,  and  cognitive  impairment. The  BDNF  protein  is normally synthesized in the brain of healthy animals, although it is absent from the cortex of diseased animals. Proteomics is predicted to aid in the creation of vaccinations in the years ahead, other than a medicine production (Kim et al., 2013).

## 8.4.3 Personalized Medicine

The  goal  is  that  proteomics  will  create  customized  medicine  a  standard component of clinical practice as well as care delivery.  With the advancements in genomes and proteomics, it is conceivable to build diagnostic algorithms that predict the optimal person for a medicine prescription. It appears that a minimum of 200 recommended medications are ineffective or have negative consequences for a given patient (Jain, 2002). In this kind of instance, the patient possesses a gene mutation that renders a specific medicine ineffective. The antiretroviral medication abacavir, for instance, is ineffective in 20% of individuals who possess a mutation in the HLA gene. That a screening test is sufficient to assess the HLA variation in a population, abacavir may be prescribed to just those individuals who do not have HLA mutation and would advantage from its usage. Similarly, not all individuals may be benefited from warfarin, an anticoagulant utilized to help patients with thrombosis and other blood diseases (Mura &amp;Couvreur, 2012). To prevent internal bleeding in this kind of individual, the warfarin dosage should be modified. A diagnostic test for warfarin is developed, but the U.S. Food and Drug Administration has not yet authorized it (FDA). It is recognized that some cancer patients never  recover  from  tamoxifen  since  they  contain  a  mutation  in  the  2D6 gene which generates enzymes that transforms tamoxifen into endoxifen, a  chemical having cancer-fighting properties. Such breast cancer patients must take aromatase inhibitors, a different family of medications. However, aromatase inhibitors have a restricted use since they are only effective in postmenopausal  women.  This  provides  the  lady  with  breast  cancer  who still hasn't reached menopause with a variety of unusual treatment options.

Such patients need the development of new medications (Chan &amp; Ginsburg, 2011). Similarly, it has been said that some colon cancer patients with the KRAS mutation never recover from the prescription of Vectibix (Amgen, Inc., Thousand Oaks, CA). Currently, Vectibix is exclusively administered to  individuals without the KRAS mutation. In the years ahead, it will be commonplace to run personalized genomics on a person or to need a specific diagnostic test before prescribing a medicine (Ginsburg &amp; Willard, 2009). The administration of tailored medication will need the construction of an electronic repository for an individual's whole health information and drug reactions depending on many diagnostics, subgroups of illness, and genetics. Related to the creation of diagnostic tests for using pharmaceuticals and the expenditure on producing these diagnostics, the technique of personalized medicine presents several medical ethical concerns. It also includes issues about  the  prescription  of  specific  treatment  regimens  by  doctors  (Joyner &amp;Paneth, 2015).

## 8.4.4 Proteomics and Metabolomics

The research of metabolites is known as metabolic. Metabolites are chemicals produced by the enzymatic activity of proteins along any metabolic route (Titz et al., 2014). It is recognized as genes make enzymes so these enzymes accelerate  a  biochemical  to  form  metabolites,  that  define  an  organism's phenotype.  Consequently,  genomes,  proteomics,  and  metabolomics  are interconnected. Indicators of illness conditions and metabolites contribute to the development of diagnoses for common diseases (Horgan&amp; Kenny, 2011). The existence of sarcosine in urine samples has been identified as a sign of an aggressive type of prostate cancer. One type of human prostate cancer is often slow-growing, whilst the other is typically fast-growing. The species with rapid growth is invasive. Therefore, the identification of sarcosine in urine samples may be utilized to diagnose the aggressive type of prostate cancer at a preliminary phase, allowing for appropriate treatment (Yizhak et al., 2010). The detection of sarcosine in urine may be used to determine the proteome alterations in people with cancer. The existence of sarcosine implies a deficiency in the enzyme which transforms glycine to sarcosine or alterations in the protein(s) which catalyze sarcosine breakdown. Research from the University of California, Los Angeles demonstrates further impacts of molecules and metabolites on proteomics (UCLA) (Kovac et al., 2013).

Figure 8.6 . Integrated-proteomic-and-metabolomic-analysis 4-h and 24-h postIRI-A Metabolites.

<!-- image -->

Source: Huang, Hong lei &amp; Dullemen, Leon &amp; Akhtar, M Zeeshan &amp; Lo Faro, Maria Letizia &amp; Yu, Zhanru &amp; Valli, Alessandro &amp; Dona, Anthony &amp; ThÃ©zÃ©nas, Marie-LaÃ«titia &amp; Charles, Philip &amp; Fischer, Roman &amp; Kaisar, Maria &amp; Leuvenink, Henri &amp; Ploeg, Rutger &amp; Kessler, Benedikt. (2018). Proteo-metabolomics reveals compensation between ischemic and non-injured contralateral kidneys after reperfusion. Scientific Reports. 8. 10.1038/s41598-018-26804-8.

The  UCLA  researchers  have  demonstrated  that  green  tea  affects  the proteins associated with cell movement by altering the proteome of lung cells. These researchers conclude that polyphenols in green tea extract alter the proteome of lung tissue and are accountable for suppressing cancer cell spread  and  proliferation  (Lindenburg  et  al.,  2015).  Similarly,  it  has  been demonstrated  that  teenage  alcohol  intake  produces  proteome  alterations in the hippocampal area of the brain. Such research gives the biochemical foundation  for  complementary  and  alternative  medicine,  as  well  as  the connections between metabolomics, proteomics, and human health (Lange et al., 2008).

The  metabolomics  method  for  disease  detection  is  straightforward, noninvasive, and far less costly than genomic and proteomic approaches. By

analyzing the metabolic processes both in healthy and diseased cells, Israeli researchers have built computer systems that monitor multiple metabolites. A repository of metabolites has become accessible as a database. The study of metabolomics would identify a significant portion of proteomics (Zhao &amp; Lin, 2014).

## 8.5 PROTEOMICS, ENERGY PRODUCTION, AND BIOREMEDIATION

All types of energy on Earth are fundamentally bioenergy, and that is solar energy  captured  via  biological  processes.  Consequently,  biology,  like engineering  and  chemistry,  is  essential  for  solving  our  energy  concerns. Presently,  research  is  solely  engaged  in  the  generation  of  biofuels,  the filtration  of  water,  as  well  as  other  microbial  community-based  environmental issues (Zhao &amp;Poh, 2008). Future developments in synthetic genomes and proteomics are anticipated to address our power generation, bioremediation of the ecosystem, carbon sequestration, as well as other issues related. The goal of synthetic genomics is to generate new microorganisms with carefully designed  genomes  that  are  suited  for  energy  generation  and  ecological bioremediation. The age of synthetic proteomics will shortly be inaugurated by the proteomics of such new fully species (Wilkins et al., 2009).

## 8.6 PROTEOMICS AND BIODEFENSE

The rising problem of bioterrorism and the ongoing development of new contagious  diseases  have  prompted  a  significant  resurgence  in  scientific research  attempts  to  expand  better  treatments,  diagnostics,  and  vaccines, and to boost the basic knowledge of the host's immune system to bacterial infections.  The  accessibility  of  numerous  mass  spectrometry  systems,  in conjunction  with  multivariate  extraction  techniques  and  microbiological genetic databases, offers a unique opportunity to build these vital resources (Drake et al., 2005). Presents a summary of existing proteomic methodologies used on bacteria and viruses regarded as potential causes of bioterrorism. In addition, the use of immunoproteomics in the creation of novel vaccine targets has been reviewed. These effective research methods may provide a huge number of possible novel protein targets; nevertheless, the translation of  these  proteomic  findings  into  practical  anti-bioterrorism  therapies  will need extensive collaborative research across several fundamental scientific and clinical fields. Utilizing the influenza virus as an instance, a paradigm

for  translational  proteomic  research  is  presented  to  illustrate  this  method (Demirev &amp;Fenselau, 2008).

Now since the world trade center attacks on September 11, 2001, the concept of biodefense became an actuality. It is anticipated that numerous diagnostics and vaccinations against a variety of microorganisms will be produced due in great part to the Departments of Defense and Homeland Security's grasp of proteomics (Whitesides &amp;Stroock, 2001).

## REFERENCES

- 1. Chan, I. S., &amp; Ginsburg, G. S. (2011). Personalized medicine: progress and promise. Annual review of genomics and human genetics , 12, 217244.
- 2. Cheung,  T.  K.,  Lee,  C.  Y .,  Bayer,  F.  P.,  McCoy,  A.,  Kuster,  B.,  &amp; Rose, C. M. (2021). Defining the carrier proteome limit for single-cell proteomics. Nature methods , 18(1), 76-83.
- 3. Dakna,  M.,  He,  Z.,  Y u,  W.  C.,  Mischak,  H.,  &amp;Kolch,  W.  (2009).  Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry  (LC-MS)  and  capillary  electrophoresis-mass  spectrometry (CE-MS) based clinical proteomics: A critical assessment. Journal of Chromatography B , 877(13), 1250-1258.
- 4. Demirev, P. A., &amp;Fenselau, C. (2008). Mass spectrometry in biodefense. Journal of mass spectrometry , 43(11), 1441-1457.
- 5. Demkow, U. (2010). Laboratory medicine in the scope of proteomics and genomics. EJIFCC , 21(3), pp. 56.
- 6. Drake, R. R., Deng, Y., Schwegler, E. E., &amp;Gravenstein, S. (2005). Proteomics for biodefense applications: progress and opportunities. Expert Review of Proteomics , 2(2), 203-213.
- 7. Faber, M. J.,  Agnetti, G., Bezstarosti, K., Lankhuizen, I. M., Dalinghaus, M., Guarnieri, C., ... &amp;Lamers, J. M. (2006). Recent developments in proteomics. Cell biochemistry and biophysics , 44(1), 11-29.
- 8. Figeys,  D.,  &amp;  Pinto,  D.  (2001).  Proteomics  on  a  chip:  promising developments. Electrophoresis , 22(2), 208-216.
- 9. Ginsburg, G. S., &amp; Willard, H. F. (2009). Genomic and personalized medicine: foundations and applications. Translational research ,  154(6), 277-287.
- 10. Horgan, R. P., &amp; Kenny, L. C. (2011). 'Omic'technologies: genomics, transcriptomics, proteomics and metabolomics. The  Obstetrician &amp;Gynaecologist , 13(3), 189-195.
- 11. Jain, K. K. (2002). Personalized medicine. Current opinion in molecular therapeutics , 4(6), 548-558.
- 12. Joyner, M. J., &amp;Paneth, N. (2015). Seven questions for personalized medicine. JAMA , 314(10), 999-1000.
- 13. Kim, J. H., O'Brien, K. M., Sharma, R., Boshoff, H. I., Rehren, G., Chakraborty, S., ... &amp;Schnappinger, D. (2013). A genetic strategy to

identify  targets  for  the  development  of  drugs  that  prevent  bacterial persistence. Proceedings of the National Academy of Sciences , 110(47), 19095-19100.

- 14. Kovac,  J.  R.,  Pastuszak, A.  W.,  &amp;  Lamb,  D.  J.  (2013).  The  use  of genomics, proteomics, and metabolomics in identifying biomarkers of male infertility. Fertility and sterility , 99(4), 998-1007.
- 15. Lange, E., Tautenhahn, R., Neumann, S., &amp;GrÃ¶pl, C. (2008). Critical assessment  of  alignment  procedures  for  LC-MS  proteomics  and metabolomics measurements. BMC Bioinformatics , 9(1), 1-19.
- 16. Lindenburg, P. W., Haselberg, R., Rozing, G., &amp;Ramautar, R. (2015). Developments  in  interfacing  designs  for  CE-MS:  towards  enabling tools for proteomics and metabolomics. Chromatographia , 78(5), 367377.
- 17. Lindsey,  M.  L.,  Mayr,  M.,  Gomes, A.  V.,  Delles,  C., Arrell,  D.  K., Murphy, A. M., ... &amp; Srinivas, P. R. (2015). Transformative impact of proteomics on cardiovascular health and disease: a scientific statement from the American Heart Association. Circulation , 132(9), 852-872.
- 18. Liska,  A.  J.,  &amp;  Shevchenko,  A.  (2003).  Expanding  the  organismal scope  of  proteomics:  cross -species  protein  identification  by  mass spectrometry and its implications. Proteomics , 3(1), 19-28.
- 19. Malech, H. L., &amp;Gallin, J. I. (1987). Neutrophils in human diseases. New England Journal of Medicine , 317(11), 687-694.
- 20. MatÃ©s, J. M., PÃ©rez-GÃ³mez, C., &amp; De Castro, I. N. (1999). Antioxidant enzymes and human diseases. Clinical biochemistry , 32(8), 595-603.
- 21. Molloy, M. P., &amp;Witzmann, F. A. (2002). Proteomics: technologies and applications. Briefings in Functional Genomics , 1(1), 23-39.
- 22. Molloy,  M.  P.,  Brzezinski,  E.  E.,  Hang,  J., McDowell,  M.  T., &amp;VanBogelen,  R.  A.  (2003).  Overcoming  technical  variation  and biological  variation  in  quantitative  proteomics. Proteomics , 3(10), 1912-1919.
- 23. Mura,  S.,  &amp;Couvreur,  P.  (2012).  Nanotheranostics  for  personalized medicine. Advanced drug delivery reviews, 64(13), 1394-1416.
- 24. Phillips, C. I., &amp;Bogyo, M. (2005). Proteomics meets microbiology: technical  advances in the global mapping of protein expression and function. Cellular microbiology , 7(8), 1061-1076.

- 25. Procko,  E.  (2020).  Deep  mutagenesis  in  the  study  of  COVID-19:  a technical  overview  for  the  proteomics  community. Expert  review  of proteomics , 17(9), 633-638.
- 26. Risch, N., &amp;Merikangas, K. (1996). The future of genetic studies of complex human diseases. Science , 273(5281), 1516-1517.
- 27. Russell, M. R., &amp; Lilley, K. S. (2012). Pipeline to assess the greatest source of technical variance in quantitative proteomics using metabolic labelling. Journal of proteomics , 77, 441-454.
- 28. Sena, E., van der Worp, H. B., Howells, D., &amp; Macleod, M. (2007). How  can  we  improve  the  pre-clinical  development  of  drugs  for stroke?. Trends in neurosciences , 30(9), 433-439.
- 29. Steverding,  D.  (2010).  The  development  of  drugs  for  treatment  of sleeping sickness: a historical review. Parasites &amp; vectors , 3(1), 1-9.
- 30. Takahashi,  D.,  Li,  B.,  Nakayama,  T.,  Kawamura,  Y.,  &amp;Uemura, M.  (2013).  Plant  plasma  membrane  proteomics  for  improving  cold tolerance. Frontiers in plant science , 4(1), pp. 90.
- 31. Titz,  B.,  Elamin,  A.,  Martin,  F.,  Schneider,  T.,  Dijon,  S.,  Ivanov, N. V., ... &amp;Peitsch, M. C. (2014). Proteomics for systems toxicology. Computational and Structural Biotechnology Journal , 11(18), 73-90.
- 32. Tsiamis, V., Ienasescu, H. I., Gabrielaitis, D., Palmblad, M., SchwÃ¤mmle, V., &amp;Ison, J. (2019). One thousand and one software for proteomics: tales of the toolmakers of science. Journal of proteome research , 18(10), 3580-3585.
- 33. Whitesides,  G.  M.,  &amp;Stroock,  A.  D.  (2001).  Flexible  methods  for microfluidics . Phys. Today , 54(6), 42-48.
- 34. Wilkins, M. J., VerBerkmoes, N. C., Williams, K. H., Callister, S. J., Mouser, P. J., Elifantz, H., ... &amp;Banfield, J. F. (2009). Proteogenomic monitoring of Geobacter physiology during stimulated uranium bioremediation. Applied  and  environmental  microbiology , 75(20), 6591-6599.
- 35. Wilson,  A. S., Power, B. E., &amp;  Molloy, P. L. (2007). DNA hypomethylation and human diseases. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer , 1775(1), 138-162.
- 36. Winters, K. C., &amp;Arria, A. (2011). Adolescent brain development and drugs. The prevention researcher , 18(2), pp. 21.

- 37. Xu, Y., Li, X., Man, D., &amp; Su, X. (2020). iTRAQ-based proteomics analysis  on  insomnia  rats  treated  with  Mongolian  medical  warm acupuncture. Bioscience reports , 40(5), pp. 1-6.
- 38. Yizhak, K., Benyamini, T., Liebermeister, W., Ruppin, E., &amp;Shlomi, T. (2010). Integrating quantitative proteomics and metabolomics with a  genome-scale  metabolic  network  model. Bioinformatics , 26(12), i255-i260.
- 39. Zhao, B., &amp;Poh, C. L. (2008). Insights into environmental bioremediation by microorganisms through functional genomics and proteomics. Proteomics , 8(4), 874-881.
- 40. Zhao,  Y.  Y., &amp;  Lin,  R.  C.  (2014).  UPLC-MSE  application  in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chemico-biological interactions , 215, 7-16.

## INDEX

## A

| acrylamide  90                                        |                                        |
|-------------------------------------------------------|----------------------------------------|
| actin  4                                              |                                        |
| Activation Domain (AD)  171                           |                                        |
| affinity  chromatography    133,  134,  140, 142, 144 |                                        |
| agriculture  6                                        |                                        |
|                                                       | amino acid  6, 9, 13, 15, 27, 32, 33,  |
| 34, 35, 37, 39, 50, 53                                |                                        |
| amniotic fluid  203                                   |                                        |
| Aneuploidy  61                                        |                                        |
| an implanted pH gradient (IPG)  91                    |                                        |
| arginine  149, 167                                    |                                        |
| beta-galactosidase gene  173                          |                                        |
| Artificial intelligence (AI)  222                     |                                        |
| automation  88                                        | automation  88                         |
| B                                                     | B                                      |
| bacterial cells  68                                   | bacterial cells  68                    |
| bacteria organisms  66                                | bacteria organisms  66                 |
| beta-galactosidase  171, 172, 173                     | beta-galactosidase  171, 172, 173      |
| binding domain (BD)  171, 172                         |                                        |
| biochemistry    151,  164,  165,  167,                | biochemistry    151,  164,  165,  167, |

| Bioinformatics  60, 85 bisacrylamide  90                                                            | brain proteome  202, 205, 215, 216   |
|-----------------------------------------------------------------------------------------------------|--------------------------------------|
| C cell division  61                                                                                 |                                      |
| cardiovascular disease  201 cellular metabolism  201 cerebrospinal fluid  203 chimeric protein  173 |                                      |
| chromatogram  135 Chromatography    91,  93,  94,  120,                                             |                                      |
| 121, 122, 123, 124, 125, 126,                                                                       |                                      |
| 127                                                                                                 |                                      |
| chromosomes  61, 65, 69, 71, 72, 73                                                                 |                                      |
| Coimmunoprecipitation  175                                                                          |                                      |
| combinatorial chemistry  226                                                                        |                                      |
| complexosomes  170                                                                                  |                                      |
| computational biology  60                                                                           |                                      |
| cytokines  221                                                                                      |                                      |
| plexes (DALPC)  142                                                                                 |                                      |
| direct analysis of large protein com-                                                               |                                      |
| cytosine  62                                                                                        |                                      |
| Dephosphorylation  150                                                                              |                                      |
| D                                                                                                   |                                      |

| diversification  223                                                          |
|-------------------------------------------------------------------------------|
| Down syndrome  61                                                             |
| electrical charges  88, 94                                                    |
| Electrophoresis    88,  89,  121,  123,                                       |
| 125                                                                           |
| electrostatic forces  88 embryonic stem cells  223                            |
| etiology  2 eukaryotes  2, 17, 20, 26, 27, 41 eukaryotic organisms  2, 19, 20 |
| Epigenesis  223 ethical,  legal,  and  social  implica-                       |
| tions (ELSI)  65                                                              |
| fer (FRET)  176                                                               |
| eukaryotic  phosphorylate  tyrosine  149                                      |
| fibronectin  4                                                                |
| fluorescence resonance energy trans -                                         |
| G                                                                             |
| 56, 57                                                                        |
| genome sequencing  68, 71, 74, 77 glycosylation    149,  153,  154,  155,     |
| 157, 161, 164, 165, 167                                                       |
| guanine  62                                                                   |
| gel filtration chromatography  138 genome  2, 7, 14, 18, 26, 29, 46, 52,      |
| Gradient elution  135                                                         |

## H

| Heightened sensibility  222 hemoglobin protein  200         | Heightened sensibility  222 hemoglobin protein  200   |
|-------------------------------------------------------------|-------------------------------------------------------|
| higher  performance  liquid  chroma-                        |                                                       |
| high  throughput  screening  (HTS)                          |                                                       |
| human growth hormone (HGH)  4                               |                                                       |
| immobilized metal affinity chroma - tography (IMAC)  133    |                                                       |
| immunoglobulin  149                                         |                                                       |
| immunoprecipitation  221                                    |                                                       |
| insulin  149                                                |                                                       |
| Interactome analysis  170 Ion-exchange chromatography  134, |                                                       |
| 144 isoelectrofocusing (IEF)  89                            |                                                       |
| 151                                                         |                                                       |
| isotope-coded  affinity  tag  (ICAT)                        |                                                       |
| label transfer  176                                         |                                                       |
| malaria  225                                                |                                                       |
| mass spectrometry analysis  88                              |                                                       |
| 98,  99,  103,  115,  119,  120,                            |                                                       |
| 121, 122, 124, 125, 126                                     |                                                       |
| mass spectrometry  88, 91, 95,  96,                         |                                                       |
| Medical proteomics  202                                     |                                                       |

| messenger RNAs (mRNA)  148                                                                |
|-------------------------------------------------------------------------------------------|
| metabolic interactions  222 microfluidics  221, 234                                       |
| molecular  biology    170,  184,  186,  189, 192, 193                                     |
| Multidimensional  chromatography  139                                                     |
| multidimensional strategy  88 N                                                           |
| nasopharyngeal aspirate  203 neurological disorders  201 Novel computational systems  222 |
| O                                                                                         |
| organism  2, 7, 11, 12, 14, 22, 27, 32                                                    |
| P paper chromatography  130 pharmaceuticals  2                                            |
| pharmacological therapy  226 phosphoprotein isotope-coded affin - ity tag (PhIAT)  151    |
| Phosphoproteomics  151, 165, 167,  168 phosphorylated isomers  150                        |
| Phosphorylation  149, 150, 153 plasma  203, 208                                           |
| Polyacrylamide  gel  electrophoresis  (PAGE)  90                                          |
| polymerase chain reaction (PCR)  68 posttranslational  protein  alteration                |
| protease system  149                                                                      |
| protein composition  89, 109                                                              |

| Protein kinases  150 Protein pulldown  176 protein pulldown assay  175 Proteomics  2, 3, 5, 7, 49, 52, 53, 56,   |
|------------------------------------------------------------------------------------------------------------------|
| Reversed-phase  (RP)  chromatogra- phy  135                                                                      |
| ribosomal RNA (rRNA)  61                                                                                         |
| S salivary gland secretion  203                                                                                  |
| Sepharose  138                                                                                                   |
| serum proteome  202, 215                                                                                         |
| severe  acute  respiratory  syndrome                                                                             |
| (SARS)  225 Size  exclusion  chromatography                                                                      |
| 138, 143                                                                                                         |
| sodium dodecyl sulfate (SDS)  91                                                                                 |
| solar energy  230                                                                                                |
| solid substrate  88, 89 stem cells  223                                                                          |
| systems biology  170, 193, 194                                                                                   |
| T                                                                                                                |
| tandem  affinity  purification  (TAP)                                                                            |
| 176 therapeutic discovery  222 Thin-layer chromatography  130 threonine  149, 154, 155                           |
| thymine  62, 72                                                                                                  |
| Transcription activator (TA)  171                                                                                |
| thyroxin medicine  201                                                                                           |
| transcription factor  171, 172, 173                                                                              |
| transmission of RNA (tRNA)  61                                                                                   |

tyrosine  149, 162, 165

U

ubiquitin  149, 158, 160, 161, 164, 165, 166, 168 ubiquitination    149,  158,  160,  161, 166 urine  203, 209, 212

Y

YAC  (yeast  artificial  chromosome) 68 yeast  171, 172, 173, 174, 176, 180, 182, 183, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198 yeast two-hybrid (Y2H) technology 172

Z

Zellweger syndrome  201

## Introduction to Proteomics

With the previous decade, technological revolution culminated in the sequencing of the human genome and the beginning ofthe postgenomic era. In the early 1990s, Marc Williams and his colleagues created the phrases proteomics and proteome, which have subsequently been used by the research community at large. The proteome is the collection of all proteins encoded by the genome. Historically; biochemical investigations of protein function have concentrated on analy single molecular species. The fast identification of novel gene products through large-scale genomic and proteomic programs has forced the development of alternate methods for assessing protein activity. In recent years, the has been to create high-throughput methods to permit systematic protein analysis in biological samples, to map functional connections between proteins on global scale, and to position them in biological context. This book introduces the emerging topic of proteomics. It aims to describe how proteins and proteomes may be researched and assessed. In spite of the increased interest in proteomics, the scientific community as a whole is only slowly gaining knowledge of proteomics methods and technology. This book tackles the need to introduce biologists to new tools and anyone who has attended a graduate-level biochemistry course with a reasonable knowledge of what proteomics is and how it is conducted. Much of this should be recognizable to the seasoned biologist; but refocused to assist proteome research. Long-sought benchmarks in genome sequencing, analytical apparatus, computing power; and user-friendly software tools have fundamentally altered the profession of biology. After years of researching the separate components of biological systems; it is now possible to examine the systems as a whole in molecular detail . We must thus efficiently deploy new technology; cope with mounds of data; and, most importantly; adapt our thinking to comprehend complex systems as opposed to their component parts. The book is divided into eight chapters. The first chapter introduces the readers to the fundamentals of Proteomics . Chapter 2 deals with the discussion of proteomics with respect to genome and genomics. Chapter 3 thoroughly discusses the methodology for the separation and identification of proteins and their interactions. Chapter 4 introduces the readers to information on chromatography and its application in protein studies. Chapter 5 focuses on proteomics of protein modifications. Chapter 6 illustrates the phenomena of proteomics in protein-protein interactions. Chapter describes the modern applications of proteomics in various fields. Finally; chapter 8 focuses on the recent developments in the field of proteomics and protein studies The book provides an excellent overview of the many facets of the proteome. The text succeeds in presenting the information in a manner that familiarizes the inexperienced reader with the important concepts and tools of proteomic\_ 'zing goal

Introduction to Proteomics is equally beneficial for students of physics and other multidisciplinary fields.

<!-- image -->

Prof. Sudhir K. Awasthi did his M.Sc in Life Sciences securing first position in CSJM University; Kanpur. Thereafter he completed his PhD in the same discipline from CSJM University, Kanpur and joined the faculty of Life Sciences as Asstt. Professor in 1991.He became Professor in 2008 &amp; presently working as Pro-Vice Chancellor &amp; Dean , Faculty Life Sciences in this university . He is also holding the post of Director , Deendayal Shodh Kendra of the University campus from past one year he is also occupying the post of Co-ordinator; Recruitment &amp; Assessment Cell (RAC) responsible for the recruitment &amp; assessment of university faculty members. Prof: Awasthi has more than 30 years of teaching &amp; research experience His area of research has been Immuno-toxicology &amp; Environmental Biochemistry: He has been widely recognized as one of those few researchers who did excellent work in the field of Mycobacterial Dormancy &amp; the role of Heat Shock Proteins Chaperons in its granuloma state. He published more than 40 research papers &amp; completed two research projects funded by DST &amp; UPCST respec tively. He is Principle Investigator of Centre of Excellence Project for Department of Life Sciences funded by UP Council of Higher Education. He is reckoned as prolific orator &amp; popular article writer in different domains of knowledge related to higher education. He has been successful in advocating the importance of traditional Indian Knowledge System which is being reexplored in present context. He has participated in several conferences as Lead Speaker &amp; Chaired the session in numerous seminars &amp; symposia. has

<!-- image -->

<!-- image -->